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Abstract 
 
 
Mutations in the insulin/IGF-1 signalling (IIS) pathway lead to large lifespan 
extensions in the nematode Caenorhabiditis elegans. The role of IIS in ageing is 
evolutionarily conserved and requires the forkhead trancription factor DAF-16.  
In this thesis, I have attempted a novel strategy to identify genes involved in 
differential gene expression downstream of IIS in C. elegans. Using microarray data, 
I found that the H-ferritin gene ftn-1 is strongly regulated by IIS in a daf-16 –
dependent manner. Ferritins act as intracellular iron-storage proteins. I then induced 
expression of a fluorescent GFP reporter of ftn-1 by introducing a mutation in daf-2. 
I subsequently screened a library of RNAi clones targeting transcription factors in 
order to identify mediators of IIS-dependent gene regulation. Candidate RNAi 
treatments were subsequently tested for their effects on expression of endogenous 
ftn-1 and on ageing. None of the genes identified had as important a role in either ftn-
1 expression or lifespan as daf-16, but several weaker determinants, like mdl-1, were 
identified.  
During the course of my screen, I found that loss of the hypoxia inducible 
factor hif-1 and its binding partner aha-1 leads to a large increase in expression from 
the ftn-1 GFP reporter, indicating that HIF-1 may act as a repressor of ftn-1 
expression. Both HIF-1 protein levels and ftn-1 transcription are known to be 
responsive to iron levels. I found that regulation of the ftn-1 reporter by iron requires 
hif-1 and that repression of ftn-1 reporter expression occurs via a 63bp iron 
dependent element. An unexpected role of the upstream prolyl hydroxylase EGL-9 
was also identified.  
I also contributed to a project aimed at identifying the consequences of over-
expression of superoxide dismutases (SOD) on C. elegans ageing. Our efforts 
revealed that SOD over-expression extends lifespan by affecting signalling, not by 
reducing oxidative damage.  
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Chapter 1: Introduction 
 
1.1. Ageing 
 
We are all familiar with the effects of ageing, having experienced them 
ourselves or witnessed them in friends or family members. There is no tissue or 
biological system that does not suffer the effects of old age through deterioration of 
function and efficiency. Older people experience a number of detrimental changes, 
including a loss of force and elasticity in their skeletal muscles, lower glomeral 
filtration in their kidneys and lower pulmonary ventilation. They also often suffer 
from deterioration of their senses, including losses in vision and hearing, as well as 
loss of memory and motor coordination and a decreased capacity to maintain 
homeostasis of many systems. Problems with their immune system lead to both 
increases in autoimmune disease and a decreased ability to combat infections (Vina 
et al., 2007).  
And yet, despite being an inevitable component of our lives, the truth is that 
we are fundamentally ignorant of the causes of ageing. Maybe because of its 
ubiquity, ageing is often seen as a natural consequence of the passage of time, but it 
is clear that a biological process affecting cells or tissues must underlie the many 
biological manifestations of ageing. Whatever its nature, this process must be a risk 
factor for the many diseases that increase in incidence with age. The risk of 
succumbing to cancer, for example, increases so dramatically that DePinho (2000) 
pointed out that “advancing age is the most potent of all carcinogens”.  
Because it can describe maturation as well as senescence, use of the word 
“ageing” can lead to confusion. A wine can improve as it ages, for example, and 
certain traits found in the elderly, such as wisdom, experience and maturity, are 
positive, not negative ones. In this thesis, I will use the term only to describe its 
deleterious effects. I will avoid using the term ‘senescence’ in order to avoid 
confusion with the process of cellular senescence. 
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1.1.1. Searching for a cause of ageing 
 
To those not working in the field of ageing, the purpose of studying this 
particular problem is often unclear. Why does ageing remain such a mystery to 
biologists, when others just consider it a fact of life? For many, the ageing of 
organisms is comparable to that of any other objects in daily life: Old computers 
slow down and malfunction, cars rust and fabrics start to tear. Why should human 
beings be any different?   
In fact, some aspects of biological ageing are very similar to everyday wear 
and tear. Examples include teeth that wear out after time and the exoskeletons and 
wings of insects, which can break. However, the ultimate cause of ageing is less clear 
for other biological features because there is clear evidence that different rates of 
ageing (estimated using maximum lifespans) are possible in very similar, and 
similarly sized, organisms (bats and mice are good examples (Austad and Fischer, 
1991)). This strongly suggests that the ageing process is not an unalterable one.  
One may even ask why we age at all. The fact that the passage of time and 
the number of cell divisions carried out does not in itself require a loss of function is 
clear, since the entire history of life on earth can be seen as an uninterrupted line of 
germ cell divisions. Even though no organism was created from scratch, every 
generation’s young are born as healthy as the last. Our existence after so many 
million years of evolution therefore itself argues against the inevitability of 
degeneration with time. An unfathomable number of cell divisions occurred in the 
lineage of every human before birth to produce a healthy child, so why are the 
comparatively small number that transpire since birth and in such a short period of 
time sufficient to cause ageing? 
Much work has gone into understanding ageing and the questions posed in 
the above paragraphs are partly addressed by work on the evolution of ageing. The 
evolutionary theory of ageing has provided possible explanations for why different 
rates of ageing would evolve, but this has been reviewed elsewhere and will not be 
discussed here (Rauser et al., 2006). What evolutionary theories cannot address are 
the ultimate causes of ageing, ie. what is it about old organisms that is making them 
more likely to succumb to disease, to lose mobility, etc. Attempts to answer this have 
been numerous.  
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1.1.2. Theories of ageing 
 
So what causes ageing? A natural starting point is the observation that 
inanimate objects deteriorate with time, and more fundamentally, that in any system, 
disorder, or entropy, tends to increase. That ageing of organisms may also occur 
through simple wear and tear is a reasonable hypothesis to begin with. At what level 
this damage is occurring and what exactly is being damaged is the subject of 
numerous theories. Many propose that it is the accumulation of molecular damage 
that causes ageing and the most popular one states that free radicals, through their 
attack of macromolecules in the cell, are the cause of ‘wear and tear’ at the molecular 
level (Weinert and Timiras, 2003). Others propose that ageing occurs at the cellular 
or the organismal level (Jeyapalan et al., 2007). Too many theories of ageing have 
been proposed to discuss comprehensively, so I will present a few key ideas.  
 
1.1.2.1. Molecular damage 
 
Molecular damage to components of the cell, such as proteins, lipids and 
DNA is thought to accumulate during the course of the organism’s life and lead to 
progressive deterioration of function. An example for a reaction that can cause 
damage to proteins is glycation. This is involves a condensation reaction between 
sugars (such as glucose) and free amino acid groups in proteins. This results in 
advanced glycation end products (AGE) (Chang et al., 1985) which may be 
deleterious to the cell and particularly to extracellular structures, like the collagen in 
cartilage.  
Another, more frequently cited source of damage to molecules is oxidation by 
reactive oxygen species (ROS). ROS are produced as by-products of a number of 
biological processes, most notably mitochondrial respiration. The fact that damage 
caused by oxidation increases with age is well supported (see Chapter 6) and the 
oxidative stress theory of ageing predicts that this accumulation is a major cause of 
ageing (Harman, 1956). See Chapter 6 for a more detailed review of oxidative stress 
and ageing.  
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1.1.2.2. Somatic mutation theory 
 
One source of damage that could be causing ageing are mutations to DNA 
within somatic cells. Mutations can occur spontaneously, for example via reactions 
with reactive oxygen species (ROS). As mutations accumulate throughout life, it is 
possible that increasing numbers of faulty proteins get translated with advancing age, 
which may lead to deterioration of cellular function.  
Higher levels of DNA damage have been detected in old animals (see 
Chapter 6), though whether or not the accumulation of mutations during the course 
of an organism’s life can cause sufficient damage to explain ageing remains to be 
seen. In one study, mice were serially cloned for six generations using somatic 
nuclear transfer and their rate of ageing was not affected, indicating that, at least in 
mice, the rate of somatic mutation is not sufficient to have major effects on ageing 
(Wakayama et al., 2000).  
 
1.1.2.3. Error catastrophe theory 
 
The error catastrophe theory of ageing is based on the knowledge that the rate 
of mis-incorporation of amino acids during translation is quite high (compared to, for 
example, the rate of error during transcription) and that large numbers of aberrant 
proteins are therefore constantly being produced (Rattan, 2006). Because the 
translational machinery is itself made of proteins, the production of faulty copies of 
parts of this machinery may cause an even greater rate of amino acid mis-
incorporation. This theory predicts that through positive feedback, this mis-
incorporation will eventually cause an ‘error catastrophe’ with large increases in the 
production of aberrant proteins and that this catastrophe is the cause of ageing. Initial 
experiments on amino-acid mis-incorporation during translation were ambiguous 
(Holliday, 1996) and at least in C. elegans, 2D gel analysis was not able to detect 
evidence of an ‘error catastrophe’ in old animals (Vanfleteren and De Vreese, 1994). 
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1.1.2.4. Gene regulation theory 
 
The gene regulation theory of ageing predicts that ageing is caused by 
changes in gene expression with time. A gradual loss of fine-tuning of gene 
regulatory pathways would presumably lead to a dysregulation of gene expression, 
which could have deleterious effects. Some studies have tested the effects of ageing 
on gene expression using microarrays in model organisms and found remarkably 
little variation in gene expression in some tissues of ageing mice (Weindruch et al., 
2001, 2002). Microarray studies in worms identified changes in the transcriptome 
that occur during ageing and which are regulated by a small set of GATA 
transcription factors. The authors hypothesised that this network of GATA factors 
has evolved to regulate gene expression during development but may become 
unbalanced in old animals, thereby effecting the changes in gene expression 
observed with age (Budovskaya et al., 2008). This drift in gene expression does have 
an effect on C. elegans lifespan, but whether it is a minor modulatory factor in 
ageing or a major cause of it is still unclear.  
 
1.1.2.5. Cellular senescence theory 
 
The finding that most cells have a limit to the number of cell divisions they 
can undergo in culture (Hayflick, 1965) before they enter a state of replicative 
senescence led to the theory that this intrinsic limit also limits organismal lifespan. 
Cells are restricted in the number of cell divisions they can go through by a 
progressive shortening of the chromosome ends, the telomeres. Immortal cells, such 
as stem cells and germline cells, achieve their immortality at least partly through the 
expression of telomerase, which extends telomere ends (Cech, 2004). 
The presence of senescent cells in old tissues may affect neighbouring cells 
through the creation of a hazardous environment (Krtolica and Campisi, 2002). The 
cause for this effect on neighbouring cells is unknown, although senescent cells have 
been found to have increased expression of pro-inflammatory cytokines (Maier et al., 
1990), which has been suggested as a possible mechanism (Weinert and Timiras, 
2003), and also secrete enzymes that degrade the extracellular matrix. Although 
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some studies have found a correlation between the ability of cells derived from a 
tissue to replicate in vitro and age of the donor, some doubt has recently been cast on 
the relevance of the in vitro Hayflick limit to cellular senescence in vivo (Rubin, 
2002). However, studies on baboons have demonstrated that a large percentage of 
skin cells from old animals are senescent (possibly more than 15%), which could 
have profound physiological effects (Herbig et al., 2006). No such effect was found 
in muscle, a post-mitotic tissue, so the degree to which senescent cells may 
contribute to ageing may vary in different tissues and different organisms (Jeyapalan 
et al., 2007).  
 
1.1.2.6. Theories of systemic ageing 
 
While most of the theories described above assume an intracellular cause of 
ageing, the complexity of multicellular organisms suggests that causes of ageing 
could also be found at the systemic (organismal) level.   
Possible examples are human neural and endocrine systems, which are crucial 
for the body’s ability to programme responses to environmental stimuli and to 
maintain an optimal functioning state. The passage of time, and possibly chronic 
exposure to stress, may weaken the body’s capacity to respond to certain cues and 
may thereby cause dyshomeostasis. Ageing has also long been known to affect the 
immune system: older people experience a decreased resistance to infectious 
diseases, less protection against cancer and a decreased ability of the immune system 
to recognise the body’s own cells. Some immune functions remain well preserved in 
old age, whereas others rapidly lose efficacy. The thymus, for example, reaches its 
largest size during puberty and then atrophies (Weinert and Timiras, 2003).  
 
 
The existence of a great number of theories of ageing and the conspicuous 
dearth of good evidence that either clearly supports or contradicts them indicates that 
the causes underlying this phenomenon are not very well understood. This is not too 
suprising given how difficult it is to study ageing directly, especially in long lived 
organisms. Data on ageing therefore often consists of observations, not rigorous 
experiments in which a theory is put a decisive test using controlled experiments. 
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Early work on the oxidative stress theory of ageing is a good example for this and the 
question of how to best test theories of ageing is addressed in to Chapter 6. The 
complexity of the ageing process and the long time periods required for the effects of 
ageing to manifest themselves do make it clear that this biological process cannot be 
studied effectively in long-lived organisms, especially not in humans. It is in this 
context that the use of short-lived model organisms such as C. elegans became an 
attractive alternative. 
 
1.2. C. elegans as a genetic model organism 
 
In the wild, nematode Caenorhabditis species, including C. elegans, are often 
found in compost, rotting fruit and in the soil (Barriere and Felix, 2005). C. elegans 
are bacteriovores and are commonly fed the E. coli strain OP50 in the lab (Brenner 
1974), although other bacterial strains can also be used. Lab cultures can be 
maintained on agar plates or in liquid culture. The worm’s short generation time 
(approximately 3 days at 20oC), it small size (approximately 1.2mm) and ability to 
grow at high densities in Petri dishes allow it to be cultured with the ease of micro-
organisms such as E. coli or S. cerevisiae. Worms can also be frozen at -70oC for 
long-term storage, which is not only convenient, but also allows for the integrity of 
strains to be preserved, since an aliquot of an original stock can always be thawed to 
remove any mutations that may have accumulated during subculture in the lab. The 
short lifespan of C. elegans (mean of 18-20 days at 20oC) has led to it being 
extensively used in ageing research, an application that will be discussed throughout 
this thesis.  
 
1.2.1. Anatomy 
 
The adult hermaphrodite C. elegans contains only 959 somatic cells and has a 
simple anatomy. The outside boundary of the worm is called the cuticle, which is 
made up of collagens and is secreted by the hypodermal cells that lie just underneath. 
The cuticle is tough but flexible, protects the animal and acts as a type of external 
skeleton to which muscles are attached. C. elegans muscles used for movement are 
striated, whereas the pharyngeal muscles that pump food into the intestine and the 
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muscles controlling intestinal contraction and defecation are non-striated. Food is 
taken in through the mouth, crushed and pumped into the intestine by the pharynx 
(Wormatlas.org (accessed Aug 2010)).  The worm’s nervous system consists of 302 
neurons and their connectivity has been extensively investigated by electron 
microscopy (White et al., 1986). The intestine is a relatively large tissue that runs 
from the pharynx to the anus at the tail of the worm.  
 
 
 
Figure 1 
from Wormatlas.org (accessed Aug 2010) 
A. Differential interference contrast (DIC) image of an adult hermaphrodite. Scale 
bar 0.1 mm.  
B. Schematic drawing of C. elegans anatomy. See Figure 2 for cross sections at the 
levels 2B, 2C, 2D, 2E and 2F.  
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Figure 2 
from Wormatlas.org (accessed Aug 2010). A. cross-section at level 2A in Figure 1; 
B. cross-section at level 2B in Figure 1; C. cross-section at level 2C in Figure 1; D. 
cross-section at level 2D in Figure 1; E. cross-section at level 2E in Figure 1; F. 
cross-section at level 2F in Figure 1 
 
1.2.2. Life cycle 
 
After hatching and under favourable conditions, C. elegans goes through four 
larval stages (named L1, L2, L3 and L4), each separated by a moult in which the 
collagen cuticle is shed and replaced (see Figure 3). Development from egg to 
reproductive adult takes approximately three days but varies with temperature. 
Unfavourable conditions, such as high temperature, low food availability or high 
population density lead worms to develop into an alternative third stage, known as 
the dauer larva. Under these conditions, L1s moult into an alternative L2 stage called 
L2d and then develop into dauers unless conditions improve. Dauer larvae are 
specialised in long-term survival and were named from the German verb meaning “to 
endure”. They have thick protective cuticles, large lipid stores, are non-feeding, have 
an occluded mouth to protect against entry of toxic substances, and are highly 
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resistant to stress (Cassada and Russell, 1975). The length of time worms remain in 
the dauer state does not affect their post-dauer lifespan (Klass and Hirsh, 1976), 
possibly because advancing into the adult stage allows them to rejuvenate 
(Houthoofd et al., 2002).  
 
 
 
Figure 3 
Life cycle of C. elegans at 22oC.  
From Wormatlas.org (accessed Aug 2010). Development times indicated in blue next 
to arrows. Size of worms indicated in gray.  
 
The entire cell lineage of C. elegans has been determined, making it a 
powerful organism to study development (Sulston and Horvitz 1976). This is aided 
by the fact that worms are transparents and epi-fluorescence microscopy can 
therefore be used to track individual cells expressing fluorescent proteins.  
 
1.2.3. GFP reporters 
 
The transparency of C. elegans allows the study of gene regulation through 
the expression of fluorescent reporter genes introduced via transgenesis. In most 
cases, a construct is made in which regulatory sequences are fused to the sequence of 
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GFP (green fluorescent protein), although other fluorescent proteins can be used. 
This construct is then micro-injected into worms, which creates a multi-copy 
extrachromosomal array expressing GFP from the regulatory elements included in 
the construct. This technique is in widespread use and projects aimed at producing a 
GFP reporter for every gene in the genome are underway (Dupuy et al., 2007; Dupuy 
et al., 2004). 
Because most regulatory elements in the compact C. elegans genome are 
thought to occur within several kilobases of the start codon (Boulin et al., 2006), 
between 500bp and 2kb of upstream sequences fused to GFP are ofen sufficient to 
investigates a genes’ transcriptional regulation. Constructs in which GFP expression 
is driven only by upstream sequences are called transcriptional reporters.  The 
limitations of these constructs must be kept in mind, since GFP reporters can only re-
iterate the expression of endogenous genes if all important regulatory elements are 
present. Many regulatory elements are often found within introns, especially large 
introns, and microRNAs can regulate expression via a gene’s 3' UTR (un-translated 
region). A gene’s coding and intronic sequences (and with a few additional cloning 
steps, the 3' UTR) can also be included in the reporter construct to try to mimic 
endogenous expression more closely. These reporters are called translational 
reporters. If the gene’s coding sequence is fused to GFP, then this leads to the 
expression of a GENE::GFP chimeric protein, which is often functional and can 
therefore be used for rescue experiments and to investigate the effects of over-
expression. GFP fusion proteins can also be useful in ascertaining a protein’s sub-
cellular localisation.  
 
 
1.2.4. C. elegans: a genetic model organism 
 
C. elegans has two sexes, which are determined by the presence or absence of 
a second copy of the X chromosomes: XX animals are hermaphrodites and XO 
animals are male. Hermaphrodites are self-fertilising but cannot cross-fertilise with 
other hermaphrodites. They produce both sperm and eggs, but are protandrous, 
meaning that their male function precedes the female function, so sperm produced 
during development becomes limiting during reproduction (Hodgkin and Barnes, 
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1991). Males are usually a rare occurrence, with a frequency of about 0.1% in 
progeny from a self-fertilised hermaphrodite. After mating, the progeny is 50% male, 
since half will not inherit an X chromosome from their fathers. Males are shorter and 
thinner than hermaphrodites and are easy to recognise through their characteristic tail 
structures.  
The hermaphrodites’ ability to self-fertilise makes growing isogenic 
populations very easy, which makes C. elegans particularly useful for carrying out 
genetic screens. When needed, males can be used to cross mutant strains with each 
other in order to create ones carrying multiple mutations, an important requirement 
for epistasis analysis.  
This has made C. elegans a very important genetic model organism through 
the use of forward genetic screens. Mutations in the genome can be generated using, 
for example, X-ray irradiation or exposure to ethyl methane sulfonate (EMS). This 
allows for the investigation of the genes responsible for any biological trait. After 
mutagenesis, usually by EMS, animals with defects are identified and the mutations 
that cause the defects are mapped to a genomic locus. For example, genes 
responsible for egg laying could be identified by screening for mutants incapable of 
ejecting their eggs. After mapping, the genomic loci identified can be cloned, 
sequenced and their gene product can therefore be identified, which would then be 
known to play some role in egg laying. If several genes are known to affect the same 
phenotype, then epistasis analysis can be used to organise these genes into pathways. 
This approach has been used extensively and a very large number of mutants are now 
available through a central stock centre (Caenorhabditis Genetics Center).  
  The genome sequence of C. elegans was published in 1998 (C. elegans 
genome sequencing consortium, 1998) and has since been steadily improved. The 
genome is 102Mb long and currently thought to contain approximately 20300 
protein-coding genes, or approximately 24600 if one includes alternative splice 
variants, although these figures are constantly being revised (wormbase.org, 2010).  
While C. elegans was initially used primarily as a model organism for 
forward genetics, the availability of its genomic sequence has provided other 
opportunities.  Possible functions of previously unexamined genes can be identified 
by sequence homology and the role of these genes can then be examined using 
deletion mutants. Extensive efforts are currently underway to obtain deletion mutants 
for all C. elegans genes by the C. elegans Knockout Consortium (US-Canadian 
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collaboration; celeganskoconsortium.omrf.org) and the National Bioresources 
Project (in Tokyo, Japan; www.shigen.nig.ac.jp/c.elegans). RNA interference is also 
being extensively used for studying the function of ‘candidate’ genes. Using the 
genome sequence, large libraries of RNAi clones were created, which target most C. 
elegans genes. The mechanisms and use of RNAi will be discussed in more detail 
later in this chapter. Large-scale RNAi screens, even full genome screens, have now 
mostly replaced forward EMS screens. However, recent advances in C. elegans 
whole genome sequencing, which allow for much faster pinpointing of mutations, 
may lead to a resurgence of classical forward genetics (Hobert, 2010).  
 
1.2.5. Nomenclature 
 
As in any field of research, the worm research community has adopted an 
exact nomenclature, which will be adhered to in this thesis. Genes are given names 
consisting of three to four letters, a hyphen, and an Arabic number and are always 
written in italicized lower-case letters. The proteins these genes code for have the 
same name, but are written in capital non-italicized letters. For example, the gene 
egl-9 codes for the EGL-9 protein. The three or four letter abbreviation can refer to 
the phenotype observed in mutants of the gene. For example, egl-9 mutants were 
identified because they are “EGg-Laying abnormal”. In other cases, the name is 
derived from the protein product of the wild-type gene, such as aak-2 for a subunit of 
the AMP-Activated protein Kinase. Phenotypes are described by three letter codes as 
well, but only the first letter is capitalised, so egl-9 mutant animals can be described 
as appearing “Egl”.  
Unique names are given to alleles using a letter code, which refers to the lab 
they were generated at, followed by a number. If the Gems lab (allele code wu) 
produced a novel mutation that affects the egl-9 gene, then the genotype of these 
worms would be written with the allele number (eg. wu4321) in brackets next to the 
gene name: egl-9(wu4321). Transgenes are also given names based on the lab 
designation, but the letters “Ex” are added if the transgene is present as an 
extrachromosomal array, “Is” if it is integrated in the genome, and “Si” if it was 
inserted using the MosSci homologous recombination method. A number is added to 
create a unique allele name and the contents of the transgene can be written in square 
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brackets following the allele name. For example, an extrachromosomal array made 
by micro-injections of an egl-9::gfp reporter construct in the Gems lab would create 
the wuEx987[egl-9::gfp] transgene. If crossed into the egl-9(wu4321) genetic 
background, the genotype of the resulting strain would be written as wuEx987[egl-
9::gfp] egl-9(wu4321). 
Because of the extensive use of mutants in various genes in C. elegans 
research, a shorthand for refer to them is to simply state the gene name to refer to 
animals in which this gene is mutated. Thus, in this thesis, I will often use statements 
such as “daf-2 animals were found to be long-lived” instead of specifically saying 
“animals with a mutation in the gene daf-2 were found to be long lived”. I will only 
do this when the specific allele being used has already been mentioned earlier in the 
text.  
1.2.6. The use RNA interference (RNAi)  
 
As described earlier, the first genetic studies of C. elegans employed forward 
genetic screens. Ever since the C. elegans genome was sequenced, and the 
phenomenon of RNAi was discovered (Fire et al., 1998), researchers have been able 
to knockdown transcript levels of any given gene, a much quicker approach to 
examine the phenotypic consequences of gene inactivation and to study gene 
function.  
 
1.2.6.1. The RNAi mechanism 
 
RNAi refers to the phenomenon where cells exposed to dsRNA respond by 
silencing genes with identical sequences. The bulk of this effect is achieved by a 
post-transcriptional mechanism in which the dsRNA is cleaved into small interfering 
RNAs (siRNA) by the enzyme Dicer. These siRNAs, once bound to an RNA-
induced silencing complex (RISC), can base-pair to cognate mRNAs in the cell. An 
enzyme within RISC then cleaves the bound mRNA (see Figure 4), thus initiating its 
degradation (briefly reviewed in Montgomery, 2006).  Although RNAi is mostly 
thought of as a post-transcriptional mechanism, some transcriptional effects of RNAi 
have also been identified (Grishok et al., 2000; Vastenhouw et al., 2006). The 
mechanism is thought to exist as a defence against threats such as retroviruses and 
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other invasive genetic elements (Ketting et al., 1999; Mourrain et al., 2000). After its 
discovery, researchers began to take advantage of this innate mechanism in order to 
specifically knock down expression of the worm’s own genes. This is done by 
introducing dsRNA copies of parts of the gene’s sequence, thereby triggering an 
RNAi response that degrades mRNA copies of the gene. RNAi quickly became a 
widespread method for quick and easy analysis of gene function in C. elegans and 
other systems.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There are several methods to expose worms to the dsRNA that triggers RNAi. 
Initially, researchers injected the dsRNA into adult worms (Fire et al., 1998), but it 
was later found that soaking them in solutions of dsRNA has the same effect (Tabara 
et al., 1998). Even more usefully, C. elegans can be fed a strain of E. coli that has 
been specifically engineered to produce large amounts of dsRNA and this too leads 
to the knockdown of the gene in question (Timmons and Fire, 1998). A sequence 
specific to the gene in question is cloned into the L4440 vector and transformed into 
the E. coli strain (HT115), engineered to be RNase deficient. Effective RNAi 
mediated knockdown of gene expression has also been achieved through expression 
of dsRNA via transgenesis in worms (Tavernarakis et al., 2000). 
 
 
Figure 4 
A schematic of the RNAi 
mechanism. RISC stands for 
RNA-induced silencing complex  
(nobelprize.org, accessed July 
2010) 
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1.2.6.2. Differences between RNAi and genetic loss of function 
alleles 
 
One of the major differences between loss of gene function via RNAi or 
genomic mutations is that the effects of RNAi can be more variable and usually 
resemble hypomorphic rather than null alleles. Some genes are more difficult to 
target, such as those coding for proteins with long half-lives, as sufficient protein 
may still be present despite efficient knockdown of transcript copies (Kamath and 
Ahringer, 2003). In addition, the effectiveness of RNAi differs for different tissues, 
with neurons being particularly refractory to the effects of RNAi (Timmons et al., 
2001) although this problem can be partially overcome through the use of an rrf-3 
mutant background (and a few others), which enhances the effects of RNAi (Sijen et 
al., 2001).  
When using RNAi, the possibility of cross-reactivity with other genes should 
also be considered. Because gene silencing is sequence-specific, other genes with 
sequence similarity to the target gene may be silenced along with the targeted gene. 
How much similarity between genes is required for cross-reactivity to occur is 
uncertain. A general rule of thumb is to avoid more than 80% nucleotide identity 
over 200bp of recognition sequence (Fraser et al., 2000), although one recent study 
found that off-target effects occur when mRNA sequences contain 95% identity over 
as little as 40bp (Rual et al., 2007). It is therefore important to confirm RNAi 
phenotypes, preferably by comparing them to the phenotypes caused by deletion 
mutants.  
 
1.2.6.3. The use of RNAi for large scale screens 
 
RNAi is typically used as a quick alternative to screening for deletion 
mutants in reverse genetics experiments. While screening for a deletion mutant of a 
sequence of interest is very time-consuming, an RNAi culture for any given sequence 
can be created much more quickly. This has allowed the creation of RNAi libraries 
that contain RNAi clones targeting a large proportion of the C. elegans genome 
(Kamath and Ahringer, 2003; Rual et al., 2004), which greatly facilitates carrying out 
large scale RNAi screens.    
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Full genome screens have therefore been carried out to identify new players 
in a number of different processes. This approach is similar to the one used in 
classical forward genetic screens, except that instead of using a mutagen to identify 
new alleles exhibiting the coveted phenotype, worms are exposed to RNAi against a 
large number of genes to identify ones with the desired effect. Examples for large 
scale RNAi screens are numerous and range from those looking for genes required 
for the first two rounds of cell division (Sonnichsen et al., 2005) to screens aimed at 
understanding the regulation of ageing. One set of screens attempted to search for 
novel regulators of ageing by looking for RNAi clones that extend lifespan 
(Hamilton et al., 2005; Hansen et al., 2005). Another one  aimed at identifying genes 
involved in mediating the extended lifespan of daf-2 mutant animals by looking for 
clones that decreased the extended lifespan of daf-2 (Samuelson et al., 2007).  
The method of knocking down gene expression by RNAi has penetrated 
every area of C. elegans research. While the sequencing effort has revealed a large 
number of genes, the function of most has not been characterised. Large-scale RNAi 
screens are helping the C. elegans research community bridge this gap by identifying 
novel functions for many of these genes and hopefully contributing greatly to our 
understanding of biology.  
 
 
1.3. Ferritin 
 
In this section, I will briefly introduce the function of the iron storage protein 
ferritin and its regulation. This introduction is required because most of my work 
during the course of this PhD has been centred on understanding how a C. elegans 
ferritin gene, ftn-1, is transcriptionally regulated. My focus on this gene in particular 
will be explained in later chapters, but is based on the finding that ftn-1 is very 
strongly regulated by insulin/IGF-1 signalling (IIS) in a daf-16 -dependent manner. I 
have therefore used a reporter strain that expresses GFP from the promoter of ftn-1 as 
a readout for IIS signalling.  
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1.3.1. Introduction to vertebrate ferritin and ferritin regulation 
 
Very few studies have investigated the role of ferritins in C. elegans. Most of 
our knowledge on the function of this protein is derived from studies carried out in 
vertebrate cell lines. Before discussing ferritin in C. elegans, I will therefore briefly 
introduce functional studies of ferritin in vertebrates.  
1.3.1.1. Ferritin and iron homeostasis 
 
In vertebrates, the cytosolic form of ferritin consists of 24 subunits of either 
H or L (heavy- or light-chain) ferritin, which together form the 450kDa apoferritin 
molecule that can store up to 4500 atoms of iron in its hollow shell. The ratio of H to 
L ferritin is highly variable and differs from tissue to tissue as well as under different 
conditions (Torti and Torti, 2002). H ferritin contains a ferroxidase centre, which has 
the capacity to convert Fe(II) to Fe(III) when the iron atom enters the complex’s core 
(Lawson et al., 1989). This ferroxidase centre is highly evolutionarily conserved.  
Iron availability is required for a number of different cellular processes due to 
its crucial role in many enzymes. Processes that require iron include the cell cycle, 
electron transport, the production of deoxyribonucleotides, cellular detoxification 
(Hentze et al., 2004) and many others. On the organismal level, the iron in heme is of 
critical importance in the transport of oxygen. However, high levels of free 
intracellular iron is harmful to the cell, particularly due to iron’s role in the Fenton 
reaction, which generates hydroxyl radicals from hydrogen peroxide: 
 
Fe (II) + H2O2  Fe (III) + OH  + OH. 
 
The maintenance of iron homeostasis is therefore of great importance in the cell and 
ferritin, with its ability to store free iron, is capable of reducing free iron levels and 
thereby controlling the cell’s pool of labile iron (Picard et al., 1998; Torti and Torti, 
2002). 
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1.3.1.2. Post-transcriptional regulation in response to iron 
 
In vertebrates, the requirement for tight regulation of labile iron levels is met 
with a well-defined mechanism for post-transcriptional regulation of several proteins 
involved in iron homeostasis. Two proteins with opposite roles, ferritin, which stores 
free iron, and the transferrin receptor, which imports iron from outside the cell, will 
be used here to illustrate this mechanism, which also affects translation of other 
players in the maintenance of iron homeostasis. When cellular iron levels are low, 
ferritin levels also need to be kept low, as more ferritin would take up the little 
remaining free iron. At the same time, levels of the transferrin receptor need to be 
increased in order to import more iron into the cell. Low iron levels would therefore 
be expected to lead to increased expression of the transferrin receptor and decreased 
levels of ferritin, which in fact has been observed ((Torti and Torti, 2002).  
The regulation of these two proteins in response to iron is achieved post-
transcriptionally by the actions of iron regulatory proteins (IRPs), which bind to iron 
responsive elements (IREs) in the mRNAs of the two genes in vertebrates. Both IRPs 
(IRP1 and IRP2) are active only when iron levels are low. IRP1 is only capable of 
binding IREs when it has assumed an open configuration, which it does when it loses 
the iron atoms in its iron-sulfur cluster. The IRP2 protein is degraded in conditions of 
iron excess. Binding of IRPs to IREs has opposite effects on the mRNAs of ferritin 
and the transferrin receptor. IRPs bind to IREs on the 3' UTR of the transferrin 
receptor mRNA and enhance the mRNA’s stability, leading to increased levels of the 
receptor being translated. The ferritin mRNA contains an IRE in its 5' UTR and here, 
binding of the IRP prevents translation. When iron levels are low, high levels of IRP 
therefore inhibit ferritin translation, but enhance transferrin receptor translation (see 
Figure 5 and (Torti and Torti, 2002). 
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Figure 5  
The post-transcriptional regulation of iron-responsive genes by IRPs. from (Torti and 
Torti, 2002) 
 
In the case of ferritin, high iron levels lead to loss of binding of IRPs to the IREs in 
the 5' UTR and subsequent recruitment of the ferritin transcript from monosomes to 
polysomes (Rogers and Munro, 1987). 
 
1.3.1.3. Transcriptional regulation of ferritin 
 
In contrast to the post-transcriptional regulation of ferritins described above, 
the study of the transcriptional regulation of ferritins is much more recent and 
therefore a lot less well defined. It seems that ferritin transcripts are regulated in 
response to a number of different cues (Macdonald et al., 1994) and seems to be 
responsive to stress, which supports the view of ferritins as cytoprotective proteins. 
H ferritin regulation in response to stressors probably occurs through the binding of 
two stress-responsive transcription factors to an electrophile response element 
(EpRE) upstream of its coding sequence (Pietsch et al., 2003; Tsuji, 2005). The core 
sequence of the EpRE, thought to be involved in the regulation of many antioxidant 
genes, is 5'-TGAnnnnGC-3' (Zhang and Forman, 2010). Other regulatory responses 
are less well understood, such as the links between ferritin transcription and hypoxia 
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as well as that with cancer. In the case of cancer, it seems that both cMyc (Wu et al., 
1999), which regulates cellular growth and proliferation, and the adenoviral 
oncogene E1A (Tsuji et al., 1993), repress ferritin expression. It is thought that iron 
may be a limiting factor in cellular proliferation due to its role in the synthesis of 
deoxynucleotides, which could explain why genes that induce proliferation would do 
so partly by increasing iron availability by decreasing ferritin levels. This section will 
briefly review the literature on the subject of transcriptional regulation of vertebrate 
ferritins.  
 
1.3.1.3a Transcriptional effects through the EpRE 
 
H and L ferritin is strongly transcriptionally up-regulated in response to a 
number of different oxidants and pro-oxidant xenobiotics in both humans and mice 
(Bosio et al., 2002; Pietsch et al., 2003; Tsuji, 2005; Tsuji et al., 2000). This 
induction by at least some stressors has been shown to be mediated by the two 
transcription factors JunD and Nrf2 through an EpRE present upstream of the human 
and mouse H-ferritin genes (Pietsch et al., 2003; Tsuji, 2005). The control of ferritin 
expression by this EpRE was initially discovered in mouse cells while searching for 
the mechanism by which mouse ferritin H is downregulated when cells are 
transformed with the adenovirus E1A oncogene (Tsuji et al., 1993). A 75bp region 
4.1kb upstream of the ferritin H gene was found to be mediating the repression by 
E1A (Tsuji et al., 1995) and this region was found to contain an EpRE.  
Nrf2 binds to the EpRE and is considered to be a mediator of the 
transcriptional activation of phase II detoxification enzymes in response to a number 
of different stressors (Itoh et al., 1997; Nguyen et al., 2000; Venugopal and Jaiswal, 
1996, 1998). Nrf2 knockout mice develop normally (Chan et al., 1996), but seem to 
be sensitive to environmental stress (Rangasamy et al., 2004; Rangasamy et al., 
2005) and have decreased ferritin H expression (Thimmulappa et al., 2002). 
Activation of Nrf2 by a number of different inducers occurs by the dissociation of 
Nrf2 from the cytosolic actin-binding protein Keap1 and the subsequent nuclear 
translocation of Nrf2 (Itoh et al., 1999; Zipper and Mulcahy, 2002).  
JunD has been shown to bind the EpRE upstream of the human H ferritin 
gene and is also thought to be involved in mediating a cytoprotective response 
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(Gerald et al., 2004). The JunD protein is phosphorylated in response to H2O2 and t-
BHQ treatment (Tsuji, 2005) and this phosphorylation may recruit the transcriptional 
co-activators p300/CBP and thus transcriptionally activate ferritin H through the 
EpRE (Tsuji et al., 1999). The role of both Nrf2, a transcription factor known to 
regulate phase II detoxification enzymes, and JunD, which may be involved in 
protection against ROS (Gerald et al., 2004), in the regulation of ferritin H supports 
the view that ferritin may be regulated in response to environmental stressors and 
may have a cytoprotective role in the cell. The transcriptional regulation of ferritin is 
summarised in Figure 6. 
 
 
 
Figure 6  
This figure depicts a number of different transcription factors thought to regulate H-
ferritin in mice and humans. ARE refers to the “anti-oxidant response element”, also 
termed the “electrophile response element” EpRE (Mackenzie et al., 2008). 
 
 
The EpRE seems to also be the target of transcriptional repression human 
ferritin H expression by the transcription factor ATF1. The mechanisms for this 
repression are unclear, though it is possible that this occurs by preventing the binding 
of PIAS3, a potential activator of ferritin H (Iwasaki et al., 2007). The regulation of 
human L ferritin has been less well characterised, but it seems that the gene is 
induced by tBHQ, sulforaphane (an electrophilic isothiocyonate), hemin, and high 
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levels of iron through the EpRE sequence present 1.35kb upstream of the gene 
(Hintze and Theil, 2005).   
1.3.1.3b Post-transcriptional effects 
 
Oxidative stress can act on ferritin levels through its effect on IRPs. 
Reversible oxidation of IRP1 at cysteine residues can reduce binding to IREs as was 
shown in rat liver lysates exposed to H2O2 and O2- (Cairo et al., 1996). However, the 
opposite effect was seen in murine fibroblasts, in which exposure to H2O2 led to the 
activation of IRP, leading to reduced ferritin translation (Pantopoulos and Hentze, 
1998).  
 It is possible that exposure to oxidative stress may lead to increased ferritin 
levels by releasing iron from iron-containing proteins. This could lead to iron-
dependent increases in ferritin levels by both the post-transcriptional and 
transcriptional route. Increases in cellular labile iron levels would lead to decreased 
levels of IRP and increased ferritin translation and have also been shown to lead to 
the transcriptional induction of ferritin mRNA levels (White and Munro, 1988).  
Multiple studies have also demonstrated that ferritin levels increase after 
exposure to a hypoxic environment (Cheepsunthorn et al., 2001; Chi et al., 2000; Qi 
and Dawson, 1994; Qi et al., 1995). There is evidence for both transcriptional and 
post-transcriptional regulation. In neonatal rat oligodendrocytes and human 
oligodendrogliomas, ferritin levels were induced by hypoxia, but H ferritin mRNA 
levels were unaffected (Qi and Dawson, 1994; Qi et al., 1995). A rat model for 
hypoxia also showed induction of ferritin levels, with an increase in both protein and 
mRNA levels. (Chi et al., 2000) 
At least part of the response to hypoxia is mediated by altered binding of 
IRPs to IREs.  In rat hepatoma cells, IRP1 binding activity decreased under hypoxia 
(Hanson and Leibold, 1998) and in mouse macrophages, hypoxia was accompanied 
by a decrease in IRP1 and an increase in ferritin levels. However, an increase in IRP2 
activity was also detected in the macrophage cell lines in a different publication 
(Hanson et al., 1999). In human cell lines, hypoxia was found to induce IRP activity 
and decrease ferritin protein levels (Toth et al., 1999).  
These effects of hypoxia on ferritin levels are not consistent with some of my 
own findings in C. elegans. During the course of my work on the transcriptional 
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regulation of ftn-1, I uncovered a major role of hypoxia signalling, although the 
effect seems to be the opposite of what one would predict from the findings in 
vertebrate systems. This will be discussed in depth in Chapter 5.  
 
1.3.1.3c Hormonal regulation of ferritin 
 
Insulin and IGF-1 are also thought to be involved in the regulation of ferritin. 
In C6 glioma cells, both insulin and IGF-1 induced H and L ferritin mRNA levels. In 
rat insulin-secreting pancreatic cells, glucose was shown to cause a strong induction 
of H ferritin mRNA and a strong decrease in the levels of L ferritin mRNA. Overall 
ferritin protein levels were increased in response to glucose in these same insulin-
secreting cells. (Macdonald et al., 1994) 
Insulin signalling has long been linked to iron levels due to the association 
between type II diabetes and high levels of iron stores, measured by proxy through 
serum ferritin levels. It was even found that frequent blood-letting, which decreases 
iron stores, was associated with a decreased incidence of type II diabetes in humans 
(Ascherio et al., 2001) and rats (Yale et al., 1988). In humans, blood letting also was 
shown to increase insulin sensitivity (Fernandez-Real et al., 2002). The causes for 
this possible link between iron and type II diabetes are unknown.  
Whether there truly is a role for ferritin and iron in insulin signalling is not 
understood. The finding, described in Chapter 2, that mutants with reduced 
insulin/IGF-1 signalling (IIS) show greatly elevated levels of ftn-1 mRNA 
demonstrates that an interaction between IIS and ferritin regulation exists in C. 
elegans, although it does not help explain how lower iron levels could lead to greater 
insulin sensitivity. The studies are also not similar enough to be able to draw any 
conclusions about whether the interaction is conserved: while ferritin was increased 
in response to glucose in one study, H- and L- ferritin responded differently. In 
addition, this study was performed in insulin-secreting pancreatic cells and it is 
unclear what the equivalent cells would be in C. elegans.  
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1.3.1.3d Ferritin and cancer 
 
Alterations of ferritin levels in different types of cancer have been reported 
but both high and low ferritin levels have been found in tumours (Hazard and 
Drysdale, 1977) and the molecular mechanisms for the regulation of ferritin in cancer 
are not well understood  (Torti and Torti, 2002).  
The adenovirus gene E1A, an oncogene that can reprogram the regulation of 
cell growth to immortalise cell lines, was found to specifically repress expression of 
H ferritin, but not L ferritin in mouse fibroblasts (Tsuji et al., 1993). Additionally, 
transformation of B cells with c-Myc led to a downregulation of ferritin H and 
induction of IRP2 (Wu et al., 1999). c-Myc has an important role in promoting cell 
proliferation and transformation and the downregulation of ferritin levels were found 
to be a requirement for this to occur. Wu et al. found that when H ferritin was re-
expressed in three different c-Myc transformed cell lines, a significant decrease in in 
vitro clonogenicity could be observed. This effect could be rescued by the addition of 
hemin (which carries iron), but not iron-free hemin (protoporphyrin IX), 
demonstrating that it is the effects of H ferritin on the intracellular iron pool that 
affect the clonogenicity (Wu et al., 1999).  The authors hypothesise that the 
requirement for iron in the synthesis of dNTPs by ribonucleotide reductase (Cooper 
et al., 1996; Elledge et al., 1992) could explain this relationship between iron levels 
and proliferative capacity. However, iron is also required for other processes 
involved in proliferation (Hoyes et al., 1992; Kulp and Vulliet, 1996).  
Further support for the idea of a requirement for low levels of ferritin for 
proliferation and high levels for growth arrest comes from a series of experiments 
showing that differentiation and cellular senescence leads to an upregulation of 
ferritin levels in a variety of systems (Thweatt et al., 1992; Torti et al., 1988). 
Additionally, overexpression of H ferritin has been shown to strongly reduce cell 
growth (Cozzi et al., 2000) of HeLa cells. While several pieces of evidence suggest 
that H ferritin is repressed by c-Myc, a microarray analysis of c-Myc responsive gene 
did not identify H ferritin as being differentially regulated (Guo et al., 2000).  
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1.3.2. Introduction to C. elegans ferritin 
 
The C. elegans genome contains two ferritin genes, ftn-1 and ftn-2, which are 
both considered H-type ferritins due to the presence of ferroxidase centres (Kim et 
al., 2004). A C. elegans gene, aco-1 was identified as the homologue of IRP-1, but 
there are a number of reasons to believe that the post-transcriptional mechanisms by 
which the IRPs regulate ferritin levels in vertebrates are not conserved in C. elegans. 
Beside its function as an RNA-binding protein, mammalian IRP1 is known to 
function as an aconitase, which catalyzes the reaction between citrate and isocitrate 
(Eisenstein and Blemings, 1998). While ACO-1 was shown to exhibit aconitase 
activity and the total aconitase activity in worms shown to be post-transcriptionally 
regulated by iron, ACO-1 could not be shown to bind to IREs, the 5' UTRs of ftn-1 
and ftn-2 do not contain consensus IREs and no binding of ACO-1 to their 5' UTRs 
was detectable, thus arguing against the presence of non-consensus IREs in these 
sequences (Gourley et al., 2003).  Instead, C. elegans ferritins seem to be 
transcriptionally regulated by iron, although ftn-2 seems to be less inducible than ftn-
1 (Gourley et al., 2003; Kim et al., 2004; Romney et al., 2008).  
 
1.3.2.1. C. elegans expression pattern 
 
Using GFP reporters, ftn-1 seems to be expressed solely in the intestine (Kim 
et al., 2004; Romney et al., 2008) and is expressed through all life stages beginning 
at gastrulation (Romney et al., 2008).  
There is some ambiguity surrounding the true expression pattern of ftn-2, 
with some authors reporting that a ftn-2::gfp construct is not expressed in the 
intestine (Kim et al., 2004), while others find strong intestinal expression for a 
similar construct (Romney et al., 2008). The constructs used in the two publications 
differed in the length of the 5'-regulatory sequence used, which could explain the 
discrepancy. Romney et al. make a good case for intestinal expression of ftn-2 by 
using a histone tagged GFP reporter and presenting microscopy of staged worms of 
all developmental stages clearly exhibiting nuclear GFP expression in their 
intestines. They also describe conserved regulatory sequences in the promoter that 
are sufficient to drive intestinal expression of a different construct. It is possible that 
without the nuclear GFP localisation, the diffuse fluorescence in the intestinal cells 
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was difficult to detect in the constructs used by Kim et al., especially given that the 
intestine is the site of worm auto-fluorescence, which makes intestinal GFP 
expression hard to detect. Outside of the intestine, ftn-2::gfp is reported to be 
expressed in body wall muscle, pharynx, and hypodermal cells in Kim et al. and in 
hypodermal cells in Romney et al. The true distribution of endogenous ferritin 
expression will remain unclear until this is investigated by antibody staining. 
 
1.3.2.2. Regulation of nematode intestinal ferritin expression 
 
Given that the post-transcriptional regulation of ferritins found in vertebrates 
does not seem to be conserved in worms, the mechanisms by which C. elegans 
ferritins are regulated in response to iron remain to be discovered. Romney et al. 
attempted to do this by analysing the promoters of ftn-1 and ftn-2 in C. elegans, as 
well as their two homologues in C. briggsae and looking for conserved sequences. 
They identified a conserved 63bp element containing two GATA motifs and three 
direct repeats (DRs). Cloning this sequence in front of a pes-10 minimal promoter 
and the GFP-his sequence revealed that these 63bp are sufficient to drive GFP 
expression in the C. elegans intestine. GFP expression from this construct was 
responsive to iron and mutation of the three DRs abrogated this response, indicating 
that these 63bp represent an iron-dependent enhancer of nematode ferritin gene 
expression (see Figure 7). The authors named this sequence the ‘iron dependent 
element’ (IDE).  
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Figure 7  
Location of the IDE in the 5′-upstream regions of the ftn-1 and ftn-2 genes in C. 
elegans and in C. briggsae. Open boxes, GATA motifs; boxes with three arrows, 63-
bp element with arrows depicting three direct repeats (DR1–3). Numbers are in 
reference to the ATG start site (arrow, +1). The 63-bp element in ftn-1 and ftn-2 is 
expanded, and the nucleotide differences among the genes are indicated. (Romney et 
al., 2008) 
 
 
Due to the presence of two GATA motifs, the authors were able to identify 
ELT-2 as a regulator of the IDE, which most likely binds to the GATA motifs and 
specifies intestinal expression. elt-2 is thought to be the intestinal terminal 
differentiation factor which binds to all intestinally expressed genes (McGhee et al., 
2009). 
No transcription factor has so far been identified to bind the DR elements in 
the IDE, though Romney et al. note that the DR consensus motif shows some 
homology with the E-box motif, which serves as a binding site for basic helix-loop-
helix transcription factors. They hypothesise that an iron-responsive transcription 
factor may bind to the DR elements and activate gene expression when iron levels 
are high, leading to increased iron storage capacity in the cell (see Figure 8).  
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Figure 8  
Proposed model for regulation of ftn-1 transcription by iron through an iron-
responsive direct repeat -binding protein (DRBP) (Romney et al., 2008). 
 
 
1.4. The discovery of long-lived IIS mutants in C. elegans 
 
1.4.1. Initial discovery of the role of daf-2 and age-1 
 
As described earlier in this chapter, ageing remains an unexplained biological 
phenomenon. Given the effectiveness of using genetic model organisms to identify 
genes responsible for previously unexplained phenotypes, genetic approaches were 
soon applied to the search for the cause of ageing. While it is clear that loss of 
function mutations in genes promoting longevity would shorten lifespan, performing 
genetic screens to identify such genes is tricky, since it is difficult to distinguish 
mutations in genes promoting longevity from those alleles that cause life shortening 
pathology unrelated to ageing. Initially, searching for long-lived mutants did not 
seem like a good idea, since this would require the existence of genes that reduce an 
organisms longevity, which one would not predict from evolutionary theories of 
ageing. However, an early EMS screen for long-lived mutants (Klass, 1983) revealed 
at least one long-lived strain, which was later found to contain a mutation in the gene 
age-1 (Friedman and Johnson, 1988). A chance discovery revealed that a mutant of 
the gene daf-2 were also long-lived (Kenyon et al., 1993) and the same mutant had 
already been known to cause a constitutive dauer formation at restrictive 
temperatures (the so-called Daf-c phenotype). Not all Daf-c mutants tested 
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subsequently showed an extended lifespan, but a very large effect was found in three 
different alleles of the gene daf-2. Testing other strains that exhibit Daf-c also 
identified an allele of daf-23, which extended lifespan (Larsen et al., 1995), but this 
allele was later found to be in the same gene previously described as age-1 (Malone 
et al., 1996; Morris et al., 1996).  
Much work had already gone into epistasis analysis of genes involved in 
dauer development and it was already known that the Daf-c phenotype of daf-2 
alleles required the presence of the gene daf-16, which has a Daf-d phenotype (Daf-d 
indicates that the strain is incapable, or less capable, of forming dauers than wild-
type strains) (Riddle et al., 1981). This led to the finding that the longevity phenotype 
of daf-2 mutant animals also requires daf-16 (Kenyon et al., 1993). Cloning and 
sequence analysis of daf-16 revealed daf-16 to be a homologue of human fork-head 
transcription factors FOXO3 and FOXO4 (Ogg et al., 1997).  
The discovery that single gene mutations in the insulin/IGF-1 signalling (IIS) 
pathway were capable of having such radical effects on C. elegans lifespan was 
unexpected since it contradicts earlier thinking about how different organisms 
achieve their rates of ageing. In the evolutionary theory of ageing, an organism’s 
specific rate of ageing is the consequence of a lack of evolutionary selection against 
mutations that are detrimental late in life, which suggests that changes in the rate of 
ageing can only come from many generations of selection. The discovery that the 
rate of ageing can instead be modulated to a great extent by a single pathway 
represents an exciting departure from this view. As a consequence, much research 
has since been carried out on how this lifespan extension is achieved. The fact that 
the lifespan extension is completely dependent on a single transcription factor has 
given researchers the hope that the cause of ageing can be identified by investigating 
long-lived C. elegans IIS mutants and that this discovery may be within reach.  
 
1.4.2. Other elements of the pathway 
 
The discovery of the extended lifespan of daf-2 mutants was found to be 
remarkably robust and reproducible. In one study, 15 different alleles of daf-2 were 
tested and were all found to extend lifespan (Gems et al., 1998). The central role of 
daf-16 in mediating the effects of reduced IIS was established using different 
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approaches. In addition to the daf-16 dependence of the daf-2 lifespan and Daf-c 
phenotypes (Gottlieb and Ruvkun, 1994; Larsen et al., 1995), other phenotypes of 
daf-2 mutants, such as increased fat storage (Ogg et al., 1997), reduced motility, 
adult body shrinkage and altered gonad morphology (Gems et al., 1998) also 
required daf-16. A genetic screen using daf-2; daf-12 (as well as age-1; daf-12) 
double mutants supported this view (Tissenbaum and Ruvkun, 1998). daf-2; daf-12 
animals are known to arrest as L1 or L2 under certain conditions, an effect that is 
also completely dependent on daf-16. This screen of 7000 genomes for suppressors 
of the daf-2; daf-12 phenotype resulted in the identification of four alleles. All four 
mapped to the daf-16 genomic locus, strongly indicating that daf-16 is the major 
target for daf-2 (Tissenbaum and Ruvkun, 1998).   
The discovery that age-1 codes for a phosphoinositide-3-OH kinase (PI3K) 
(Morris et al., 1996) led to the identification of further downstream elements in the 
pathway.  
 
Figure 9 
Adapted from (Baumeister et al., 2006) 
 
 
  
 
 
 
 
 
 
 
 
 
 
Akt/PKB serine/threonine kinases had already been found to act as 
downstream effectors of PI3 kinases in other systems (Toker and Cantley, 1997), so 
the newly sequenced C. elegans genome was used to try to identify homologues in 
worms. The two genes akt-1 and akt-2 were identified and found to have a role in 
signalling to daf-16. The activating mutation mg144 in akt-1 was capable of fully 
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suppressing the Daf-c phenotype of age-1, as was the over-expression of akt-1(+). 
Simultaneous inhibition of akt-1 and akt-2 activity led to 100% dauer arrest and this 
Daf-c phenotype could again be fully suppressed by a null mutation in daf-16, 
demonstrating that the two C. elegans Akt/PKB homologues AKT-1 and AKT -2 act 
redundantly to antagonise DAF-16 (Paradis and Ruvkun, 1998). 
An additional member of the IIS pathway was identified in a forward genetic 
screen for alleles causing a Daf-c phenotype. Loss of function alleles of pdk-1 extend 
lifespan and cause a Daf-c phenotype and sequence analysis revealed homology to 
the mammalian 3-phosphoinositide-dependent kinase-1 (PDK1). In mammals, the 
phospholipid products of PI3K are required for PDK1 to activate the Akt/PKB kinase 
via phosphorylation (Paradis et al., 1999). In C. elegans the Akt/PKB homologues 
AKT-1 and AKT-2 are also required for the phenotypes of a dominant activated form 
of PDK-1. Loss of function of pdk-1 had many pleiotropic phenotypes, all of which 
required daf-16, further evidence for the important role of pdk-1 in IIS (Paradis et al., 
1999).  
In mammalian cells, SGK acts in parallel to Akt/PKB kinases in response to 
PI3K signalling (Brunet et al., 2001). Mutations in the C. elegans homologue sgk-1 
were found to extend lifespan in a daf-16–dependent manner and SGK-1, AAK-1, 
and AAK-2 protein constructs were all found to be capable of phosphorylating DAF-
16 in vitro. Loss of activity (by either mutation or RNAi) of PDK-1, SGK-1, AAK-1 
as well as AAK-2 lead to the nuclear localisation of a DAF-16::GFP transgene, 
which strongly supports a role of all four of these subunits in cytoplasmic 
localisation of DAF-16::GFP (see review of DAF-16::GFP localisation later in this 
chapter). There is evidence that SGK-1, AAK-1 and AAK-2 form a multimeric 
complex, which presumable phosphorylates DAF-16 in the cytoplasm thus 
preventing nuclear localisation (Hertweck et al., 2004). For a summary of how IIS is 
thought to regulate DAF-16, see Figure 9. 
 
1.4.3. Cell autonomous and non-autonomous effects of IIS 
 
As described in the previous section, traditional forward genetic approaches 
combined with epistasis analysis identified a pathway with very large effects on the 
lifespan of C. elegans (see Figure 9). Since we do not know what worms typically 
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die of in old age, it is difficult to predict in which cells the lifespan–promoting 
effects of reduced IIS may be occurring. This also presents the question of whether 
IIS acts cell autonomously or non-autonomously, i.e. whether signalling between 
cells rather than just within cells plays a role or not. Given that the decision to enter 
into the dauer stage involves responding to environmental cues and that dauer entry 
is controlled by IIS, it seems likely that intercellular signalling should feed into IIS.  
 
1.4.3.1. Tissue specific expression of IIS transgenes 
 
One approach to identify the tissues in which IIS acts to extend lifespan is to 
express an IIS gene in specific tissues using transgenes in animals that lack this gene 
globally. If this tissue–specific expression is sufficient to rescue the mutant 
phenotype, this provides evidence that IIS is affecting lifespan through its actions 
within this tissue. This was first attempted in daf-2 and age-1 mutants over-
expressing wild-type daf-2 or age-1 cDNA specifically in either neurons, the 
intestine or muscle cells. It was found that neuronal expression had by far the 
greatest effect on lifespan, with a smaller effect also seen upon intestinal expression. 
This study indicated that it is the activity of IIS in neurons that is extending lifespan 
(Wolkow et al., 2000). A similar approach by a different group (Libina et al., 2003) 
involved the expression of a daf-16::gfp transgene in daf-16; daf-2 double mutants in 
order to identify the tissues in which daf-16 acts to extend lifespan. This study also 
supports an important role of neurons and the intestine, although it found the 
magnitudes were reversed: The greater effect on lifespan followed intestinal instead 
of neuronal expression. In support of a major non-neuronal role of IIS, it was also 
found that RNAi-mediated knockdown of daf-16, which does not affect neuronal 
daf-16 expression, was sufficient to fully eliminate the longevity of daf-2. The 
relative importance of these two tissues in IIS- mediated determination of lifespan 
still needs to be established and it is possible that different tissues have distinct roles 
in mediating different functions of the IIS pathway. For example, Libina et al. found 
that while the lifespan effects of reduced IIS could only be rescued to a very small 
extent (5%-20%) by neuronal expression of daf-16::gfp, the Daf-c phenotype could 
be fully rescued.   
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1.4.3.2. Evidence for cell non-autonomous effects of IIS 
 
The study by Libina et al. also took up an additional important question: Do 
the effects of IIS on lifespan occur cell autonomously or non-autonomously? To 
address this, they used a GFP reporter of the manganese superoxide dismutase 
(MnSOD) gene sod-3 as readout for daf-16 activity. They found that tissue specific 
expression of daf-16 in daf-16;daf-2 mutants carrying the sod-3::gfp transgene 
increased GFP expression only in the tissue in which daf-16 was expressed, 
demonstrating that daf-16 regulates sod-3 expression cell autonomously. However, 
when daf-16 was expressed in the intestine of daf-16(+) animals carrying the sod-
3::gfp reporter, expression was increased not only in the intestine, but also in other 
tissues. A similar but slightly weaker effect was found upon neuronal daf-16 
expression. This strongly suggests that DAF-16 activity in one tissue leads to the 
release of an intercellular signal that regulates DAF-16 activity in other tissues and 
argues for the existence of cell non-autonomous effects of IIS.  
 
1.4.3.3. Role of sensory neurons 
 
Before the discovery of the important role of the IIS pathway in ageing, many 
of the genes involved had already been identified as important players in the 
formation of the dauer stage, a non-reproductive life stage which developing worms 
can enter when conditions are unsuitable for reproduction. The decision of whether 
to enter the dauer stage or not depends on a number of environmental cues, so it is 
clear that mechanisms to sense these cues must feed into the decision. It was soon 
found that sensory neurons have a role in dauer formation as the ablation of some of 
them leads to dauer arrest (Bargmann and Horvitz, 1991).  
The role of sensory neurons in the determination of lifespan was soon 
investigated: A very large number of mutations that cause impaired sensory 
perception were tested and all were found to extend lifespan. The same study also 
found that laser ablation of the two amphid sheath cells, an intervention that also 
leads to impaired chemosensation, also extends lifespan (Apfeld and Kenyon, 1999). 
This effect is presumably due to the loss of a signal secreted from sensory neurons 
when conditions are appropriate for reproduction, which activates IIS. Loss of this 
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signal through a change in the conditions would therefore lead to dauer arrest or 
extended lifespan in adults. The possible involvement of IIS in the lifespan extension 
of mutants with reduced sensory perception is supported by the finding that loss of 
daf-16 mostly abolishes the lifespan effect of five such mutants. The two sensory 
mutations that were crossed into a daf-2 mutant background were also not able to 
further extend daf-2 lifespan. Similarly, three of these mutants were found to have a 
weak Daf-c phenotype, which was also completely dependent on daf-16 (Apfeld and 
Kenyon, 1999).   
More detailed analysis of the role of individual neurons in mediating IIS –
dependent lifespan extension was performed using laser ablation. Ablation of ASI 
and ASG neurons was found to lead to an extension in lifespan. The effects on 
lifespan by ablation of the ASI neurons is completely daf-16 dependent, indicating 
that a signal secreted by ASI neurons may stimulate IIS in responsive cells and that 
loss of it can extend lifespan via reduced IIS through DAF-16. Interestingly, the 
lifespan extension by ablation of ASI was found to be dependent on two other 
sensory neurons ASJ and ASK, indicating that some sensory neurons enhance and 
others may suppress IIS, although details of these interactions are not known (Alcedo 
and Kenyon, 2004).  
 
1.4.3.4. C. elegans insulin-like peptides 
 
There is clearly strong evidence for the existence of intercellular signalling, 
which affects IIS and ageing. The fact that the DAF-2 protein, which crowns the IIS 
pathway, is a receptor similar to the human insulin and IGF-1 receptor, suggests that 
identifying its ligands could be useful in understanding these interactions. 
Unfortunately, genetic screens carried out in search for genes involved in dauer 
formation did not reveal a loss of function mutant in a DAF-2 ligand (they did 
produce a dominant negative mutation in daf-28 –discussed later). Bioinformatic 
analysis of the C. elegans genome performed since then revealed a very large 
number of genes that may code for insulin-like peptides (Pierce et al., 2001). The 
worm genome is believed to contain 40 such genes and this large number (compared 
to 7 currently identified in the human genome) suggests that functional redundancy 
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may be a reason they hadn’t been previously identified using forward genetic 
approaches.  
The IIS pathway regulates the developmental decision to enter the dauer 
stage, a decision made in response to environmental signals such as the presence of a 
dauer pheromone and the availability of food. Signals from sensory neurons have 
long been known to be required for this decision because ablation of certain sensory 
neurons has been shown to lead to dauer arrest (Bargmann and Horvitz, 1991). A 
possible model for the role of insulin-like peptides in C. elegans could involve the 
secretion of these peptides from sensory neurons under non-dauer inducing 
conditions to activate IIS in other tissues. When food levels in the environment are 
low or overcrowding causes elevated pheromone levels, loss of this signal could be 
the cause for decreased IIS and subsequent dauer arrest. The expression pattern of ins 
genes is consistent with a role for ins genes in transmitting these signals: out of 15 
ins genes investigated in one study, 13 are expressed in at least some sensory amphid 
neurons. ins-1 for example, is expressed in the ASI and ASJ neurons, as well as in 
some other tissues (Pierce et al., 2001).  
Possible functions for a small number of these proteins are slowly being 
identified. Overexpression of the most conserved of the insulin-like genes, ins-1, was 
found to cause a weak Daf-c phenotype and to enhance the Daf-c phenotype of daf-2 
mutants. Another one of the ins genes, ins-18, was found to have the same effect and 
even expression of the human insulin gene in C. elegans causes Daf-c when driven 
by the promoter of ins-1. However, this result indicates that ins-1 and ins-18 act as 
antagonists of DAF-2, since it is reduced IIS that causes dauer formation (Pierce et 
al., 2001). As mentioned earlier, the identification of agonists of DAF-2 may be 
made difficult by functional redundancy among the large number of ins genes. 
However, a semidominant allele sa191 was identified to cause a Daf-c phenotype 
and a 10% lifespan extension in an early screen (Malone et al., 1996) and mapped to 
the gene daf-28, which was later found to code for an insulin/IGF-1 –like peptide (Li 
et al., 2003). The sa191 variant of DAF-28 is thought to reduce IIS by binding to 
DAF-2 without activating it, thereby preventing other, functional, agonists from 
binding.  
 
As one would predict for a mutation that causes decreased IIS, the transient 
dauer arrest of daf-28(sa191) was found to be partially suppressed by mutations in 
 49 
daf-16 and to cause nuclear localisation of DAF-16::GFP in larvae. The expression 
pattern of a Pdaf-28::gfp reporter were also found to be consistent with a role as an 
agonist of DAF-2 that is secreted by sensory neurons under reproductive growth 
conditions. Pdaf-28::gfp is expressed in ASI and ASJ neurons as well as other 
tissues. Expression was also found to be dramatically reduced in dauers and in 
mutants with impaired sensory neuron signal transduction (DAF-11/guanylyl cyclase 
mutants). When conditions are inappropriate for reproductive growth, less DAF-28 
may be secreted, leading to reduced IIS and therefore dauer formation. The existence 
of the semidominant sa191 allele of this putative DAF-2 agonist allowed for a new 
approach to identifying other agonists using transgenic over-expression. If the 
phenotype of sa191 is caused by the binding of inactive DAF-28 to DAF-2, thereby 
preventing other agonists from binding, then over-expression of other agonists could 
suppress this phenotype by outcompeting DAF-28. Nine ins genes were therefore 
over-expressed in a daf-28(sa191) genetic background and two of them, ins-4 and 
ins-6, were capable of suppressing Daf-c, indicating that the proteins they code for 
can functionally replace DAF-28. INS-4, INS-6 and DAF-28 may therefore be 
agonists of DAF-2 and at least DAF-28 seems to have a role in preventing dauer 
formation by activating IIS, possibly after being secreted by sensory neurons (see 
Figure 10).  
An additional ins gene was identified as a possible DAF-2 agonist through 
microarray analysis of long-lived daf-2 mutant animals. ins-7 was identified as a 
gene down-regulated in daf-2 mutants and RNAi –mediated knock-down of this gene 
led to an increase in lifespan as well as DAF-16::GFP nuclear localisation and the 
increased expression of a DAF-16 target, consistent with a role as an agonist of 
DAF-2 (Murphy et al., 2007; Murphy et al., 2003).  
Further evidence was subsequently found that INS-7, like DAF-28, may be 
secreted by sensory neurons to activate IIS in the intestine as well as evidence for the 
secretion by intestinal cells to activate IIS in other cells (Kawli and Tan, 2008). INS-
7 activation of IIS may also be inhibiting innate immune response, since loss of ins-7 
was found to cause a daf-16–dependent increase in worms’ resistance to infection. 
daf-2 mutant animals are also resistant to infection and this is also daf-16 dependent 
(Kawli and Tan, 2008). It seems likely that further research into these DAF-2 ligands 
will shed light into how IIS–mediated phenotypes such as growth and stress response 
are regulated, how signals are transmitted across tissues and how environmental cues 
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are processed. This is clearly a prerequisite to understanding organismal ageing in C. 
elegans.  
 
 
 
Figure 10 
Representation of possible 
mechanism by which 
environmental cues could 
alter IIS signalling. From 
(Nelson and Padgett, 2003) 
 
 
 
 
 
 
 
1.4.4. Evolutionary conservation of the role of IIS in ageing 
 
 
Much research has been conducted on IIS mutants of C. elegans. This is often 
justified by pointing to human ageing related diseases, their prevalence, their human 
cost and their cost on society. Of course research into IIS in C. elegans is only 
relevant to humans and human diseases if the role of IIS in ageing is conserved. 
There is now fairly strong evidence that this is the case.  
Like mutations in C. elegans daf-2, mutations in the Drosophila 
melanogaster insulin receptor homologue InR also greatly extend lifespan (Tatar et 
al., 2001), as do mutations in the downstream insulin receptor substrate chico 
(Clancy et al., 2001). Foxo, the Drosophila homologue of daf-16, has also been 
implicated in longevity assurance, since over-expression of dFoxo in the fat body 
also extends lifespan (Giannakou et al., 2004; Hwangbo et al., 2004). Of course, for 
those worried about how research on ageing in a nematode worm could ever be 
relevant for humans, the finding that the same processes are involved in another far 
removed organism might not be sufficiently reassuring. Is the role of insulin and 
IGF-1 signalling in ageing conserved in mammals? 
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The first suggestion that the effects of IIS on worms may be conserved in 
mice came from two mutants with hypopituitarism called the Ames and Snell mice. 
Both were shown to have decreased levels of IGF-1 and to be long-lived (Brown-
Borg et al., 1996; Flurkey et al., 2001). More concrete evidence came from the 
extended lifespan of mice heterozygous for a mutation in the IGF-1 receptor 
(Holzenberger et al., 2003). These mutants are significantly less long-lived than 
Ames and Snell mice, which may indicate that the longevity phenotype of 
hypopituitarism may be caused by more than just decreased IGF-1. Mutants of the 
insulin receptor substrate Irs1 and Irs2 also exhibit delayed ageing (Selman et al., 
2008a; Taguchi et al., 2007), although this second finding is controversial (Selman et 
al., 2008b). Deletion of the insulin receptor itself specifically in fat tissue was also 
found to significantly increase mouse lifespan (Bluher et al., 2003).  
There is also growing evidence for a role of FOXO transcription factors in 
human ageing. A genome wide association study using single nucleotide 
polymorphisms (SNPs) in a group of 1345 participants identified SNPs near the two 
genes FOXO1A and FOXO3A as being associated with longevity (Lunetta et al., 
2007). Other studies have supported the findings regarding FOXO3A using a 
candidate gene approach, in which presence of genetic variations specific genes was 
compared between particularly long-lived individuals and younger ones. Variations 
in five candidate genes, including FOXO3A and FOXO1A, were investigated in a 
population of Japanese-American men and a strong association was identified 
between FOXO3A genotype and longevity (Willcox et al., 2008). A similar study 
investigating only polymorphisms within the FOXO3A gene confirmed this 
association in German centenarians (Flachsbart et al., 2009). A study genotyping six 
SNPs in a Han Chinese population also identified an association between the genes 
FOXO1A and FOXO3A and longevity (Li et al., 2009). An additional study 
confirmed the association of FOXO3A in further populations and also found that the 
AKT1 tyrosine kinase, located downstream of insulin/IGF-1 signalling, was also 
associated with longevity (Pawlikowska et al., 2009).  
 
Another interesting link between IIS in lower organisms and ageing in 
humans came from an Ashkenazi Jewish cohort, consisting of offspring of 
particularly long-lived individuals and age-matched controls. This study found that 
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mutations in the IGF1R gene, which codes for the IGF-1 receptor, were associated 
with longevity. Biochemical studies of these mutations showed that they led to a 
partial loss of function, suggesting that decreased IGF-1 signalling might lead to 
longevity in humans as well (Suh et al., 2008).  
As discussed in this chapter and further discussed in Chapters 4 and 6, the 
mechanisms that regulate C. elegans ageing downstream of DAF-16 are still 
completely unknown and the fundamental processes responsible for ageing are also a 
complete mystery. However, the role of IIS in affecting longevity seems to be 
conserved across species, suggesting that findings in worms will be highly relevant 
in the understanding of human ageing related diseases.  
 
1.5. The DAF-16 transcription factor and the search for 
target genes 
 
As described above, signalling through the insulin/IGF-1 pathway plays a 
central role in determining the lifespan of the nematode, with decreased signalling 
leading to a lifespan extension. Given that the true causes of ageing have so far 
remained a mystery, it is no surprise that the effects of reduced IIS on ageing have 
become the focus of intense interest in the ageing field. While studying long-lived 
worms may seem esoteric to some, they are in fact an ideal model for studying the 
ageing process. Populations of long-lived and normal lived worms are genetically 
identical, except for the single mutation in the IIS pathway. If we can therefore 
understand which of the changes that altered IIS is causing in the worms, such as 
biochemical changes or changes at any other level of its physiology, are the ones 
responsible the lifespan extension, then the causes of ageing itself might become 
clear. Clearly, attempting to understand the differences between wild-type and long-
lived mutant animals will be far simpler than say comparing species with different 
lifespans would be.  
In C. elegans, the effects of IIS on lifespan require the actions of DAF-16, a 
FoxO class forkhead transcription factor. Signalling through the IIS pathway leads to 
the phosphorylation and cytoplasmic localisation of DAF-16 and reduced insulin 
signalling leads to nuclear localisation of DAF-16. Once in the nucleus, DAF-16 
affects transcription of its target genes, which are assumed to extend lifespan, albeit 
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by unknown mechanisms. Since the effects of this pathway on ageing were 
discovered, much effort has gone into identifying the targets of DAF-16. Knowledge 
of how DAF-16 alters the cells’ biochemistry could help in understanding how the 
ageing process itself is delayed and in fact what ageing is caused by, at least in 
nematodes. What follows is a brief, up-to-date summary of different approaches that 
have been taken to learn more about how DAF-16 acts in long-lived IIS mutants and 
also the approaches taken to identify its targets.  
 
 
1.5.1. The role of different daf-16 isoforms 
 
 
Several different daf-16 transcripts are expressed and some effort has gone 
into both characterising the expression patterns and the roles of each of the 
transcripts in daf-16 –dependent phenotypes. Initially, this work was confined to the 
a and b isoforms (Henderson and Johnson, 2001; Lee et al., 2001; Lin et al., 2001), 
but an additional exon has since been discovered far upstream and a recent 
publication investigated the role of a third isoform, termed d/f (see Figure 11 (Kwon 
et al., 2010). This nomenclature was used because both a d and f isoform exist, but 
the expression patterns cannot be easily distinguished since the two forms have 
almost identical transcriptional start sites. Similarly, the difference between the two 
isoforms a1 and a2 was also mostly ignored since the predicted protein product only 
differs by two amino acids. Researchers have therefore focused their efforts on 
identifying the roles of the three daf-16 transcripts daf-16a, daf-16b and daf-16d/f.  
 
Figure 11 
From (Kwon et al., 2010). Shows three different GFP reporters of daf-16 
corresponding to three different isoforms. The transgenes were used in this 
publication in order to characterise the expression patterns of the three different 
transcripts.  
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The nomenclature in the above figure is similar to the one used in the other 
publications addressing this issue and will be continued here. It should be noted that 
wormbase.org, the main online resource for C. elegans researchers, has now adopted 
a different nomenclature and also lists the two additional transcripts daf-16e.1 and 
daf-16e.2. However, for simplicity’s sake, I will continue to use the nomenclature 
used by Kwon et al., and will not be discussing the roles of daf-16e.1 and daf-16e.2, 
since they have so far not been investigated.  
Null mutations of daf-16 fully abrogate the lifespan extension and Daf-c 
phenotype of daf-2 mutants (see Section 1.4.2.) and also reduce wild-type lifespan by 
approximately 20% (Lin et al., 2001). The contribution of each transcript to these 
phenotypes can be investigated by using mutations in exons absent from some 
isoforms. Another approach is to use RNAi against these exons, although this can be 
less specific, since RNAi is known to be capable of affecting pre-mRNAs and 
therefore knock-down all isoforms of a gene, regardless of which part of the 
transcript was targeted (Bosher et al., 1999). Using alleles of daf-16 that do not target 
the shorter b variant and testing the effects on daf-2 lifespan and dauer formation 
revealed that expression of a functional daf-16b was not sufficient to rescue neither 
the lifespan nor the Daf-c phenotype of daf-2 mutant worms (Lee et al., 2001). RNAi 
knock-down of either daf-16a or daf-16d/f also revealed that loss of neither of these 
forms can fully abrogate the extended lifespan of daf-2 mutants. RNAi of both 
transcripts almost completely abrogates it, although additional RNAi of daf-16b 
leads to a further slight reduction in daf-2 mutant lifespan (Kwon et al., 2010).  
 
1.5.1.1. Investigating the role of daf-16a by transgene over-
expression 
 
The role of daf-16a in conferring the extended lifespan of daf-2 mutants was 
studied by over-expressing transgenes containing this variant. Because daf-2 mutant 
animals are long-lived but the double mutant daf-16; daf-2 is not, one approach to 
investigate the role of daf-16a specifically is to express a transgene containing daf-
16a in a daf-16; daf-2 mutant background. It was found that this almost fully rescued 
the lifespan back to that of daf-2 mutants (Kwon et al., 2010; Lin et al., 2001).  
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In an otherwise wild-type genetic background, daf-16a over-expression was 
found to have little or no effect on lifespan in some studies (Henderson and Johnson, 
2001; Lin et al., 2001) and cause significant extensions in a different study (Kwon et 
al., 2010). In a daf-16(-) background, daf-16a was found to incompletely rescue the 
shortened lifespan in one case (Lin et al., 2001) but significantly extend lifespan 
beyond the levels of a wild-type strain in others (Kwon et al., 2010; Lee et al., 2001). 
The smaller effects of daf-16a over-expression in a daf-2(+) background are 
probably due to the role of IIS in repressing daf-16 function. Unless IIS is reduced, 
the over-expressed DAF-16A presumably remains cytoplasmic. However, daf-16 
mutations shorten lifespan even in a daf-2(+) background, suggesting that even when 
IIS is wild-type, DAF-16 cytoplasmic localisation is not complete. This indicates that 
DAF-16 over-expression should extend lifespan even in daf-2(+) animals. One 
explanation is that only very high levels of over-expression can lead to lifespan 
extension in daf-2(+) and indeed Kwon et al. note that high-copy over-expression of 
daf-16a leads to the greatest lifespan extensions.  
The role of daf-16a in the Daf-c phenotype of daf-2 mutants was investigated 
using a similar approach, since daf-2 mutant animals are Daf-c, but daf-16; daf-2 
animals are not. daf-16a expression was found to fully restore Daf-c in this 
background (Henderson and Johnson, 2001; Kwon et al., 2010). In a wild-type 
background, daf-16a over-expression was found to cause a Daf-c phenotype when 
worms were grown at very high temperatures. In the same study, over-expression 
was also shown to cause a slow growth phenotype, which is also seen in daf-2 
mutants, and this phenotype disappeared when worms were grown on daf-16 RNAi 
(Henderson and Johnson, 2001). Another study observed no dauer phenotype in daf-
16a over-expressing animals (Lin et al., 2001).  
daf-2 mutant animals are also resistant to a number of different stresses (see 
Section 6.1.2.) and this resistance also requires daf-16. daf-16a expression was found 
to partially rescue the thermo-tolerance of daf-16; daf-2 animals (Kwon et al., 2010). 
In a wild-type background an increase in thermo-tolerance has also been observed 
with daf-16a over-expression. A slight increase in resistance to UV was also 
observed (Henderson and Johnson, 2001).  
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1.5.1.2. Investigating the role of daf-16b by transgene over-
expression 
 
daf-16b GFP reporters were found to be expressed in a smaller set of cells 
than daf-16a. One study found expression in the pharynx, some neurons and the 
somatic gonad (Lee et al., 2001) and another found expression in the pharynx, 
spermathecae and some neurons (Kwon et al., 2010).  
Effects of daf-16b on lifespan are modest. Mutation of a daf-16b –specific 
exon in a transgene expressing both a and b demonstrated that daf-16b was not 
required for restoring the lifespan extension of daf-2 mutants by this transgene. 
Expression of daf-16b in a daf-16 mutant background only extended lifespan by 14% 
compared to 65% when daf-16a was expressed (Lee et al., 2001). A similarly small 
role of daf-16b was also found in dauer development: the Daf-c phenotype of daf-2 
mutants did not require daf-16b, although dauers formed in the absence of daf-16b 
showed incomplete pharynx  remodelling, indicating that this transcript plays a role 
in at least this aspect of dauer formation (Lin et al., 2001). 
 
1.5.1.3. Investigating the role of daf-16d/f by transgene over-
expression 
 
daf-16d/f, like daf-16a, seems to be expressed in almost all tissues. However, 
within the set of tissues that show expression of these transcripts, the distribution of 
expression levels differs for various tissues. While daf-16a is enriched in muscles 
and neurons, daf-16d/f seems to be enriched in the pharynx, the hypodermis, neurons 
and the intestine (Kwon et al., 2010). 
The daf-16d/f transcript seems to play a major role in the determination of 
lifespan. d/f –specific RNAi reduces both wild-type and daf-2 mutant lifespan and 
over-expression of daf-16d/f leads to an extension in daf-16 mutant lifespan that goes 
beyond the levels of wild-type lifespan. There is evidence that all three transcripts 
play a role in lifespan determination, since it takes knock-down of all three transcript 
variants to fully suppress the daf-2 lifespan extension. However, RNAi of both daf-
16a and daf-16d/f accounts for most of this effect (Kwon et al., 2010). While 
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expression of a daf-16a transgene can rescue a large part of the daf-2 lifespan 
extension in daf-16; daf-2 mutants (Kwon et al., 2010; Lin et al., 2001), the presence 
of a daf-16d/f transgene can fully rescue it. Over-expression of both daf-16d/f and 
daf-16a has no further effect on lifespan compared to daf-16d/f alone (Kwon et al., 
2010), indicating that it is daf-16d/f that has the most important role in the 
determination of daf-2 mutant longevity.  
daf-16d/f also seems to play a large role in mediating other phenotypes of 
daf-2 mutants. daf-2 animals have long been known to have higher levels of fat 
storage than wild-type animals (Kimura et al., 1997) and this effect was also 
dependent on daf-16. Only the daf-16d/f transgene was found to be capable of fully 
restoring the altered fat levels in daf-16; daf-2 double mutants. The increased 
thermotolerance of daf-2 animals is thought to be due to the combined effects of daf-
16a and daf-16d/f as only the combined over-expression of these two transcript could 
restore the phenotype in daf-16; daf-2 animals. Similarly, the Daf-c phenotype of 
daf-2 mutants also seems to be due to the joint activity of daf-16a and daf-16d/f, 
although at 25oC, it is daf-16a that seems to play the greatest role (Kwon et al., 
2010).  
 
1.5.2. The contribution of each DAF-16 isoform to various IIS mutant 
phenotypes  
 
It therefore seems that the daf-16a and the daf-16d/f transcripts play the 
largest role in the determination of most daf-2 phenotypes and that daf-16b plays a 
far less important role. The different transcripts differ both in their expression 
patterns, with the a and d/f transcripts being widely expressed and the expression of b 
confined to a smaller subset of cells, as well as in their protein sequences. By 
swapping promoters, researchers were able to address the question of which of these 
differences accounts for the difference in the effects of the three transcripts in the 
determination of lifespan. It was found that the coding region of daf-16b could have 
the same effect on lifespan as the coding region of daf-16a if the daf-16a promoter 
was used to drive its expression (Lee et al., 2001). Similar results were found when 
the promoters of the daf-16a and daf-16d/f coding regions were swapped (Kwon et 
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al., 2010). This demonstrates that it is not the protein sequence of the various DAF-
16 isoform expressed by these transcripts that accounts for their differing effects on 
lifespan but their expression pattern. Interestingly, it is the daf-16d/f transcript that 
has been shown to play the greatest role in restoring daf-2 lifespan and it is this 
transcript that is enriched in the intestine (Kwon et al., 2010), a tissue thought to be 
particularly important in the determination of lifespan in daf-2 mutants (see Section 
1.4.3.).  
 
1.5.3. Nuclear-cytoplasmic shuttling of DAF-16 
 
The fluorescence observed after expression of DAF-16::GFP from transgenes 
is usually distributed cytoplasmically, but mutations in daf-2 or RNAi of daf-2 lead 
to nuclear localisation (Henderson and Johnson, 2001; Lee et al., 2001; Lin et al., 
2001). This indicates that the inhibition of daf-16 by IIS occurs through cytoplasmic 
localisation of the DAF-16 protein and that the nuclear localisation of DAF-16 under 
conditions of low IIS may be the cause of the daf-16–dependent phenotypes. 
Consistent with this, mutations in daf-18/PTEN, which suppress the longevity and 
dauer phenotypes of daf-2 mutants, also inhibit the nuclear localisation of DAF-
16::GFP in daf-2 mutants (Lin et al., 2001). Mutations in the important IIS PI3-
kinase age-1 also cause nuclear localisation at elevated temperatures (Henderson and 
Johnson, 2001). Because DAF-16 nuclear localisation is thought to occur due to 
phosphorylation by AKT-1 and AKT-2 (see section 1.4.2.), the effect of RNAi –
mediated knock-down of both kinases was tested and found to indeed cause nuclear 
localisation (Henderson and Johnson, 2001). Nuclear localised DAF-16::GFP was 
also observed in dauers of both daf-2(+) and daf-2(-) genotypes (Lin et al., 2001).  
Since DAF-16 is thought to be a stress-responsive transcription factor, the 
effects of stress on localisation were also investigated. Heat stress was found to lead 
to rapid and dramatic nuclear localisation (Henderson and Johnson, 2001) and this 
move to the cytoplasm could also be blocked by a mutation in daf-18 (Lin et al., 
2001), demonstrating that this response also occurs via IIS. Oxidative stress, through 
exposure to juglone, also led to nuclear localisation, though this effect was less 
dramatic than the one caused by heat stress (Henderson and Johnson, 2001). Even the 
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extended time spent on the agarose pads used for microscopy in C. elegans led to 
nuclear localisation (Lin et al., 2001).  
DAF-16 seems to also be very sensitive to changes in the food availability. It 
was found that starvation led to strong nuclear localisation of DAF-16::GFP but that 
this localisation was lost within ten minutes of worms being returned to plates 
containing food (Henderson and Johnson, 2001). Germline ablation has also been 
shown to extend lifespan (Hsin and Kenyon, 1999) and this effect was also found to 
be daf-16–dependent. Germline ablation also led to nuclear localisation of DAF-
16::GFP although the pattern and timing was different than for IIS mutant animals 
and those exposed to stress (Lin et al., 2001). This supports previously presented 
evidence of a non-cell autonomous role of IIS (see Section 1.4.3.) and suggests that 
intercellular signalling acts on lifespan by changing the localisation of DAF-16.  
 
1.5.4. Phosphorylation-defective DAF-16::GFP 
 
Since nuclear localisation is thought to be caused by phosphorylation through 
AKT-1 and AKT-2, the sites at which this phophorylation takes place were identified 
by homology to vertebrate homologues of DAF-16 and then mutated to make the 
protein product of a daf-16a::gfp transgene phosphorylation defective. These 
mutations  do indeed lead to nuclear localised DAF-16::GFP even in a daf-2(+) 
genetic background (Lin et al., 2001). While this mutant transgene is constitutively 
nuclear, Lin et al. report that its expression does not extend lifespan and has little or 
no effect on dauer formation, and therefore conclude that nuclear localisation of 
DAF-16 is not sufficient to cause the phenotypes associated with decreased IIS. 
Indeed, they find that daf-2 RNAi can extend the lifespan of worms carrying this 
transgene in a daf-16 mutant background, thus indicating the IIS has other effects, 
other than the phosphorylation of DAF-16 at these sites (Lin et al., 2001). However, 
a different study over-expressing phosphorylation–defective DAF-16 found a high 
degree of either dauer arrest or arrest at a non-dauer larval stage. This phenotype was 
so severe that worms of this strain had to be grown on daf-16 RNAi to maintain the 
stock (Lee et al., 2001) and no lifespan assays could be carried out. This severe 
lethality and Daf-c phenotype contrasts sharply with the results published by Lin et 
al. Whether or not nuclear localisation of DAF-16 is sufficient for the lifespan effect 
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of IIS mutants is unclear. However, several long-lived IIS mutants show very weak 
and transient nuclear localisation of DAF-16::GFP (Henderson and Johnson, 2001; 
Patel et al., 2008), either indicating that the amount of nuclear DAF-16 required for 
the effects on lifespan is small enough to be undetectable through microscopy or 
possibly that reduced IIS is affecting gene expression in a daf-16–dependent manner 
without nuclear localisation being required.  
 
1.5.5. Differences in nuclear localisation of different isoforms of DAF-
16 
 
The studies on the localisation of DAF-16::GFP described above were carried 
out using the DAF-16A isoform coded for by the daf-16a transcript. Investigation on 
the localisation of DAF-16D/F::GFP indicated that the nuclear localisation of this 
isoform in a daf-2 mutant background is not as great as that of DAF-16A::GFP. As 
with the lifespan phenotype, the question of whether this difference was due to the 
expression pattern of the isoform or due to the protein itself was investigated. In this 
case, it was found that swapping promoters had no effect on the degree of nuclear 
localisation. This demonstrates that the DAF-16D/F protein itself is less readily 
shuttled into the nucleus when IIS is reduced than the DAF-16A isoform is, at least 
in these GFP-tagged reporter constructs (Kwon et al., 2010).  
Kwon et al. then investigated whether the DAF-16A or DAF-16D/F isoforms 
were phosphorylated to the same degree by AKT-1 and AKT-2. This was done by 
testing the effects of mutations in either kinase on the lifespan of daf-16 mutant 
animals in which the daf-16 activity has been rescued by either a daf-16a  or a daf-
16d/f transgene. It was found that the effect of akt-1 on lifespan occurs mainly 
through daf-16d/f while the effect of akt-2 on lifespan occurs mostly through daf-
16a.  
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Figure 12 
From Kwon et al. Depicts DAF-16 isoforms and 
the upstream kinases that modulate the IIS-
mediated processes. The thickness of lines 
represents the strength of regulation. The dotted 
line represents minor or no regulation. 
 
 
 
 
 
Figure 12 is a graphical representation of the strength of the interactions 
between DAF-2, the kinases downstream that regulate DAF-16 and the different 
DAF-16 isoforms.  In summary, the evidence suggests different roles of the different 
isoforms of DAF-16 in the phenotypes regulated by IIS. While this is thought to be 
mediated by different expression patterns through the various promoters, evidence 
also supports preferential phosphorylation of different DAF-16 isoforms by the 
kinases.   
 
1.5.6. Regulation of targets of IIS by the different isoforms of DAF-16 
 
After these extensive efforts to identify the role of different isoforms of DAF-
16 in regulating IIS-mediated phenotypes, an interesting question that remains is that 
of how target genes are regulated by different isoforms. The differences in 
phenotypes of worms caused by expression of different isoforms of DAF-16 suggests 
either that the set of target genes regulated by the isoforms differs or that the same 
set of genes is being regulated more or less strongly in different tissues by different 
isoforms. The fact that it is possible to exchange coding sequences between daf-16a 
and daf-16b transgenes and maintain the same phenotypes supports the latter 
possibility. However, DAF-16D/F is less strongly nuclear localised than DAF-16A 
and this was found to be due to the coding and not the promoter region. Additionally, 
the DAF-16A and DAF-16D/F isoforms are preferentially phosphorylated by 
different kinases. These two findings indicate that differences in protein sequences 
may very well affect the gene sets regulated by these two isoforms of DAF-16.  
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One experiment (Kwon et al., 2010) that addresses this question involves 
regulation of a sod-3::gfp transgene frequently used to estimate DAF-16 activity. 
Over-expression of both daf-16a as well as daf-16d/f led to an increase in SOD-
3::GFP levels. However, daf-16a over-expression led to an increase in SOD-3::GFP 
in the muscle and daf-16b over-expression led to an increase in the intestine, which 
correlates with the tissue enrichment of the daf-16 transcripts themselves. While this 
experiment only addresses the regulation of a single gene, it demonstrates at least 
one example where the same gene is being up-regulated in different tissues by 
different isoforms of DAF-16. Whether or not this is how the entire set of DAF-16 
target genes is regulated by the different isoforms is unknown. An attempt to address 
this using qRT-PCR of various genes thought to be DAF-16 targets by Kwon et al. 
led to no clear pattern: some genes seemed to be co-operatively regulated by several 
isoforms but at least one was not (Kwon et al., 2010).  
 
1.5.7. The search for DAF-16 targets 
 
Besides investigating the regulation of the various isoforms of DAF-16 by IIS 
and the role of each of them in contributing to IIS phenotypes, much effort has also 
gone into identifying the downstream targets of DAF-16. Since the proximal 
determinants of ageing and longevity are thought to lie downstream of this 
transcription factor, finding genes, pathways and biological processes regulated by 
DAF-16 has become an important focus in the field.  
 
1.5.7.1. Mutational and ‘candidate gene’ approaches 
 
Given the C. elegans research community’s use of this species as a genetic 
model organism, the obvious approach towards identifying downstream effectors 
would be to carry out a forward genetic screen to identify suppressors of a daf-16–
dependent phenotype of an IIS mutant. This was done by searching for suppressors 
of daf-2(e1370) Daf-c phenotype after exposure to the mutagen EMS. In order to 
avoid merely identifying new alleles of daf-16, this screen was carried out in the 
presence of an additional copy of daf-16 in the form of a functional daf-16a::gfp 
transgene (Lin et al., 2001). However, instead of identifying downstream effectors, 
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this screen only identified four alleles of the gene daf-18, which acts upstream of daf-
16. 
Another approach involves testing genes predicted to play a role in aging 
based on existing theories of ageing. For example, the oxidative damage theory of 
ageing predicts that superoxide dismutases (SODs) should play a major role in 
determining lifespan, since they are capable of detoxifying the harmful superoxide 
radical. Since reduced insulin signalling was found to lead to increased resistance 
against oxidative stress and the superoxide dismutase sod-3 was identified as 
strongly up-regulated by daf-16 in IIS mutants (Honda and Honda, 1999), a major 
role for SODs in mediating the extended lifespan of IIS mutants was often presumed. 
More recent work suggests that the influence of SODs in the determination of 
lifespan is very small or non-existent (Gems and Doonan, 2009). Evidence 
supporting and contradicting the oxidative stress theory of ageing is discussed in 
Chapter 6. 
Another possible mechanism by which the longevity of IIS mutants may be 
achieved is through up-regulation of chaperone proteins. This is based on the 
prediction that misfolded proteins may contribute to pathology in old age. age-1 
mutants were indeed found to have higher levels of HSP16 protein small heat-shock 
protein hsp-16 (Walker et al., 2001). Molecular chaperones are regulated by the 
transcription factor hsf-1 and several studies indicate that hsf-1–dependent gene 
regulation plays an essential role in determining lifespan. Not only does loss of hsf-1 
lead to accelerated ageing (Garigan et al., 2002), but over-expression of hsf-1 was 
found to extend lifespan and the extended lifespan of daf-2 mutants was found to 
require hsf-1 (Hsu et al., 2003).  Elevated protein chaperone levels through altered 
hsf-1–dependent gene regulation may therefore be a mechanism by which IIS 
mutants delay ageing.  
 
1.5.7.2. Identifying differentially expressed genes 
 
However, a candidate gene approach assumes the existence of correct pre-
existent ideas, by no means a certainty in ageing research (see Chapter 6). A non-
biased approach was therefore needed to study the role of DAF-16. Researchers 
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turned to genome-level studies, with the aim of eventually fully characterising the 
DAF-16 –mediated changes in gene expression.  
 
1.5.7.2a Bioinformatic approaches 
 
Several attempts were made to identify DAF-16 target genes by searching the 
genome for genes linked to the daf-16 binding element (DBE). The DBE sequence 
TTGTTTAC was identified in vitro using a method in which random 
oligonucleotides were allowed to bind to the purified transcription factor, DNA-
protein complexes were isolated after gel electrophoresis and the oligonucleotides 
bound by protein were identified by sequencing (Furuyama et al., 2000). The DBE 
sequence strongly resembles the mammalian FOXO insulin-response element (IRE) 
TT(g/a)TTTT(c/g) (O'Brien et al., 1990).  
One study that used the DBE sequence to search DAF-16 target genes (Lee et 
al., 2003) identified 947 genes that contain the DBE within 1kb of their promoters 
and narrowed down this list to 17 genes known to have a clear Drosophila 
orthologue. They studied the function of these genes by using RNAi  and found that 
four affect lifespan and that two of these affect dauer formation. A second study took 
a similar approach (Ookuma et al., 2003) and identified genes which had mammalian 
orthologues and DBEs in their promoters. They ultimately discovered that the gene 
scl-1 was upregulated by mutations in daf-2 and seems to be required for the effects 
of daf-2 mutations on fat storage as well as heat and UV resistance. Some evidence 
for a weak requirement for scl-1 in mediating daf-2 lifespan extension was also 
uncovered.  
1.5.7.2b Microarray studies 
 
The first attempt to characterise global changes in the gene expression of 
long-lived mutants used differential display RT-PCR to identify changes in the 
transcriptomes of daf-2(m41) animals compared to wild-type (Yu and Larsen, 2001). 
They identified nine differentially expressed genes, which were later confirmed in 
more comprehensive studies (McElwee et al., 2003; Murphy et al., 2003) 
  In an effort to gain a more complete picture of the transcriptional changes that 
occur in long-lived mutants, microarray technology was soon applied to the problem. 
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Microarrays use thousands of DNA oligonucleotide probes anchored to the surface of 
a chip to quantify binding of specific sequences in a DNA in or RNA sample. This 
can be used to quantify expression of all transcripts and to compare expression levels 
of individual genes in two samples. Originally this was done using so-called spotted 
arrays, in which genes of interest were amplified from the genome by PCR and 
‘spotted’ onto glass. This allowed for inexpensive in-house comparison of transcript 
levels for any set of genes. Later technologies, called oligonucleotide arrays, used 
shorter probes that were directly synthesised onto the surface of the chip and were 
supplied by commercial manufacturers. The advantage of these arrays includes the 
fact that for each transcript, binding to a number of oligonucleotide probes is used to 
estimate expression levels, which prevents cross-hybridisation and facilitates more 
sensitive statistical analysis. The advantages of different platforms and the validity of 
comparing across platforms has been extensively discussed (Sherlock, 2005).  
The first microarray study (McElwee et al., 2003) compared daf-2 mutant 
animals to daf-16; daf-2 animals in order to identify those genes that are upregulated 
by daf-2 in a daf-16 dependent manner. They identified 1646 genes to be 
differentially regulated, with 602 genes up-regulated and 1044 genes down-regulated 
in daf-2 mutants compared to daf-16; daf-2 double mutants. A large number of 
stress-response genes, including heat-shock proteins, super-oxide dismutases and 
cytochrome P450s were differentially regulated by IIS through DAF-16. Out of these 
data, 35 differentially regulated genes were tested for their effects on lifespan and 
dauer formation by using RNAi to knock down expression. RNAi of only three genes 
up-regulated in daf-2 mutants were found to affect lifespan and RNAi of two of these 
led to increases, rather than decrease in daf-2 mutant lifespan.  
A second microarray study carried out by a different team (Murphy et al., 
2003) focused on avoiding false positives by comparing a number of different 
conditions. Several long-lived mutants (three alleles of daf-2, one of age-1, and one 
daf-16 over-expressing strain) were compared to wild-type animals and daf-16; daf-2 
double mutants. The authors were concerned that using a single time-point would 
lead to mis-identifying gene expression changes, since the two conditions would be 
of different biological ages (the long-lived animals age more slowly), despite being 
of the same chronological age. They therefore used a number of additional time-point 
comparisons in order to distinguish age-related changes from true daf-2/daf-16 
related changes. They used RNAi of the two genes in these comparisons.  
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Follow-up RNAi tests on 58 genes showed that 50/58 had significant effects 
on lifespan and 49/50 had effects on lifespan that matched expectation based on the 
expression level changes. RNAi of genes up-regulated in long-lived animals 
generally decreased lifespan and RNAi of down-regulated genes increased it, in most 
cases by a small percentage. This may indicate that each of these genes contributes to 
lifespan by either increasing or decreasing it and that in IIS mutants, the expression 
of these genes is either repressed or enhanced in a way that ultimately produces the 
observed Age phenotype through the sum of small effects.  
A third experiment was carried out by McElwee et al. with the more sensitive 
Affymetrix whole genome oligonucleotide array technology (McElwee et al., 2004) 
on five biological replicates. They also used two daf-2 alleles and compared daf-2 
mutants with daf-2; daf-16 mutants to identify daf-16-dependent changes in 
expression levels. The results will be discussed in the next section.  
 
1.5.7.2c Linking classes of differentially regulated genes from 
microarray studies to biological mechanisms 
 
The analysis of microarray data is clearly a complex process given the large number 
of transcripts being quantified. The analysis must take into account the large amount 
of variation found in biological systems, subtraction of background signal, and a 
statistical analysis needs to be performed that takes into account the very large 
number of comparisons being made. Even once a set of genes that exhibit 
statistically significant changes in expression levels has been identified, the question 
of what to do next is not straightforward. Especially when a large number of 
differentially expressed genes have been identified, it is difficult to know which are 
relevant to the phenotype being investigated, especially in the case of a complex and 
poorly understood phenomenon such as ageing. Here one can fall back on a 
candidate gene approach in which one looks for genes that are involved in processes 
believed to be involved in the phenotype. However, this is not ideal approach in the 
type of situation faced by ageing researchers, since the processes causing ageing 
might be truly unknown.  One approach used by McElwee et al. (2004), is to assign 
genes to different categories such as gene ontology (GO) or protein structure 
information and then ask the question: Which categories of genes are over-
represented in the set of differentially expressed genes?  
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Another resource for analysing expression data is based on the fact that 
transcripts tend to be regulated in blocks (synexpression blocks). In other words, if a 
large number of microarray experiments are carried out under different conditions, 
using different genotypes, or different interventions, one would not expect that the 
sets of differentially regulated genes are different in every experiment. Instead, genes 
will tend to be regulated jointly with other genes in these different conditions. This 
could be due the transcriptional architecture regulating them, the tissue distribution 
of their expression or other factors. In one study, over 500 C. elegans microarray 
experiments were used to identify such sets of genes, and the data was displayed as a 
terrain map (topomap) in which clusters of jointly regulated genes formed 
‘mountains’, numbered 1-43. Some of these were identified to consist of genes 
expressed mostly in certain tissues, such as the intestine (mount 8), genes involved in 
specific biological processes, such as lipid metabolism (mount 21), or those 
expressed during specific stages, such as the dauer (mount 15) (Kim et al., 2001). 
This data can now be used in the analysis of other microarray experiments in order to 
identify any sets of genes that are differentially regulated, which may help identify 
biologically relevant changes.  
 
Tissue specificity 
 
A large proportion of the genes identified by analyses of IIS regulated genes 
(McElwee et al., 2004) are intestinally expressed and map to the so-called intestinal 
‘topomountain’, mount 8. As mentioned earlier in this chapter, IIS seems to act in 
both neurons and the intestine to extend lifespan and the relative importance of these 
tissues is not completely clear. While neuronal expression of daf-2 was shown to be 
sufficient to rescue the lifespan effects of daf-2 mutants (Wolkow et al., 2000), 
intestinal expression of DAF-16 was found to extend daf-16 mutant lifespan by up to 
60% (Libina et al., 2003) in a daf-2 mutant background. In this context, the finding 
that intestinally expressed genes are over-represented in the set of genes 
differentially regulated by IIS seems to support a central role of the intestine in 
mediating the daf-2 Age phenotype.  
The reasons behind the central role of the intestine in the determination of 
lifespan are unknown, but even the effects of germline loss on lifespan were found to 
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be dependent on intestinal daf-16 activity (Libina et al., 2003). It is possible that the 
intestine’s role as the primary fat storage organ of C. elegans (Ashrafi et al., 2003; 
Kimura et al., 1997) makes it an important tissue for metabolism. This is supported 
by the finding that over-expression of D. melanogaster FoxO in fat-body is sufficient 
to extend fly lifespan (Giannakou et al., 2004; Hwangbo et al., 2004) and that mice 
lacking the insulin receptor in fat tissue were also long-lived (Bluher et al., 2003). 
Alternatively, if lifespan determination is in fact tightly linked to an animal’s ability 
to deal with damage and stress, then the intestine could be of great importance due to 
its direct contact to food and to xenobiotics. Another explanation could be that the C. 
elegans intestine functions as a pancreas and secrets an insulin-like signal in 
response to food. Indeed, the mammalian pancreas and C. elegans intestine are both 
endodermal organs and the ability of the pancreas to secrete insulin is regulated by 
the insulin receptor (Kulkarni et al., 1999), just as IIS signalling seems to mediate an 
intercellular signal emitted from the C. elegans intestine (Libina et al., 2003; Murphy 
et al., 2007).  
Overlap with dauer transcriptome 
 
A number of similarities between the Daf-c and Age phenotypes of IIS 
mutants suggests that the same mechanisms may be causing both these phenotypes. 
These similarities include the fact that many, if not most, long-lived IIS mutants 
show a constitutive dauer phenotype, that the lifespan phenotype, like the IIS Daf-c 
phenotype, is completely dependent on daf-16 and that dauers are very long-lived. 
These similarities strongly suggest that ageing might be delayed in adult IIS mutants 
due to a mis-expression of a dauer longevity program. Indeed, microarray analyses 
show a strong overlap between the dauer transcriptome and that of long-lived IIS 
mutant adults (McElwee et al., 2003; McElwee et al., 2004; Wang and Kim, 2003).  
 
Functional genomics 
 
Microarray data from IIS mutants is often mined for genes thought to be 
responsible for IIS Age based on existing theories of ageing. This includes stress 
response genes such as superoxide dismutases (Honda and Honda, 1999) and heat-
shock proteins (Walker et al., 2001) both of which are indeed up-regulated in 
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microarray studies (McElwee et al., 2004; Murphy et al., 2003). However, combing 
through microarray data and ‘fishing’ for certain classes of genes from the long lists 
generated through microarray experiments is a flawed approach, since it invariably 
leads to finding support for existing theories. Given that the true causes of the 
lifespan extension remain unknown, expression data needs to be analysed in a more 
unbiased fashion (Gems and McElwee, 2003).  
Using data from their own oligonucleotide array analysis (McElwee et al., 
2004) and another study on dauer gene expression (Wang and Kim, 2003), McElwee 
et al. used EASE analysis to identify categories of genes (using Interpro protein 
classes, Gene Ontology categories and gene sets from other microarray experiments) 
that are over-represented in the differentially expressed gene set of long-lived IIS 
mutants and of dauers. This led them to the identification of cellular detoxification 
processes as up-regulated in both longevity contexts. They went on to propose that C. 
elegans can delay ageing by up-regulating a large number of enzymes with roles in 
removing toxins that would otherwise accumulate and cause ageing.  The up-
regulated enzymes include those involved in phase I and phase II cellular 
detoxification, such as glutathione-S-transferases, cytochrome P450s, short-chain 
dehydrogenases/reductases and UDP-glucuronosyltransferases. This suggested to the 
authors that ageing might be caused by molecular damage that is at least partly 
caused by toxic compounds that can be removed by enzymes involved in cellular 
detoxification, also called drug metabolising enzymes (DMEs) or collectively 
described by the term “xenobiotic metabolism”. Supporting this idea, at least one 
glutathione-S-transferase (gst-10) can extend lifespan by detoxifying 4-
hydroxynonenal, a product of lipid peroxidation (Ayyadevara et al., 2005a; 
Ayyadevara et al., 2005b). Moreover, over-expression of skn-1, a transcription factor 
known to regulate phase II detoxification enzymes, also extends lifespan and the daf-
2 Age phenotype is partly skn-1 dependent (Tullet et al., 2008).  
 
1.5.7.3. Identifying direct regulatory targets of DAF-16 
 
Given the large number of genes that are differentially regulated by IIS, 
identifying the effectors of lifespan extension has proven to be difficult. In addition, 
given the large number of genes that probably work together to affect lifespan, 
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finding ways to test any emerging theory is technically challenging. This problem 
can be illustrated using the detoxification theory of ageing described above, based on 
which we can make certain predictions: If the cellular detoxification system 
contributes to the extended lifespan of daf-2 mutants, then daf-2 mutant lifespan 
should be reduced when the up-regulation of these enzymes is abolished. However, 
given the large number of detoxification genes that are up-regulated in insulin 
signalling mutants, one would expect that each makes an only small contribution to 
the extended lifespan. Given the technical limitations of even the comparatively 
simple method of RNAi knock-down of C. elegans genes, only a small number of 
them can be knocked-down at any time and tested for suppression of the daf-2 Age 
phenotype. Clearly, only small reductions in daf-2 lifespan would be expected from 
such experiments, and even here we are assuming that there is no redundancy in the 
roles of these enzymes in lifespan determination, which, if present, would only 
exacerbate the problem. Experiments to test suppression of daf-2 longevity by RNAi 
of detoxification enzymes that are up-regulated in daf-2 mutants were in fact carried 
out and only in a few cases could even a small reduction of daf-2 lifespan be 
observed (Weinkove and Gems, unpublished results). Similarly, in earlier lifespan 
assays carried out using RNAi of candidate genes found to be up-regulated in daf-2 
animals compared to daf-16; daf-2 double mutants, very few of the genes tested had 
any effect on lifespan, and most of those that did were not found to affect lifespan in 
the right direction (McElwee et al., 2003). In sharp contrast, most of the genes tested 
by RNAi in (Murphy et al., 2003) did seem to affect lifespan as one would expect 
from the change in transcript levels.  
A large step forward for the field of ageing research would be to resolve the 
topology of the network of transcriptional regulation downstream of DAF-16. 
Greater understanding of how different subsets of genes are regulated would give 
researchers better tools to test which sets of genes affect lifespan. This could be done 
by up-regulating or knocking down downstream regulators or by interfering with 
feed-back loops or intercellular signalling. One way to make inroads into the 
unchartered territory downstream of DAF-16 would be to identify those differentially 
regulated genes that are direct targets of DAF-16. Presumably not all of the 
approximately 2000 genes differentially regulated by IIS (McElwee et al., 2004), are 
direct targets. Identifying them could make the task of finding the genes relevant for 
mediating daf-2 longevity more tractable, as one would presumably be left with a 
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smaller number of genes with a more important role in ageing. Two attempts to do 
this will be discussed here.  
 
1.5.7.3.1. Identifying direct targets by chromatin 
immunoprecipitation 
 
Chromatin immunoprecipitation can be used to test for binding between a 
known protein and genomic DNA. This is achieved by cross-linking proteins and 
DNA, fragmenting the DNA through sonication, using an antibody against the 
protein of interest for immunoprecipitation, and then isolating the DNA that was 
bound to it. This was done using an antibody against endogenous DAF-16 (Oh et al., 
2006) and the DNA was subsequently cloned and sequenced. This allowed the 
researchers to identify 130 C. elegans genes as linked to a DAF-16 binding site.  
While there is not much overlap between the 130 genes identified by Oh et al. 
and lists of differentially expressed genes obtained from microarray data (9 of them 
up- and 1 down- regulated in data used for (McElwee et al., 2007; Schuster et al., 
2010)), the authors performed qRT-PCR and found that more than half of the genes 
were either up- or down-regulated in daf-16 mutant compared to wild-type animals. 
Knock-down of candidate genes by RNAi led to both increases and decreases in daf-
2 lifespan, in fat content and in dauer formation, but these effects rarely correlated 
with the changes in expression observed by qRT-PCR.  
 
1.5.7.3.2. Dam Identification 
 
A second approach to identifying direct targets of DAF-16 was carried out 
through Dam identification (DamID) using a daf-16::dam fusion construct (Schuster 
et al. 2010). The principle of this approach is to create a fusion of DAF-16 with the 
bacterial Dam methylase, which methylates the site GATC. Binding of this fusion to 
the genome causes nearby GATC sequences to be methylated, thereby creating 
restriction sites for the enzyme DpnI. DpnI digestion can then be used to isolate 
DNA to which the construct binds. In this study, the animals were treated with daf-2 
RNAi to ensure the nuclear localisation DAF-16::Dam and methylated DNA was 
subsequently hybridised to whole genome tiling arrays in order to identify areas of 
DAF-16 binding in the genome (see Figure 13). The authors then cross-referenced 
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this data to that from their previous microarray analysis in order to identify genes 
that are both differentially regulated by IIS and direct targets of DAF-16.  
 
 
 
This study identified a large number of sites in the genome to which DAF-16 
seems to bind, but only a small subset of these (a total of 65 genes) are also 
differentially regulated by IIS. EASE analysis of the data indicates that genes 
involved in somatic maintenance, including cellular detoxification enzymes such as 
glutathione S-transferases and cytochrome P450s, are not overrepresented among 
these 65. It is possible that these processes may be regulated indirectly by DAF-16 
through one of its targets. The analysis also demonstrates that DAF-16 acts primarily 
as a transcriptional activator and not a repressor, as genes up-regulated by reduced 
IIS were overrepresented in the list of direct targets but down-regulated ones were 
not.  
The 65 genes that are differentially regulated by IIS and that are also directly 
bound by DAF-16 define three classes of targets, although many targets fall into 
neither of these classes. The first group of genes up-regulated by direct binding of 
DAF-16 are transcription factors. This finding may help explain why such a large 
number of genes are differentially regulated by IIS in a daf-16–dependent manner 
while a relatively small number seem to be direct targets. It seems possible that 
Figure 13 
(Schuster et al., 2010) 
Schematic describing the procedure 
to identify DAF-16 targets via 
DamID.  
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changes in the expression levels of even a small number of transcription factors 
could lead to large changes in the transcriptome of an organism. The second group 
are members of the IIS pathway itself, including akt-1, akt-2, the ist-1 insulin 
receptor substrate, and possibly even daf-16. This suggests a feed-back mechanism 
by which sensitivity of IIS is increased by DAF-16 when IIS signalling is low. Other 
signalling proteins known to activate DAF-16 also seem to be up-regulated. A third 
set of genes over-represented in this list of 65 are those associated with carbohydrate 
metabolism, which fits the role of DAF-16 in the response to starvation (Weinkove et 
al., 2006) as well as the altered metabolism found in the dauer stage.  
 
1.6. Using a ferritin reporter to screen for transcription 
factors regulating gene expression downstream of IIS  
 
Clearly, significant progress is slowly being made in unravelling the topology 
of the transcriptional network downstream of DAF-16. This progress should 
eventually lead to an understanding of how reduced IIS extends lifespan in C. 
elegans and will hopefully also play a part in finally understanding what biochemical 
or physiological processes are the cause of ageing.   
The total number of genes differentially regulated by DAF-16 has been 
estimated to be as high as 10% of the C. elegans genome (McElwee et al., 2004). 
This alone suggests that other signalling proteins (including many transcription 
factors) are probably involved in mediating the response. The recent finding by 
Schuster et al. that many direct targets of DAF-16 are transcription factors and 
signalling proteins supports this view (Schuster et al., 2010).  
The methods to investigate the activity of DAF-16 described above all work 
by somehow manipulating DAF-16 and examining the downstream consequences. In 
the microarray studies, DAF-16 is activated by mutations in IIS and this condition is 
compared to a strain in which DAF-16 is inactivated. In the study using DamID, 
DAF-16 was tagged with a methylase and genomic locations at which DAF-16 
binding sites were identified through the increased methylation found at such sites. 
This could be described as a ‘top-down’ approach: DAF-16, which crowns an IIS–
dependent transcriptional network, is manipulated in order to learn more about the 
network downstream of it. In this project, I took a different, one could call it a 
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‘bottom-up’, approach to the problem: I identified a gene that is highly regulated by 
IIS in a daf-16-dependent manner and then carried out an RNAi screen to identify 
transcription factors that play a role in this induction.  
1.7. Aims 
 
The root causes of the ageing process are unknown both in simple organisms 
such as C. elegans as in humans. The existence of long-lived single gene mutants of 
C. elegans provides a powerful model for unearthing these causes. To date, important 
discoveries include the finding that reduction in insulin/IGF-1 signalling (IIS) 
extends lifespan and that the effects of these longevity-inducing IIS mutations occur 
through the actions of the transcription factor gene daf-16. Numerous attempts at 
identifying the downstream targets of daf-16 have been carried out. A very large 
number of transcripts have been identified that are differentially regulated in long-
lived mutants via daf-16, but it has not been possible so far to pin the effects of the 
IIS pathway on ageing on distinct biological processes. Studies of direct binding of 
the DAF-16 protein to chromatin have suggested that DAF-16 acts as a regulator of a 
number of key signalling proteins and therefore may exert its effect on ageing 
through manipulating a large number of downstream signalling cascades.  
 The aim of this project was to help identify transcription factors that act in 
concert with DAF-16 to regulate downstream targets genes. This would help shed 
light on the mechanisms by which DAF-16 affect the expression of so many genes 
and allow for a more nuanced approach to the investigation of the causes of IIS 
mutants’ daf-16-mediated longevity phenotypes.   
This was done by creating a transcriptional GFP transgene that is highly 
induced by reductions IIS in a daf-16-dependent manner. I induced the transgene’s 
expression by crossing it into a daf-2 mutant background and then monitored GFP 
expression or worms picked into wells of a microtitre plate using a platereader. I then 
carried out an RNAi screen of over 800 genes encoding putative transcription factors 
to identify ones that may be involved in this induction. Candidate genes could then 
be tested for their role in determining IIS mutant longevity.  
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Chapter 2: Materials and Methods 
2.1 General methods and C. elegans stock maintenance 
 
Worms were grown on 60mm or 100mm tissue culture plates containing 
nematode growth medium (NGM), an agar and nutrient mix, and seeded with the E. 
coli strain OP50 (Brenner, 1974). OP50 is a uracil auxotroph and NGM is uracil –
limited, which prevents the bacterial lawn from overgrowing and obscuring the 
worms. When RNAi was used to knock down gene transcripts, the agar was 
supplemented with 1mM IPTG and 20mg/L carbenicillin and the strain of E. coli 
used was HT115, not OP50. Both HT115 and OP50 strains were obtained from the 
CGC (Caenorhabditis Genetics Center, University of Minnesota).  
Stocks were maintained by periodically transferring 3-10 gravid adults to 
fresh plates or by cutting a section of agar from one plate and placing it upside down 
on a fresh plate (chunking), thus allowing the worms to leave the agar and crawl onto 
the fresh lawn of E. coli. The worms were transferred to plates or microtitre wells 
using a thin platinum wire (worm pick). When picking worms, the end of the pick is 
covered in E. coli from the bacterial lawn and is then used to lift worms off the agar.  
 
2.1.1. Lifespan analysis 
 
In many experiments, the effects of different genetic mutations as well as of 
RNAi and pharmaceutical treatments on lifespan were tested. This was done by 
placing 25-30 L4 animals on fresh plates and recording all deaths. Plates were 
monitored approximately every 2 days. Any animals that could not be made to move 
by repeatedly tapping the plate were directly prodded using a pick. If no movement 
was seen after repeated prodding, the worm was scored as dead. Animals lost, found 
on contaminated plates, or ones that died of causes unrelated to ageing were scored 
as ‘censored’, which was taken account of during statistical analysis. Worms that 
dried out on the sides of plates and those that burst from progeny production are 
examples of deaths that were censored.  
Worms were generally transferred to fresh plates at least once a week, 
although the details of transferring schedules varied depending on the assay. 
Lifespan assays performed to test the effects of RNAi treatments on lifespan were 
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always transferred at least once a week to maximise RNAi efficacy. When FUdR (5-
fluoro-2'-deoxy-uridine) was not used to prevent progeny formation, the animals 
were transferred several times during the first week of adulthood in order to 
eliminate progeny.  
 
2.1.2. Drug treatment 
 
Some lifespan assays required the use of drugs. FUdR was often added to prevent 
progeny production and N-acetyl cysteine (NAC) was added to test its effects on 
lifespan. In both cases, the drug was added topically to the solidified, cooled agar 
after pouring but before seeding with E. coli. FUdR was used at a final concentration 
of 10µM. NAC was added to a final concentration of either 5mM or 1mM.  
 
2.1.3. Genetic crosses 
 
New strains are often generated by crossing two existing strains. Males were 
generated either by mating mutant hermaphrodites with males from a wild-type male 
stock, or by heat-shocking hermaphrodites. Heat-shock increases the incidence of 
non-disjunction of the X-chromosome during meiosis and therefore leads to a higher 
incidence of males. 5-15 L4 hermaphrodites were exposed to 31oC for six hours and 
the progeny of these animals were then screened for males. These were then mated 
with hermaphrodites of the same strain in order to create a population rich in males.  
 
2.1.4. Alkaline hypochlorite treatment 
 
This method was used frequently and for a variety of reasons. Stocks  often  become 
contaminated with foreign microorganisms, like bacteria, yeast and fungi, which 
need to be removed. Axenisation of stocks by alkaline hypochlorite treatment works 
by exposing worms to bleach, which dissolves the parent, kills any contaminants, but 
leaves the eggs unharmed. This is also essential when animals are transferred from 
OP50 bacteria to HT115 RNAi bacteria, since carrying over OP50 to RNAi plates 
needs to be avoided.  
 
 77 
Protocol: 
 
1. Gravid adults washed off plates using M9 buffer and pipetted into a 1.5mL 
capped tube.  
2. After the adults settle (~1min), the supernatant is removed, leaving 200µl of 
M9 and worm pellet in the tube.  
3. 125µl of a 7:8 solution of sodium hypochlorite (Sigma) and 4M NaOH is 
added and the contents of the tube are mixed by inversion. The tubes are left 
at room temperature (not held in hand) for four minutes, during which they 
are mixed (by gentle flicking) about once a minute.  
4. After four minutes, the reaction is stopped by filling the tube with M9. Eggs 
are pelleted immediately by centrifuging at 1000g on a table-top centrifuge.  
5. The supernatant is removed and replaced by more M9. After gentle mixing, 
the sample is again centrifuged at the same settings. This washing step is 
repeated three or four times to remove any remaining bleach.  
 
The method is also used to purify eggs, which is necessary for some experiments, 
since it synchronises the progeny. However, the synchronisation is not perfect, since 
some of the embryos will be further developed than others. An improved 
synchronisation is achieved by leaving the eggs in M9 overnight. This allows all 
eggs to hatch, but because they lack food, the L1s cannot develop any further. These 
arrested L1s can then be pipetted onto seeded plates. The time left in M9 varied 
depending on the temperature they were incubated at. At 20oC, eggs were left in M9 
overnight and at 15oC they were left for 36h.  
 
2.2. Transgenesis via microinjection 
 
Needles were pulled from borosilicate glass capillaries (Harvard Apparatus) 
using a P97 micropipette puller (Sutter Instrument Company). Injection pads were 
made by placing a drop of hot 2% agarose on a glass coverslip and then covering the 
drop with a second coverslip. After the agarose solidified, the coverslips were pealed 
apart and the pad was left in the 37°C oven overnight.  
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 For the microinjection itself, I used an inverted microscope, model DM IRB 
(Leica) with Nomarski optics and a 40x Nomarski non-oil immersion objective. This 
microscope was equipped with a micromanipulator (Leica) and a Picospritzer II 
pressurized injection system (General Valve Corporation) with a needle holder. 
Pressurized nitrogen gas was used for injections. Worms were manipulated and 
placed onto the injection pads on a dissecting microscope before being moved to the 
inverted microscope for injection. 
A drop of mineral oil (Sigma) was placed on the injection pads and single 
worms were placed into the oil. Young adults with few or no eggs in the uterus were 
placed in the oil and either left to sink to the bottom of the drop or gently pressed 
down using a platinum pick. Once the animals come into contact with the surface of 
the injection pad, they usually stick to it quite strongly.  
The coverslip was then moved onto the inverted microscope. The 40x 
objective was used to find the syncytial gonad and the plane of focus was adjusted so 
that the nuclei at the periphery of the gonad arm were in focus. The needle is then 
brought down until it too is in focus, which ensures that the injection is occurring at 
the correct vertical level. The needle was then injected into one of the gonad arms 
and the DNA solution was injected. This was repeated for the other gonad arm if 
possible.  
When the injection was completed, the needle was lifted out of the oil and the 
coverslip was moved to the dissecting microscope. There, a drop of M9 solution was 
quickly dropped on top of the worm and into the oil. This leads to the animal 
detaching from the agarose pad and reviving in the M9 solution. Animals were then 
picked out of the drop of M9 using a platinum pick, placed singly onto seeded NGM 
plates, and left to recover and lay eggs at 20°C. Around 20 – 40 animals were 
injected for each transgene.  
Worms were injected with a mix of the reporter construct and a plasimid 
containing the lin-15(+) coding sequence. Three days after injection, F1 progeny 
were scored for either the absence of the Muv phenotype or the presence of the Rol 
phenotype. As lin-15(-) animals were used for injection and all lin-15(-) animals 
exhibit the Muv phenotype when grown at 20°C, non-Muv animals were transgenics 
expressing the lin-15(+) copy from the plasmid that was coinjected alongside the 
fusion PCR product. Not all F1 transgenics are generally capable of transmitting the 
transgene, so F1 animals were picked singly onto NGM plates and left to lay eggs at 
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20°C. Plates were screened three to four days later for non-Muv F2 animals. Once 
found, a new transgenic line was established.  
 
2.3. Transgene integration  
For the integration of the extrachromosomal array into the genome of C. 
elegans, around 130 animals at the L4 stage were picked onto a 10cm plate on NGM 
(containing 2x peptone) seeded with OP50 bacteria. These worms were then exposed 
to 40 Gy of X-ray radiation. This was carried out at the Department of Immunology 
and Molecular Pathology and Department of Infection (UCL, Windeyer Building). 
X-ray irradiation of worms carrying an extrachromosomal array causes the 
array to become integrated in the genome of only a small fraction of their offspring. 
A selection process is therefore used to facilitate their identification. Most of the 
offspring of irradiated worms carry the transgene as an extrachromosomal array pass 
it on to their offspring with a transmission rate of around 60-70%, in the case of the 
wuEx135 array. The few integrants among them, however, pass it on 100% of the 
time. This means that the integrants have 100% non-Muv offspring while the non-
integrants will have mixed Muv and non-Muv offspring. Because Muv animals have 
reduced fertility compared to non-Muv animals, letting them compete for a number 
of generations should cause the integrants to become more common. Ten sets of ten 
irradiated animals were therefore left to compete for a number of generations. Using 
this selection process, non-Muv animals picked in the end were far more likely to be 
integrants than if selection had not been used.  
 After irradiation, ten non-Muv adult hermaphrodites were picked onto each of 
ten 10cm NGM (2x peptone) plates seeded with OP50 bacteria and left at 20°C until 
several generations had passed and no food (OP50 bacteria) was left on the plates. A 
large piece of agar from each of the ten plates, presumably containing several 
hundred animals, was transferred to fresh seeded 10cm plates. Once these new plates 
had run out of food, they too were chunked onto fresh, seeded, 10cm plates.  
Fifteen adult animals from the next generation were then picked from each of 
the ten plates onto 150 individual seeded (6cm) NGM plates. The plates were then 
left at 20C. Four days later, the progeny were screened for the Muv phenotype. 
Integrants were identified because 100% of their progeny had a wild-type appearance 
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(100% non-Muv). Three independent integrants of the wuEx135[Pftn-1::GFP, lin-
15(+)] transgene were identified. The two alleles wuIs176[Pftn-1::GFP, lin-15(+)] 
and wuIs177[Pftn-1::GFP, lin-15(+)] were outcrossed to the parent strain MT1642.  
 
2.4. Microscopy  
2.4.1. Preparing slides  
2% w/v agarose was made using dH2O. One or two drops of agarose were placed on 
a glass slide and quickly covered with a second slide. Spacers were used ensure that 
the layer of agar formed was of consistent thickness. The top slide was removed after 
several minutes and the microscopy pad was used immediately.  
A few drops of 0.06% w/v levamisole were then added to the agarose pad and worms 
were picked into the drop, which immediately anaesthetised them. A coverslip was 
then carefully placed over the pad.   
2.4.2. Fluorescence quantification  
Images of GFP expressing worms were taken using a Leica DMRXA2 microscope 
using the 10x objective. Images were taken both using brightfield and 
epifluorescence using a GFP filter cube (Excitation: 470/40; Emission: 525/50) and a 
Hamamatsu C10600 digital camera. In order to quantify the GFP fluorescence, the 
Volocity software package (Improvision) was used. A protocol was set up in which 
the GFP image was searched for objects whose fluorescence intensity exceeded a set 
threshold. This threshold was manually set to fit the intensity of the fluorescent 
signal and fluorescence below this threshold was ignored. The strains used expressed 
GFP containing a nuclear localisation signal in the intestine, meaning that the GFP 
signal was clearly distinguishable by eye from intestinal autofluorescence. I was 
therefore able to adjust the threshold to a high enough level to detect only GFP, 
which was nuclear, and not autofluorescence. Using this protocol, the Volocity 
software was therefore able to recognise fluorescent objects (nuclei) in the intestine 
of the worm and quantify their intensity. The fluorescence intensity for all ‘objects’ 
in a worm was then added to quantify the levels of GFP expression for each worm 
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separately.  Within any experiment, the threshold was kept at the same level, 
enabling me to compare fluorescence across strains and treatments.   
2.5. Molecular biology 
2.5.1. RNA extraction  
Animals washed off the plates were then washed in M9 to remove bacteria.  
200µl of worm pellet and M9 were added to 800µl of Trizol reagent in a tube of 
Lysing Matrix D (MP Biomedicals). The tube and its contents were then immediately 
frozen in liquid nitrogen. A Ribolyser (Hybaid) was then used to homogenise the 
samples in the lysing matrix tube. Homogenisation was carried out at setting 6.5 for 
two periods of ten seconds. The tubes were then left at room temperature for five 
minutes before 200µl of 1-bromo-3-chloropropane (BCP) was added and the tubes 
were vortexed for fifteen seconds. The tubes were then incubated at room 
temperature for three minutes, and then centrifuged at 4°C for 15 minutes at 16000g 
to separate phases. Sterile, RNAse free Eppendorf tubes were prepared on ice and the 
aqueous upper layer of the centrifuged tubes was pipetted directly into the chilled 
tubes.  
 500µl of isopropanol and 1µl of the co-precipitant GlycoBlue (Ambion) at 
15mg/ml was then added, carefully mixed and then incubated at room temperature 
for ten minutes to precipitate RNA. RNA was then recovered by centrifugation at 
4°C for ten minutes at 22000g. The aqueous solution remaining was then carefully 
pipetted away from the pellet. 100µl of 75% ethanol was added, the tubes were 
briefly vortexed to wash the pellet, and then spun at 4°C for five minutes at 6300g. 
The supernatant was then carefully removed and the pellet air-dried for five to ten 
minutes. The pellets were then dissolved in sterile water by incubating at 60°C for 
ten minutes.   
2.5.2. RNA quantification  
The Invitrogen Quant-iT TM RiboGreen RNA Assay Kit was used to quantify 
RNA levels for the qRT-PCR assays. This was done using the high range assay 
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described in the manufacturers instructions. Briefly, a standard curve was prepared 
using a 2µg/mL solution of ribosomal RNA. Each RNA sample was diluted 1000x to 
10 000x and then added, in triplicate, to wells of a black sided, clear bottom 
microtitre plate. A working solution (20x dilution of stock solution) of Quant-iT 
RiboGreen RNA reagent was then added to the wells in equal volume to the RNA 
dilution. After a 5-minute incubation period, the fluorescence of these samples was 
measured (wavelengths: excitation 480nm, absorbance 520nm). The standard curve 
was used to calculate the relationship between fluorescence and RNA concentration 
and the concentrations of the RNA samples, so long as their fluorescence fell within 
the bounds of the standard curve, were calculated by interpolation. If the 
fluorescence of any samples did not fall within the standard curve, then the initial 
dilution of the RNA sample was adjusted and the assay was repeated.  
2.5.3. DNAse I treatment  
Amplification grade DNaseI (Invitrogen) was used to remove any contaminating 
genomic DNA from the isolated RNA. 1µg of RNA, manufacturer supplied reaction 
buffer and DNAseI were incubated at room temperature for 15min. To inactivate the 
DNaseI, EDTA was added to a final concentration of 2.3mM and the reaction was 
heated to 65oC for 10min. The resulting DNA-free RNA was then used for cDNA 
synthesis. The samples of daf-2 and daf-16; daf-2 animals prepared for semi-
quantitative RT-PCR were not DNAseI treated.  
 
2.5.4. cDNA synthesis 
 
cDNA was synthesised using SuperScript II reverse transcriptase 
(Invitrogen). The following components were added to a nuclease-free 
microcentrifuge tube: 1µl Oligo(dT) (Invitrogen) at 500µg/ml, 500ng to 2µg of total 
RNA (kept consistent within experiments) from RNA extraction described above, 
1µl dNTP mix at 10mM each, sterile water made up to 12µl. These were then heated 
at 65°C for 5 minutes and then immediately chilled on ice.  
 Contents of the tube were then collected by centrifugation and the following 
components added: 4µl First Strand Buffer (Invitrogen), 2µl 0.1M DTT, 1µl 
RNaseOUT (Invitrogen) and 1µl of SuperScript II. Contents were then gently mixed 
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and incubated at 42°C for 52 minutes. The reaction was then inactivated by 
incubating the tubes at 70°C for 15 minutes.  
 
2.5.5. Semi-quantitative rtPCR 
 
 Semi-quantitative PCR reactions from cDNA templates were performed to 
estimate the differences in expression of ftn-1 and sod-3 between daf-2 and daf-16; 
daf-2 mutants. Primers for these reactions were designed to anneal to exon-exon 
boundaries in order to exclude amplification from genomic DNA.  
To estimate this change in expression, two parameters needed to be evaluated 
for each set of primers: the number of PCR cycles required and the template 
concentration. It is important to use an initial template concentration that lies within 
the central portion of the linear phase of the amplification reaction, as this will allow 
the detection of both increases in template concentration (ie.: upregulation of the 
gene) and decreases (downregulation). An appropriate PCR cycle number also needs 
to be found.   
 The optimal cycle numbers for the ama-1, ftn-1 and sod-3 reactions were 
established by running the PCR reactions using the same template concentration at 9 
different cycle numbers from 23 to 43. The resulting bands were quantified and the 
linear phase established by plotting the intensities. A cycle number was picked for 
each primer pair (for ama-1, ftn-1, sod-3) that fell within the central portion of the 
linear phase. Next, PCR reactions using this cycle number for each of the three 
primer pairs were set up 8 different template concentrations. The intensities of the 
resulting bands were quantified and plotted on a graph. An appropriate cDNA 
concentration was chosen from the linear phase of this response curve for each the 
three primer pairs.  
 The changes in expression levels of ftn-1 and sod-3 were evaluated through 
the use of expression levels of ama-1, which codes for the large subunit of RNA 
polymerase II, as a reference gene. Assuming the levels of ama-1 transcript remain 
constant, changes in the expression of other genes can be estimated by looking at 
changes in the genes’ expression as a proportion of ama-1 expression.  
 PCR reactions were set up with optimised template concentrations and cycle 
numbers for each primer pair. These factors were of course kept constant between 
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the two different samples (two different genotypes) of each primer pair. Two 
replicates of each PCR reaction were run. The product was then run on a 1% agarose 
gel and the band intensities were quantified. The intensities were then normalised 
using the intensities of the ama-1 bands. The mean of the two replicates was used in 
all cases and the results graphed in Figure 19. 
 
2.5.6. Quantification of transcripts by quantitative RT-PCR 
 
Quantitative reverse transcription PCR (qRT-PCR) is a method to quantify a 
DNA template that usually takes advantage of one of several dyes that fluoresce 
when bound to double stranded DNA. This is achieved by monitoring the 
amplification of the template by measuring fluorescence during the course of the 
PCR reaction. Here, a system using the SybrGreen dye was used (Fast SYBR Green 
Master Mix –Applied Biosystems) to quantify cDNA and therefore the RNA 
transcript it was derived from. This was done using the 7900HT Fast Real-Time PCR 
System (Applied Biosciences).  
cDNA was pooled from all samples being tested and this cDNA pool was 
then used to create a standard curve consisting of two technical replicates for each of 
five ten-fold dilutions. A standard curve was included with each qRT-PCR plate and 
each primer pair. cDNA from each sample being tested was then used to set up 
reactions on the same plate in triplicate. After running the reaction, the relative 
transcript quantities in each reaction were calculated by determining the cycle 
number at which the amplification curves crossed a manually set threshold (Ct 
value). This threshold was set manually in order to ensure that all amplification 
curves crossed it within their exponential phase. The Ct value for each reaction was 
then converted to transcript quantities using the standard curve. The mean of three 
technical replicates was calculated to obtain the transcript quantity for each sample.  
Transcript quantities need to be normalised for the total amount of cDNA 
present. While this is at least partly achieved by using equal amounts of RNA for all 
cDNA synthesis reactions, this alone has been found to be insufficient since total 
RNA levels are not a good estimate of total mRNA levels (Johnson et al., 1995; 
Solanas et al., 2001; Spanakis, 1993). Additional normalisation is therefore required. 
The preferred method is to quantify other transcripts (so-called reference genes) as a 
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way to normalise for cDNA input. The quantity of reference gene transcript is then 
used as a normalisation factor and dividing the quantity of the transcript of interest 
with this factor then results in a more accurate estimate of the true relative expression 
level. The transcripts used for the normalisation needs to be stably expressed, since 
any variations in the reference gene levels from sample to sample would result in 
artefactual findings. For qRT-PCR assays performed here, four different reference 
genes were tested. The first is ama-1, which codes for the large subunit of RNA 
polymerase II, and was used for this purpose in the Gems lab before my arrival. The 
other three, Y45F10D.4, pmp-3, and cdc-42, were recommended in a study that 
analysed 500 C. elegans microarray experiments and identified a set of stably 
expressed genes (Hoogewijs et al., 2008).  
The GeNorm algorithm (Vandesompele et al., 2002) was then used to 
compare the four reference genes used and rank them according to their stability. 
This algorithm compares the stability of expression of all reference genes tested by 
calculating the average pair-wise variation of each transcript with all other 
transcripts. The geometric mean of the three most stably expressed transcripts was 
then used as a normalisation factor to control for cDNA input. Relative ftn-1 
expression was calculated as a ratio of ftn-1 transcript quantity to this normalisation 
factor.  
qRT-PCR conditions 
 
The basic setup of qRT-PCR reactions consisted of  
5µl 0.1x cDNA 
10µl 2x Fast SYBR Green Master Mix (Applied Biosystems) 
x µl fwd primer 
x µl rev primer 
made up to 20µl with H2O.  
The amounts of primer added differed depending on the primer pair.  
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Table 1 
Primer amounts used for 
qRT-PCR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All qRT-PCR reactions were run using the following cycling conditions:  
 
1. 95oC 20 sec 
2. 95oC 1 sec 
3. 60oC 20 sec 
 
Stages 2. to 3. were repeated for 40 cycles 
 
 The product of a qRT-PCR reaction is never run out on an agarose gel, since 
the only point of interest is the rate at which the product is formed, not its size. A 
danger is that non-specific amplifications cannot be distinguished from the target 
gene cDNA. This is a possible source of inaccuracy, since different samples may 
have different proportions of non-specific product. This can be partly controlled for 
by including non-template control reactions that are run with every qRT-PCR plate. 
If amplification occurs when no cDNA was added, then this is clear evidence for 
non-specific amplification. However, adding the cDNA could change the reaction 
conditions sufficiently to cause non-specific amplification that would not occur 
otherwise, since the cDNA mix contains a number of substances, such as glycerol, 
salts, and EDTA, which could alter the reaction chemistry.  
gene primer µl added (10pmol/µl ) 
cdc-42 DA86 0.2 
 cdc-42 DA87 0.2 
pmp-3 DA88 0.2 
pmp-3 DA89 0.2 
Y45F10D.4 DA90 0.2 
Y45F10D.4 DA91 0.2 
ftn-1 ftn-1_fwd_RT2 0.75 
ftn-1 ftn-1_rev_RT2 0.5 
ama-1 ama-1_fwd 0.75 
ama-1 ama-1_rev 0.5 
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 The presence of non-specific product can be tested after running a qRT-PCR 
reaction using the same detection system as used during PCR. After the 40 cycles of 
PCR, the sample is cooled to 60oC, at which the DNA is mostly double-stranded and 
fluorescence is therefore at its highest. The sample is then slowly heated while 
fluorescence is monitored to produce a melting curve for each reaction. Since each 
sequence has a characteristic melting temperature, the presence of more than one 
PCR product can be detected.  This procedure was performed for all qRT-PCR 
reactions and no reactions were included in the analysis in which multiple products 
had been amplified.  
 
2.5.7. Single-worm PCR 
 
A single worm was picked into a PCR tube containing 5µl of single worm 
lysis buffer containing 1mg/ml proteinase K. This was either stored at -80oC or 
immediately lysed by incubating at 65oC for 2h. The proteinase K was then 
deactivated by incubating at 95oC for 15min. 1-2µl of this lysis was typically used 
for genotyping PCR reactions using the primers listed in section 2.6.   
 
 Genotyping PCR reactions were carried out using the ReddyMix PCR Master 
Mix (Thermo Scientific). Reaction volumes were typically 20µl, with primers added 
at a final concentration of 0.5pmol/µl, 1-2µl of worm lysis and 10µl of ReddyMix. 
The cycling conditions used were: 
 
1. 94oC 5 min 
2. 94oC 35 sec 
3. 55oC 30 sec (annealing temperature 55 oC typical, but varied) 
4. 72 oC 45sec/kb 
 
2. – 4. repeated 34x 
5. 72 oC 7 min 
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2.5.8. Fusion PCR 
 
PCR fusions of gene promoter regions to GFP were carried as described by 
Oliver Hobert (Hobert, 2002). Two primary PCR products were produced, one of the 
GFP coding region + unc-54 3' UTR, and the other of the fragment being fused to 
GFP. The first product was readily amplified from the pPD95.75 plasmid (Fire 
vector kit- Addgene). For this reaction, the TC12 and TC13 primers were used (see 
Section 2.6). For the next step, a 5' External primer (5'Ex) primer and a fusion primer 
was designed. The fusion primer (fus) consists of a reverse primer added to the 
sequence 5'-agtcgacctgcaggcatgcaagct-3', which is complementary to the GFP coding 
sequence. The reverse primer part of the fusion primer is designed to produce a 
product in a PCR reaction with the 5'Ex primer that includes the ATG start codon of 
the gene of interest as well as any number of codons of the coding region in the 
product. This can go as far as containing the whole gene, but care needs to be taken 
that the second (complementary to GFP) part of the fusion primer remains in frame 
with the start codon. The PCR product of the reaction using these two primers carries 
a 24bp overhang that is able to bind to the GFP PCR product generated by the first 
reaction.  
 
 Figure 14 
Adapted from Hobert et al. (2002) 
 
 A small amount of each PCR product is then added to a third PCR reaction 
which uses a 5' Internal (5'Int) primer nested within the gene’s upstream sequence 
and a 3' Internal (TC14) primer nested just 5' of the TC13 primer within the GFP 
PCR fragment. Because the 24bp overhang causes the two sequences to anneal and 
the primers are located on opposite ends of either sequence, this third PCR reaction 
fuses the two fragments. PCR reactions were carried out using the Phusion 
(Finnzymes) proofreading enzyme. This fusion PCR fragment is then injected.   
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Figure 15 
Adapted from Hobert et al. (2002) 
 
PCR products were then injected into MT1642, a lin-15(-) strain, along with a 
lin-15(+) plasmid that rescues transformed animals from the Muv phenotype of lin-
15(-) worms.  
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2.6. Reagents 
   
2.6.1. Primers 
    
primer name sequence   used for … 
    
TC12 agcttgcatgcctgcaggtcgact 5' amplification of GFP fragment for fusion PCR 
TC13 aagggcccgtacggccgactagtagg 3'ex  
TC14 ggaaacagttatgtttggtatattggg 3'in  
    
C06B3.4.5ex tgccaaatcagctctgaacac 5'ex construction of stdh-1::gfp by PCR fusion 
C06B3.4.5in gaaagtagtgtagcggttttattcg 5'in  
C06B3.4.3fus 
agtcgacctgcaggcatgcaagctCATCAAAGGCTTATTTTCATTCTTT
GCC 3'fus  
    
C10H11.5.5ex ggaacaacttcccccattaactg 5'ex construction of ugt-27::gfp by PCR fusion 
C10H11.5.5in ttttcaacaccgcctaccgactg 5'in  
C10H11.5.3fus agtcgacctgcaggcatgcaagctGGTTCTCTTGATAAGCCAACGTTTC 3'fus  
    
F10D2.11.1 gttcacgctcggatttggagttc 5'ex construction of ugt-41::gfp by PCR fusion 
F10D2.11.3 aaaagacccatgttagttcacgctc 5'in  
F10D2.11.2 agtcgacctgcaggcatgcaagctATCCCGCTTTGATTTGATAGTCAA 3'fus  
    
dhs-9.5.ex tgaagcatcatccagaactcg 5'ex construction of dhs-9::gfp by PCR fusion 
dhs-9.5.in aactcgaagatgatgaagaagaagc 5'in  
dhs-9.3.fus agtcgacctgcaggcatgcaagctCAATCTGCTGTTTCCAGCCCA 3'fus  
    
ftn-1.5'ex tgcttactggttctgccgag 5'ex construction of ftn-1::gfp by PCR fusion 
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ftn-1.5'in tgtagggtttgattgtggtttg 5'in  
ftn-1.3'fus agtcgacctgcaggcatgcaagctTTGACGAGCTAGAGACATGAC 3'fus  
    
cdr-3.5'ex acctatgatagtctcggcattg 5'ex construction of cdr-3::gfp by PCR fusion 
cdr-3.5'in cgacggaccatgtagaagag 5'in  
cdr-3.3'fus agtcgacctgcaggcatgcaagctTAAGGTTCTGGTTTTGCACG 3'fus  
    
R06A10.1.5'ex tacctgcttagacactttctcg 5'ex construction of PR06A10.2::gfp by PCR fusion 
R06A10.1.5'in ccgacgatagctcggtgttag 5'in  
R06A10.1.3'fus agtcgacctgcaggcatgcaagctGGACAACCAGGCAATCACTAC  3'fus  
    
sod-3_fwd attaagcgcgacttcggttc sod-3 rtPCR 
sod-3_rev ttcttccagttggcaatcttcc sod-3 rtPCR 
ftn-1_fwd cgtcatgtctctagctcgtc ftn-1 rtPCR 
ftn-1_rev cattgatcgaatgtacctgctc ftn-1 rtPCR 
ama-1_fwd atctcgcaggttatcgcgtg ama-1 rtPCR 
ama-1_rev cggtgaggtccattctgaaatc ama-1 rtPCR 
DA86 ctgctggacaggaagattacg cdc-42 qRT-PCR 
DA87 ctcggacattctcgaatgaag cdc-42 qRT-PCR 
DA88 gttcccgtgttcatcactcat pmp-3 qRT-PCR 
DA89 acaccgtcgagaagctgtaga pmp-3 qRT-PCR 
DA90 gtcgcttcaaatcagttcagc Y45F10D.4 qRT-PCR 
DA91 gttcttgtcaagtgatccgaca Y45F10D.4 qRT-PCR 
ftn-1_fwd_RT2 cggccgtcaataaacagattaacg ftn-1 qRT-PCR 
ftn-1_rev_RT2 cacgctcctcatccgattgc ftn-1 qRT-PCR 
    
DA42 tcgtagaactgaagacaagagtgtg hsf-1 sy441 genotyping PCR 
DA43 tcctcggctccatcataattcg hsf-1 sy441 genotyping PCR 
DA44 attttcagccgcaacaagac hsf-1 sequencing primer 
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hif-1_ex_fwd1 gctcctcctactccacctttg hif-1 ia4 genotyping PCR 
hif-1_int_rev1.2 tcggcgatggtgtcttcagtc hif-1 ia4 genotyping PCR 
hif-1_ex_rev1 gtgacgagttgtgaatgcacc hif-1 ia4 genotyping PCR 
    
rrf-3_ex_fwd1 gagttcgcatcaagtttcac rrf-3 pk1426 genotyping PCR 
rrf-3_ex_rev1 tgccttcgtacatttcaacc rrf-3 pk1426 genotyping PCR 
rrf-3_int_rev2 ggtatttattgcttcctgccac rrf-3 pk1426 genotyping PCR 
    
T7  taatacgactcactataggg pL4440 vector identification of RNAi cultures by PCR 
JJM130 gggaagggcgatcggtgcgggcc pL4440 vector identification of RNAi cultures by sequencing 
JJM131 gcgcagcgagtcagtgagcgagg pL4440 vector identification of RNAi cultures by sequencing 
    
All oligonucleotides where ordered from MWG Biotech.  
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2.6.2. C. elegans strains used 
   
Strain  Genotype Origin 
   
DR1567 daf-2(m577) received from the Riddle lab 
GA1001 aak-2(ok524)  generated by Jennifer Tullet (3x outcrossed RB754) 
GA134 glp-4(bn2ts); daf-2(m577)  generated by Josh McElwee 
GA226 wuEx122[sod-1(+), rol-6(su1006)] generated by David Gems 
GA228 wuEx123[sod-1(+), rol-6(su1006)] generated by David Gems 
GA230 wuEx122[sod-1(+), rol-6(su1006)] generated by David Gems 
GA300 daf-16(mgDf50); daf-2(m577) generated by Dhaval Patel 
GA303 rrf-3(pk1426); daf-2(m577)  generated by Dhaval Patel 
GA362 wuEx106[stdh-1::GFP, lin-15(+)] lin-15(n765ts) generated by David Weinkove 
GA365 wuEx109[dhs-9::GFP, lin-15(+)] lin-15(n765ts)         generated by David Weinkove 
GA368 wuEx112[ugt-41::GFP, lin-15(+)] lin-15(n765ts)        generated by David Weinkove 
GA379 wuEx106[stdh-1::GFP, lin-15(+)] daf-2(m577); lin-15(n765ts) generated by David Weinkove 
GA380 wuIs128[ugt-27::gfp, lin-15(+)]  lin-15(n765ts) generated by David Weinkove 
GA514 glp-4(bn2ts), daf-16(mgDf50); daf-2(m577) generated by Glenda Walker 
GA602 wuEx109[dhs-9::GFP, lin-15(+)] daf-2(m577); lin-15(n765ts)         * generated by crossing GA365 and DR1567 
GA604 wuEx112[ugt-41::GFP, lin-15(+)] daf-2(m577); lin-15(n765ts)        * generated by crossing GA368 and DR1567 
GA611 wuEx129[gst-15::GFP, lin-15(+)] lin-15(n765ts)     * generated by micro-injection using MT1642 
GA614 wuEx135[Pftn-1::GFP, lin-15(+)] lin-15(n765ts)     * generated by micro-injection using MT1642 
GA620 wuEx141[PR06A10.1::GFP, lin-15(+)] lin-15(n765ts)   * generated by micro-injection using MT1642 
GA624 wuEx145[Pcdr-3::GFP, lin-15(+)] lin-15(n765ts)    * generated by micro-injection using MT1642 
GA630 wuIs176[Pftn-1::gfp, lin-15(+)] lin-15(n765ts)    * generated by X-ray irradiation of GA614, outcrossed 6x 
GA631 wuIs177[Pftn-1::gfp, lin-15(+)] lin-15(n765ts)    * generated by X-ray irradiation of GA614, outcrossed 6x 
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GA633 wuIs177[Pftn-1::GFP, lin-15(+)] daf-2(m577) * generated by crossing GA631 with DR1567 
GA636 wuIs177[Pftn-1::GFP, lin-15(+)] rrf-3(pk1426); daf-2(m577) * generated by crossing GA633 with GA303 
GA639 daf-16(mgDf50) wuIs177[Pftn-1::GFP, lin-15(+)]       * generated by crossing GA631 with GR1307 
GA641 wuIs177[Pftn-1::GFP, lin-15(+)]  * generated by crossing GA631 with N2 
GA642 wuIs177[Pftn-1::GFP, lin-15(+)] hif-1(ia4) * generated by crossing GA641 and ZG31 
GA643 wuIs177[Pftn-1::GFP, lin-15(+)] daf-16(mgDf50); daf-2(m577) * generated by crossing GA633 with GA300 
GA644 wuEx123[sod-1(+), rol-6(su1006)] daf-16(mgDf50) * generated by crossing GA228 and GR1307 
GA646 wuIs152[sod-1(+), rol-6(su1006)] hsf-1(sy441) * generated by crossing GA801 and PS3551 
GA648 wuIs152[sod-1(+), rol-6(su1006)] aak-2(ok524)  * generated by crossing GA801 and GA1001 
GA675 xtEx79[pes-10::IDE::GFP-his, pha-1(+)] * generated by crossing UZ96 and N2 
GA676 xtEx79[pes-10::IDE::GFP-his, pha-1(+)] hif-1(ia4) * generated by crossing GA675 and ZG31 
GA702 wuIs128[ugt-27::gfp, lin-15(+)]  daf-2(m577); lin-15(n765ts) generated by David Weinkove 
GA800 wuIs151[ctl-1,2,3 (+), myo-2::gfp] generated by Ryan Doonan 
GA801 wuIs152[sod-1(+), rol-6(su1006)] generated by Ryan Doonan 
GA805 wuIs156[sod-2(+), rol-6(su1006)] generated by Ryan Doonan 
GA811 wuIs152[sod-1(+), rol-6(su1006)] daf-16(mgDf50) generated by Ryan Doonan 
GA824 wuEx196[rol-6(su1006)] generated by Ryan Doonan 
GR1307 daf-16(mgDf50) received from CGC 
GR1307 daf-16(mgDf50) received from CGC 
MT1642 lin-15(n765ts)   received from CGC 
N2 wild-type received from CGC 
NL2099 rrf-3(pk1426) received from CGC 
PS3551 hsf-1(sy441) received from CGC 
UZ96 xtEx79[pes-10::IDE::GFP-his, pha-1(+)] pha-1(e2123ts)    received from Leibold lab 
XA6900 qaEx6900[Pftn-1::[delta]pes-10::GFP-his, pha-1(+)] pha-1(e2123ts) received from Leibold lab 
XA6902 qaEx6902[Pftn-1(delta63)::[delta]pes-10::GFP-his, pha-1(+)] pha-1(e2123ts) received from Leibold lab 
ZG31 hif-1(ia4) received from CGC 
* These strains were generated by me during the course of my PhD research. 
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2.6.3. RNAi clones 
 
RNAi by feeding is induced by growing C. elegans on HT115 bacteria 
containing the L4440 plasmid, into which a fragment of the gene of interest has been 
cloned. This vector contains two T7 promoter sites flanking the insert and in opposite 
orientation in order to induce transcription of the insert by the T7 RNA polymerase 
from both ends.  
Most RNAi clones were produced as part of large-scale efforts to create 
genome-wide RNAi libraries. Confirming their identity was important in the later 
stages of this project. An RNAi culture was grown from the frozen stock in the 
presence of ampicillin and tetracycline. The plasmid was then purified using the 
QiaSpin MINIprep kit (Qiagen) and was then sent for sequencing to the Wolfson 
Institute for Biomedical Research (WIBR) using the JJM130 and JJM131 primers.  
 
2.6.4. Transcription factor RNAi library  
 The transcription factor RNAi library used for this project was generously 
provided to me by the Weiqing Li (University of Washington) and contained over 
1500 clones from both the Ahringer and Vidal libraries (Kamath and Ahringer, 2003; 
Rual et al., 2004). The presence of sequences in the genes’ coding sequence that are 
likely to code for protein domains thought to act in DNA binding was used as a 
criteria for inclusion in this library. The library therefore most likely includes some 
genes that are not in fact transcription factors. Many clones in this library were 
duplicates and after some quality control, just over 800 were used for the screen. 
Similar libraries are now available commercially (geneservice.co.uk).  
 
2.6.5. Buffers 
 
NGM agar (1L in H2O) 
3g NaCl 
20g Agar 
2.5g Peptone 
 
Autoclave, then add the following sterile solutions: 
1mL 1M CaCl2  
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1mL 1M MgSO4  
1mL 5mg/mL cholesterol 
25mL 1M KH2PO4 (pH 6.0) 
 
NGM IPTG agar (1L in H2O) 
3g NaCl 
20g Agar 
2.5g Peptone 
 
Autoclave, then add the following sterile solutions: 
400µl 50mg/mL Carbenicillin  
1mL 1M IPTG 
1mL 1M CaCl2  
1mL 1M MgSO4  
1mL 5mg/mL cholesterol 
25mL 1M KH2PO4 (pH 6.0) 
 
 
OP50 growth solution (1L in H2O) 
5g Tryptone 
2.5g Yeast extract 
Add H2O, then autoclave.  
 
M9 solution (1L in H2O) 
7g Na2HPO4.2H2O 
3g KH2PO4 
5g NaCl 
0.25g MgSO4.7H2O 
Add H2O, then autoclave.  
 
 
Freezing medium (200mL in H2O) 
20mL 1M NaCl 
10mL 1M KH2PO4 (pH 6.0) 
60mL 100% glycerol 
 
Add H2O, autoclave, then add: 
0.6mL sterile 0.1M MgSO4 
 
LB (Luria-Bertani) Medium (1L in H2O) 
10g Tryptone 
5g Yeast Extract 
10g NaCl 
Add H2O, adjust pH to 7.5 with NaOH and autoclave.  
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2.7. Statistical analysis 
 
Survival analysis 
C. elegans survival under various conditions and of various genotypes was 
monitored as described previously. Whether survival was different from that of 
controls was tested using both the Wilcoxon and the Log-Rank test. These tests allow 
for the inclusion of right-censored data, which is necessary when performing this 
type of experiment. Censoring is necessary when the lifespan of individual animals 
cannot be monitored past a certain time-point. This may occur when worms die of 
causes unrelated to ageing, such as by crawling up the side of the plate and drying 
out. In such a case, we can only say that the animal was still alive until the day it was 
censored, but the day it would have died of ageing-related causes can of course not 
be determined. Omitting these animals would not be appropriate as it would bias the 
data and lead to a loss of information. Log-rank and Wilcoxon p-values were 
obtained using JMP version 7.0 (SAS).  
 
Two-way ANOVA 
ANOVA was performed to test for statistical significance in experiments in 
which the effects of several treatments were compared to a single control. Before 
ANOVA, the data was first transformed using the natural logarithm. This was done 
when the data had first been normalised using the control treatment, since ratios are 
not usually normally distributed and ANOVA assumes a normal distribution.  
Because ftn-1 transcript levels showed large differences between 
experimental blocks performed on different days, two-way ANOVA was used to test 
the effects of the treatments as well as of the experimental blocks. All ANOVA was 
performed using the open-source program R (R-project.org, accessed Feb 2010).  
2.8. Platereader protocols 
 
The method by which GFP expression was measured in strains expressing 
Pftn-1::gfp was adapted from a published protocol to measure sod-3::gfp expression 
(Wolff et al., 2006). Worms of the appropriate age were picked into the wells of V-
shaped microtitre plates (Greiner) and measured in the GeniosPlus platereader 
(Tecan) at the appropriate GFP wavelengths (excitation: 495; emission: 535nm). 40 
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adult, or 60 L4 animals were picked into each well. A constant gain was set in the 
platereader for each condition.  
 
2.8.1. Protocol 1 
 
This protocol was used for the screen itself using GA636 as well as for much of the 
follow up work using GA636, GA633, GA639, GA641 and GA643.  
 
1. Worms were grown at 15oC for the first generation until a large number of 
gravid adults were present.  
2. Eggs were isolated by alkaline hypochlorite treatment.  
3. Eggs were pipetted onto NGM plates seeded with OP50 bacteria and returned 
to 15oC where they were left to develop.  
4. At L4 stage, worms were washed off plates and pipetted onto RNAi plates. 
These plates were then incubated for two days at either 25oC or 20oC.  
5. For each RNAi treatment, 40 two–day old adults were picked into a well of a 
clear microtitre plate (V-shaped wells (Greiner)), containing 50µl M9.  
6. Once animals from all RNAi treatments and worms grown on control RNAi 
had been picked, the animals were anaesthetised by adding 10µl of 50mM 
sodium azide.  
7. Fluorescence was measured in a GeniusPlus platereader (Tecan) at the 
excitation wavelength 495nm and emission wavelength 535nm.  
 
In some experiments described in Chapter 5, the switch from 15oC to 25oC was not 
required. Instead, worms were grown at 20oC throughout. The screen itself was 
carried out as described in Figure 16. 
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Figure 16 
Protocol for finding transcription factors involved in the up-regulation of expression 
from reporter construct.  
 
2.8.2. Protocol 2 
 
1. Worms were grown at 15oC for the first generation until a large number of 
gravid adults were present.  
2. Eggs were isolated by alkaline hypochlorite treatment.  
3. Arrested L1 animals were obtained by leaving the eggs to hatch in M9 at 
15oC for 36h.  
4. L1s were pipetted directly onto RNAi plates and these plates were then 
returned to 15oC for 3 days.  
5. At the L3 stage, worms were transferred to 25oC and left to incubate for a 
further 2 days.  
6. Adult worms were subsequently either 
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a. picked into wells of a microtitre plate (clear, V-shaped wells 
(Greiner)). 40 worms were picked per well. (See protocol 1) 
b. washed off plates using M9 and into 1.5mL capped tubes. Worms 
were left to settle, supernatant was removed, M9 replaced. This 
washing step was repeated four times to remove E. coli  and L1 
larvae. After final washing step, 200µl of M9 (including worms) were 
left in the tube and the tube was kept on ice. 800µl of Trizol reagent 
was then added and the contents were transferred to a ribolizer tube 
(manufacturer). See protocol on RNA extraction for further details.  
 
2.8.3. Protocol 3 
 
1. Eggs were isolated by alkaline hypochlorite treatment and were placed on 
RNAi plates.  
2. Worms were grown at 25oC for the first generation. 
3. Gravid adult animals were transferred to fresh RNAi plates and returned to 
25oC.  
4. 60 L4 animals of the second generation were picked into wells of microtitre 
plate.  
5. Fluorescence was measured in a GeniusPlus platereader (Tecan) at the 
excitation wavelength 495nm and emission wavelength 535nm.  
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Chapter 3: The Screen 
 
As described in Chapter 1, section 1.6, my first task was to identify a GFP 
reporter strain that I could use as a readout for the transcriptional consequences of 
altered IIS. This task was aided by the availability of microarray data. I therefore 
tested GFP reporters for genes found to be up-regulated in daf-2 mutant animals 
compared to daf-16; daf-2 mutants. Initially, I focused on drug metabolising 
enzymes (DMEs), with the aim of identifying regulators of DME metabolism, since 
these had been found to be up-regulated in a number of models of long-lived IIS 
mutants (McElwee et al., 2007). GFP reporters tested later in the project were not 
necessarily selected using the same criteria (eg. ftn-1 and R06A10.1).  
3.1. Testing existing reporters 
 
Because of the potential role of drug metabolising enzymes (DMEs) as 
effectors of the longevity phenotype of insulin signalling mutants, GFP reporters of 
DMEs were tested for up-regulation in daf-2 mutant animals compared to daf-2 wild-
type animals. Several GFP reporter strains of drug metabolising enzymes had already 
been created before my arrival at the Gems lab and these were the first to be tested. 
These first four reporter constructs I examined were so-called translational GFP 
fusion constructs, for which upstream and coding sequences of DME genes were 
fused to GFP. Induction by reduced insulin signalling was tested by crossing these 
constructs into a daf-2(m577) mutant background and then comparing the 
fluorescence of the two strains at 25oC, the restrictive temperature of this allele.  
Of these four genes, ugt-27 and ugt-41 code for putative UDP-glucuronosyl 
transferases, dhs-9 for a putative short-chain dehydrogenase/reductase and stdh-1 for 
a putative steroid dehydrogenase. The GFP expression levels of the ugt-41, dhs-9, 
and stdh-1 reporters are very low, and their fluorescence was found to be below the 
detection threshold of the platereader method being used. This was ascertained by 
measuring their fluorescence alongside a non-fluorescent control strain and in none 
of the three cases did the fluorescence rise to detectable levels in daf-2 mutants 
(Figure 17 and data not shown). None of these daf-2(-) reporter strains exhibited 
statistically significantly higher levels of fluorescence than daf-2(+)  controls. A 
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GFP reporter strain for ugt-27 showed high GFP expression, which was easily 
detectable above the background fluorescence. However, it showed no statistically 
significant increase in the daf-2 mutant background (see Figure 17). This was 
surprising, since microarray data showed a highly significant, 29.6–fold difference in 
expression of this gene between daf-2 and daf-16;daf-2 mutant animals. The reasons 
for this discrepancy were not investigated. One possibility is that ugt-27 is not up-
regulated in response to reduced IIS, but simply requires daf-16 to be expressed even 
in a wild-type background. However, RNAi of daf-16 in a separate experiment did 
not statistically significantly reduce ugt-27::gfp expression in a daf-2(+) background 
(data not shown). It is also possible that not all of the regulatory elements required 
for the induction of expression in daf-2 mutants were contained in the sequence used 
in this transgene.  
 
 
Figure 17 
Gene names refer to translational GFP reporters of the gene mentioned. Error bars 
represent ±s.e.m. Statistical significance tested using Student’s t-tests.  
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3.2. Making new reporter constructs 
 
Four more transgenic reporter lines were made for the genes R06A10.1, ftn-1, 
cdr-3 and gst-15. The gst-15::GFP construct was created by David Weinkove and I 
created the strain expressing it using microinjection; for the remaining three genes, I 
made the constructs and the transgenic lines. These genes were selected using a 
number of criteria, including whether they belonged to functional groups thought to 
be involved in determining lifespan (eg. DMEs), whether they were especially 
strongly IIS–regulated in microarray data, or for other reasons.  
  These were not crossed into the daf-2(m577) background but daf-2 RNAi was 
used instead to test the effect of reduced IIS on GFP expression. This was done to 
avoid the time-consuming process of crossing the array into a new genetic 
background. Unlike the previous strains, only the genes’ upstream sequences was 
fused to GFP for these four constructs (ie. the coding sequence was not included). 
All of these genes were included because they were found to be up-regulated in 
microarray data comparing glp-4(bn2ts); daf-2(m577) animals to the glp-4(bn2ts), 
daf-16(mgDf50); daf-2(m577) mutant animals (McElwee et al., 2004), thus 
indicating that they were regulated by insulin signalling in a daf-16 dependent 
manner (see Table 2).  
 
Gene name Fold change q putative gene function 
stdh-1 3.94 0.000367 steroid dehydrogenase 
ugt-27 29.56 0 UDP-glucuronosyl transferase 
ugt-41 3.38 0.00316 
 
UDP-glucuronosyl transferase 
dhs-9 2.45 0.0167 short-chain dehydrogenase/reductase 
gst-15 3.55 0.00707 glutathione S-transferase 
R06A10.1 5.32 0.00205 unknown 
ftn-1 47.14 0 ferritin, iron-storage protein. 
cdr-3 19.35 0.000103 glutathione S-transferase 
 
Table 2 
Microarray experiment was performed in (McElwee et al., 2004) and reanalysed for 
(McElwee et al., 2007). Fold change refers to the ratio of glp-4(bn2ts); daf-2(m577) 
to glp-4(bn2ts), daf-16(mgDf50); daf-2(m577). q-values under 0.1 were considered 
statistically significant. I did not contribute to the work shown in Table 2.  
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Figure 18 
Effects of daf-2 RNAi treatment on reporter strain fluorescence. Error bars represent 
±s.e.m. Statistical significance tested using the Student’s t-test. 
 
 All four of these further genes tested showed statistically significant up-
regulation of their GFP transgenes upon RNAi of daf-2. In summary, of the eight 
GFP reporter strains tested here, only one, Pftn-1::gfp, was found to both express at 
sufficiently high levels and be sufficiently induced by reduced IIS to be useful for 
this screen. While insufficient biological replicates were tested to ascertain this with 
confidence, GFP expression from the other constructs may very well be increased 
upon daf-2 RNAi treatment. However, this feature alone does not make them suitable 
for use in the screen, since the response to reduced IIS on GFP levels must be readily 
detectable in a platereader. This underscores one of the problems of using the fold-
change of expression in microarray data to guide the making of reporter constructs: 
While the genes chosen on the basis of the microarray experiment (McElwee et al., 
2004) all have a statistically significant increase in GFP levels in response to daf-2 
RNAi, this data gives no prediction of how high expression levels are in absolute 
terms. Knowledge of absolute expression levels is very important in the design of a 
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reporter construct for the type of high-throughput RNAi screen being prepared here 
because the GFP levels need to be easily detectable above the background 
fluorescence.  
In order to illustrate this issue, Table 3 contains the same data as Figure 18, 
but expression is displayed as a percentage of the control RNAi –treated reporter 
strain. Comparison with the non-GFP control strain measured alongside it allows for 
an approximate estimation of the contribution of background fluorescence to the 
signal measured in the platereader. Comparison with the daf-2 RNAi –treated 
animals demonstrates the extent to which the induction of the reporter construct is 
detectable using the platereader.  
 
 
 
 non-GFP control control RNAi daf-2 RNAi 
 % % % 
gst-15::gfp 65.8 100 116.9 
R06A10.1::gfp 71.3 100 128.2 
Pftn-1::gfp 13.1 100 364.6 
Pcdr-3::GFP 69.7 100 129.6 
 
Table 3 
Fluorescence was measured for strains containing the reporter construct and treated 
with both control and daf-2 RNAi. Fluorescence of a non-GFP control strain was 
measured alongside the reporter strain. The fluorescence was statistically 
significantly higher than the non-GFP control strain for all four of these strains (t-test 
results: gst-15: p=1.27E-06; R06A10.1: p=0.0255; ftn-1: p=0.00521; cdr-3: 
p=0.00109) 
 
Table 3 shows that only the Pftn-1::gfp reporter emits a GFP signal that is 
clearly distinguishable from background fluorescence, since background 
fluorescence only accounts for 13% of the fluorescent signal. Additionally, the 
induction of GFP expression by reducing IIS through daf-2 RNAi is by far the most 
easily detectable in the Pftn-1::gfp reporter strain.  
The degree to which GFP expressed from the reporter construct is detectable 
above background fluorescence by the platereader being used depends on both the 
intensity of expression and the expression pattern of the reporter. In the Pftn-1 
reporter strain, GFP is expressed in the intestine, one of the largest tissues of C. 
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elegans, and is expressed at very high levels, making it easily detectable above the 
low levels of background fluorescence.  
3.3. Semi-quantitative rtPCR verification of microarray 
data 
 
The large fold change in ftn-1 levels detected in the microarray experiment 
comparing glp-4(bn2ts); daf-2(m577) mutant animals to glp-4(bn2ts), daf-
16(mgDf50); daf-2(m577) mutant animals was confirmed in a preliminary semi-
quantitative rtPCR study. The results are shown in Figure 20. Band intensities were 
normalised using levels of the ama-1 transcript. ama-1 codes for the large subunit of 
RNA polymerase II. Expression of sod-3, a superoxide dismutase gene known to be 
up-regulated in IIS mutants (see Chapter 1), was also quantified as a positive control.  
 
 
Figure 19 
A glp-4(bn2) mutant background 
was used to prevent the 
emergence of progeny. This 
experiment was carried out on a 
single biological replicate and 
sqRT-PCR was carried out in 
two technical replicates. Error 
bars represent the range of these 
technical replicates.   
 
 
The combined microarray, rtPCR and reporter gene results establish with 
confidence that daf-2(m577) mutant animals have far higher levels of the ftn-1 
transcript than daf-16(mgDf50); daf-2(m577) animals do. The results of changes in 
reporter strain fluorescence (Figure 18) suggest that this is due to up-regulation of 
ftn-1 expression by daf-2 mutations in a DAF-16 dependent manner, not by the 
downregulation of ftn-1 expression in daf-16 mutants.  
 
 
 
 107 
3.4. The ftn-1::gfp reporter: A useful readout for the IIS 
pathway? 
 
Several characteristics of the Pftn-1::gfp reporter strain make it suitable for 
the type of high-throughput RNAi screen I attempted in this screen. One is its 
intestinal GFP expression, which leads to high levels of fluorescence given large size 
of the intestine. Additionally, RNAi is not equally effective in different tissues of C. 
elegans, with neurons being particularly resistant to its effects. As the worms ingest 
the dsRNA through their food source, the intestine is likely to be exposed to higher 
concentrations relative to other tissues and is presumably more strongly affected. The 
Pftn-1::gfp construct was found to express GFP at particularly high levels and this 
made for more sensitive quantification in the platereader, which I wanted to use as a 
quick means of quantifying expression. Additionally, a very strong induction of GFP 
expression by reduced insulin was detectable using the platereader. This reporter 
construct, so far present in a multi-copy extra-chromosomal array, was therefore 
integrated in order to obtain a 100% transgenic population and subsequently out-
crossed six times to the parent strain to remove mutations produced by the process of 
integration. The strong induction of Pftn-1::gfp expression by mutations in IIS can be 
seen in Figure 20.  
 
 
daf-2(+)        daf-2(m577) 
Figure 20 
Adult C. elegans carrying the integrated Pftn-1::gfp transgene in both daf-2 
genotypes. Worms were grown at 15oC until the L4 stage and then switched to 25oC 
for two days before images were taken.  
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Other benefits of studying ftn-1 expression can be found in the role of ftn-1 as 
encoding an iron storage protein. Given that the post-transcriptional regulation of 
vertebrate ferritins in response to iron does not seem to be conserved in C. elegans 
and that the mechanisms involved in the transcriptional regulation of  worm ferritins 
are unknown, an RNAi screen aimed at identifying regulators of ftn-1 would go a 
long way in furthering our understanding of how iron homeostasis is maintained in 
C. elegans. Given the importance of maintaining stable labile iron pools to ensure 
sufficient availability for a number of different processes requiring iron, 
understanding how iron homeostasis is maintained should be of interest to a large 
number of researchers that use the worm as a model organism. In addition, given that 
oxidative stress has been proposed to be a primary cause of ageing (see Chapter 6), 
and iron catalyzes the formation of reactive oxygen species (ROS) via the Fenton 
reaction, there may be a direct role of ftn-1 in ageing through its role in the 
maintenance of iron homeostasis.  
 
3.5. General description of screen 
 
The aim of the screen was to identify transcription factors that regulate ftn-1 
expression in C. elegans. In particular, I was interested in identifying those 
transcription factors that regulate the daf-16–dependent induction of ftn-1 levels by 
reduced insulin signalling. The rationale behind using a ftn-1 reporter and of this 
approach in general is discussed in section 1.6 of Chapter 1. Before beginning the 
screen, I first integrated the Pftn-1::gfp transgene into the genome by X-ray 
irradiation and outcrossed the resulting strain six times to remove mutations 
introduced through the mutagenesis. This was done in order to obtain 100% 
transgenic populations of worms, which greatly facilitated accurate quantification of 
fluorescence during the screen.  
In order to induce expression, I crossed this integrated Pftn-1::gfp reporter 
described above into a daf-2(m577) mutant background. I also introduced the rrf-
3(pk1426) allele in order to increase susceptibility to RNAi. Worms of the resulting 
Pftn-1::gfp rrf-3(pk1426); daf-2(m577) genotype were used to screen a library of 
RNAi clones. To do this, a synchronised population was grown at 15oC, then 
switched at the L4 stage both to RNAi plates containing individual RNAi treatments 
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and to 25oC, the restrictive temperature for the m577 allele. Animals were kept at 
25oC for two days before fluorescence intensity was measured. This was done by 
picking 40 worms into the wells of V-bottom microtitre plates (Greiner) containing 
50µl of M9 media. Worms were anaesthetised through the addition of 10µl of 50mM 
sodium azide and fluorescence was then measured at the standard wavelengths for 
GFP (excitation 495nm, emission 535nm). Each measurement included at least two 
wells of control RNAi-treated worms and one well of worms from each RNAi 
treatment. Two such ‘batches’ were measured on the same day from each set of 
RNAi plates. The raw data from these measurements was normalised to the mean 
signal from control RNAi-treated worms in the same ‘batch’. This protocol was used 
to screen a library of RNAi clones targeting transcription factors (described in 
Chapter 2). In total, RNAi of 812 genes was tested for their effects on Pftn-1::gfp 
expression in rrf-3(pk1426); daf-2(m577) mutant animals. The results of this screen 
are displayed as a histogram in Figure 21, which shows how the results (normalised 
to fluorescence from control RNAi–treated worms) are distributed.  
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Figure 21 
Screen results: Data is displayed as a histogram. The raw data was normalised to 
represent a percentage of the signal obtained from control RNAi-treated worms. The 
screen was carried out by measuring fluorescence of RNAi treated Pftn-1::gfp rrf-
3(pk1426); daf-2(m577) animals following the protocol described in Section 2.8.1. 
Protocol 1.  
 
In the central screen, treatment with many RNAi clones led to alterations in 
the fluorescence of my reporter strain. Most candidate genes that scored above 120% 
or below 80% of control were re-tested. After this re-testing phase, I focused on 
RNAi treatments that led to a reduction in the induced fluorescence rather than those 
that further increased fluorescence, since I was interested in genes involved in 
inducing gene expression in response to reduced IIS. Table 4 lists the 32 RNAi 
treatments that led to such a reduction. The mean of these measurements is displayed 
as a percentage of the fluorescence of control–RNAi treated worms. For RNAi 
treatments that led to an increase in fluorescence, see Appendix 1 and Chapter 5. 
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Gene mean % of control n st. dev. description 
daf-16 19.7 5 3.9  
ast-1 26.8 2 9.8 determinant of DA neuron fate. ETS-box.  
hsf-1 31.5 2 5.4 heat shock factor 
nhr-116 45.6 2 0.2 nuclear hormone receptor 
dve-1 55.9 2 0.7 Drosophila DVE homologue 
psa-1 57.2 2 5.7 component of the SWI/SNF complex 
hlh-30 58.5 2 6.2 helix loop helix factor 
blmp-1 58.8 2 9.8 zinc finger protein 
pbrm-1 60.6 2 14.7 polybromo 1 ortholog 
mdl-1 64.3 2 7.1 similar to vertebrate MAD 
nhr-66 67.4 2 11.5 nuclear hormone receptor 
T07C12.11 68.5 2 10.4 unknown 
nhr-34 69.6 2 9.5 nuclear hormone receptor 
F44E2.7 74.6 2 2.4 unknown 
nhr-36 75.8 2 6.8 nuclear hormone receptor 
lin-29 76.4 2 2.9 zinc finger protein 
jun-1 77.4 2 19.3 JUN homologue 
lir-1 77.6 2 4.0 zinc finger protein 
nhr-80 78.1 2 0.2 nuclear hormone receptor 
lin-40 78.4 2 20.1 zinc finger protein 
cdc-14 79.8 3 36.7 Cdc14p homologue 
 T26A8.4 80.7 2 14.0 Ccr4-Not deadenylase complex component 
zfp-3 83.4 2 2.7 zinc finger protein 
D1046.2 83.7 2 10.4 zinc finger protein 
 T11G6.8 84.2 2 13.8 predicted RNA-binding protein 
him-8 84.6 2 25.4 zinc finger protein 
C28H8.9  85.8 2 12.7 unknown 
mxl-1 86.4 3 8.1 mdl-1 binding partner 
F21D5.9  87.8 2 31.0 unknown 
mab-3 87.9 2 6.3 DM domain-containing 
rad-26 93.5 2 30.1 predicted DNA helicase 
 npax-4 93.8 2 31.2 unknown 
 
Table 4 
32 genes for which knockdown led to reduced fluorescence of the Pftn-1::gfp rrf-
3(pk1426); daf-2(m577) strain, ranked in order of severity of effect of RNAi.   
 
In order to confirm the validity of the screen’s initial findings, RNAi 
plasmids were purified, sequenced to confirm their identity, and subsequently re-
transformed into competent HT115 E. coli. Several RNAi clones were discarded due 
to incorrect sequence of the insert. The HT115 strain of E. coli was obtained from the 
CGC and made competent using a standard CaCl2 protocol (Sambrook and Russell, 
2001). These re-transformed strains were used for all subsequent tests.  
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3.6. Testing the effects of candidate gene RNAi on ageing  
The screen for transcription factors affecting Pftn-1::gfp expression in daf-2 
mutants revealed a large number of possible regulators, although the mechanisms by 
which the recorded effect on fluorescence occurs in each case is unknown. Since the 
ultimate aim of this project was to identify genes that contribute to the longevity of 
daf-2 mutants, the next logical step was to attempt to identify whether any of the 
RNAi treatments were effective not only at suppressing the induced Pftn-1::gfp 
expression in daf-2 mutants, but also at suppressing their longevity. I therefore 
proceeded to test the effects of RNAi of candidate genes on lifespan of daf-2 
mutants. I used the rrf-3(pk1426); daf-2(m577) strain and grew worms at 15oC until 
they reached the L4 stage of development, then transferred them to RNAi plates and 
to 25oC.   
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Figure 22 
The effects of several candidate RNAi–treatments on lifespan of rrf-3;daf-2 animals 
at 25oC was tested.  
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All lifespan assays were carried out on rrf-3(pk1426); daf-2(m577) animals 
RNAi treatment 
[Trial number] n Censored Mean Lifespan 
Median 
Lifespan % Changea 
Log-Rank p-
valueb 
Wilcoxon p-
valueb 
        
Control [1] 42 10 29.3 30    
ast-1 [1] 74 7 29.3 31 none 0.7625 0.8132 
B0336.3 [1] 71 8 25.3 25 -14 [-17] <.0001 0.0011 
blmp-1 [1] 44 2 20.6 19 -30 [-37] <.0001 <.0001 
mdl-1 [1] 60 16 25.9 25 -12 [-17] 0.0003 0.0056 
pbrm-1 [1] 42 8 22.9 23 -22 [-23] 0.0001 0.0001 
T07C12.11 [1] 46 4 29.9 31 none 0.7724 0.9493 
        
Control [2] 231 2 29.09 29    
ada-2 [2] 139 6 27.77 29 -5 [-0] 0.0006 0.0203 
egr-1 [2] 95 1 20.74 22 -29 [-24.1] <.0001 <.0001 
klf-1 [2] 132 6 26.53 26 -9 [-10.3] <.0001 0.0002 
nhr-116 [2] 110 2 29.73 31 none 0.1748 0.4519 
psa-1 [2] 105 2 26.32 26 -10 [-10.3] <.0001 0.0002 
        
Control [3] 186 6 29.44 33    
dve-1 [3] 97 16 17.27 17 -41 [-48.5] <.0001 <.0001 
B0336.3 [3] 111 13 22.56 24 -23 [-27.3] <.0001 <.0001 
mdl-1 [3] 128 12 26.88 29 -9 [-12.1] 0.0427 0.0127 
pbrm-1 [3] 87 11 24.78 25 -16 [-24.2] 0.0027 0.0006 
        
Table 5 
This table contains data corresponding to Figure 22. a Describes reduction in median 
lifespan [change in mean lifespan in brackets] compared to corresponding control 
RNAi–treated group. The percent reduction is only displayed when it was found to 
be statistically significant. b all statistical tests were calculated between RNAi 
treatment in question and the corresponding control RNAi–treated group.  
 
 
The initial expectation for this set of experiments was that very few RNAi 
treatments would be effective at reducing the lifespan of daf-2 mutants. This was 
based on previous work in the lab in which the roles of a large number of phase I and 
II detoxification enzymes in mediating the extended lifespan of daf-2 mutants was 
tested in a similar manner (D. Weinkove, unpublished results). Another former 
member of the lab had similar experiences when investigating candidate genes from 
a microarray experiment comparing daf-2 to daf-16; daf-2 mutants (McElwee et al., 
2003). In these two cases, as well as in a genome wide RNAi screen for genes 
involved in mediating daf-2 longevity (Samuelson et al., 2007), only a very small 
proportion of RNAi treatments was able to reduce the lifespan of daf-2 mutants. My 
aim was therefore to screen a relatively large number of ‘candidate’ RNAi treatments 
for their effects on lifespan. I was expecting to be left with a small number of genes 
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that both reduced Pftn-1::gfp expression and also reduced lifespan in daf-2 mutants. 
My plan was to focus my efforts on this greatly reduced set of genes and hopefully 
characterise their role in mediating the longevity of daf-2. 
Instead, I found that RNAi of most of these genes I tested reduced lifespan of 
rrf-3; daf-2 from the small but statistically significant effects of ada-2 RNAi (no 
reduction in median lifespan and a small reduction in mean lifespan) to the very large 
effect of RNAi of dve-1. Many of the lifespan assays were repeated and the reduction 
in lifespan was generally reproducible (see Table 5). This seemed to suggest that my 
screen had been successful in using the IIS-regulated Pftn-1::gfp reporter to identify 
factors involved in mediating daf-2 longevity. However, it is also possible that RNAi 
of these genes was merely making the worms sick, thus reducing their lifespan, 
rather than accelerating ageing. Designing experiments that distinguish these two 
possibilities is quite difficult.  
One approach is to test whether the reduction in lifespan is less marked or 
non-existent upon RNAi–mediated knockdown of the gene in question in a wild-type 
background. If yes, this would imply that the gene is contributing to daf-2 longevity. 
One may also test the effects of gene knockdown on daf-16; daf-2 lifespan to 
distinguish reductions in IIS-mediated longevity from simple pathology. Testing the 
effects of over-expressing the gene in question on lifespan is another approach, since 
higher levels of a gene that regulates downstream targets of IIS may itself extend 
lifespan. Over-expression of the important transcription factors hsf-1, daf-16 and skn-
1 was found to extend lifespan in all three cases.  
Clearly, while all of these approaches have their weaknesses, a combination 
of them could establish the role of any given transcription factor in mediating daf-2 
longevity. However, given the large number of RNAi treatments that had significant 
effects on daf-2 lifespan and the work-intensive nature of lifespan assays, especially 
when creation of transgenic strains is required, finding ways to reduce the number of 
genes being investigated was necessary to expedite the process. I therefore decided to 
abort the lifespan assays before all candidate genes had been tested and to instead 
proceed by confirming the results of the screen before continuing, asking the 
question: Which of the genes identified in my screen are true regulators of ftn-1?  
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3.7. Confirming the effects of RNAi on Pftn-1::gfp 
fluorescence 
 
In order to confirm that the genes identified earlier in this chapter were 
indeed true regulators of ftn-1, I proceeded in two stages. First, I sought to confirm 
that the results of my screen were accurate and that the genes in question were indeed 
true regulators of the Pftn-1::gfp transgene. Second, I confirmed that genes that have 
effects on Pftn-1::gfp expression also affect transcription of the endogenous ftn-1 
gene, thereby excluding the possibility of transgene–specific effects.   
Since some of the strains required for work later in this chapter were not 
available in a genetic background carrying the rrf-3(pk1426) mutation, which would 
therefore need to be crossed into these strains, I simultaneously tested whether this 
background was even required. I therefore tested the effects of a number of different 
‘candidate’ RNAi treatments on Pftn-1::gfp daf-2(m577) fluorescence in both the 
presence and absence of the rrf-3 allele. Results were very similar regardless of the 
rrf-3 genotype, indicating that the increased sensitivity of rrf-3(pk1426) mutants to 
RNAi is not necessary for the effect on Pftn-1 expression. The results presented in 
Figure 23 were generated in an rrf-3(+) genetic background. See Appendix 3 for the 
same tests performed in the presence of rrf-3(pk1426).   
 For this experiment, the identity of RNAi plasmids were verified by 
sequencing and used to transform competent HT115 bacteria that had been freshly 
obtained from the CGC. I grew Pftn-1::gfp daf-2(m577) worms at 15o C until the L4 
stage, then treated them with RNAi and measured their fluorescence after two days at 
25oC.  
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Figure 23 
Shows the reduction in Pftn-1 fluorescence in response to RNAi treatment of 
candidate genes in the Pftn-1::gfp daf-2 animals. Fluorescence of RNAi-treated 
worms was measured following Protocol 1 (see section 2.8.1. Protocol 1). Error bars 
represent ±s.e.m. Statistical significance tested using two-way ANOVA: *: p<0.05, 
**: p<0.01, ***:p<0.001. p-values were adjusted for multiple comparisons using the 
Bonferroni correction.  
 
Of these 14 genes, 7 significantly reduced Pftn-1::gfp expression, but none 
had as strong an effect as RNAi of daf-16. Thus, the screen did not identify any gene 
that acts downstream of daf-16 to mediate all of the effects of reduced IIS on ftn-1 
expression. Weaker determinants could, however, still be important. I therefore 
proceeded to the second stage: confirming that the genes regulating Pftn-1::gfp also 
regulate the ftn-1 transcript. 
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3.8. Using qRT-PCR to quantify ftn-1 transcript levels in 
response to RNAi 
 
Several transcription factors were confirmed to affect the transcription of 
GFP from a Pftn-1::gfp promoter, but it remained to be shown whether this effect 
was reproducible for the endogenous ftn-1 transcript or whether it is specific to the 
regulation of the GFP reporter. Artefactual findings of changes in Pftn-1::gfp 
expression could occur if RNAi treatments were having effects on, for example, GFP 
protein translation rather than transcription from the Pftn-1 promoter. Quantitative 
real-time PCR (qRT-PCR) is a sensitive method for the detection of differences in 
transcript abundance. This technique was used to monitor endogenous ftn-1 transcript 
levels in worms of different genotypes that were treated with RNAi against the 
transcription factors in question.  
However, before being able to collect the RNA samples, the protocol needed 
to be adjusted. Under the current protocol, worms were grown until L4 at 15°C on 
OP50 E. coli, then shifted to RNAi treatment and 25°C, and grown for two days 
before they were scored. This meant that the progeny of the worms being tested had 
already reached the late larval stages by the time the parents were ready to be scored. 
In the case of the platereader assay, this was not a problem, as it is a simple matter to 
pick only the adults into the microplate wells. However, when collecting RNA, 
worms needed to be washed off the plates in large numbers. In this case, a large 
portion of the RNA pool under examination will have been contributed by the 
progeny, not the adults. To circumvent this problem, the protocol was slightly altered 
to allow the worms to be collected two days earlier (see Section 2.8.2. Protocol 2). I 
confirmed that the effect of RNAi on the GFP reporter strain was preserved despite 
this change and found that it was (see Appendix 2) 
RNAi of the following genes was tested: daf-16, pqm-1, T07C12.1, hsf-1, 
blmp-1, mdl-1, egr-1, pbrm-1, ada-2, elt-2, klf-1. These genes were selected because 
RNAi of each of them was capable of reducing daf-2 lifespan in preliminary studies 
(Figure 22) and reduced Pftn-1::gfp expression. The three genes pqm-1, T07C12.1 
and egr-1 were included despite the fact that the observed small reductions in the 
mean fluorescence expressed from Pftn-1::gfp was not statistically significant 
(Figure 23).   
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3.8.1. Quantifying ftn-1 transcript levels 
 
Because of the high cost of performing a qRT-PCR assay with such a large 
number of samples, a preliminary experiment using only two biological replicates 
was carried out first. I collected two biological replicates of daf-2(m577) animals 
exposed to RNAi against the genes daf-16, pqm-1, T07C12.1, hsf-1, blmp-1, mdl-1, 
egr-1, pbrm-1, ada-2, elt-2, klf-1. The aim was to identify the true regulators of ftn-1 
expression before carrying out further work on them. I also collected samples of 
wild-type, daf-16(mgDf50); daf-2(m577) and daf-16(mgDf50) worms treated with the 
same RNAi in parallel to the daf-2(m577) worms. Analysis of ftn-1 levels in these 
samples will be discussed in the next chapter.  
RNA was isolated from these samples, DNAse I treated, cDNA was 
synthesised using oligodT and quantitative real-time PCR (qRT-PCR) was performed 
to quantify ftn-1 mRNA transcript levels in these samples. ftn-1 transcript levels were 
normalised by dividing the ftn-1 transcript quantity by the geometric mean of three 
reference genes cdc-42, pmp-3 and Y45F10D.4 transcript quantities (the reasons for 
selecting this set of reference genes will be discussed later in this chapter). The result 
of this analysis is shown in Figure 24.  
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Figure 24 
Preliminary screen: ftn-1 expression levels were quantified  for daf-2(m577) animals 
treated with RNAi of a number of different candidate genes. The y-axis represents 
the ftn-1 expression levels when normalised to the geometric mean of cdc-42, pmp-3 
and Y45F10D.4 expression levels (see section 3.6.1.1a below). No statistical analysis 
of these results was performed as only two biological replicates were measured. 
However, these results were pooled with further replicates collected later and the 
result of that analysis is presented in Figure 26. Samples were collected following 
protocol 2 (see 2.8.2. Protocol 2).   
Comparison of the results of fluorescence measurements performed on Pftn-
1::gfp daf-2(m577) and quantification of ftn-1 transcript levels in daf-2(m577) by 
qRT-PCR (see Figure 23 and Figure 24) shows that while RNAi of several genes did 
show the expected effects on ftn-1 expression, most did not. Those that did were hsf-
1, mdl-1, ada-2 and elt-2. Many genes that had not shown a statistically significant 
effect on the expression of Pftn-1::gfp were nevertheless tested for the effects on ftn-
1 transcript. This was done because a trend towards a reduction of expression had 
been observed, even if this trend was not statistically significant, and because RNAi 
of many of these genes had reduced daf-2 longevity. RNAi of none of these genes 
were found to reduce levels of ftn-1 transcript. RNAi of the three genes klf-1, pbrm-1 
and blmp-1 had no observable effect on transcript levels despite having led to a 
statistically significant reduction in GFP expression from the reporter strain. The 
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possible basis for the discrepancy between fluorescence and mRNA data is discussed 
below (see Chapter discussion).  
 
3.8.1.1. Further work on remaining candidate regulators 
 
While many candidate gene RNAi treatments did not result in a decrease in 
ftn-1 levels, some did show the expected effect (Figure 25). However, given the high 
variability in ftn-1 expression levels, more biological replicates were needed to 
establish whether the observed effects were statistically significant. 
 
 
Figure 25 
Reduced list of candidate regulators. 
The effect of RNAi treatments is displayed as a percentage of the ftn-1 transcript 
levels in control RNAi treated worms. The same data was used for this figure as for 
Figure 24.  
Further samples were therefore prepared following the same protocol and ftn-
1 transcript abundance was measured. Due to the high variability in ftn-1 transcript 
levels (compare the two biological replicates control–RNAi treated worms in Figure 
24) and the uncertainty regarding the magnitude of the effects of RNAi on ftn-1 
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transcript levels, particular care was taken to select the correct reference genes to 
normalise the data. The following section explains how this was done:   
 
3.8.1.1a  Normalisation of qRT-PCR data 
 
Accurate normalisation is of critical importance in the evaluation of of qRT-
PCR results. After RNA extraction, the RNA was quantified and then reverse 
transcribed into cDNA. Despite identical amounts of RNA being introduced into the 
cDNA synthesis reaction, the samples cannot be assumed to contain identical 
concentrations of cDNA. This is partly due to the fact that most of the RNA being 
quantified consists of rRNA, not mRNA. The ratio of rRNA to mRNA has been 
shown to be highly variable in other systems and is affected by a variety of biological 
factors and drugs (Johnson et al., 1995; Solanas et al., 2001; Spanakis, 1993) making 
total RNA levels an inadequate measure of total mRNA. Additionally, the cDNA 
synthesis reaction is known to be of highly variable efficiency, generating different 
amounts of cDNA in different reactions, and thus adding additional variation in the 
final cDNA concentration of different samples.  
Normalising quantified transcript levels to a set of internal controls is 
therefore necessary for the interpretation of qRT-PCR data. Reference genes should 
be used that are stably expressed and not affected by the experimental treatments 
being investigated. Since this experiment involves the use of insulin signalling 
mutants, which are known to differentially regulate a large fraction of expressed 
transcripts (McElwee et al., 2004), selecting reference genes that were not affected 
by insulin signalling was of particular importance. To do this I consulted a 
publication that compared the stability of expression of 12 different reference genes 
and used them to quantify superoxide dismutase expression in 6 different C. elegans 
strains: N2, daf-2 mutants, daf-16 mutants, daf-16; daf-2 double mutants, dauer 
larvae, and L3 N2 larvae (Hoogewijs et al., 2008). Fortunately, this set of samples 
was similar to the four genotypes used in my own experiments, meaning that the 
authors’ conclusions about the suitability of their reference genes could be applied to 
my own analysis. A reliable method for normalising transcript quantities in qRT-
PCR is to divide the quantity of the transcript of interest by the geometric mean of 
three stably expressed genes. I therefore selected cdc-42, pmp-3 and Y45F10D.4, the 
 123 
three most stably expressed genes as identified by Hoogewijs et al., as well as ama-1, 
the reference gene mostly commonly used in the Gems’ lab, as my reference genes. 
Transcripts of all four genes were quantified for all samples using qRT-PCR and 
transcript quantities were introduced into the GeNorm algorithm, which ranks the 
reference genes according to their stability by calculating average pairwise variations 
between each reference gene and all other reference genes (Vandesompele et al., 
2002).  
 
3.8.1.1b. Quantifying ftn-1 transcript abundance for further 
biological replicates 
 
Four reference genes were used to normalise for cDNA input: cdc-42, ama-1, 
pmp-3, and Y45F10D.4. Transcript quantities for these reference genes were 
analysed for the stability of expression. The result of this analysis is shown in Table 
6.  
 
Transcript M-value  
ama-1 1.189001  
pmp-3 0.938806  
cdc-42 1.041868  
Y45F10D.4 1.05109  
 
 
 
Table 6  
M-values of four different reference genes 
M describes the average pair-wise variation of each 
reference gene with all other reference genes. The M-
values in this table were calculated using the 
transcript quantification of all samples that had been 
treated with one of the RNAi treatments in Figure 26. 
This include four biological replicates of four strains 
treated with six different RNAi treatments.  
 
 
An important publication on optimal normalisation procedures for analysis of 
qRT-PCR results (Vandesompele 2002) recommends using only the three most 
stable reference genes for normalisation. The ama-1 transcript was the least stably 
expressed of the four reference genes I used and was therefore omitted from the 
analysis. A normalisation factor was then calculated from the three remaining 
reference genes by taking their geometric mean. ftn-1 expression levels were 
quantified by dividing the ftn-1 transcript quantity by this value.  
qRT-PCR analysis of these additional samples is summarized in Figure 26. 
As with the first two biological replicates (see Figure 25), a high variance in ftn-1 
 124 
transcript levels was found even in the untreated controls. This mirrors the findings 
from Pftn-1::gfp expression in the platereader assay performed for the screen. Large 
variation in GFP levels in the control RNAi treated animals were found from one day 
to the next, even when downregulation of the GFP levels by a candidate RNAi 
treatment was reproducible. This suggests that ftn-1 levels are sensitive to subtle 
changes in the environment. One possible source of variation is the temperature of 
the incubators, which could be causing large changes in ftn-1 induction by reduced 
insulin signalling as the daf-2 allele being used is very sensitive to temperature. 
Slightly different temperatures may lead to different levels of reduction in insulin 
signalling, which may translate to radically different Pftn-1::gfp expression as well 
as endogenous ftn-1 transcript expression. Whatever the source, it seems that there is 
a large batch to batch variation in ftn-1 transcript levels, which does not seem to 
influence the effect of the RNAi treatment of candidate regulators. The data was 
therefore displayed as a percentage of the control to illustrate the effects of the RNAi 
treatments within each batch while ignoring the differences between batches. 
Statistical analysis was performed using a two-way ANOVA for the same reasons, as 
it takes the treatment effect into account regardless of batch-to-batch differences. The 
two way ANOVA was performed using the RNAi treatment and the batch number as 
the two nominal variables and the ftn-1 transcript level as the measurement variable 
(after log transformation).  
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Figure 26 
daf-2(m577) animals were treated with RNAi bacteria. Expression levels are 
expressed as a percentage of the control RNAi treatment. Error bars represent ±s.e.m. 
Statistical significance was calculated using two-way ANOVA and p-values were 
adjusted for multiple testing using the Bonferroni correction: *: p<0.05, 
***:p<0.001.  
 
 
RNAi of gene Average ftn-1 
transcript abundance 
As % of 
control 
n p-value 
     
control 3.34 100 5  
daf-16 0.133 3.97 4 1.18E-13 
hsf-1 1.91 57.2 5 0.0103 
mdl-1 1.36 40.7 5 1.81E-05 
ada-2 2.05 61.2 5 0.0204 
elt-2 2.34 69.8 5 0.0420 
Table 7 
Summary table of qRT-PCR quantification of ftn-1 transcript abundance following 
candidate gene RNAi. p-values were calculated by two-way ANOVA of log-
tranformed transcript abundance values. p-values were adjusted for multiple testing 
using the Bonferroni correction.  
 
 126 
As shown in Figure 26 (and Table 7), I found a statistically significant down-
regulation of ftn-1 transcript in daf-2(m577) animals by RNAi of hsf-1, mdl-1, ada-2 
as well as the known regulator of ftn-1 transcription elt-2 (Romney et al., 2008). This 
screen was therefore successful in identifying hsf-1, mdl-1, and ada-2 as putative  
regulators of ftn-1 expression. The fact that RNAi of these genes was found to reduce 
ftn-1 transcript levels in daf-2(m577) animals demonstrates that the effect was not an 
artefact of transgene expression.   
 
3.9. Chapter discussion  
After very promising initial results, in which RNAi of a large number of 
genes led to large changes in expression of Pftn-1::gfp (see Table 4) and subsequent 
lifespan assays of these genes demonstrated that RNAi of most of them reduced daf-
2 lifespan, follow up work was unable to replicate some of the large changes in 
reporter gene expression found in the initial screen. Good examples for this include 
the genes ast-1, nhr-116, dve-1 and  hlh-30, RNAi of all of which led to very large 
decreases in Pftn-1::gfp expression in the initial screen but had no, or very little, 
effect on Pftn-1::gfp in later trials. One possible explanation is that the initial screen 
results for many of these genes had been spurious and that later tests were able to 
identify the true effects.  
Differences in how the initial screen was carried out and the experiments 
performed later could also be a cause of this discrepancy. For example, after carrying 
out the initial screen, I purified the RNAi plasmids, sequenced them and re-
introduced into the HT115 strain of E. coli used for RNAi. This was done after work 
from a colleague in the lab, who discovered that worms lived substantially longer 
after being fed a certain RNAi strain, only to find that this effect was unrelated to 
RNAi but was instead due to a spontaneous mutation in the E. coli host strain. The 
re-transformation into a fresh E. coli stock (obtained from the Caenorhabditis 
Genetic Centre) may have avoided similar bacterial strain-specific effects on 
expression from Pftn-1::gfp and therefore be a cause for some of these discrepancies.   
  Another possibility is that there was a loss of effectiveness of RNAi between 
the time the initial screen was carried out and the later assays. However, the 
consistently strong reduction in expression from Pftn-1::gfp after RNAi of daf-16 
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strongly argues against this possibility. The plasmid used for RNAi of daf-16 was re-
introduced into fresh HT115 just as the other plasmids tested in Figure 23 had been. 
RNAi of daf-16 was included in every trial and robustly reduced expression both of 
Pftn-1::gfp and of the ftn-1 transcript. The most likely explanation therefore seems to 
be that the large effects seen in the initial screen were spurious and probably due to 
the large variation in Pftn-1::gfp expression.  
 
3.9.1. Explaining the discrepancy between platereader and qRT-
PCR results 
 
Surprisingly, the results of the qRT-PCR validation shown in Figure 24 
demonstrate that the findings from platereader analysis of GFP expression from the 
Pftn-1::gfp construct do not, in many cases, coincide with expression changes of 
endogenous ftn-1 transcript levels in the same daf-2(m577) background. However, a 
closer look at the data reveals that RNAi of the three genes hsf-1, mdl-1 and ada-2 
that were found to cause a statistically significant reduction in ftn-1 transcript levels 
were also the ones that had the largest effect on Pftn-1::gfp expression. RNAi of 
several of the other genes tested did not lead to statistically significantly reductions 
in Pftn-1::gfp in the first place, so their inclusion in the preliminary qRT-PCR screen 
was probably over-optimistic to begin with. RNAi of only three genes led to a clear 
significant down-regulation of Pftn-1::gfp expression but no reduction in ftn-1 
transcript in the qRT-PCR trial.  
While there are several possible explanations for this discrepancy, it is 
possible that two biological replicates were not sufficient to detect a small decrease 
in expression. The preliminary results for pbrm-1 RNAi, for example, show a slight 
reduction in expression in one of the two replicates, but not in the other, so further 
experiments may have identified an overall statistically significant but small effect 
on ftn-1 transcript levels. However, given the very large number of genes found to 
have an effect on Pftn-1::gfp in the primary screen, I could not exhaustively test the 
effects of all RNAi treatments on the ftn-1 transcript, especially given the high cost 
of qRT-PCR. The focus on investigating only genes for which RNAi knockdown 
leads to large effects on ftn-1 expression may have come at the cost of losing the 
capacity to identify transcription factors with minor roles in ftn-1 regulation. My 
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central interest, however, was not to compile a comprehensive list of transcription 
factors that affect ftn-1 transcription to any degree, but to identify factors involved in 
the very large effects of reduced IIS on ftn-1 expression. RNAi of major players in 
IIS signalling upstream of ftn-1 regulation would be expected to have large effects on 
ftn-1 expression, so this loss of sensitivity may not be a serious concern, at least in 
this regard.   Given the large variability in the efficacy of RNAi, what cannot be 
excluded is that some of the RNAi treatments that had minor effects on ftn-1 
expression actually did target genes with important roles in ftn-1 regulation but that 
the RNAi treatment itself was not particularly effective at knocking down expression 
of the target gene. Additionally, if several genes act redundantly to regulate ftn-1 
expression, knocking them down individually may not have large effects. Thus it is 
easy to imagine that this screen may have missed some important players in IIS 
regulation of ftn-1 despite targeting such a large number of transcription factors. 
Other possible explanations for the discrepancy between the results derived 
from RNAi of worms carrying the transgene and from qRT-PCR can be imagined, 
though it is beyond the scope of this project to establish the cause of the discrepancy. 
One possibility is that a physical change in the RNAi treated worms, such as the size 
of the intestinal cells themselves, led to a decrease in the fluorescent signal emitted, 
without actually affecting the amount of GFP expressed. Worms treated with blmp-1 
RNAi, for example, consistently appeared considerably darker than control RNAi 
treated worms and this phenotype may interfere somewhat with the detection of the 
fluorescent signal. If this is true, blmp-1 RNAi may be producing a false positive 
result due to reasons unrelated to altered ftn-1 transcription. It is also possible that 
some RNAi treatments lead to an altered translation, maturation or degradation of the 
GFP protein, which would clearly affect the intensity of the fluorescent signal. Any 
transcription factors involved in the transcription of elements of the translation 
machinery could have such an effect. While this was not investigated further, the 
lifespan experiments performed do show that RNAi of klf-1, blmp-1 and pbrm-1 all 
reduce daf-2 lifespan, indicating that RNAi of these genes does have effects other 
than specifically on Pftn-1::gfp. Effects on processes unrelated to ftn-1 transcription, 
such as on transcription or translation in general, could explain the reduction in GFP 
fluorescence as well as of lifespan found upon RNAi of klf-1, blmp-1 and pbrm-1. A 
third explanation revolves around the absence of the endogenous ftn-1 3' UTR of the 
GFP construct, which only uses the ftn-1 promoter to drive GFP expression. If ftn-1 
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is post-transcriptionally regulated through its 3' UTR, then this effect would be 
missed when the GFP construct is used to report expression. It is hard to envisage a 
scenario in which this would lead to false positive findings during this screen, 
especially since the Pftn-1::gfp reporter and the endogenous ftn-1 transcript behave 
similarly in response to mutations in daf-2, daf-16 and in double mutants of the two 
(see Figure 38). However, it should be noted that ferritin transcript and protein have 
been shown to be very tightly regulated by post-transcriptional mechanisms in other 
organisms, so it is far from inconceivable that the ftn-1 transcript should be regulated 
via its 3' UTR.   
3.9.2. Why does RNAi of no other factor reduce ftn-1 expression 
as much as RNAi of daf-16?  
As described in Chapter 1, a study on direct targets of DAF-16 (Schuster et 
al., 2010) concluded that DAF-16 acts as a ‘regulator of regulators’ by directly 
activating a number of signalling molecules and transcription factors. Understanding 
the transcriptional architecture downstream of DAF-16 would presumably go a long 
way in helping us understand the mechanisms by which IIS mutants exhibit such 
large changes in their transcriptome and such large extensions in their lifespans. My 
project aimed at understanding how DAF-16 acts to regulate expression of distinct 
sets of genes by choosing a single target, ftn-1, and attempting to identify if there are 
any transcription factors that act downstream of DAF-16 to regulate this gene. If this 
was occurring through a single transcription factor downstream of DAF-16, then 
presumably RNAi of this factor would lead to a complete or almost complete 
abrogation of the ftn-1 induction by daf-2(m577). However, no single gene was 
identified with as important a role in ftn-1 regulation as daf-16.  
Of course, the expectation that a transcriptional cascade exists in which DAF-
16 activates a single transcription factor which itself then activates ftn-1 could be 
incorrect. It is likely that the promoter of ftn-1 binds many proteins which act in 
concert to regulate ftn-1 transcription. Several of these factors may act downstream 
of DAF-16 to increase gene expression in IIS mutants and may do so in a redundant 
fashion. If this is the case, then RNAi of each of them may have an effect on ftn-1 
expression that is smaller than RNAi of daf-16 itself. It is also possible that no RNAi 
treatment is effective as daf-16 RNAi in reducing ftn-1 expression merely because of 
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differences in the efficacy of the RNAi knockdown itself. Other genes may have as 
important a role in ftn-1 regulation as daf-16, but may not be as easily silenced by 
RNAi.  
A possible alternative explanation is that under conditions of low IIS, DAF-
16 may bind to the promoter of ftn-1 directly to activate expression. During the initial 
stages of this project, there were several strong indications that this is not the case. 
The study by Schuster et al. had not yet been published, but the preliminary data was 
available and no binding to the ftn-1 promoter was detected (Eugene Schuster, 
personal communication). In addition, a separate publication that used Chromatin 
Immuno-precipitation (ChIP) to identify DAF-16 targets did not identify ftn-1 as a 
candidate. Very recently however, results started to become available from a large-
scale effort to identify the targets of C. elegans transcription factors 
(www.modencode.org). This was done by expressing transcription factors fused to 
GFP in worms and assessing binding to DNA by ChIP using an anti-GFP antibody 
and subsequent deep-sequencing.  
The results for a DAF-16::GFP transgene recently became available and may 
be useful in assessing whether DAF-16 may bind to the ftn-1 promoter directly. It 
should be noted that, except for carrying the DAF-16::GFP transgene, the strain used 
was wild-type for all elements of the IIS pathway, so it is unclear whether this data is 
really informative about the consequences of reduced IIS on binding of DAF-16 to 
its target genes. However, as depicted in Figure 27, some evidence of binding to the 
sequence immediately upstream of the ftn-1 promoter was found (q=4.47E-14). A 
sequence resembling the daf-16 binding element (DBE) is present 150bp upstream of 
the ftn-1 start codon, which could be the site at which DAF-16 binds.  
 
 
 
 
 
Figure 27 
Possible binding of DAF-16::GFP to the ftn-1 promoter. Figure adapted from the 
ModEncode project (modencode.org, accessed Jul 2010).  
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While much more work would need to be done to establish that transcription 
of ftn-1 is indeed induced under reduced IIS by direct binding of DAF-16 to its 
promoter, the data from the ModEncode project at least demonstrates that DAF-16 is 
capable of binding ftn-1. This raises the prospect that the RNAi screen performed 
here was ineffective at identifying another gene with as important a role as daf-16 in 
the regulation of ftn-1 in daf-2 mutants simply because this induction is occurring via 
direct binding of DAF-16. 
At this stage in the project, two transcription factors, hsf-1 and mdl-1, as well 
as ada-2, a gene thought to act as a subunit of a histone acetyl transferase complex,  
were identified as having important roles in the regulation of ftn-1. hsf-1 has long 
been known to be an important player in the lifespan extension of IIS mutants (Hsu 
et al., 2003) and links between mdl-1 and IIS have also been discovered (see Chapter 
4). Lifespan assays on daf-2 mutants show that RNAi of both mdl-1 and ada-2 
statistically significantly reduce their lifespan, although the effects of ada-2 RNAi 
were very modest, with no reduction in median and only a very small reduction in 
mean lifespan. In Chapter 4, I will therefore proceed to further characterise their role 
in mediating daf-2 longevity.  
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Chapter 4: Further investigation of genes 
influencing ftn-1 expression 
 
4.1. The biological functions of hsf-1, mdl-1 and ada-2  
The work described Chapter 3 identified three genes hsf-1, ada-2 and mdl-1, 
which regulate expression of ftn-1. RNAi knockdown of each of them leads to 
reductions in both Pftn-1::gfp expression and ftn-1 transcript levels. In this chapter, I 
will investigate these genes further first by briefly introducing the literature on these 
genes and then describing how I attempted to test the genes’ involvement in IIS in 
order to assess their role in the extended lifespan of daf-2 mutants.  
 
4.1.1. hsf-1  
One of the genes identified in the screen is the transcription factor hsf-1 
(heat-shock factor 1), RNAi of which greatly reduces ftn-1 levels in daf-2 mutants. 
The fact that this discovery was made as part of an unbiased, large scale screen, not a 
candidate gene approach, is encouraging, since hsf-1 is one of the few transcription 
factors known to act downstream of IIS to regulate ageing. At the least, this finding 
demonstrates that the screen is capable of identifying the genes it was designed to 
identify, namely those involved in mediating daf-2 longevity.  
Like daf-16, hsf-1 is absolutely required for the longevity phenotype of daf-2 
animals and its over-expression is sufficient to extend lifespan on its own (Hsu et al., 
2003; Morley and Morimoto, 2004). This is thought to occur because hsf-1 activates 
expression of a number of cytoprotective genes, such as small heat shock proteins 
(sHSPs) (Hajdu-Cronin et al., 2004), which act as molecular chaperones and prevent 
incorrect protein folding. hsf-1 also has an important role in mediating the increased 
resistance of daf-2 mutants to infection by pathogenic bacteria (Singh and Aballay, 
2006).  
 
 133 
4.1.2. mdl-1  
MDL-1 (MAD- like 1) is believed to be the C. elegans homologue of the 
MAD proteins that act within the MYC/MAD/MAX network of basic helix-loop-
helix (bHLH) transcriptional regulators. These genes have been extensively 
researched in vertebrate models due to the network’s involvement in a number of 
important cellular processes, such as proliferation, differentiation and apoptosis. The 
high levels of interest in this group of regulators was driven by the tumour promoting 
abilities of Myc proteins, with many tumours showing enhanced levels of Myc 
(Dang, 1999). Both Myc and Mad proteins bind to Max to form a heterodimer, but 
while Myc/Max has been shown to usually activate gene expression, Mad/Max acts 
as a repressor antagonising the effects of Myc on proliferation. This antagonism is 
thought to occur via binding to common target genes and recruitment of either a 
histone acetyl transferase (HAT) complex in the case of Myc/Max or a histone 
deacetylase (HDAC) complex in the case of Mad/Max. The binding of Myc/Max or 
Mad/Max to common binding elements in target genes promoters (termed E-box 
sequences) and the predicted effects on gene regulation by recruitment of these 
chromatin modifying factors is depicted in Figure 28.   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Figure 28 
A model for the activity of the Myc/Max/Mad network of transcriptional regulators 
on common target genes (Luscher, 2001).  
 
The degree to which the function of Mad proteins is conserved in C. elegans 
is unclear. mdl-1 was identified as the worm homologue based on sequence 
similarity (60% identical and 72% similar to human MAD1). Several features of the 
MDL-1 protein make it likely to be the homologue of Mad and not Myc or Max 
proteins, including the overall protein organisation, the presence of several residues 
specific to the Mad family and the presence of the consensus sequence for Sin3 
binding (see Figure 28). Its binding partner was identified in a protein interaction 
screen; it showed high sequence identity as well as common protein domains with 
MAX and was therefore named mxl-1 (MAX-like gene 1). In vitro assays showed 
binding of the MDL-1/MXL-1 heterodimer to an oligonucleotide containing the E-
box sequence. Thus it seems that certain features Mad/Max are reiterated in MDL-
1/MXL-1, which suggests that the genes’ functions could be conserved. This is 
supported by the finding that MDL-1 is capable of forming a dimer with mouse 
MAX  in vitro (Yuan et al., 1998).     
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However, C. elegans does not seem to have a clear Myc homologue. One 
gene mml-1 has low sequence identity to both Myc and to another bHLH gene called 
Mondo (26% and 25% identity respectively). The amino acid sequence of this gene 
lacks Myc signature sequences but does possess certain sequences characteristic of 
Mondo. Its binding partner was also identified and was named mxl-2. MML-1 and 
MXL-2 were shown to form heterodimers capable of activating a luciferase reporter 
via E-box sequences (Pickett et al., 2007). The expression patterns of these four 
genes (mdl-1, mxl-1, mml-1, mxl-2) do overlap in intestinal and epithelial cells, so it 
is possible that MML-1/MXL-2 and MDL-1/MXL-1 activate and repress target 
genes in C. elegans much like Myc/Max and Mad/Max do in vertebrates. However, 
no target genes antagonistically regulated by these two heterodimers has thus far 
been identified, so there is currently no evidence for conservation of the Mad-Myc 
antagonism in C. elegans. That MML-1 seems to be more closely related to MondoA 
than to Myc genes suggests that it might not be. Additionally, the phenotype of 
mutation of mml-1 is limited to a subtle male tail abnormality.  
At least in the case of its role in the regulation of ftn-1, mdl-1 has not been 
found to act as a repressor, since RNAi of it leads to decreased, not increased, 
expression. Of course, the mechanism by which MDL-1 might activate ftn-1 
expression is also unknown, so an indirect activation, for example via repression of a 
third regulator, is possible.   
4.1.3. ada-2  
Far less is known about the C. elegans gene ada-2 since no studies have 
directly investigated its function. By sequence homology, ada-2 it is thought to be a 
homologue of the Ada2 subunit of various histone acetyl transferase (HAT) 
complexes that activate gene expression by modifying chromatin via histone 
acetylation. Ada2 subunits form part of the three yeast complexes SAGA, ADA and 
HAT-A2 which acetylate H3 and H2B histones and the human PCAF complex, 
which acetylates H3 and H4 histones (Carrozza et al., 2003). The catalytic element of 
these complexes is also thought to be conserved in C. elegans based on sequence 
similarity to the gene pcaf-1 (Poulin et al., 2005).   
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There is a possibility that the effects of ada-2 and mdl-1 RNAi are not 
unrelated. In vertebrates, cMyc activates gene expression by recruiting HAT 
complexes via the cofactor TRRAP (McMahon et al., 2000). While the human HATs 
containing TRRAP are not thought to also contain Ada2, yeast HATs containing the 
yeast homologue of TRRAP, Tra1, do contain yeast Ada2. However, uncertainty 
about the extent to which both the Myc/Max/Mad network and the Ada2 containing 
HAT complexes are conserved across these species make it difficult to predict if this 
potential link is likely to be real.   
4.1.4. Focus on mdl-1  
Several studies on downstream effects of reduced IIS have suggested a role of 
mdl-1 in mediating phenotypes associated with reduced IIS. The first hint came from 
microarray studies aimed at identifying differentially regulated genes in long-lived 
IIS mutants (see Chapter 1). mdl-1 was found to be up-regulated in long-lived 
mutants in two separate experiments (McElwee et al., 2004; Murphy et al., 2003) and 
this result was confirmed in a third study by qRT-PCR quantification of mdl-1 
transcript level (see Figure 29).  
 
 
  Figure 29 
Figure adapted from Pinkston-Gosse et al. (2007) 
The y-axis depicts the fold change in mdl-1 transcript 
levels in daf-2(-) compared to daf-16(-); daf-2(-) 
animals, which confirms microarray experiments that 
found increased mdl-1 expression in long-lived mutants 
(McElwee et al., 2004; Murphy et al., 2003). 
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Of course, given the large number of genes that have been shown to be differentially 
regulated in long-lived IIS mutants, evidence of increased expression alone is 
insufficient to demonstrate involvement in mediating IIS mutant phenotypes. 
 
4.1.4.1. Direct binding of DAF-16 to mdl-1 promoter 
 
An additional and very interesting link between IIS and mdl-1 came from the efforts 
of Schuster et al. to identify direct targets of DAF-16 by genome-wide chromatin 
profiling using DamID. They found  strong evidence for direct binding of DAF-16 to 
the promoter of mdl-1 (see Figure 30), indicating that the up-regulation of mdl-1 
expression by reduced IIS may occur through increased binding of DAF-16.  
 
 
 
 
Figure 30 
Adapted from (Schuster et al., 2010). DamID data indicating binding of a DAF-16 
transgene to the promoter of mdl-1. The black bars at the top of the figure indicate 
areas of the promoter to which DAF-16 is likely to bind.  
 
 This result was subsequently confirmed by Jennifer Tullet and Michèle 
Riesen, two post-doctoral researchers in David Gems’ lab. They used chromatin 
immuno-precipitation against endogenous DAF-16  followed by PCR (ChIP-PCR) to 
show direct binding to the mdl-1 promoter (see Figure 31).   
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Figure 31 
ChIP-PCR on two biological 
replicates seems to support direct 
binding of DAF-16 to the mdl-1 
promoter. DAF-16–target M01H9.3 
was used as a positive control. These 
experiments were carried out by 
Jennifer Tullet and Michèle Riesen.    
4.1.4.2. Effect on gld-1 tumour phenotype  
A possible biological function of mdl-1 was identified in an RNAi screen on 
a C.  elegans tumour model (Pinkston-Gosse and Kenyon, 2007). In worms, mutation 
of the tumour suppressor gene gld-1 leads to the formation of germline tumours, 
which form because meiotic cells re-enter the mitotic cell cycle. While gld-1(-); daf-
2(+) animals die of these tumours, the severity of this phenotype is greatly reduced 
in gld-1(-); daf-2(-) due to higher levels of germline apoptosis and inhibited cell 
proliferation within the tumour. The protection conferred by daf-2(-) requires daf-16 
(Pinkston et al., 2006), which makes protection from gld-1(-) tumours another 
phenotype of IIS mutants mediated by daf-16. Pinkston-Gosse et al. investigated 
which genes downstream of IIS were contributing to this effect. They compiled a list 
of over 700 genes thought to be regulated by IIS in microarray and ChIP experiments 
and tested their involvement in conferring the phenotype through RNAi. The aim 
was to identify RNAi treatments which lead to increased tumour lethality in the 
otherwise protected gld-1(-); daf-2(-) animals, and RNAi of mdl-1 was one of the 
genes found to have this effect.   
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Figure 32 
Adapted from Pinkston-Gosse et al. (2007). RNAi of 
 mdl-1 leads to an increase in tumour formation in gld-
 1; daf-2 animals as well as in associated lethality.    
 
 
 
 
 
Loss of mdl-1 by RNAi led to an increase in tumour lethality and an increase 
in the number of dividing germ cells, demonstrating that mdl-1 plays a role in 
conferring protection against gld-1 tumours in daf-2.  Given its transcriptional up-
regulation in IIS mutants, the direct binding of DAF-16 to its promoter and the 
evidence of its involvement in conferring a protective effect of daf-2 mutants, mdl-1 
is the prime candidate in the search for a true mediator of IIS signalling downstream 
of DAF-16.   
4.1.4.3. Role of mdl-1 in lifespan  
The role of mdl-1 in daf-2 longevity was also investigated. This was first 
done in the follow up work to one of the microarray experiments on IIS. Murphy et 
al. tested a large number of differentially regulated genes on their effects on daf-2 
lifespan and found that RNAi of mdl-1 statistically significantly reduces daf-
2(mu150) lifespan by 9% (full genotype of strain used: fer-15(b26); daf-2(mu150); 
fem-1(hc17)) at 25oC.  
Similar results were obtained in the study by Pinkston-Gosse: two trials on 
daf-2(e1370) animals found a 10% and an 8% reduction in lifespan upon mdl-1 
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RNAi. As described in Chapter 3, I obtained similar results using RNAi of mdl-1 in 
rrf-3; daf-2 animals (see Figure 22 and Table 5). This indicates that mdl-1 may be 
acting downstream of daf-2 to mediate two different phenotypes of daf-2 mutants: 
The extended lifespan and the increased protection against gld-1 tumour formation. 
If so, one might expect mdl-1 RNAi to reduce daf-2(-) lifespan to a greater extent 
than daf-2(+) lifespan. If, on the other hand, mdl-1 RNAi reduces lifespan to a 
similar extent regardless of daf-2 genotype, then this would imply that loss of mdl-1 
shortens lifespan by a mechanism unrelated to IIS and that mdl-1 is unlikely to be 
acting on lifespan downstream of DAF-16. Pinkston-Gosse et al. found that mdl-1 
RNAi caused no reduction in daf-2(+) lifespan in two trials, thus supporting the first 
of these hypotheses (see Figure 33).  
 
 
Figure 33 
Figure adapted from Pinkston-Gosse 
(2007) and illustrates their findings on the 
effect of mdl-1 RNAi on daf-2(-) and daf-
2(+)  lifespan.   
4.1.4.4. Other possible interactions of mdl-1 
 
mdl-1 may also be regulated by microRNA binding. A miRNA- microarray 
based study identified mdl-1 as a target of degradation via miR-64 and miR-65, two 
transcripts differentially regulated in C. elegans models of Parkinson’s disease 
(Asikainen et al., 2010). A different study also identified a direct interaction between 
the DAF-3 transcription factor and the promoter of mdl-1 and suggested that DAF-3 
acts as a suppressor of mdl-1 in the worm pharynx during the dauer stage (Deplancke 
et al., 2006). Whether or not these interactions are related to the regulation of mdl-1 
by IIS has not been investigated.   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4.1.4.5. Does mdl-1 regulate ftn-1 directly?  
Very recently, the ModEncode project released data on binding of an MDL-
1::GFP fusion protein. While this data was generated from L1 animals and did not 
test the effects of mutations in IIS, it nonetheless demonstrates that direct binding of 
MDL-1 to the ftn-1 promoter may be occurring (see Figure 34).  
 
 
 
Figure 34 
Figure adapted from the ModEncode project (modencode.org, accessed Jul 2010). 
The blue bars in the bottom track indicate statistically significant binding of MDL-
1::GFP in L1 larvae.   
The evidence for regulation of mdl-1 by IIS via direct binding of DAF-16 to 
its promoter, for a role of mdl-1 in effecting daf-2 mutant phenotypes such as tumour 
protection and lifespan, and the possibility of direct binding of MDL-1 to the ftn-1 
promoter suggests the following model of IIS regulation:  
 
Figure 35 
MDL-1 may act downstream of DAF-16 to activate ftn-1 
transcription. This may be occurring either as the only mechanism by 
which IIS affects ftn-1 transcription or in addition to the possible 
direct activation of ftn-1 by DAF-16.      
For a direct interaction to be occurring, mdl-1 also needs to be expressed in 
the intestine. In a study that used a tagged, intestinally expressed polyA-binding 
protein to isolate mRNA specifically enriched in this tissue, mdl-1 was identified as 
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one of the intestinally expressed genes (Pauli et al., 2006). A mdl-1 reporter gene 
was also found to be intestinally expressed (Yuan et al., 1998).    
4.1.5. Epistasis analysis of new regulators of ftn-1 expression  
When investigating the regulation of a DAF-16–regulated gene such as ftn-1, 
one problem is that DAF-16 is responsive to many different cues, such as stress and 
starvation and its activity is therefore most likely affected by many different 
interventions. This is problematic because RNAi of many genes may indirectly affect 
its activity.  If RNAi of a transcription factor leads to a reduction in DAF-16 
activation, for example by altering a signalling pathway that DAF-16 is responsive 
to, this could lead to lower ftn-1 levels. The question of whether the genes being 
targeted act upstream, downstream, or independently of DAF-16 to regulate ftn-1 
needs to be addressed. Since RNAi of the genes being investigated have already been 
shown to reduce ftn-1 transcript levels in daf-2 animals, I investigated whether they 
are also capable of doing this in daf-16; daf-2 animals. If not, then this would 
provide evidence that they act upstream of daf-16. If they are capable of reducing 
ftn-1 levels in daf-16; daf-2, then this possibility could be excluded.  
The second approach was to investigate the role of these transcription factors 
in IIS mutant longevity. To do this, I tested the lifespan of daf-2(-) and daf-2(+) 
animals (both in an rrf-3(pk1426) mutant background) treated with RNAi of the gene 
of interest. RNAi of genes involved in mediating the longevity of daf-2 animals 
would be expected to reduce lifespan in daf-2(-) animals to a much greater extent 
than daf-2(+) animals. This experiment has already been carried out for mdl-1 by 
Pinkston-Gosse et al., but only in the context of a large-scale screen. Because the 
lack of a lifespan reduction by mdl-1 RNAi in wild-type animals is such an important 
result, I felt it was important to establish that this finding was reproducible. The role 
of hsf-1 on lifespan was not investigated further, since this transcription factor’s 
involvement in IIS mutant longevity has already been well established.  
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4.2. Testing daf-16 and daf-2 dependence of the effects of 
RNAi treatment of candidate regulators 
 
As indicated in microarray data, rt-PCR experiments and platereader 
experiments shown previously (see Figure 19 and  Figure 18), both the endogenous 
ftn-1 transcript and the Pftn-1::gfp reporter are strongly negatively regulated by 
DAF-2 and positively regulated by the FOXO transcription factor DAF-16. This 
screen was not primarily designed to identify general regulators of ftn-1 expression, 
such as elt-2, but  to identify transcription factors that act downstream of daf-2 to 
effect the differential gene expression seen in long-lived insulin signalling mutants 
(McElwee et al., 2004). My hope was to identify one or several transcription factors 
that acted downstream of DAF-16, which would be an important step in 
understanding how the activation of DAF-16 is able to so strongly affect C. elegans 
lifespan.  
 
4.2.1. The use of elt-2 RNAi as a positive control treatment 
 
 The elt-2 gene is thought to act as a terminal differentiation factor for the 
intestine and to regulate all intestinally expressed genes (McGhee et al., 2009). The 
direct regulation of ftn-1 by ELT-2 was demonstrated via an electrophoretic mobility 
shift assay (EMSA) (Romney et al., 2008) and as expected, RNAi of elt-2 led to 
large decrease in expression of a ftn-1 reporter gene in this same study. In my hands 
RNAi of elt-2 also led to decreased expression of Pftn-1::gfp in daf-2 animals.  
 Since this gene is thought to act as a regulator of all intestinal genes, it is 
unlikely to be involved in the induction of ftn-1 by reduced IIS. Instead, its 
regulation of ftn-1 is likely to occur regardless of genetic background, which is 
supported by the fact that elt-2 RNAi reduced ftn-1 transgene expression in wild-type 
animals in Romney et al. (2008) and in daf-2 mutants in my own hands.  
In this section, I tested the effects of hsf-1, mdl-1 and ada-2 RNAi on ftn-1 
expression in several genetic backgrounds. The overall levels of ftn-1 vary greatly 
between genotypes and it is possible that the efficacy of RNAi may also vary. Since 
the most likely role of elt-2 is independent of IIS, I decided to use RNAi of this gene 
as a positive control in the experiments described in this section. If the efficacy of 
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RNAi and the sensitivity of the assays of ftn-1 expression level are equal across all 
genotypes, then the effects of elt-2 RNAi on ftn-1 expression should also be equal. If 
I find that this is not the case for any of my assays, then this could be considered 
when analysing the results.   
 
4.2.2. Testing the daf-16 dependence of the candidate gene RNAi effects 
 
The presence or absence of DAF-16 has already been shown to have large 
effects on expression of both Pftn-1::gfp and endogenous ftn-1. One possibility is 
that any of the candidate gene RNAi treatments decrease expression of ftn-1 and 
Pftn-1::gfp  by decreasing DAF-16 activity, for example by affecting elements of IIS 
or other pathways upstream of DAF-16 (see Figure 36).  
 
Figure 36 
Model 1: Possible mechanism by which a candidate gene may 
be affecting ftn-1 transcription. In this case, ADA-2 may be 
activating DAF-16 activity, thus affecting ftn-1 transcription 
indirectly. This scenario is consistent with the finding that 
RNAi of ada-2 reduces ftn-1 transcript levels. This possibility 
needs to be considered for all candidate gene RNAi treatments, 
given the important role of DAF-16 in IIS-mediated ftn-1 
induction.  
 
 
I therefore tested whether the effects of candidate gene RNAi on ftn-1 
expression were dependent on DAF-16: if any of them affected ftn-1 expression by 
changing the expression or activation of DAF-16, then they should no longer do so in 
DAF-16 mutant animals.  
 
4.2.1.1. Using the Pftn-1::gfp transgene 
 
My first attempt to test the dependence on DAF-16 was to use the Pftn-1::gfp 
transgene to measure the effect of candidate gene RNAi in different genetic 
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backgrounds. I therefore crossed the Pftn-1::gfp construct into several different 
genetic backgrounds, obtaining the following strains: 
 
Pftn-1::gfp 
Pftn-1::gfp daf-2(m577) 
Pftn-1::gfp daf-16(mgDf50) 
Pftn-1::gfp daf-16(mgDf50); daf-2(m577) 
 
I then tested the effect of the candidate RNAi treatments on the GFP 
expression from these strains. As described earlier, I used the RNAi treatment of the 
gene elt-2 as a positive control for knockdown of a known regulator of ftn-1. As can 
be seen in Figure 37, despite the clear down-regulation of Pftn-1::gfp by elt-2 RNAi 
in the daf-2 strain, this effect was not seen in the other strains.  
 
 
Figure 37 
Use of Pftn-1::gfp in various genetic backgrounds.  
This experiment tested the effect of daf-16 and elt-2 RNAi on Pftn-1::gfp 
fluorescence in various genetic backgrounds. Fluorescence was measured as 
described in protocol 1 (see 2.8.1. Protocol 1). Error bars represent ±s.e.m. Statistical 
significance tested using two-way ANOVA. Unless otherwise indicated, statistical 
significance was calculated for the comparison to control RNAi treatment of worms 
of the same genotype *: p<0.05, **: p<0.01, ***: p<0.001, n.s.: not significant 
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This could imply that the elt-2 RNAi effect on ftn-1 expression is DAF-16 
dependent. However, this seems unlikely since elt-2 is thought to be a general 
activator of intestinally expressed genes (McGhee et al., 2009). Instead, given the 
nature of the assay, in which fluorescence of live worms was measured in a 
platereader, and the large difference in signal intensity between the ‘induced’ levels 
of Pftn-1::gfp in the daf-2 mutant strain and the much lower levels of GFP in the 
other strains, it seems likely that Pftn-1::gfp expression cannot be sensitively 
quantified in the three ‘non-induced’ strains. I therefore decided to use ftn-1 
transcript levels rather than Pftn-1::gfp fluorescence to test the daf-16 –dependence 
of the effects of candidate gene RNAi.   
 
4.2.1.2. Effect of mutations in IIS on endogenous ftn-1 levels 
 
After abandoning the use of Pftn-1::gfp, I switched to measuring endogenous 
ftn-1 transcript levels by qRT-PCR on the following strains directly: 
 
Wild-type 
daf-16(mgDf50) 
daf-16(mgDf50); daf-2(m577) 
 
This was done using the same protocol as described previously for the daf-2(m577) 
samples (see Chapter 2 and 3). Worms of the four genotypes were grown 
simultaneously and samples were collected together for all RNAi treatments. As 
shown in Figure 38, ftn-1 transcript levels responded to alterations in IIS as expected. 
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Figure 38 
Error bars represent ±s.e.m. Transcript levels on the y-axis were calculated using a 
normalisation factor derived from three reference genes (see Chapter 3). Statistical 
significance was tested using two-way ANOVA: Unless otherwise indicated, 
statistical significance was calculated for the comparison to control RNAi treatment 
of worms of the same genotype. p-values were adjusted for multiple testing using the 
Bonferroni correction *: p<0.05, **: p<0.01, ***: p<0.001, n.s.: not significant 
 
 
ftn-1 levels are highly upregulated in daf-2 mutant animals and this effect is 
completely dependent on daf-16. Wild-type worms show an intermediate level of ftn-
1 transcript that is itself completely dependent on daf-16, indicating that some 
residual daf-16 activity remains in N2 animals despite an intact IIS signalling 
pathway. This is consistent with the role of daf-16 in wild-type lifespan and stress 
resistance since loss of daf-16 in daf-2(+) also leads to a reduction in both these 
traits (Weinkove et al., 2006). This indicates that even when IIS is unperturbed, 
residual DAF-16 activity exists, which seems to be increasing ftn-1 expression. This 
result was also seen when Pftn-1::gfp was used as a readout of ftn-1 expression (see 
Figure 37).  
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4.2.1.3. Testing daf-16 dependence 
 
I therefore tested whether the effects of candidate gene RNAi treatments on 
ftn-1 transcript levels require daf-16. This was done in a daf-16; daf-2 mutant 
background. If any RNAi treatment was able to reduce ftn-1 transcript levels in this 
genotype, then this would demonstrate that the effect of this treatment did not occur 
upstream of daf-16, for example by leading to altered DAF-16 activation (see Figure 
36).  
 
Figure 39 
Expression levels are expressed as a percentage of the control RNAi treatment. Error 
bars represent ±s.e.m. Statistical significance was calculated as in Figure 38. 
 
RNAi of gene as % of control n p-value 
control 100 5  
daf-16 100.1 4 >0.2 
hsf-1 294.4 5 0.0116 
mdl-1 55.6 5 0.0268 
ada-2 88.3 5 >0.2 
elt-2 89.2 5 >0.2 
 
Table 8 
This table contains data corresponding to Figure 39. The p-values were adjusted for 
multiple testing using the Bonferroni correction, but in this case this correction did 
not lead to a loss of statistical significance in the effects of any of the treatments.   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As expected, daf-16 RNAi had no effect on this strain since it already lacks 
daf-16. hsf-1 RNAi had the unexpected effect of increasing ftn-1 levels, the opposite 
of its effect on daf-16(+); daf-2(m577), in which it greatly reduced ftn-1 levels. This 
implies that the effects of hsf-1 RNAi on ftn-1 require DAF-16. This result is 
consistent with previous findings on the joint action of DAF-16 and HSF-1 (Hsu et 
al., 2003). See the chapter discussion for a detailed interpretation of this finding.  
No effects of ada-2 or elt-2 RNAi on ftn-1 levels were detected in this 
genotype. This could merely imply that the assay’s sensitivity was insufficient and 
more samples would be required to detect the changes. This would not be 
unexpected, since the effect of RNAi of these two genes had been much smaller than 
that of mdl-1 RNAi  in daf-2(m577), both on ftn-1 transcript and on Pftn-1::gfp 
expression levels. The absence of a statistically significant effect by RNAi of elt-2 in 
particular suggests that the assay may simply not be sensitive enough, since RNAi of 
this GATA transcription factor has previously been shown to regulate ftn-1 in a daf-2 
and daf-16 wild-type background. Given its role as the intestinal terminal 
differentiation factor, it seems unlikely that it requires daf-16 to regulate ftn-1. It is 
possible that including additional biological replicates would demonstrate that there 
is a small effect of elt-2 RNAi on ftn-1 levels in all genetic backgrounds, as 
previously reported (Romney et al., 2008). The fact that small reductions were 
observed in both the mean ftn-1 expression level of worms treated with RNAi of both 
these genes (see Table 8) suggests that this is indeed a sensitivity issue and that 
collection of more replicates may make this result statistically significant. 
Of the genes tested here, only mdl-1 RNAi was capable of reducing ftn-1 
transcript levels in this genotype. Since mdl-1 RNAi has already been found to 
strongly reduce ftn-1 transcript levels in daf-2 animals, showing that the same occurs 
in daf-16; daf-2 demonstrates that daf-16 is not required for the treatment’s effects. 
Figure 40 depicts two possible models for the regulation of ftn-1 by MDL-1.   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Model 2: MDL-1 may be 
affecting ftn-1 transcription by a 
mechanism unrelated to IIS. This 
is consistent with the results of 
qRT-PCR, since loss of MDL-1 
by RNAi would lead to decreased 
ftn-1 transcript levels regardless 
of IIS genotype. Given the 
evidence that mdl-1 is a 
regulatory target of DAF-16, a 
role of MDL-1 in the regulation 
of ftn-1 that is completely 
independent of DAF-16 (Model 
2) seems unlikely. 
 
 Model 3: MDL-1 may act downstream 
of DAF-16 to activate ftn-1 
transcription. This may be occurring 
either as the only mechanism by which 
IIS affects ftn-1 transcription or in 
addition to the possible direct activation 
of ftn-1 by DAF-16. This scenario is 
also consistent with qRT-PCR data as 
long as MDL-1 has a role in regulating 
ftn-1 even in the absence of DAF-16.  
 
Figure 40 
Schematic representation of possible involvement of ‘candidate’ genes in ftn-1 
regulation by IIS.   
 
4.2.1.4. Effect of candidate gene RNAi on daf-16(mgDf50) and 
wild-type animals  
In parallel, I also tested the effects of candidate gene RNAi on N2 and daf-
16(mgDf50) animals. The levels of ftn-1 transcript in control and daf-16 RNAi–
treated animals of all four strains can be seen in Figure 38, which demonstrates that 
ftn-1 transcript levels respond to mutations in IIS as one would predict from the 
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experiments using Pftn-1::gfp. Unfortunately, none of the RNAi treatments, not even 
the positive control treatment against elt-2, had a statistically significant effect on 
ftn-1 transcript levels (Figure 41). The only exception to this was RNAi against daf-
16, which did reduce transcript levels in wild-type animals as expected.  
 
 
Figure 41 
Expression levels are expressed as a percentage of the control RNAi treatment. Error 
bars represent ±s.e.m. Statistical significance was calculated as in Figure 38. 
 
 
Wild­type animals    daf­16(mgDf50) animals 
RNAi 
of gene 
ftn-1 transcript 
levels 
 (as % 
 of control) 
 
n 
 
p-value 
 RNAi 
of gene 
ftn-1 transcript 
levels 
 (as % 
 of control) 
 
n 
 
p-value 
control 100 4     control 100 5   
daf-16 29.1 3 0.014   daf-16 82.5 4 >0.2 
hsf-1 191 4 >0.2   hsf-1 189.5 5 0.15a 
mdl-1 54.3 4 >0.2a   mdl-1 56.6 5 0.13a 
ada-2 68.8 4 >0.2   ada-2 74.9 5 >0.2 
elt-2 108.3 4 >0.2   elt-2 131.9 5 >0.2 
 
Table 9 
p-values calculated as described in Figure 41. Correction for multiple testing was 
carried out using the Bonferroni correction. a These p-values were <0.05 before 
Bonferroni correction.  
 
 
The same trends were visible in these genotypes as in daf-16; daf-2 mutants: 
hsf-1 RNAi seems to cause an increase, rather than a decrease in ftn-1 expression and 
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mdl-1 RNAi–treated animals show lower mean transcript levels regardless of 
genotype, although both effects are not statistical significant in the two genotype 
shown in Figure 41. Given the cost of qRT-PCR, I decided not to collect additional 
biological replicates to confirm these effects since the results of the analysis on daf-
16; daf-2 animals was sufficient to answer the central question about the daf-16 –
dependence of the effect. Clearly, the effect of mdl-1 RNAi on ftn-1 expression does 
not require daf-16. However, daf-16 is required for the reduction in ftn-1 transcript 
levels by hsf-1 RNAi in daf-2 mutants, since the opposite is seen in daf-16; daf-2. 
The effects of ada-2 RNAi may also require daf-16, although the absence of a 
statistically significant result could merely reflect insufficient biological replicates.  
It should be mentioned that the conservative Bonferroni correction was used 
to adjust p-values for multiple testing and that in the tests marked with a, this 
correction caused a loss of statistical significance. Given the many comparisons 
being made, correcting for multiple comparisons was necessary to avoid false 
positive results. The reduction in the mean expression level of ftn-1 in mdl-1 RNAi 
treated animals is similar across genotypes (reduced to 39.5% of control in daf-2; to 
55.6% in daf-16; daf-2; to 54.3% in wt; and to 56.6% in daf-16). This suggests that 
further biological replicates would likely confirm the trend that mdl-1 RNAi reduces 
ftn-1 levels regardless of IIS genotype.  
 Taken together with other evidence, this analysis implies that mdl-1 is a 
direct regulatory target of daf-16, and that when daf-2 is mutated, activation of DAF-
16 further activates mdl-1, thereby increasing ftn-1 expression (see Figure 35).  
 
4.2.3. Effect of mdl-1 and ada-2 on C. elegans lifespan 
 
While the regulation of ftn-1 levels by ada-2, hsf-1 and mdl-1 is interesting, 
the aim of this project was to identify novel mediators of the longevity of daf-2 
mutants. Previous publications by another group (Murphy et al., 2003; Pinkston-
Gosse and Kenyon, 2007), as well as my own work (see Figure 22 and Table 5), 
have already demonstrated that RNAi of mdl-1 is capable of reducing daf-2 
longevity. The effect of ada-2 RNAi on daf-2 lifespan had not been previously 
described but a single experiment had shown a very slight but statistically significant 
reduction (-5% in daf-2. see Figure 22). I decided to test the effect of ada-2 and mdl-
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1 RNAi on daf-2 lifespan again. I did not re-test the effect of hsf-1 RNAi given that 
the role of hsf-1 in the longevity of IIS mutants is well established (Hsu et al., 2003; 
Morley and Morimoto, 2004).  
 
 
Figure 42 
The effect of ada-2 and mdl-1 RNAi on rrf-3(pk1426); daf-2(m577) animals at 25oC.  
 
RNAi 
treatment  
 
n 
 
 
 
 
censored 
Mean 
Lifespan 
 
Median 
Lifespan 
 
% 
Change 
in mean 
[median] 
Log-Rank 
p-valueb 
 
Wilcoxon 
p-valueb 
 
control 118 4 25.6 29    
daf-16 127 4 16.1 17 -37 [-41] <0.0001 <0.0001 
ada-2  108 20 25.5 29 none 0.4946 0.9693 
mdl-1  99 4 21.5 23 -16 [-21] <0.0001 0.0013 
 
Table 10 
This table contains data corresponding to Figure 42  
I was able to confirm that RNAi of mdl-1 statistically significantly reduces 
the lifespan of daf-2 mutants. In combination with my previous findings (see Chapter 
3) and similar findings by a different group (Murphy et al., 2003; Pinkston-Gosse 
and Kenyon, 2007), this demonstrated that RNAi of mdl-1 does reduce daf-2 
longevity. The effect of ada-2 RNAi is not robust. In the previous assay (see Chapter 
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3), this treatment only reduced mean daf-2 lifespan by 5% and had no effect on the 
median lifespan. In this second trial, ada-2 RNAi had no effect on daf-2 lifespan.   
The lifespan curves shown in Figure 42 look slightly unusual due to an 
unusual pulse of early mortality on day 11. This may be due to differences between 
experimenters in scoring lifespan assays as I had been unavailable to score this 
experiment on that particular day and a colleague had been kind enough to take over 
this task. Since the early mortality seems to affect all strains equally, this is unlikely 
to have affected the overall result, but I reanalysed this data to account for this 
difference (see Appendix 3). While the mean and median values calculated in this 
reanalysis do change, the effects of each treatment are consistent with the analysis 
presented here (see Table 11).  
A number of different results suggest that mdl-1 is regulated by IIS (Murphy 
et al., 2003; Pinkston-Gosse and Kenyon, 2007; Schuster et al., 2010), so the finding 
that mdl-1 RNAi is capable of reducing daf-2 lifespan supports a role of mdl-1 in 
mediating the daf-2 Age phenotype downstream of DAF-16. However, the reduction 
in daf-2 lifespan by mdl-1 RNAi alone is insufficient evidence for such a role, as loss 
of this transcription factor could simply be causing pathologies that shorten lifespan. 
If so, then the effect of mdl-1 RNAi on lifespan would be completely unrelated to the 
lifespan extension of IIS mutants. One piece of evidence that argues against this is 
the finding by Pinkston-Gosse et al. that RNAi of mdl-1 is effective at reducing daf-
2(-) but not daf-2(+) lifespan. If true then this would suggest that mdl-1 is indeed 
required for at least a proportion of the lifespan extension seen in daf-2. I therefore 
decided to attempt to corroborate this finding by treating rrf-3; daf-2(+) mutants 
with mdl-1 RNAi. RNAi of ada-2 was also tested on this strain for the same reasons.    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Figure 43 
The effect of ada-2 and mdl-1 RNAi on rrf-3 lifespan at 25oC. 
RNAi treatment 
[Trial number] n censored 
Mean 
Lifespan 
Median 
Lifespan 
% Change 
in mean 
[median] 
Log-Rank 
p-value 
Wilcoxon 
p-value 
        
control [1] 123 0 13.9 12    
daf-16 [1] 109 2 11.6 12  -17 [- 0]  <0.0001 0.0049 
ada-2 [1] 97 17 12.1 10 -13 [-17]  0.0052 0.0016 
mdl-1 [1] 120 3 11.6 10 -17 [-17] 0.0006 <0.0001 
        
control [2] 88 31 13.3 13    
daf-16 [2] 97 28 11.4 12 -14 [-8] 0.0002 0.0009 
ada-2 [2] 114 18 12.5 12 -6 [-8] 0.2171 0.0138 
mdl-1 [2] 78 37 12.2 12 -8 [-8] 0.2111 0.1013 
        
combined data        
control [1 + 2] 211 31 13.7 12    
daf-16 [1 + 2] 206 30 11.5 12 -16 [-0] <0.0001 <0.0001 
ada-2 [1 + 2] 211 35 12.2 12 -11 [-0] 0.0009 0.0013 
mdl-1 [1 + 2] 198 40 11.7 10 -15 [-17] <0.0001 <0.0001 
 
Table 11 
This table contains data corresponding to Figure 43. All lifespan assays were carried 
out on on rrf-3(pk1426) at 25oC. 
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Against expectation, RNAi of mdl-1 was also effective at reducing wild-type 
lifespan, at least to some degree.  This is based on two trials: In the first, mdl-1 RNAi 
reduced daf-2(+) mean and median lifespan by 17%. In the second trial the same 
trend was visible (mean and median lifespan both reduced by 8%), but this effect 
was not statistically significant, possibly because significantly fewer animals were 
used this time. When the data from the two trials is pooled, a reduction in both mean 
(-15%) and median (-17%) lifespan is seen (see Figure 43) and this effect is highly 
statistically significant (p<0.0001; see Table 11).  This evidence contradicts the 
finding by Pinkston-Gosse et al. and demonstrates that loss of mdl-1 may reduce 
lifespan in daf-2(+) as well as daf-2(m577) animals.   
The evidence for a role of ada-2 in mediating daf-2 lifespan is even weaker: 
While ada-2 RNAi resulted in a very small reduction in daf-2 lifespan in one of two 
trials, the same treatement caused a greater reduction in wt lifespan. A role of ada-2 
in mediating the lifespan extension of daf-2 animals therefore seems unlikely.  
 
4.3. Chapter discussion 
 
4.3.1. The use of elt-2 RNAi as a positive control 
 
A number of features of the elt-2 gene suggest that it should be a good 
control gene for use in the qRT-PCR assay. ELT-2 has already been shown to bind to 
the promoter of mdl-1 and to regulate its expression (Romney et al., 2008). Loss of 
elt-2 via RNAi led to a large decrease in ftn-1 expression. The fact that elt-2 is 
thought to be required for expression of all intestinally expressed genes (McGhee et 
al., 2009), makes it seem unlikely that it would have different roles in IIS mutants. I 
therefore expected elt-2 RNAi to reduce ftn-1 transcript levels equally in all 
genotypes tested, making it a suitable positive control.  
However, no significant down-regulation of ftn-1 was detected in any of the 
strains other than the daf-2 mutant line. This could indicate that RNAi is not as 
effective in these genotypes, that the qRT-PCR assay is not sensitive enough to 
detect this magnitude of change in the non-induced ftn-1 levels of daf-2(+) and daf-
16; daf-2 animals, or that elt-2 acts downstream of IIS to mediate ftn-1 expression.  
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The first possibility, that RNAi is not effective in these genotypes, is 
unlikely, because both mdl-1 and hsf-1 RNAi had large effects on ftn-1 expression in 
daf-16; daf-2 mutants. It seems likely that qRT-PCR assay used here was not 
sensitive enough to detect these changes in ftn-1 expression. The absence of a 
significant finding was presumably due to the relatively small effect of elt-2 RNAi 
by feeding on ftn-1 levels, which in the daf-2 mutant strain only reduced ftn-1 levels 
by approximately 30%, the smallest effect of any of the RNAi treatments tested. 
Romney et al. did find a significant reduction by elt-2 RNAi, but this was done using 
a GFP reporter and RNAi was administered via injection rather than feeding, which 
may have been more effective. Given the large variance in ftn-1 levels, it would have 
required an unreasonably high number of replicates to detect a statistically 
significant reduction. A better positive control treatment might have been RNAi of 
ftn-1 itself.   
It is also possible that elt-2 may have a role downstream of IIS to regulate 
target gene expression. This seems unlikely given the function of elt-2 in the 
regulation of all intestinal genes, but none of the findings in this chapter contradicts 
such a role. While loss of elt-2 by RNAi had large effects on ftn-1 expression in daf-
2(+) animals in a different study (Romney et al., 2008), the effects on IIS mutants 
was not investigated. 
4.3.2. The role of hsf-1 in ftn-1 regulation 
 
One of the interesting findings from the qRT-PCR analysis of daf-2 and daf-
16; daf-2 animals is the different response to knockdown of hsf-1 in the two lines. 
That RNAi of hsf-1 substantially lowers the induced ftn-1 transcript levels of daf-2 
mutants is consistent with hsf-1’s established role as a co-activator with DAF-16 of 
longevity in daf-2 mutants. However, the fact that this does not occur in daf-16; daf-
2 is intriguing. The involvement of hsf-1 in the longevity phenotype of IIS mutants 
was demonstrated when loss of hsf-1 was found to be sufficient to completely 
abrogate the lifespan extension of long-lived IIS mutants, suggesting an essential role 
of hsf-1, similar to that of daf-16, in mediating IIS longevity (Morley and Morimoto, 
2004). However, whether this occurs through joint regulation of a common set of 
target genes or through independent regulation of different genes that are essential 
for the lifespan extension is unclear.  
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Evidence for the first model comes from the apparent joint regulation of 
small heat-shock proteins (sHSPs), which were differentially regulated in daf-2 
mutants in a manner dependent on DAF-16 (McElwee et al., 2004; Murphy et al., 
2003) and are also regulated by HSF-1 (Hajdu-Cronin et al., 2004; Tonkiss and 
Calderwood, 2005). These heat shock proteins have been shown to be potential 
mediators of the longevity phenotype of IIS mutants (Morley and Morimoto, 2004). 
It therefore seems likely that reduced IIS leads to an up-regulation of sHSPs via the 
joint activities of DAF-16 and HSF-1. Other genes may be regulated by HSF-1 or 
DAF-16 independently and are not required for the extended lifespan of IIS mutants 
(see Figure 44). 
 
 
 
 
Figure 44 
Adapted from Hsu et al. (2003). Model of joint regulation of target genes by HSF-1 
and DAF-16.  
 
The case of ftn-1 may be similar: HSF-1 and DAF-16 may be acting 
downstream of IIS to activate ftn-1 expression (see Figure 45: HSF-1 model 1). This 
would explain why RNAi of hsf-1 reduces ftn-1 expression in a daf-2 mutant 
background. But why should it increase ftn-1 expression in a daf-2(+) or daf-16; daf-
2 background? It seems possible that under normal conditions HSF-1 acts as a 
repressor of ftn-1 expression and that only when under conditions of reduced IIS, 
DAF-16 changes HSF-1 from an inhibitor to an activator of ftn-1 expression (see 
Figure 45: HSF-1 model 2). 
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HSF-1 model 1: HSF-1 may be 
acting downstream of DAF-2 and 
jointly with DAF-16 to regulate 
ftn-1 transcription. This is 
consistent with the results of 
qRT-PCR analysis, since loss of 
HSF-1 was capable of reducing 
ftn-1 transcript levels in daf-2 but 
not daf-16; daf-2 mutant animals.   
 HSF-1 model 2: When IIS is not 
reduced, HSF-1 may act as a repressor 
of ftn-1. DAF-16 still acts as an 
activator of ftn-1 under these conditions.  
 
Figure 45 
Possible roles of hsf-1 in the regulation of  ftn-1 
 
 
4.3.3. The role of mdl-1 in ftn-1 regulation  
qRT-PCR of ftn-1 transcript levels demonstrated that both daf-2 and daf-16; 
daf-2 worms treated with mdl-1 RNAi show reduced ftn-1 expression. Given the 
many studies indicating a role of mdl-1 downstream of DAF-16, it seems likely that 
mdl-1 is regulating ftn-1 expression downstream of daf-16, as shown in Model 3 of 
Figure 40. If this is true, then RNAi of mdl-1 should have a larger effect on ftn-1 
levels in daf-2(-) than in daf-2(+) or in daf-16; daf-2 animals. This was in fact found 
to be the case: In daf-2(m577) animals, RNAi of mdl-1 reduced ftn-1 levels to 39.5% 
of control RNAi treated, whereas the same treatment reduced ftn-1 levels to 55.6% of 
control in daf-16; daf-2 mutants. While a role of mdl-1 in ftn-1 regulation that is 
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completely independent of IIS is possible (Model 2 of Figure 40), this and the results 
of other studies, in which mdl-1 was found to be up-regulated by DAF-16 by direct 
binding (discussed previously in this chapter), make a role of mdl-1 downstream of 
daf-16 seem more likely. In addition, the recent finding by the ModEncode project 
that MDL-1 can bind to the ftn-1 promoter also supports this model, although one 
should keep in mind that this study was carried out in L1 animals. While ftn-1::gfp 
transgenes are expressed at this stage (Romney et al., 2008), the regulation of ftn-1 
during early development was never investigated.  
It would be very interesting to investigate further the possibility that direct 
binding of MDL-1 to the ftn-1 promoter is mediating its regulation by IIS. This could 
be investigated using ChIP, using either the same MDL-1::GFP strain as used by the 
ModEncode project and an anti-GFP antibody, or ChIP of the endogenous protein 
could be attempted using a commercially available anti-MDL-1 antibody. The anti-
MDL antibody has already been purchased and will soon be tested by Michèle 
Riesen. In either case, establishing whether higher levels of MDL-1 binding to the 
ftn-1 promoter could be detected in daf-2 animals compared to wild-type or daf-2; 
daf-16 mutants would go a long way in explaining whether at least part of the 
induction in ftn-1 by decreased IIS occurs because the long-lived mutants have 
increased expression of mdl-1.  
As indicated in Chapter 3, very recent findings suggest that DAF-16 may be 
directly binding to the ftn-1 promoter. This was unexpected, since ftn-1 has not been 
identified in other studies of DAF-16 targets (Schuster et al. 2010). However, direct 
regulation of ftn-1 by DAF-16 could explain both the very large effects that loss of 
daf-16 has on ftn-1 levels and the fact that the RNAi screen did not uncover another 
transcription factor with as large a role in the regulation of ftn-1. Further 
investigation of a possible direct interaction between DAF-16 and ftn-1 promoter 
may clarify this issue. This could be investigated by ChIP using an anti-DAF-16 
antibody by testing whether there is enhanced binding of DAF-16 to the ftn-1 
promoter in daf-2 mutants.  
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4.3.4. mdl-1 binding partner 
 
Previous work on mdl-1 suggests that the MDL-1 protein can only bind DNA 
by forming a heterodimer with MXL-1. The effects of mxl-1 RNAi on ftn-1 
expression were investigated only in the context of the initial screen, in which a 
small reduction in Pftn-1::gfp fluorescence was detected, but the magnitude of this 
effect fell below the threshold that I set of a 20% reduction. I did not further 
investigate the role of mxl-1, but further work could focus on whether the effect of 
mdl-1 RNAi on ftn-1 expression requires mxl-1. This would help establish whether 
the two proteins are in fact acting as a dimer to regulate ftn-1 levels. 
 
4.3.5. ada-2 
 
This work shows that ada-2 influences ftn-1 expression, but its exact role 
remains unclear. Loss of ada-2 by RNAi leads to a reduction in ftn-1 transcript levels 
as well as in Pftn-1::gfp expression in daf-2 mutant animals. However, the same 
reduction could not be detected in daf-16; daf-2 animals, implying that the effects of 
ada-2 RNAi may act via daf-16. This would place ADA-2 upstream of DAF-16 in 
the regulation of ftn-1.  
 
 
 
Figure 46 
Schematic representation of potential role of ADA-2 in ftn-1 regulation by IIS.   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However, this conclusion is based on the finding that ada-2 RNAi has no 
effect on ftn-1 expression in daf-16; daf-2 animals, but that the positive control used 
in these assays also had no effect. It therefore remains possible that a reduction in 
ftn-1 levels does in fact occur upon RNAi of ada-2 in daf-16; daf-2 animals, but 
wasn’t detected because of insufficient assay sensitivity.  
Other approaches may be needed to investigate the role of ada-2 in ftn-1 
regulation. One possibility is to test the involvement of pcaf-1, which is thought to 
code for the catalytic subunit of the HAT complex ADA-2 may act in. If RNAi of 
this gene also reduces ftn-1 expression, then this would support a role for an ADA-2 
and PCAF-1 containing complex in regulating ftn-1. Another approach would be to 
use a genetic deletion of ada-2. However, only one mutant allele of ada-2 is 
available (ok3151), which only deletes one exon from one of two isoforms of the 
gene and unfortunately also affects an adjacent gene. Even if these problems were 
overcome, the allele is lethal when homozygous and would therefore be very 
difficult to work with. If RNAi of pcaf-1 can be shown to affect ftn-1 expression, 
then mutant alleles of pcaf-1 could be used instead.  
 
4.3.6. Effect on lifespan 
 
Disappointingly, lifespan assays on worms treated with ada-2 RNAi did not 
provide evidence that this gene acts downstream of IIS to extend lifespan. If this had 
been the case, one would expect RNAi knockdown to have reduced daf-2 lifespan to 
a greater extent than wild-type lifespan. Instead, ada-2 RNAi seems to cause an even 
greater reduction in wild-type lifespan than in daf-2 lifespan.  
The results for mdl-1 are slightly more ambiguous. Based on results for 
microarray studies, the DamID study and the ModEncode project, the following 
model could be proposed: Decreased IIS activates DAF-16 and therefore increases 
expression of the DAF-16 target MDL-1, which in turn affects gene expression. In 
this model, the lifespan extension of IIS mutants is caused by a large number of 
transcriptional changes downstream of DAF-16, some of which are mediated by 
MDL-1. The model predicts that increased levels of MDL-1 are part of the reason 
why IIS mutants are long lived. See Figure 46 for a depiction of this model. Whether 
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or not loss of mdl-1 leads to a greater reduction in lifespan in daf-2 mutants than in 
wild-type animals is an important test of this model.   
 
 
 
  
 
Figure 46 
Possible role of MDL-1 in the longevity caused by reduced IIS.  
 
 
This question currently remains unresolved, since a statistically significant reduction 
in wild-type lifespan was seen in one out of two trials. In the second trial, a trend 
towards reduction was seen, although this was not statistically significant, possibly 
partly due to a smaller sample size. If the two trials are pooled, a statistically 
significant reduction is seen overall. This is unexpected given that Pinkston-Gosse et 
al. found no lifespan reduction in daf-2(+) animal treated with mdl-1 RNAi. This 
could be explained by a stronger RNAi effect in the assays I performed, since rrf-3 
mutant animals were used, or be due to other differences in assay conditions.  
That RNAi of mdl-1 reduces wild-type lifespan does not in itself exclude the 
possibility that MDL-1 may act as a mediator of daf-2 lifespan: loss of either hsf-1 or 
daf-16 has similar effects on daf-2(+) lifespan. However, the fact that the magnitude 
of the reduction in lifespan is similar is hard to reconcile with a model in which 
increased levels of MDL-1 in IIS mutants is one of the causes of the daf-2 lifespan 
extension. The trial described in this chapter shows that in daf-2(m577), mdl-1  
RNAi causes a 16% reduction in mean and a 21% reduction in median lifespan and 
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two previous trials described in Chapter 3 showed a 12% reduction in mean and 17% 
reduction in median lifespan in the first and a 9% reduction in mean and 12% 
reduction in median lifespan in the second trial. These reductions are similar in 
magnitude to those seen in pooled data from daf-2(+) animals, for which mdl-1 
RNAi causes a 15% reduction in mean and 17% reduction in median lifespan under 
similar conditions. Table 12 shows the results of individual trials performed in 
various studies on the effects of mdl-1 RNAi on lifespan.   
 
daf-2 genotype lifespan change 
(mean) 
 
rrf-3 genotype see… 
daf-2(mu150) -9% wild-type (Murphy et al., 2003) 
daf-2(e1370) -10% wild-type (Pinkston-Gosse and Kenyon, 
2007) 
daf-2(e1370) -8% wild-type (Pinkston-Gosse and Kenyon, 
2007) 
daf-2(m577) -12% pk1426 Figure 22, Table 5 
daf-2(m577) -9% pk1426 Table 5 
daf-2(m577) -16% pk1426 Figure 42 
daf-2(+) +4% (n.s.) wild-type (Pinkston-Gosse and Kenyon, 
2007) 
daf-2(+) -1% (n.s.) wild-type (Pinkston-Gosse and Kenyon, 
2007) 
daf-2(+) -17% pk1426 Figure 43 
daf-2(+) -8% (n.s.) pk1426 Figure 43 
 
 
Table 12 
Summary of data on effects of mdl-1 RNAi on lifespan. n.s.: not statistically 
significant.  
 
It is possible that mdl-1 may still turn out to be an important player in the 
longevity of IIS mutants, since the interpretation of this type of epistasis analysis 
using a quantitative trait such as lifespan is difficult. It is also possible that 
differences in the efficacy of RNAi in the two different strains may be complicating 
this interpretation further. To exclude possible problems with mdl-1 RNAi treatment, 
an mdl-1 deletion strain could be used to confirm the results I obtained using gene 
knockdown.  
In fact, a colleague in the lab (Michèle Riesen) has taken over the project to 
illuminate the role of mdl-1 in daf-2 lifespan. For this purpose, she has already 
obtained and outcrossed an mdl-1 deletion strain and crossed it into two different 
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alleles of daf-2. Comparing the lifespan of daf-2 animals to daf-2; mdl-1 animals and 
wild-type to mdl-1 mutants will hopefully help answer the question of whether loss 
of mdl-1 shortens daf-2 lifespan due to a reduction in DAF-16–mediated longevity or 
simply due to pathology related to the loss of an important transcription factor. Using 
this deletion instead of RNAi will help rule out any artefacts due to changes in RNAi 
efficiency.  
Another approach to testing this model would be to over-express MDL-1 via 
transgenesis, thus mimicking the effects of reduced IIS on MDL-1 levels without any 
genetic mutations in IIS. If mdl-1 over-expression leads to a lifespan extension, then 
this would demonstrate that the genes downstream of MDL-1 are capable of 
extending lifespan, as the model would predict. Michèle Riesen is therefore currently 
working on constructing mdl-1 over-expressing strains. Given the large effects of 
mdl-1 on the expression of the IIS- regulated gene ftn-1, it will be fascinating to find 
out whether this gene does in fact act downstream of DAF-16 to extend lifespan.  
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Chapter 5: The regulation of ftn-1 by iron levels 
is regulated by hypoxia signalling  
5.1 Introduction  
5.1.1. Hypoxia signalling and C. elegans ageing  
The screen described in Chapter 3 was primarily designed to identify 
transcription factors with a role in promoting expression from the Pftn-1::gfp 
transgene. The aim was to identify RNAi treatments that reduce GFP fluorescence 
from the induced levels found in daf-2(m577) animals. However, treatment with a 
large number of RNAi clones led to increases, rather than decreases, in GFP 
fluorescence in this strain (see Appendix 1). For the most part, the role of these genes 
was not followed up, but I did decide, for several reasons, to further investigate the 
two transcription factors hif-1 and aha-1.  
The first reason that these two factors seemed particularly interesting was 
simply the magnitude of the effect on Pftn-1::gfp upon RNAi of either gene. Both led 
to a very strong increase in expression and a look at the literature quickly revealed 
that the two are known to form a dimer in C. elegans (Jiang et al., 2001a). Due to the 
high variability in the expression of Pftn-1::gfp and the large number of positive 
‘hits’ identified in my screen, I was concerned that the long list of candidates 
identified might contain a high number of false positives. The finding that RNAi of 
both subunits of the HIF dimer have similarly large effects on Pftn-1::gfp expression 
suggested that this effect was not a false positive. Additionally, HIF transcription 
factors are known to be regulated post-translationally by a mechanism that is 
dependent on iron. The FTN-1 protein is predicted to be involved in iron storage and 
ftn-1 mRNA levels have been shown to be responsive to iron (see Chapter 1). The 
discovery of a possible regulatory role of the iron responsive transcription factor 
HIF-1 in the regulation of the iron responsive gene ftn-1 seemed a promising lead in 
discovering how worms maintain iron homeostasis. A recent publication described 
efforts to identify how ftn-1 is regulated by iron (Romney et al., 2008) and identified 
a region of the promoter that is sufficient for the induction of ftn-1 by iron. This 63bp 
‘iron dependent element’ (IDE), contains three direct repeat (DR) sequences that are 
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required for the IDE to be responsive to iron (Romney et al., 2008). These DR 
sequences are similar to the E-box motif, a binding site for basic helix-loop-helix 
(bHLH) family of transcription factors. Since both aha-1 and hif-1 are bHLH 
transcription factors, it is possible that the HIF-1/AHA-1 dimer is repressing 
expression by binding to the DR sequences. This section will therefore describe my 
efforts to confirm the initial findings and investigate the role of hypoxia signalling in 
the regulation of ftn-1 in C. elegans.  
In vertebrates, the transcriptional response to hypoxia is regulated by the HIF 
transcription factors. HIF functions as a dimer consisting of one α and one β subunit. 
In vertebrates, the three genes HIF-1α, HIF-2α and HIF-3α code for the α subunit. In 
order to regulate gene expression, alpha subunits must dimerize to HIFβ, also called 
ARNT (the aryl hydrocarbon receptor nuclear translocator), which is 
ubiquitously expressed and unresponsive to hypoxia. Under normoxia, HIFα protein 
is hydroxylated at conserved proline residues by a group of prolyl hydroxylases 
(PHDs) and this modification increases the affinity of HIF for the von Hippel-
Landau protein (VHL) (Kaelin, 2005). Binding of VHL targets the HIFα protein for 
ubiquitination and subsequent degradation by the proteosome. HIFα levels are 
therefore very low under normoxic conditions and increase dramatically under 
hypoxia. The activation of HIF in response to hypoxia occurs due to the conditions 
required for the PHDs to hydroxylate the HIFα proline residue. PHDs require oxygen 
as well as iron and 2-oxoglutarate for the hydroxylation reaction. When cells are kept 
under hypoxic conditions or when an iron chelator is added, the proline residue in 
HIFα is not hydroxylated and the HIFα protein accumulates (Mole, 2010).    
5.1.2. HIFα in C. elegans  
It is clear that not all functions of HIF in higher organisms can be conserved 
in C. elegans. An obvious example is the role of HIF-1α in angiogenesis, which 
accounts for a severe embryonic–lethal phenotype of HIF-1α mutant mice. In the 
simple nematode C. elegans, which lacks a circulatory system, this function of HIF 
will not be conserved. However, levels of HIF-1, the C. elegans homologue of the 
vertebrate HIFα genes, seem to be regulated by the same mechanisms as its 
vertebrate counterparts. In fact, it was in C. elegans that the role of the PHDs was 
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first discovered when the C. elegans PHD gene EGL-9 was identified as a gene 
required for the stabilisation of HIF-1 (Epstein et al., 2001).  
Only one gene, hif-1, codes for HIFα in C. elegans and, like its vertebrate 
homologues, the HIF-1 protein is stabilised by hypoxia and degraded by normoxia. 
HIF-1 has been shown to bind to AHA-1, the C. elegans homologue of ARNT and 
the HIF-1/AHA-1 dimer has been shown to bind DNA sequences containing the 
hypoxic regulatory element (Jiang et al., 2001b). The VHL homologue VHL-1 has 
been shown to bind HIF-1 and vhl-1 mutant worms have constitutively high HIF-1 
levels. As mentioned above, the role of PHDs in the regulation of HIFα protein levels 
was identified in C. elegans using a candidate gene approach that ultimately 
identified EGL-9 as the gene responsible for targeting HIF-1 for degradation via 
VHL-1 (Epstein et al., 2001). The role of HIF-1 in protection against hypoxia is also 
conserved: animals homozygous for the strong loss-of-function allele hif-1(ia4) are 
perfectly viable and appear completely wild-type under normoxia. They are however 
highly sensitive to hypoxic conditions (Jiang et al., 2001b). The evolutionary 
conservation of the roles of HIF-1, VHL-1, EGL-9 and their homologues makes C. 
elegans a good model organism for the study of the HIF pathway.  
In vertebrates, the HIF-1α and HIF-2α proteins are degraded by the 
proteosome in response to hydroxylation of proline residues in two oxygen–
dependent degradation domains located within the central region of the protein. The 
hydroxylation reaction is catalysed by PHD1, 2 and 3. As discussed previously, in C. 
elegans the hydroxylation reaction is carried out by EGL-9 and targets a single 
proline residue at position P621 (see Figure 47). A P621G mutation in a HIF-1::Myc 
transgene leads to stabilisation and greatly increased HIF-1::Myc levels as measured 
by western blotting (Zhang et al., 2009).  
 
 
Figure 47 
The hypoxia pathway in C. elegans (Shen and 
Powell-Coffman, 2003)  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Other than mediating the degradation of HIF-1 by the proteosome, recent 
work  suggests an additional role for EGL-9 in the regulation of HIF-1 target genes 
(Shao et al., 2009). This had already been suspected due to the extraordinarily strong 
induction of hif-1 target genes in egl-9 mutants, which far exceeds the induction 
found in vhl-1 mutants (Shen et al., 2006). This second pathway (see Figure 48) is 
independent of the VHL-1–mediated pathway described in Figure 47. Using egl-9 
transgenes with a mutation in the hydroxylase domain, which completely abolished 
oxygen dependent degradation of HIF-1, Shao et al. found that the vhl-1–independent 
effects of EGL-9 do not to require hydroxylase activity .  
  
Figure 48 
(adapted from Shao et al., 2009) 
EGL-9 affects HIF-1 target gene 
expression via a second unknown. 
mechanism, which does not require 
hydroxylase activity.       
5.1.3. Effect of HIF-1 over-expresson on ageing in C. elegans  
While research into the role of daf-16 and IIS in C. elegans lifespan is well 
established, the examination of the possible role of hif-1 in ageing has only been 
carried out recently and has so far yielded contradictory results. Two reports state 
that higher levels of HIF-1 protein extend lifespan. Mehta et al. found that the 
knockdown of vhl-1 and egl-9 levels by RNAi, which stabilises HIF-1 levels, extends 
worm lifespan in a HIF-1 dependent manner and also enhances survival of two 
models of proteotoxicity (Mehta et al., 2009). This result was corroborated by a 
separate publication (Zhang et al., 2009) in which five different strains over-
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expressing HIF-1::Myc were created with or without the stabilising P621G mutation. 
All over-expressing strains were found to be long-lived and the levels of HIF-1::Myc 
over-expression were found to correlate with mean lifespan.  
Increases in the levels of HIF-1 therefore extend C. elegans lifespan, both 
when a HIF-1::Myc transgene is over-expressed and when endogenous HIF-1 is 
stabilised by knocking out VHL-1, a protein involved in targeting HIF-1 for 
degradation by the proteasome. However, there is some suggestion that the role of 
the prolyl hydroxylase EGL-9 is more complicated. Reduction of EGL-9 by RNAi 
was shown to extend lifespan, which fits the finding that higher levels of HIF-1 
extend lifespan since reductions in EGL-9 have consistently been found to stabilise 
HIF-1 levels. However, two separate groups found that a strong loss of function 
mutation in egl-9 did not affect lifespan (Chen et al., 2009; Zhang et al., 2009), 
despite leading to highly elevated levels of HIF-1. This contrasts with the findings 
from vhl-1 knock-out animals, which have similar levels of HIF-1, but an extended 
lifespan.  
However, the fact that vhl-1 and egl-9 should differ in their effects on 
lifespan is not completely unexpected, even given their joint role in the regulation of 
hif-1 target genes. As discussed in the previous section, egl-9 has pleiotropic effects 
on HIF-1 target gene expression and the discrepancy in the effects of vhl-1 and egl-9 
mutations on lifespan may be due to this alternate pathway. For example, it is 
possible that less severe reductions in EGL-9 by RNAi would increase the levels of 
HIF-1 sufficiently to extend lifespan but that in severe loss-of-function mutants the 
lifespan extension gained through increased HIF-1 levels is lost through pleiotropic 
effects that occur through altered signalling of the alternate pathway.   
 
5.1.4. HIF-1 and IIS  
Because the greatest effects on C. elegans lifespan are caused by reductions 
in IIS, testing whether the effects of increased HIF-1 levels on C. elegans lifespan 
are the consequence of interaction with IIS would seem like a good idea.  So far, 
studies of interactions between the hif-1 pathway and IIS in the regulation of lifespan 
present a contradictory picture.  
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Given the large changes in lifespan in animals with reduced IIS and the 
complete dependence of this effect on the transcription factor daf-16, the effects of 
HIF-1 over–expression were tested for dependence on daf-16 as well. Mehta et al. 
found that the vhl-1 deletion mutant is still long-lived even when daf-16 is knocked 
down by RNAi and Zhang et al. report that over-expression of HIF-1::Myc levels in 
a daf-16 mutant background is still capable of extending lifespan. This was further 
supported by the finding that vhl-1 RNAi does not lead to a nuclear localisation of a 
DAF-16::GFP transgene (Mehta et al., 2009). The authors of both publications 
therefore conclude that the effects of increased HIF-1 on lifespan are independent of 
daf-16. 
However, the lifespan extension by HIF-1 over-expression would only be 
found to be dependent on daf-16 or lead to the nuclear localisation of DAF-1::GFP if 
HIF-1 acted upstream of DAF-16 in the IIS pathway. However, as exemplified by 
skn-1, the Nrf2–like transcription factor, this is not necessary the case for all factors 
downstream of the insulin/IGF-1–like receptor DAF-2.  
A different approach would be to test if increased levels of HIF-1 are capable 
of further extending the lifespan of long-lived daf-2 animals. While Mehta et al. find 
that mutation of vhl-1 further extends the lifespan of long-lived daf-2 RNAi–treated 
animals, Zhang et al. report that over-expression of stabilised HIF-1::Myc cannot 
further extend daf-2(e1370) lifespan. This finding, along with suggestions in the 
literature that hif-1 may be regulated by DAF-16 (Hoogewijs et al., 2007; Pocock and 
Hobert, 2008) led Zhang et al. to test whether reduced IIS affects the regulation of 
HIF-1 and its known target genes. They found no statistically significant difference 
in HIF-1::Myc levels in in daf-2(e1370) animals compared to daf-2(+) and no 
significant difference in the expression of GFP reporters of two known HIF-1 targets 
in the same genotypes (the mean of one seems to be about 40% higher, but 
measurement show a high variance, possibly explaining the lack of statistical 
significance). However, they note that if daf-2 has tissue or stage–specific effects on 
HIF-1 levels, these may not have been detectable by Western blotting.  
The relationship between HIF-1 and IIS with respect to ageing remains 
unclear. While no increase in HIF-1::Myc levels or in the levels of hif-1–target genes 
was detected in daf-2(e1370) animals, the lifespan data is more ambiguous. Whether 
or not the effects of HIF-1 on lifespan occur downstream of the insulin/IGF-1–like 
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receptor DAF-2 will hopefully be addressed with further study of the role of hif-1 in 
ageing .   
 
5.1.5. Effect of lower hif-1 levels on lifespan  
 
Surprisingly, loss of HIF-1 also extends C. elegans lifespan. Zhang et al. 
tested three different alleles of hif-1 as well as RNAi of hif-1 and in each case saw 
extended lifespan (at 20oC). The authors note that hif-1 mutants had previously been 
found to form dauers more readily at high temperatures (Shen et al., 2005), which 
suggests that DAF-16 may be activated in these mutants. In fact, the extended 
lifespan of hif-1(ia4) requires daf-16 and also skn-1, which demonstrates that over-
expression and knockout of hif-1 extend lifespan by different mechanisms. This 
dependence on daf-16 suggests that mutations in hif-1 may exert their effects on 
lifespan by activating DAF-16. Zhang et al. also found that hif-1(ia4) was incapable 
of further extending daf-2(e1370) lifespan thus supporting this interpretation. 
However, even here conflicting findings can be found from a different research 
group. While Chen et al. can corroborate the finding that hif-1 RNAi extends 
lifespan, they find that this is even the case in daf-16(mgDf47) animals, which would 
make the effects of reductions in HIF-1 levels on lifespan independent of DAF-16.  
 
5.1.6. Possible role of HIF in iron metabolism 
 
Iron chelators have been effectively used to stabilise HIF levels in a number 
of different contexts, including in C. elegans (Epstein et al., 2001). This occurs due 
to the requirement for iron as a cofactor in the hydroxylation reaction by which 
PHDs (EGL-9 in C. elegans) hydroxylate HIF, which ultimately leads to degradation 
by the proteasome. While exposing worms or cells to high levels of iron chelators is 
an extreme intervention unlikely to reflect physiologically relevant conditions, it has 
been found through analysis of the Km of the hydroxylation reaction in response to 
iron that the hydroxylation reaction should be responsive to changes in physiological 
iron levels (Mole, 2010). In mammals, a number of genes involved in the regulation 
of iron homeostasis have been identified as targets of HIF, including the transferrin 
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receptor (TfR) (Lok and Ponka, 1999; Tacchini et al., 1999), ceruloplasmin 
(Mukhopadhyay et al., 2000), hepcidin (Peyssonnaux et al., 2007) and heme 
oxygenase-1 (Lee et al., 1997) and ferroportin (Peyssonnaux et al., 2008). 
Interestingly, an iron responsive element was identified in the 5' UTR of HIF-2α 
mRNA and this element was found to repress translation when iron was limiting 
(Sanchez et al., 2007), suggesting that HIF-2α  may be regulated in response to iron 
at the translational level as well as the post-translational level. It therefore seems 
likely that HIF transcription factors act as iron sensors and mediate cellular response 
to aberrant iron levels. In fact, there is evidence to suggest that HIF levels are 
responsive to iron even at physiological iron levels. For example, iron starvation 
leads to increased HIF-1α levels in the livers of mice (Peyssonnaux et al., 2007; Shah 
et al., 2009). 
In vertebrates, this response is thought to be a part of the role of HIF in 
erythropoiesis. When oxygen levels are low, HIF levels in the kidney are stabilised 
and the HIF target gene erythropoietin is upregulated (Semenza and Wang, 1992) 
and secreted. Iron use from erythropoiesis is by far greater than from any other 
process and iron is the most common limiting factor in red blood cell production. 
Increased erythropoietin and the associated manifold upregulation of erythropoiesis 
would alone quickly lead to a state of iron deficiency. The concomitant upregulation 
of a number of proteins involved in increasing iron availability by HIF is therefore 
often seen as a way to cope with the increased requirement for iron from 
erythropoiesis. In this scenario, hypoxia in the kidney occurs either due to anaemia or 
to systemic hypoxia, which could for example be caused by movement to higher 
altitudes in which atmospheric oxygen levels are lower. To combat systemic 
hypoxia, erythropoiesis needs to be upregulated to improve tissue oxygenation. This 
is achieved when HIF is stabilised: more erythropoietin is secreted from the kidney 
and the bone marrow starts producing more red blood cells (Mole, 2010).  
In order to supply the large amounts of iron that is now required, HIF also 
directly affects transcription of transferrin (Rolfs et al., 1997), which transports iron 
in blood, and the transferrin receptor (TfR) (Lok and Ponka, 1999; Mukhopadhyay et 
al., 2000; Tacchini et al., 1999), which binds transferrin and imports it into the cell 
using endosomes. The up-regulation of ceruloplasmin (Mukhopadhyay et al., 2000), 
a ferroxidase, can also be interpreted as aiding this process since transferrin can only 
bind Fe3+ and ceruloplasmin catalyses the formation of Fe3+ from Fe2+. HIF also 
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activates heme oxygenase expression (Lee et al., 1997), which increases iron levels 
by releasing iron from heme. The net effect of HIF activation on iron metabolism is 
therefore an increase in iron availability through the induction of this battery of genes 
involved iron transport and the mobilisation of iron stores. The repression of ferritin 
expression by HIF would not be unexpected in this context, as lowering the cells’ 
iron storage capacity would also lead to increased iron availability. In fact, mice with 
liver-specific deletions in VHL were found to have greatly reduced levels of ferritin 
in western blots of liver extracts, although the cause was never studied (Peyssonnaux 
et al., 2007). 
The discovery that HIF-1 represses transcription of ftn-1, as measured using the Pftn-
1::gfp transgene as a proxy, in the nematode worm C. elegans could have profound 
implications. Given the complete lack of a circulatory system or erythropoiesis in the 
worm, this finding strongly suggests that the evolution of a role of HIF in regulating  
iron availability predates the requirement for a tightly linked joint regulation of 
erythropoiesis and iron availability.  
 
5.1.7. Repression of ftn-1: hepcidin parallel?  
It should be noted that HIF has usually been found to be an activator of gene 
expression, not a repressor. In the context of HIF’s likely role in the regulation of 
iron availability, a role of HIF in repressing genes that lead to decreased availability 
of iron would not be unexpected. Indeed, the negative regulation of another such 
gene, hepcidin, by HIF has already been described, although two recent publications 
on this subject paint a contradictory picture. Hepcidin is a peptide hormone that 
functions by inhibiting ferroportin (Nemeth et al., 2004). This prevents ingested iron 
from being secreted into the hepatic portal system by the intestinal cells that absorb 
iron from the diet and also prevents macrophages from releasing recycled iron 
(Nicolas et al., 2002; Peyssonnaux et al., 2007). Like ferritin, hepcidin therefore also 
serves to lower iron availability.  
One study showed a strong down-regulation in hepcidin mRNA levels in 
mice with a liver specific deletion in VHL, which stabilises HIFα levels. The authors 
suggest that this effect is due to the stabilisation of HIF because VHL-/- ARNT-/- 
animals returned hepcidin mRNA to wild-type levels. ChIP experiments also showed 
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binding of HIF-1α to the hepcidin promoter in these mutants, but not in wild-type, 
suggesting a direct repression of hepcidin by HIF-1α. Wild-type animals treated with 
desferrioxamine, which also stabilises HIFα, also showed binding of HIF-1α to the 
promoter. Reporter genes using the human hepcidin promoter to drive luciferase 
expression showed a reduction in expression upon treatment with desferrioxamine, 
an iron chelator, and an increase in expression when the putative HIF binding site 
was mutated, suggesting that the role of HIF in repressing hepcidin expression is 
conserved from mouse to man (Peyssonnaux et al., 2007). 
However, a separate study found that while iron chelators reliably reduced 
levels of hepcidin mRNA in cell lines, treatment with hypoxia, which is also 
effective at stabilising HIFα levels, did not do so. Additionally, siRNA treatment of 
both HIF-1α and HIF-2α did not lead to increased hepcidin mRNA levels, nor was 
either treatment effective at preventing repression of hepcidin by iron chelators 
despite being able to affect levels on known HIF targets (Volke et al., 2009). 
 Whether or not hepcidin is indeed directly repressed by HIF in order to 
increase the availability of iron has not yet been clearly established despite strong 
evidence from in vivo studies in mice. If further research demonstrates that this 
interaction is in fact taking place, then this would set a precedent for the negative 
regulation of a gene involved in reducing iron availability by the iron sensitive HIF. 
The negative regulation of Pftn-1::gfp by hif-1 in C. elegans could be another 
example of such an interaction. While the repression of a gene involved in iron 
metabolism has not yet been unequivocally demonstrated, HIF-1α has been shown to 
negatively regulate other genes, such as alpha-fetoprotein, carbamoyl-phosphate 
synthetase 2, aspartate transcarbamylase, and dihydroorotase (Chen et al., 2005; 
Mazure et al., 2002).  
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5.2 Results 
 
The hif-1 pathway has been studied primarily for its role in regulating gene 
expression in response to hypoxia and is of great interest to researchers due to its 
involvement in cancer in higher organisms. As mentioned, I identified both hif-1 and 
its binding partner aha-1 as putative repressors of Pftn-1::gfp expression in my 
screen for regulators of ftn-1. RNAi of either of theses elements led to large increases 
in the GFP expression from the already induced levels present in the Pftn-1::gfp daf-
2(m577); rrf-3(pk1426) genotype used for this screen (Appendix 1).  
This suggests that the HIF-1/AHA-1 dimer is repressing ftn-1 expression and 
in this chapter, I set out to test this hypothesis. The first step was to confirm that the 
effects of hif-1 and of aha-1 RNAi on Pftn-1::gfp expression observed in the screen 
were robust and not an artefact of the daf-2; rrf-3 mutant background used. The 
effect of these RNAi treatments on Pftn-1::gfp–expressing strains lacking these 
mutations was therefore tested. Next, it was important to confirm that the effects of 
knocking down these two genes were not independent of each other, since this would 
contradict the notion that they were acting as a dimer. To do this, the effect of aha-1 
RNAi was tested in the absence of hif-1. Given the important role of daf-16 in the 
regulation of ftn-1 (see Chapters 1, 3 and 4), it was also important to examine 
whether hif-1 and aha-1 RNAi were acting via daf-16 to regulate gene expression 
and for this, the Pftn-1::gfp daf-16(mgDf50) strain was used.  
A separate question was then addressed. As described in this chapter’s 
introduction, the fact that hif-1 seems to play an important role in repressing 
expression of a ferritin gene is particularly intriguing because of the role of ferritins 
in storing iron, the fact that HIF-1 is known to be responsive to iron levels and the 
fact that ftn-1 transcript levels are also known to be responsive to iron levels. I 
therefore proceeded to test whether HIF-1 mediates the regulation of ftn-1 by iron. 
To this end, I first tested whether or not hif-1 mutants are still responsive to iron 
levels. In a study on ftn-1 regulation, a 63bp iron-dependent element (IDE) was 
identified in the ftn-1 promoter, which was found to be both necessary and sufficient 
for ftn-1 to respond to iron levels (Romney et al., 2008).  I therefore examined 
whether hif-1 acts on ftn-1 regulation via the IDE.  
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As described in the introduction, the responsiveness of HIF-1 levels to the 
oxygen and iron levels is known to be mediated by VHL-1 and EGL-9. Loss of these 
genes would therefore be expected to affect ftn-1 expression, a hypothesis I tested 
using RNAi.  
 
5.2.1. Confirming results from the screen     
The involvement of hif-1 and aha-1 in ftn-1 regulation was discovered within 
the context of a large-scale screen and in a genetic background containing mutations 
in rrf-3 and daf-2. I was therefore concerned about whether the finding reflected a 
real role of these two genes in ftn-1 regulation or whether it was an artefact of the 
experimental conditions, such as the genotype of the strain used. The fact that the 
screen was carried out using a single integrated Pftn-1::gfp transgenic reporter was 
another potential source of error. Since the transgene had been integrated by X-ray 
irradiation, it was inserted at a random location in the genome, which could, in 
theory, lead to artefactual results if the locus happens to be strongly regulated by 
these two genes. I therefore decided to test the effects of hif-1 and aha-1 on two 
separate integrants of the Pftn-1::gfp transgene, both of which were wild-type for rrf-
3 and daf-2.  
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Figure 49  
Worms were age-synchronised, grown at 20oC until the L4 stage, transferred to 
RNAi plates, and kept at 25oC for 2 days before measurements were taken. Error 
bars represent ±s.e.m. Unless otherwise indicated, statistical significance was 
calculated for the comparison to the control treatment of the same genotype. 
Significance was calculated by ANOVA of log-transformed values. Bonferroni 
correction for multiple testing was applied to p values. ***: p<0.001, n.s.: p>0.05   
As shown in Figure 49, the effects of hif-1 and of aha-1 on Pftn-1::gfp 
expression were not specific to the rrf-3; daf-2 background used for the screen, nor 
were they an artefact of the integration.  
While RNAi by feeding is considered a very reliable method of gene 
knockdown in C. elegans, I was able to confirm that the RNAi treatment used 
throughout this chapter is effective at knocking down hif-1. As part of a separate 
collaboration with Dr. Oliver Staples from the Rayne Institute at UCL, I treated 
worms expressing a HIF-1::Myc fusion protein (Zhang et al., 2009) with RNAi for 
hif-1 and then exposed them to hypoxia for 3h. HIF-1::Myc levels were greatly 
induced by hypoxia. RNAi of hif-1 led to reductions in HIF-1::myc levels under both 
hypoxic and normoxic conditions (see Figure 50).  
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Figure 50 
Western blot showing high efficacy of hif-1 RNAi. Anti-Myc antibody was used to 
quantify expression from a hif-1::myc transgene, or one carrying the stabilising 
P621G mutation. Hypoxia treatment consisted of 3h of 1% O2. The blot presented 
here is representative of the results of three biological replicates. This work was done 
in collaboration with Oliver Staples from the UCL Rayne institute. Worms were 
grown on RNAi plates at 20oC for two generations. RNAi treatment was carried out 
by me, samples were prepared jointly by Oliver Staples and myself and the gels were 
run and blotted by Oliver.    
While RNAi is clearly effective at knocking down hif-1 gene expression, at 
least in the context of a hif-1::myc transgene, this does not exclude the possibility 
that hif-1 RNAi is also having off-target effects. If genes other than hif-1 are being 
targeted, it is possible that a different target is responsible for the effects on Pftn-
1::gfp expression. This can be tested using genetic, hypomorphic mutants of hif-1. I 
therefore crossed the Pftn-1::gfp transgene into a hif-1(ia4) genetic background to 
see if the effect hif-1 by RNAi is recapitulated in hif-1 mutants. The ia4 deletion 
spans over 1.2kb, deletes three exons, introduces a premature stop codon and 
eliminates most of the bHLH and PAS domains. These mutants are therefore thought 
to have a complete loss of hif-1 function (Jiang et al., 2001b) and have been 
extensively used in publications studying hif-1.  As shown in Figure 51 and 
throughout this chapter, Pftn-1::gfp fluorescence is greatly elevated in hif-1 mutants 
compared to hif-1(+) animals, demonstrating that the effect of hif-1 RNAi is not due 
to off-target effects.   
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5.2.2. Testing hif-1 dependence of aha-1 RNAi effect  
Because RNAi of both hif-1 and aha-1 had similar effects on Pftn-1::gfp 
expression and previous studies had already shown that HIF-1 and AHA-1 act in 
concert (Jiang et al., 2001b), it seems likely that the HIF-1/AHA-1 dimer is working 
directly or indirectly to repress expression of Pftn-1::gfp. I tested this by treating 
Pftn-1::gfp hif-1(ia4) animals with aha-1 RNAi. If HIF-1 and AHA-1 are acting 
together, then one would expect that aha-1 RNAi should not increase expression of 
the transgene in the absence of hif-1.  
I first carried out a series of experiments in which I treated animals with 
RNAi for two generations, growing the second generation at 25oC and measuring the 
worms’ fluorescence at the L4 stage of development (see 2.8.3. Protocol 3). This was 
done to keep experimental conditions consistent with experiments in which 
measurements needed to be taken at 25oC at the L4 stage (see 
 
 
 and Figure 55). However, I was concerned about the possibility of artefactual 
results due to developmental effects caused by RNAi and also by the fact that in my 
hands the hif-1(ia4) mutant animals grow much more slowly at 25oC than hif-1(+) 
animals. This phenotype not only makes the synchronisation of experiments difficult, 
it also raised the possibility that since some effects of hif-1 are clearly dependent on 
temperature, its effects on the regulation of ftn-1 might also be affected by 
temperature.  I therefore additionally carried out many experiments at 20oC, 
transferring them to RNAi plates at the L4 stage to prevent any developmental 
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effects of the RNAi, and then measuring them on the second day of adulthood. In 
order to control for effects of temperature, I also measured the fluorescence of 
worms I kept at 20 oC until the L4 stage before transferring to RNAi plates and then 
shifting them to 25oC for two days before taking measurements (see 2.8.1. Protocol 
1). 40 adult worms were used per measurement; when measuring L4 animals, I used 
60 per measurement because of their smaller size. These three conditions were used 
in numerous instances throughout this chapter. With only a few exceptions, the 
results of these experiments were the same regardless of the conditions used.  
 
 
 
A.          B. 
 
C. 
Figure 51 
hif-1 and aha-1 work together to regulate 
Pftn-1::gfp 
A. Fluorescence of adult hif-1(+) and hif-
1(ia4) worms carrying the Pftn-1::GFP 
transgene was measured after RNAi 
treatment at 20oC. B. L4 animals were 
measured after two generations of RNAi 
and one generation at 25oC. C. Adult 
animals were measured after two days of 
RNAi at 25oC. Error bars represent 
±s.e.m. Statistical significance was  
             calculated as described in Figure 49.   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As shown in Figure 51, under three different experimental setups, aha-1 
RNAi greatly increases expression of Pftn-1::gfp in hif-1(+) animals and the 
magnitude of this effect is comparable to that seen upon hif-1 loss by RNAi or 
genetic deletion. When hif-1 is absent, aha-1 RNAi is incapable of further increasing 
expression, which supports the view that hif-1 and aha-1 are working together to 
repress Pftn-1::gfp.  
5.2.3. The effects of hif-1 and aha-1 RNAi on Pftn-1::gfp expression are 
independent of daf-16  
hif-1 and aha-1 RNAi increase Pftn-1::gfp expression in both daf-2(m577) 
(Appendix 1) and daf-2(+) (see Figure 49) genetic backgrounds. Next I tested 
whether this induction was daf-16 dependent. It is conceivable that RNAi of these 
factors may induce ftn-1 expression by activating daf-16. I therefore tested the effects 
of hif-1 and aha-1 RNAi on Pftn-1::gfp expression in the absence of daf-16. 
  I first exposed both daf-16(+) and daf-16(mgDf50) animals carrying the Pftn-
1::gfp transgene to two generations of hif-1 or aha-1 RNAi and measured 
fluorescence in L4 animals of the second generation. The second generation was 
grown at 25oC. As a positive control, worms were also grown on daf-2 RNAi, which 
increases expression from the transgene in a daf-16(+), but not a daf-16(mgDf50) 
mutant background.  
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 A.             B.  
 
C.             D.  
 
Figure 52 
hif-1 and aha-1 RNAi increase Pftn-1::gfp expression in the absence of daf-16 
Fluorescence of daf-16(+) and daf-16(mgDf50) worms carrying the Pftn-1::GFP 
transgene was measured A. at the L4 stage after two generations of RNAi treatment 
and one generation at 25oC (see B. for the same data displayed as a ratio of the 
control) and C. at 20oC after 2 days of RNAi treatment (see D. for the same data 
displayed as a ratio of the control). Error bars represent ±s.e.m. Statistical 
significance was calculated as described in Figure 49.   
Consistent with earlier results (see chapters 3 and 4), daf-2 RNAi did not 
increase Pftn-1::gfp expression in daf-16 mutants at 25oC. In contrast, both aha-1 
and hif-1 RNAi did increase expression. The fold-change in expression induced by 
hif-1 and aha-1 was similar in both genotypes (see Figure 52 B and D). Use of both 
protocols resulted in the same finding: the effects of both aha-1 and hif-1 RNAi 
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occur independently of daf-16, thus demonstrating that RNAi of either of these genes 
does not lead to increased expression of Pftn-1::gfp via activation of DAF-16. 
Instead, it seems likely that hypoxia signalling acts in parallel to IIS to regulate the 
levels of ftn-1 expression in C. elegans (see Chapter Discussion).   
5.2.4. Regulation of Pftn-1::gfp by iron is hif-1 dependent  
The hydroxylation reaction that leads to the degradation of HIF-1 requires 
iron (Epstein et al., 2001). This suggests the possibility that the induction of ftn-1 
transcription by iron occurs through HIF-1. I decided to test the ability of ferric 
ammonium citrate (FAC) to induce Pftn-1::gfp expression in hif-1(+) and hif-1(ia4) 
animals. If the transcriptional response to iron requires HIF-1, then Pftn-1::gfp 
expression will not be induced in hif-1 mutant animals. I chose to use a concentration 
of 25mM of FAC for this experiment, since the work of a colleague (Sara Valentini, 
Gems Lab, UCL), showed that this concentration is effective at inducing expression 
of this transgene. I also exposed animals to 0.1mM of the iron chelator 2’,2-bipyridyl 
(BP), which should lead to a decrease in expression from the iron-responsive Pftn-
1::gfp transgene.  
Worms in their first day of adulthood and grown at 20oC were exposed to 
either 25mM of FAC or 0.1mM of  BP for 18h before measurement. In a separate 
experiment, worms were also grown on FAC or regular NGM plates from egg at 
25oC and measured at the L4 stage. BP was not used for these experiments because 
worms do not develop well on plates containing this chelator.  
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A.            B. 
 C.            D.  
Figure 53 
Induction of Pftn-1::gfp expression by iron requires hif-1. 
A. Fluorescence of hif-1(+) and hif-1(ia4) adult worms carrying the Pftn-1::gfp 
transgene was measured after 18h of 25mM FAC or 0.1mM BP treatment at 20oC. B.  
The same data as shown in A. was represented as a ratio to its control treatment to 
illustrate the different effect of treatments in the two genotypes. C. hif-1(+) and hif-
1(ia4) worms were exposed to FAC treatment from egg to L4 at 25oC. D. the same 
data as in C. presented as a ratio of its control. Error bars represent ±s.e.m. Statistical 
tests performed as described in Figure 49.  
Both addition and chelation of iron had the expected effects on Pftn-1::gfp 
expression in hif-1(+) animals. Adding additional iron increased expression and 
chelating iron reduced expression. The magnitude of these effects was not as great as 
that of either reduced IIS or of reduced hif-1 or aha-1 levels, but nonetheless a 50% 
increase and a 50% decrease were seen with the respective treatments. This did not 
occur in hif-1(ia4) mutant animals. FAC treatment did not affect expression in this 
background and BP treatment did not reduce, but in fact increased, expression of 
Pftn-1::gfp. In the absence of hif-1, ftn-1 expression is no longer be responsive to the 
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addition of iron, at least when measured using the Pftn-1::gfp transgene, indicating 
that C. elegans may require hif-1 to respond to iron levels. The reason for the 
increase in Pftn-1::gfp expression in hif-1(ia4) animals upon BP treatment is 
unknown. However, I noticed that worms treated with BP have a sickly and thin 
appearance. It is possible that in the absence of the repressive effect of HIF-1, BP 
triggers a stress response that activates ftn-1 expression.  
What this data makes clear is that the positive link between iron levels and 
Pftn-1::gfp expression does not occur in the absence of hif-1, indicating that HIF-1 
may have an important role in iron-dependent gene regulation. Given that a known 
mechanism for the regulation of HIF-1 levels by proteasomal degradation requires 
the presence of iron, it seems likely that changes in the environmental iron levels are 
leading to different levels of HIF-1, which in turn affects transcription of Pftn-1::gfp.   
 
5.2.5. Testing the involvement of HIF-1 and AHA-1 in the regulation of 
ftn-1 via the IDE    
I next tested whether regulation of ftn-1 by hif-1 and aha-1 is mediated by the 
IDE element of the ftn-1 promoter. In the publication that first reported on the IDE 
(Romney et al., 2008), a number of transgenic reporter lines were created to 
characterise the role of this element. These were generously provided to me by 
Elizabeth Leibold (University of Utah).  
The first set of experiments were carried out using a line carrying a ftn-1 
reporter very similar to the Pftn-1::gfp reporter used for my screen. It was 
constructed using 1.9kb of upstream sequence (my own reporter contains 4kb) and 
was fused to the minimal pes-10 promoter and to GFP-histone. The pes-10 promoter 
has no basal transcriptional activity of its own but is activated by enhancers. The use 
GFP-histone rather than GFP alone localises fluorescence to the nuclei, making 
fluorescence from transgene expression easy to distinguish from endogenous 
autofluorescence, which can be a problem when GFP expression is low.  
A second line was created by Romney et al. in which the 63bp IDE was 
deleted from the Pftn-1::pes-10::gfp-his construct to make the Pftn-1(Δ63)::pes-
10::gfp-his transgene. This line also exhibits GFP expression in intestinal nuclei, 
although the expression levels are much lower. The authors found that Pftn-1::pes-
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10::gfp-his is responsive to iron but Pftn-1(Δ63)::pes-10::gfp-his is not, 
demonstrating that the mechanism that regulates the induction of ftn-1 by iron acts 
through these 63bp.  
I have hypothesised that the iron-dependent regulation of ftn-1 is occurring 
via HIF-1. In this scenario, the HIF-1/AHA-1 dimer is binding and repressing ftn-1 
expression when iron is absent. In the presence of iron, more HIF-1 is hydroxylated 
and therefore degraded, leading to less repression and increased ftn-1 expression. The 
increased levels of FTN-1 would then be able to store the excess iron. If true, then 
the effect of hif-1 RNAi on ftn-1 expression would also need to occur via the IDE. I 
therefore tested whether the effects of hif-1 RNAi could be abrogated by the deletion 
of this element.  
In the original publication, Romney et al. measured the fluorescence of these 
strains using the COPASTM (complex object parametric analysis and sorting) 
Biosort (Union Biometrica, Somerville, MA), a type of FACS sorter for worms. This 
instrument was not available to me, so I instead measured fluorescence by taking 
epifluorescent microscopic pictures of worms at the L4 stage and quantifying 
fluorescence using the Volocity 5.0 (Improvision) software. I chose L4 animals 
because little autofluorescence was seen at this stage, making GFP expression easier 
to quantify in strains with low levels of transgene expression, such as the Δ63 line.  
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Figure 54 
Two trials were combined and the mean fluorescence on control RNAi was used to 
control for inter-trial variation. Fluorescence of Pftn-1(Δ63)::pes-10::gfp-his line 
was much lower than the Pftn-1::pes-10::gfp-his line, so the data is displayed as a 
ratio of control. Due to the left-censored nature of this data, the non-parametric 
Wilcoxon test was used to compare the hif-1 RNAi treated animals to controls of the 
same genotype. Bonferroni correction for multiple testing was applied to p values. 
***: p<0.001, **: p<0.01, *: p<0.05, n.s.: p>0.05 
 
 
The two trials summarised in Figure 54 very clearly show that the effect of 
hif-1 RNAi occurs in this reporter strain as it does in my own Pftn-1::gfp strain. This 
alone is encouraging, since it shows that the effect was not an artefact of my 
construct. In support of my hypothesis on the role of HIF-1 in the regulation of ftn-1 
by iron, hif-1 RNAi had no statistically significant effect on the expression of Pftn-
1(Δ63)::pes-10::gfp-his. This indicates that the IDE is required for the regulation of 
ftn-1 by hif-1. 
 
5.2.6. The IDE is sufficient for the effects of hif-1 RNAi on ftn-1 
expression  
The next step was to identify whether the regulatory elements within the 63bp 
of the IDE were sufficient for the effects of hif-1 RNAi on ftn-1 expression. This 
would be expected if the regulation of ftn-1 by iron does occur via HIF-1, since the 
IDE has previously been found to be sufficient for the effects of iron on ftn-1 
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expression (Romney et al., 2008). Romney et al had tested this by creating a 
transgene in which the IDE alone was fused to pes-10::gfp-his. GFP fluorescence 
expressed from this IDE::pes-10::gfp-his transgene can also be seen in intestinal 
nuclei, but expression is very weak. In order to investigate the role of hif-1 in the 
regulation of this trangene by iron, I crossed the transgene into a hif-1(ia4) mutant 
background. I then tested the effect of loss of hif-1 on expression. If HIF-1 really 
represses ftn-1 expression via the IDE, then loss of hif-1 should lead to increased 
expression of the IDE::pes-10::gfp-his transgene. The effect of FAC on fluorescence 
was also tested in these two strains, since one would predict that the reporter would 
not be capable of responding to FAC in the absence of hif-1.  
  
Figure 55 
No statistically significant increase in 
fluorescence was seen when worms 
carrying the IDE::GFP hif-1(ia4) 
mutation were treated with FAC. In 
order to pool multiple trials, I 
normalised the fluorescence of each 
worm using the mean fluorescence of 
all hif-1(+) animals on NGM plates 
from the same trial. Statistical 
analysis was performed as described 
in Figure 54.   
Loss of hif-1 led to a large increase in expression, indicating that the role of 
hif-1 in ftn-1 regulation does in fact occur through the IDE. Additionally, the clear 
induction in expression after to iron seen in the hif-1(+) line did not occur in the hif-
1(ia4) mutants, strongly suggesting that the iron-dependent regulation of ftn-1 
through the IDE occurs via the actions of hif-1.  
It should be noted that before the Bonferroni correction was applied, the 
difference in fluorescence in hif-1(-) animals on FAC to those on NGM was 
statistically significant (p=0.032). While correcting for multiple testing is necessary, 
it is possible that a statistically significant increase would have been detected had a 
larger sample size been used. In any case, the fluorescence in hif-1(+) animals by 
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FAC treatment was 2.09-fold higher than in controls, whereas the potential increase 
in hif-1(-) animals was only 1.15-fold (109% increase compared to a 15% increase). 
Any hif-1–independent component to the ftn-1 induction by iron is likely to be of 
minor importance compared to the role of hif-1.  
 
5.2.7. vhl-1 RNAi reduces Pftn-1::gfp expression  
The regulation of HIF-1 by VHL-1 and EGL-9 was discussed in this 
chapter’s introduction. In brief, EGL-9 is a prolyl hydroxylase that hydroxylates the 
P621 residue of HIF-1 in the presence of O2 and iron (and 2-oxoglutarate). When 
HIF-1 is hydroxylated, VHL-1 binds and this targets HIF-1 for degradation by the 
proteosome (see Figure 47). Since it is this EGL-9 and VHL-1–mediated degradation 
of HIF-1 that makes it responsive to iron levels, I decided to investigate its role in the 
hif-1–dependent regulation of ftn-1.  
Loss of vhl-1 leads to increased HIF-1 levels. If it is correct that HIF-1 
represses transcription of Pftn-1::gfp, then RNAi of vhl-1 should lead to a decrease 
in expression from Pftn-1::gfp, since HIF-1 levels should be increased. I therefore 
tested the effects of vhl-1 RNAi on Pftn-1::gfp expression.  
 
 A.            B. 
Figure 56 
A. Fluorescence of hif-1(+) and hif-1(ia4) animals carrying the Pftn-1::gfp transgene 
was measured at the L4 stage after two generations on vhl-1 or control RNAi and one 
generation at 25oC. B. The same data as A. but presented as a ratio to the control 
treatment. Error bars represent s.e.m. Statistical tests performed as described in 
Figure 49. 
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Worms were exposed to two of vhl-1 RNAi at 25oC. This reduced GFP 
expression, presumably because vhl-1 knockdown leads to increased HIF-1 levels, 
which represses transcription from the Pftn-1::gfp transgene. Consistent with this, no 
repression was seen in a hif-1 mutant background. However, when worms were 
subjected to RNAi for a shorter period, two days of adulthood, this decrease was not 
seen. In fact, at 20oC, a small (+20%), but statistically significant increase in 
expression was observed instead. At 25oC, no increase or decrease was seen.   
 A              B         
Figure 57 
Effect of 2 days of vhl-1 RNAi at 20oC and 25oC on Pftn-1::gfp fluorescence 
A. Fluorescence of hif-1(+) and hif-1(ia4) animals carrying the Pftn-1::gfp transgene 
was measured after 2 days of RNAi at 20oC B. Fluorescence of hif-1(+) and hif-
1(ia4) animals carrying the Pftn-1::gfp transgene was measured after 2 days of RNAi 
at 25oC. Error bars represent ±s.e.m. Statistical tests performed as described in Figure 
49.  
The simplest explanation for the slightly discrepant results is that the RNAi 
treatment for vhl-1 is slightly less effective than other treatments used here and 
requires a longer exposure. VHL-1 protein may perdure for a long time, so RNAi for 
two days may still leave active VHL-1 in play.  
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5.2.8. Examining the effect of egl-9 RNAi on Pftn-1::gfp expression  
The prolyl hydroxylase EGL-9 functions upstream of VHL-1 in targeting 
HIF-1 for proteosomal degradation (see Figure 47). RNAi of egl-9, like vhl-1, should 
therefore lead to increased levels of HIF-1 and therefore reduced levels of GFP 
expression from Pftn-1::gfp.  
 
 
A.             B.  
 
 
 
 
 
C.    Figure 58  
2 days of egl-9 RNAi at 20oC and 25oC 
A. Fluorescence of L4 hif-1(+) and hif-
1(ia4) animals carrying the Pftn-1::gfp 
transgene grown at 25oC B. Fluorescence 
of hif-1(+) and hif-1(ia4) animals 
carrying the Pftn-1::gfp transgene was 
measured after 2 days of RNAi at 25oC.  
C. Fluorescence of hif-1(+) and hif-
1(ia4) animals carrying the  
Pftn-1::gfp transgene was measured after 
2 days of RNAi at 20oC. Error bars represent ± s.e.m. Statistical tests performed as 
described in Figure 49.  
Instead of the expected decrease in expression from Pftn-1::gfp upon RNAi 
of egl-9, I saw a large increase. The extent of the increase differs depending on the 
conditions used. In both experiments carried out at 25oC, egl-9 RNAi leads to an 
increase similar to that seen in hif-1 mutant animals or upon treatment with hif-1 
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RNAi. At 20oC however, the increase is much greater, such that the level of GFP 
expression is double that found in hif-1 mutant or hif-1 RNAi–treated animals.  
Under both conditions, the increase in expression is completely dependent on hif-1, 
since egl-9 RNAi never leads to an increase in ftn-1 reporter gene expression in hif-1 
mutant animals. Given that all evidence so far indicates that HIF-1 acts as a repressor 
of ftn-1, the consequences of egl-9 RNAi on Pftn-1::gfp expression indicate that egl-
9 acts here as an activator rather than a repressor of HIF-1. This is unexpected, since 
it is not consistent with the known action of PHDs on HIF.  
 
 
5.2.9. Is the effect of egl-9 RNAi due to activation of DAF-16? 
 
One possible explanation could again lie with daf-16: egl-9 RNAi might 
activate DAF-16, thereby inducing expression of Pftn-1::gfp. I therefore tested the 
effects of these two treatments in daf-16 mutants. However, both effects were 
independent of daf-16.   
 
Figure 59 
Fluorescence of wt, hif-1(ia4) and daf-16(mgDf50) animals carrying the Pftn-1::gfp 
transgene was measured after 2 days of egl-9 or control RNAi at 20oC. Error bars 
represent ±s.e.m. Statistical tests performed as described in Figure 49.  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The effect of egl-9 RNAi is therefore not due to an activation of daf-16, since it can 
still occur in the absence of daf-16. Similar results were seen at 25oC (data not 
shown).   
5.3. Chapter discussion 
 
An RNAi screen for regulators of ftn-1 expression led me to the discovery 
that expression of ftn-1 is directly or indirectly repressed by hif-1 and aha-1, as 
measured via reporter gene expression. This is potentially an important finding, since 
the mechanism by which ftn-1 is regulated in response to iron in C. elegans is 
unknown and HIF-1 itself is also regulated by iron levels. This role of HIF-1 in 
repressing ftn-1 expression matches its role in increasing iron availability found in 
vertebrate systems, because lower ferritin levels should lead to more free iron in the 
cell. While most studies focus on the regulation of ferritin levels at the translational 
level in response to iron (see Chapter 1), transcriptional up-regulation of ferritin after 
iron treatment has also been described (White and Munro, 1988). Understanding how 
ferritin is transcriptionally regulated in response to iron in C. elegans may therefore 
be useful in the study of iron regulation in higher organisms.  
RNAi of both hif-1 and aha-1 led to large increases in expression from my 
reporter of ftn-1 transcription. hif-1 and aha-1 seem to act together, since there is no 
additive effect of aha-1 RNAi and hif-1 deletion. As discussed previously (see 
chapter 1 and 2) the expression of the Pftn-1::gfp  reporter re-iterates the expression 
pattern of ftn-1 found by other groups, accurately predicts expression of endogenous 
ftn-1 mRNA levels in response to mutations in IIS and, like ftn-1 mRNA, is also 
inducible by exposure to iron, all of which strongly supports its reliability as a proxy 
for detecting changes in ftn-1 expression. Additionally, RNAi of hif-1 also leads to 
increased expression of the Pftn-1::pes-10::GFP-his reporter provided to me by 
Elizabeth Leibold (see Figure 54). I confirmed that RNAi was effectively targeting 
hif-1 by western blotting of a strain carrying a HIF-1::Myc construct. I also showed 
that the effects of hif-1 RNAi are not due to off-target effects, as a deletion in hif-1 
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shows a very similar effect on Pftn-1::expression and hif-1 RNAi has no additional 
effect on expression when hif-1 is deleted.  
There are hints that the role of HIF in the regulation of ferritin may extend to 
higher organisms. In a renal carcinoma cell line that carries a mutation in the VHL 
gene and thus increased levels of HIFα, both L- and H-ferritin transcript levels were 
decreased compared to cells transfected with a wild-type VHL clone (Alberghini et 
al., 2005).  Similarly, mice with liver-specific deletions of VHL were also found to 
express lower levels of ferritin (Peyssonnaux et al., 2007). Neither study investigated 
the HIFα dependence of the down-regulation of ferritin. Contradictory results have 
also been found. A study using a human monocyte/macrophage cell line to study the 
effects of cigarette smoke found an up-regulation of H-ferritin mRNA in response to 
the combined exposure to a cigarette smoke condensate and hypoxia. This induction 
was abrogated when cells were treated with siRNA for HIF-1α, which suggests a 
role of HIF in inducing, rather that repressing, ferritin expression in response to this 
set of stimuli (Goven et al., 2010). Similarly, northern blot analysis following a 
microarray study on renal and non-renal cell lines seems to suggest that L-ferritin 
may be induced by hypoxia and by mutation in VHL although again, the mechanisms 
by which this occurs remain unclear (Wykoff et al., 2004).  
5.3.1. Interplay between IIS and hypoxia signalling  
During the course of my PhD, I was able to show that both IIS and hypoxia 
signalling, two important stress response pathways, regulate ftn-1 expression. While 
interactions between these two pathways have not been extensively studied in C. 
elegans, there have been suggestions that they may cooperatively regulate common 
targets. daf-2 mutants, for example, are resistant to hypoxia (Mabon et al., 2009) and 
this resistance is daf-16 dependent (Scott et al., 2002), demonstrating that IIS-
regulated genes have a role in protection against hypoxia. Whether hif-1 is involved 
in this resistance is not known.  
Another interesting link between hif-1 and IIS comes from the microarray 
study on daf-2 and daf-16; daf-2 by McElwee et al. (see Chapter 1). The authors 
analysed sequences 1kb upstream of differentially regulated genes in search for 
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transcription factor binding elements enriched in these sequences. They found that 
the hif-1 response element was overrepresented in the set of IIS-regulated genes, 
suggesting that hif-1 and daf-16 may act together to regulate gene expression. The 
authors hypothesise that genes regulated jointly by hif-1 and daf-16 may be involved 
in protection against hypoxia, thus explaining the resistance against hypoxia seen in 
daf-2 mutants (McElwee et al., 2004). However, given recent findings on the role of 
hif-1 in the determination of lifespan, it is also possible that the IIS- and hif-1–
mediated effects on ageing are mediated by a set of common targets. The question of 
whether the effects of the two pathways on lifespan are independent remains 
unresolved. As described in the introduction, the data seems to suggest independent 
effects of the two pathways, since the effects of hypoxia signalling on lifespan are 
independent of daf-16 (Mehta et al., 2009; Zhang et al., 2009).  
A study investigating axon guidance in C. elegans found that HIF-1 
activation leads to axon-pathfinding defects (Pocock and Hobert, 2008). Mutations in 
daf-2 were able to rescue these defects and this suppression of the effects of HIF-1 
activation was dependent on daf-16. Because the suppressive effect of daf-2 
mutations was absent when HIF-1 activation was achieved via stabilising mutations, 
the authors predict that DAF-2 acts upstream of HIF-1 to affect axon guidance. 
Because daf-16 is known to regulate anti-oxidant enzymes, Pocock and Hobart tested 
if the changes in ROS levels could account for the interaction between IIS and HIF-
1, since in human cell lines, the elevated ROS produced by mitochondria during 
hypoxia leads to increased HIF levels (Brunelle et al., 2005). They found that loss of 
the antioxidant enzyme sod-1 did lead to the same axon guidance defects seen upon 
HIF-1 activation. They conclude that IIS may be interacting with hypoxia signalling 
by altering the levels of cellular ROS and thereby affecting HIF-1 (see Figure 60). 
Similar examples of possible regulation of HIF through alterations in ROS levels can 
be found in vertebrate systems as well (Gerald et al., 2004).   
Figure 60 
Adapted from Pocock and Hobert 
(2008). Possible mechanism by 
which IIS and hypoxia signalling 
interact to affect axon guidance.  
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A study into the role of HIF in type-2 diabetes found that mice with a deletion 
of HIF-1a in pancreatic β-cells are glucose intolerant and exhibit β-cell dysfunction. 
Treating mice on a high-fat diet with an iron chelator led to an amelioration of 
glucose intolerance and improved insulin secretion in wild-type, but not HIF-1a null 
mice, indicating that HIF can protect against glucose intolerance (Cheng et al., 
2010). Studying the regulation of ftn-1 by insulin/IGF-1 signalling and hypoxia 
signalling might be a useful approach to further our understanding of the dynamics of 
interactions between the two pathways. Expression of the Pftn-1::gfp transgene can 
be used as a readout for signalling from both pathways, allowing for interactions to 
be tested by epistasis analysis.   
 
One possible explanation for the effects of hif-1 RNAi on Pftn-1::gfp 
expression is that loss of this gene (or of aha-1) leads to an activation of DAF-16, 
possibly by causing stress. If so, then this alone could explain the elevated expression 
of Pftn-1::gfp, since daf-16 is clearly a powerful regulator of ftn-1 (see Figure 61).     
Figure 61 
Model A: The regulation of ftn-1 by HIF-1 requires DAF-
16.  
    
I therefore investigated whether the effects of hif-1 required the presence of daf-16 
and found that they did not. This excludes Model A.  
  The fact that hif-1 and aha-1 RNAi are capable of increasing Pftn-1::gfp 
expression in a wild-type, daf-2 mutant and daf-16 mutant background suggests that 
the role of HIF-1/AHA-1 in ftn-1 regulation is completely independent of IIS. 
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Figure 62 
Model B: The regulation of ftn-1 by HIF-1 is independent of 
IIS.   
 
 
 
 However, the hypoxia resistance of daf-2 mutants, the over-representation of 
putative hif-1 binding elements in IIS targets and the interactions between hif-1 and 
IIS in axon pathfinding (see above) suggests that hif-1 may act downstream of daf-2. 
Two such scenarios are possible: 
 
    
Figure 63 
Model C: hif-1 
acts downstream 
of IIS and daf-16 
to regulate ftn-1 
expression.  
 
 
 
Figure 64 
Model D: DAF-2 
regulation of 
DAF-16 and HIF-
1 are two parallel 
mechanisms of 
ftn-1 regulation.  
 
Whether or not HIF-1 acts downstream of DAF-2 to regulate ftn-1 could be tested by 
treating Pftn-1::gfp hif-1(+) and Pftn-1::gfp hif-1(ia4) animals to daf-2 and control 
RNAi. If daf-2 RNAi is equally effective at inducing transgene expressions in both 
genotypes, then this would strongly support an independent role of IIS and hypoxia 
signalling. However, if daf-2 was incapable of inducing expression in hif-1 mutants, 
then models C and D would need to be considered.   
In model C, the role of HIF-1 lies downstream of DAF-16, for example 
following the regulatory model proposed by Pocock and Hobert (see Figure 60). In 
their model, the inhibition of HIF-1 by DAF-16 is occurring through reduced ROS 
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levels by the DAF-16 –mediated up-regulation antioxidant enzymes. Since ROS are 
capable of increasing HIF-1 levels, reduced ROS would lead to less HIF-1 protein 
and therefore higher levels of ftn-1 expression. If hif-1 is indeed found to act 
downstream of daf-16, then the mechanism proposed by Pocock and Hobert could be 
tested using sod-1(0) mutants. If DAF-16 is regulating ftn-1 expression at least partly 
by increasing SOD-1 levels, thereby decreasing ROS and inhibiting HIF-1 (see 
Figure 60), then daf-2 RNAi should be less effective at increasing ftn-1 expression in 
sod-1(0) mutants.  
Alternatively, HIF-1 may act downstream of DAF-2 but in parallel to DAF-
16 to regulate ftn-1 levels (model D). This seems unlikely, as one would expect that, 
in this scenario, ftn-1 induction by mutations in daf-2 would be partially dependent 
on daf-16 and partially dependent on hif-1, but I have shown that the effect of 
mutation of daf-2 on ftn-1 expression is completely daf-16–dependent.  
 
5.3.2. hif-1: A new regulator of C. elegans iron homeostasis 
 
Why would iron homeostasis be regulated in response to the levels of  both 
iron and oxygen? One possibility is that there is a biological requirement for a 
closely linked regulation of iron homeostasis and oxygen levels. Because of C. 
elegans’ small size and the ease with which molecular oxygen diffuses through 
membranes, it is unclear whether oxygen availability is mediated by simple diffusion 
or whether active processes exist to transport and store oxygen. 30 genes are thought 
to code for globins in C. elegans and though their role is not well understood, at least 
one could potentially have a role in O2 binding and storage. This gene, glb-1, is 
induced by hypoxia (Geuens et al., 2010). Since globins require iron to store and 
transport O2, it is possible that hif-1 mediates a joint regulation of iron availability 
and globin expression in order to effectively respond to hypoxia. In this scenario 
HIF-1 activates globin expression, which increases the requirement for iron, and 
decreases ftn-1 expression to meet this requirement. This joint regulation is similar to 
that seen in vertebrates, where HIF stimulates erythropoesis, which requires high 
levels of iron, as well as a battery of genes involved in increasing iron availability 
(see Chapter Introduction).  
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Another possibility is that the levels of free iron are tightly regulated partly 
due to the extreme toxicity of the hydroxyl radical produced by Fe2+ from hydrogen 
peroxide in the Fenton reaction. It is possible that iron levels are regulated in 
response to the availability of oxygen as well as iron because the damage caused by 
reactive oxygen species is greatly exacerbated when levels of free iron are high 
(Mole, 2010). Under conditions of high oxygen levels, increased ferritin expression 
due to HIF-1 degradation may contribute to reducing ROS by sequestering iron, thus 
detoxifying the noxious combination of O2 and free iron.  
 
5.3.3. The unexpected effects of egl-9 RNAi  
Given what is known about the hypoxia pathway in C. elegans, I expected 
that knock-down of both egl-9 and vhl-1 would have the same effect on HIF-1 levels: 
Since both are required for its proteosomal degradation, RNAi of either should lead 
to a large increase in HIF-1 levels. Because HIF-1 appears to be acting as a repressor 
of Pftn-1::gfp, both RNAi treatments should therefore lead to a decrease in Pftn-
1::gfp expression. While this is in fact what I found after two generations of vhl-1 
RNAi treatment, egl-9 RNAi has the opposite effect and leads to very large increases 
in Pftn-1::gfp expression.  
One possibility is that this finding is artefactual. I confirmed the identity of 
the egl-9 RNAi clone by sequencing, so the correct clone was used for these 
experiments. It is possible that off-target effects of RNAi could be responsible, so it 
would be important to test genetic mutants of egl-9 to exclude this possibility. That 
egl-9 RNAi is in fact causing an increase in HIF-1 levels could be confirmed by 
treating worms expressing HIF-1::Myc to egl-9 RNAi and measuring protein levels 
by western blotting. If this confirms that egl-9 RNAi is having the expected effects 
on HIF-1::Myc levels, i.e. increasing them, then this would pose the interesting 
question of how increased expression from the Pftn-1::gfp transgene can be 
associated with both increases and decreases in HIF-1 levels.  
Alternatively, these results may indicate that egl-9 acts by more than one 
pathway to influence ftn-1 expression and that egl-9 has vhl-1–independent effects on 
the regulation of ftn-1. As mentioned in the chapter introduction, a recent publication 
found that egl-9 can have effects on gene expression that are independent of vhl-1 
 201 
(Shao et al., 2009). The authors were able to demonstrate that the induction of hif-1–
target genes can occur even when hif-1 is constitutively stabilised by a mutation in 
P621 (P621G). Moreover, neither mutations in vhl-1 nor the inhibition of EGL-9 
hydroxylase activity increases hif-1 target gene expression to the extent that strong 
loss-of-function alleles of egl-9 can. Further support for a dual role of EGL-9 in the 
regulation of hif-1 target genes comes from their use of an egl-9 transgene in which 
hydroxylase activity is abolished through a mutation in the Fe(II) binding pocket. 
While the mutated transgene is incapable of destabilising HIF-1, it is still able to 
strongly reduce expression of a hif-1 target gene, thus demonstrating that the vhl-1–
independent alternative pathway by which egl-9 regulates the expression of hif-1 
target genes does not require hydroxylase activity.  
If the same vhl-1–independent pathway of HIF-1 target gene regulation by 
EGL-9 is in fact responsible for the differing effects of egl-9 and vhl-1 RNAi on 
expression from my transgene, then the fact that it does not require hydroxylase 
activity is also of great interest since it is the hydroxylation reaction of hif-1 that 
requires iron.  
If the effects of egl-9 RNAi on ftn-1 expression can be verified, a 
hypothetical model could be proposed in which EGL-9 can both promote and repress 
expression of ftn-1. In this model, EGL-9 promotes the expression of ftn-1 through 
the VHL-1–dependent degradation of HIF-I, which acts as a repressor of ftn-1 
expression. This degradation presumably occurs at different rates depending on the 
concentration of iron present. By a second mechanism, EGL-9 can also repress ftn-1 
expression and interestingly, this alternative pathway also requires HIF-1. The hif-1–
dependence of the effects of egl-9 RNAi on Pftn-1::gfp expression has already been 
shown (see Figure 59).  
 
 
Figure 65 
 EGL-9 may regulate ftn-1 by two separate pathways.   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While the existence of an alternative pathway by which egl-9 regulates gene 
expression may help explain how RNAi of vhl-1 and egl-9 could have different 
effects on gene regulation, it should be noted that Shao et al. do not report that the 
vhl-1-dependent and –independent pathways have opposite effects on gene 
expression. The two genes used in their publication as hif-1–target genes are both 
induced by hif-1 and the activities of both vhl-1 and egl-9 act to reduce their 
expression. Clearly, the involvement of EGL-9 in the regulation of Pftn-1::gfp is 
more complex than expected.  
 
5.3.4. Further steps  
 Because both hypoxia signalling and IIS have such dramatic effects on ftn-1 
expression and these two pathways are thought to interact in some cases (see Chapter 
Introduction), it could be important to test whether ftn-1 just happens to be a 
common target or whether their joint regulation of ftn-1 is evidence of a specific 
interaction between these two pathways. I have proposed several models of 
regulation and some of these could be directly tested. I was already able to exclude a 
scenario according to model A, in which the regulation ftn-1 by hypoxia signalling is 
the consequence of increased activation of DAF-16. Alternatively, HIF-1 could be 
acting downstream of DAF-2 to repress ftn-1 expression, either downstream of DAF-
16 (Model C) or in parallel (Model D). Model D seems unlikely given the absolute 
requirement for DAF-16 in IIS regulation of ftn-1, but model C is possible and has 
been proposed as a possible explanation for effects of IIS on HIF-1 mediated axon-
guidance defects in C. elegans neurons (Pocock and Hobert, 2008). If IIS–mediated 
regulation of ftn-1 does occur through hif-1, then reduced IIS should not have an 
effect on Pftn-1::gfp expression hif-1(ia4) mutants. This could be tested using daf-2 
RNAi on the Pftn-1::gfp hif-1(ia4) line. If no induction of GFP expression occurs 
when IIS is reduced, or if the magnitude of the effect is less than in hif-1(+) animals, 
then IIS may be acting through HIF-1 to regulate ftn-1. If the induction is similar in 
both backgrounds, then this would strongly support model B, in which the regulation 
of ftn-1 by IIS and hypoxia signalling occurs independently.   
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The strong effects of hif-1 and aha-1 on the regulation of ftn-1 are clear, that 
this occurs through direct binding remains uncertain. My interest in hif-1 and aha-1 
was partly motivated by the fact that Romney et al. had identified three direct repeat 
(DR) sequences in the IDE of the ftn-1 promoter that resembled an E-box motif, 
leading them to the hypothesis that the iron-dependent transcription factor regulating 
ftn-1 is likely to be a bHLH factor. Indeed my experiments on the regulation of the 
IDE demonstrate that the effects of hif-1 on ftn-1 expression do occur through these 
63bp. That they act through the three DR sequences within the IDE seems likely, but 
needs to be tested further. This could be examined by crossing the IDE(123m)::pes-
10::gfp line created by Romney et al, which has mutations in each of the three DR 
sequences, into a hif-1(ia4) background. Since loss of hif-1 leads to an induction of 
IDE::pes-10::gfp (see Figure 55), demonstrating that this does not occur when the 
DR sequences have been mutated would show that hif-1 is repressing expression 
from the IDE via the DR sequences.  
HIF-1 and AHA-1 are two bHLH transcription factors that regulate ftn-1 
transgenes via a 63bp sequence that contains three sequences very similar to the E-
box sequence. While this suggests that ftn-1 might be directly repressed by the 
binding of the HIF-1/AHA-1 dimer, none of the work described in this chapter was 
designed to demonstrate direct binding. I did try to express the HIF-1 and AHA-1 
proteins in vitro in order to test binding to the IDE using an electrophoretic mobility 
shift assay. However, my attempts to express the HIF-1 protein were unsuccessful 
(data not shown). In their publication on the effects of HIF-1 on lifespan, Zhang et al. 
describe a HIF-1::Myc-expressing transgene used to over-express HIF-1. I 
successfully used this strain to confirm the efficacy of hif-1 RNAi (see Figure 50). 
Since, like mutations in vhl-1, this transgene is capable of extending lifespan, the 
HIF-1::Myc protein appears to be functional. This was confirmed to me by the 
authors, who found that the transgene was able to rescue hif-1 mutant phenotypes 
(Jo-Anne Powell-Coffman, personal communication).  Anti-Myc antibodies could 
therefore be used to perform chromatin immuno-precipitation followed by qRT-PCR 
to test whether the HIF-1/AHA-1 dimer is binding the ftn-1 promoter. The assay 
could be performed using worms expressing low levels of HIF-1::Myc and 
comparing them to ones in which HIF-1::Myc was stabilised, for example by 
mutation of vhl-1. 
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That loss of egl-9 leads to an increase rather than a decrease in Pftn-1::gfp 
expression indicates that a vhl-1–independent pathway may be regulating ftn-1 
antagonistically to the vhl-1–dependent pathway (see Figure 65). It would be 
fascinating to investigate the nature of this hypothetical second pathway using the 
reagents created by the Powell-Coffman group. Whether or not the effect of iron on 
Pftn-1::gfp expression requires EGL-9 hydroxylase activity could be investigated 
using the transgene expressing hydroxylase–deficient EGL-9. A HIF-1(P621G)::Myc 
transgene (Zhang et al., 2009) could also be used.. In hif-1(P621G)::myc hif-1(ia4) 
animals, all HIF-1 would be expressed from the transgene and would therefore not be 
susceptible to EGL-9 hydroxylation. If ftn-1 levels are still responsive to iron, then 
this would be strong evidence for a role of the vhl-1 independent pathway in iron-
dependent ftn-1 regulation. If not, then it is possible that the ftn-1 induction by iron 
occurs solely through vhl-1–dependent pathway and the vhl-1–independent pathway 
may serve to respond to different cues.  
 
5.3.5. Concluding remarks 
 
During my PhD research, I investigated the regulation of ftn-1 by means of an 
RNAi screen. The aim was to identify transcription factors that act downstream of 
DAF-16 to regulate the differential gene expression of IIS mutants and ultimately to 
identify novel genes that may play a role in the longevity of IIS mutants.  
While RNAi of many genes affected regulation of a Pftn-1::gfp transgene, the 
screen was less successful in identifying novel mediators of IIS longevity, since the 
effects of hsf-1, hif-1 and even mdl-1 on ageing  had already been described. 
However, little is known about the function of mdl-1 in C. elegans and none of its 
target genes have been identified. Its involvement in the regulation of ftn-1 may help 
identify other targets and further test its role downstream of DAF-16. mdl-1 therefore   
remains interesting and is being pursued further.  
Rather than identifying novel genes, the screen was successful in defining a 
complex gene regulatory network controlling ftn-1, which shows integration of IIS, 
hsf-1 and hif-1 pathways. The identification of hif-1 as an important regulator of ftn-1 
expression is especially interesting given that HIF-1 levels are modulated by iron. I 
was subsequently able to show that that the regulation of a Pftn-1::gfp transgene by 
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iron requires hif-1. This work will hopefully be useful to other researchers interested 
in how iron homeostasis in maintained and to those investigating hypoxia signalling. 
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Chapter 6: Investigating the role of superoxide 
dismutases in determining C. elegans lifespan 
6.1. Chapter Introduction  
During the course of my PhD studies at the Gems lab, other laboratory 
members had been working on investigating the role of reactive oxygen species 
(ROS) in ageing in C. elegans. This is a subject that greatly interested me, despite 
being far removed from my own research into the regulatory architecture 
downstream of IIS. During the course of one of my colleague’s research, he 
uncovered evidence for an atypical activation of DAF-16, which seemed to be the 
consequence of alterations in the levels of reactive oxygen species (ROS). I decided 
to get involved in this project as it allowed me to study the role of oxidative stress in 
ageing within the context of my previous work on the role of DAF-16 and IIS in C. 
elegans ageing.  
  Oxidative stress has long been thought to play a role in determining the rate 
of ageing (Harman, 1956). The theory proposes that ageing is caused by exposure to 
ROS, which leads to the oxidation of macromolecules and eventual loss of cellular 
function. This links ageing to mitochondrial metabolism, since superoxide (O2-) 
production by the electron transport chain is the greatest source of ROS in cells 
(Brand, 2000). Mitochondria produce O2- by electron leakage from bisemiquinone 
(QH
.
) or from other electron carriers in the ETC. The oxidative stress theory has 
been popular in the ageing field partly because it provides a mechanism with which 
to explain how different species achieve different lifespans, since differences in their 
metabolic rates could cause differences in O2- formation. The underlying idea that 
animals with fast metabolism live shorter than those with a slower one is also 
prevalent (the so-called “rate of living” theory). These theories seem consistent: 
selection of different metabolic rates in different organisms leads to different rates of 
O2- production and therefore, different rates of ageing (Gems, 2009; Sohal and 
Weindruch, 1996).  However, this long-held view of a direct relationship between 
metabolic rate and ROS production is now seen as naïve, given the extent to which 
these phenomena are uncoupled (Brand, 2000). Whether differences in metabolic 
rate control lifespan or not, the theory that ageing is caused by oxidative stress from 
 207 
ROS is widespread but also highly controversial in the field of ageing research.  
Some of the work on the relationship between oxidative damage and ageing will 
therefore be briefly reviewed.  
In general, three different types of investigations can be carried out on this 
subject. The first is to identify a simple correlation: Do older animals have more 
damage? The second approach is to ask whether interventions that extend lifespan 
also protect against damage. Last, one can attempt to ask whether interventions that 
specifically alter the levels of oxidative stress also affect lifespan. This last approach 
is the most effective at testing causality. I will briefly review the work done using 
these three approaches before proceeding to describe my contribution to this project.   
6.1.1. Does oxidative damage increase with age? 
 
If the oxidative stress theory of ageing is true and ageing really is the 
consequence of an accumulation of damage caused by the presence of ROS, then 
clearly one should be able to detect higher levels of damage in older animals 
compared to younger ones. Much work has therefore gone into testing for an increase 
in damage with age. As discussed in Chapter 1, not all damage is caused by oxidation 
(eg. see glycation), but this chapter will focus on oxidative damage. While looking 
for increases in oxidative damage with old age can only yield correlative data, this 
approach seems like a good place to start testing the oxidative stress theory of 
ageing: Do older animals actually have higher levels of damage? This has been 
addressed by looking for changes in the levels of damage to lipids, proteins and 
DNA.  
Lipid peroxidation has been studied because the polyunsaturated fatty acid 
component of the phospholipids in membranes are thought to be particularly 
sensitive to attack by ROS (Bokov et al., 2004). A number of studies (Sohal and 
Weindruch, 1996) have found that older animals seem to have higher levels of lipid 
peroxidation than young animals. For example, a study on levels of F2-isoprostanes, 
a product of free radical attack on membranes, in young and old rats, found 
substantial increases with age (Roberts and Reckelhoff, 2001).  
Proteins can also be damaged by ROS, both irreversibly (eg. by the formation 
of carbonyl derivatives) as well as reversibly (eg. the formation of methionine 
sulfoxide). The most widely studied alteration is the formation of carbonyl groups in 
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amino acids, which can be measured using antibodies in a western blot. Increases in 
protein carbonyl levels with age have been detected in specific proteins as well as in 
the total protein content of animals (Bokov et al., 2004). This includes samples from 
human fibroblast cell lines derived from individuals of different ages (Oliver et al., 
1987), from rat livers (Starke-Reed and Oliver, 1989), aged fly mitochondria (Sohal 
and Dubey, 1994) and the skeletal muscle of rhesus monkeys (Zainal et al., 2000). 
Age increases in protein carbonyl levels have also been detected in worms (Adachi et 
al., 1998). 
Damage to DNA by ROS is often measured by quantifying the by-product 8-
oxo-2-deoxyguanosine (oxo8dG), which can be accurately and sensitively quantified 
using high-performance liquid chromatography (HPLC). Both nuclear and 
mitochondrial DNA has been found to contain more oxo8dG in old compared to 
young rats (Fraga et al., 1990), though contradictory findings have also been 
published (Anson et al., 1999). One confounding factor is that phenol (used in DNA 
extraction) can cause DNA oxidation during extraction (Hamilton et al., 2001a), so 
more recent publications often use alternative reagents. One such study, for example 
found large increases in oxo8dG levels with age in various rat tissues when NaI was 
used instead of phenol for DNA extraction procedures (Hamilton et al., 2001b)  
The prediction that older animals should show increases in damage has 
therefore in general been found to be true. But the question remains: Is this damage 
the cause of ageing or is it merely correlated with age?  
 
6.1.2. Do manipulations that extend lifespan also protect against 
oxidative stress? 
 
There are several interventions known to extend lifespan in lower organisms. 
These include dietary/caloric restriction and genetic interventions that cause 
reductions in IIS. It is possible that these interventions lower the rate of accumulation 
of oxidative damage, thereby slowing down ageing. This prediction has been tested 
in a variety of systems.  
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6.1.2.1. CR in rodents 
 
Many studies have found that rodents fed under a caloric restriction (CR) 
regimen that extends lifespan also have reduced levels of lipid, protein and DNA 
damage (Bokov et al., 2004). One study found that CR led to increased levels of 
antioxidant enzymes in most tissues, but decreased levels in others (Xia et al., 1995). 
CR may also protect against damage by decreasing the generation of ROS. Indeed, 
mitochondria isolated from hearts and livers of CR –treated rats generated less ROS 
than from normally fed (Gredilla et al., 2001). In short, there is evidence that CR 
treatment in rodents may lead to decreased levels of damage, which is possibly due 
to decrease generation of ROS in older, CR –treated animals, and is therefore at least 
consistent with the oxidative stress theory of ageing. 
 
6.1.2.2. IIS mutations in C. elegans  
Mutations affecting IIS extend the lifespan of C. elegans (see Chapter I). IIS 
and other long-lived mutants are resistant to a number of different stresses, including 
heat, UV-irradiation, and ROS (Johnson et al., 2002). This has been taken as 
evidence that oxidative stress resistance itself extends lifespan, presumably because 
the increased antioxidant defenses that cause this resistance would also reduce the 
oxidative damage that causes ageing (Bokov et al., 2004). daf-2 mutants have 
elevated expression levels of a number of cytoprotective genes (McElwee et al., 
2004; Murphy et al., 2003), including the MnSOD sod-3 (Honda and Honda, 1999; 
Vanfleteren and De Vreese, 1995). Of course the fact that long-lived worms have 
increased levels of antioxidant enzymes does not demonstrate a causative 
relationship. Given the very large number of genes thought to be up-regulated in daf-
2 mutants, searching for genes with a specific function from the list of up-regulated 
ones is likely to lead to confirmation of existing theories and represents a weak 
approach to hypothesis testing (see Chapter 1).  
IIS mutants of C. elegans have not only been found to express higher levels 
of cytoprotective genes, but have also been found to have decreased levels of 
damage. Along with the expected increases in protein carbonyl damage with age, one 
study (Adachi et al., 1998) found lower levels of protein carbonyls in age-1 mutants 
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compared to wild-type controls. The same group reported similar results in other 
publications (Yanase et al., 2002; Yasuda et al., 1999). Because of the C. elegans 
research community’s history of using this organism mostly as a genetic model, 
biochemical techniques have not been widely used in worms. If C. elegans is to be 
effectively used to study oxidative stress and damage, more sophisticated 
measurements of how the interventions being used affect ROS and damage levels 
may be required. Of course, oxidative damage to proteins can be identified by 
western blotting and recently, expression of a transgenic H2O2 –sensitive fluorescent 
protein has been used to detect intracellular oxidative stress in vivo (Back and 
Vanfleteren, 2010 -unpublished). Hopefully these, and other similar techniques, will 
make C. elegans a more effective model for the study of molecular damage in the 
future. 
 
6.1.2.3. Drosophila melanogaster  
Mutations in IIS genes also extend lifespan in fruit-flies (see Chapter I). Like 
C. elegans IIS mutants, chico flies have increased SOD activity and females are 
slightly resistant to oxidative stress (Clancy et al., 2001). 
Several interesting selection–based experiments were carried out in 
Drosophila that indirectly address the question of whether ageing is caused by 
oxidative stress. Long term selection for late life reproductivity led to the creation of 
several long-lived lines with elevated antioxidant activity (Arking et al., 2000). 
Selection based on paraquat resistance also led to strains of flies that are long-lived 
(Vettraino et al., 2001). In another experiment, flies selected for their resistance to 
starvation were found to have gained resistance against oxidative stress, but none of 
them showed an increase in lifespan (Harshman et al., 1999). These studies support 
the idea that there is a strong link between oxidative stress resistance and longevity, 
but also suggest that stress resistance alone is not sufficient to extended lifespan.   
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6.1.2.4. Mouse 
 
Effects of altered insulin/IGF-1 signalling on the regulation of anti-oxidant 
genes have also been found in mice. Ames dwarf mice (see Chapter 1), which are 
long-lived and have reduced IGF-1 levels (Bartke et al., 2001a; Bartke et al., 2001b; 
Flurkey et al., 2001), have increased levels of catalase (Brown-Borg and Rakoczy, 
2000) and superoxide dismutase (Hauck and Bartke, 2000) and also show lower 
levels of protein oxidation (Brown-Borg et al., 2001). Embryonic fibroblast cells 
derived from long-lived Snell dwarf mice (see Chapter I) were also found to be 
resistant to a number of stressors (Murakami et al., 2003). Female mice heterozygous 
for a mutation in the IGF-I receptor were also shown to be long-lived and were also 
resistant to paraquat toxicity (Holzenberger et al., 2003). Embryonic fibroblast cells 
from these animals were also more resistant to hydrogen peroxide than controls. As 
in Drosophila and C. elegans, mice with alterations in IGF-1 signalling seem to be 
both long-lived and protected against oxidative stress. 
 
6.1.3. Do induced alterations in ROS levels lead to changes in lifespan?  
In summary, evidence from several model organisms supports the view that 
long-lived animals have increased protection against oxidative stress. But does the 
protection against stress cause the lifespan extension? The data discussed so far 
mainly serves to answer two questions: Do animals have higher levels of oxidative 
damage at old age than in their youth? and: Do interventions that extend lifespan also 
lead to reduced damage from oxidative stress? On both counts the evidence is 
generally consistent with the oxidative damage theory of ageing. However, the 
interpretation of this data is complicated by findings that show that in humans, a 
number of pathologies themselves cause increased oxidative damage (Halliwell and 
Gutteridge, 1989). Two different explanations for the correlation between oxidative 
damage and age could therefore be proposed: oxidative stress itself could be the 
ultimate cause of ageing, or ageing could cause a higher incidence of pathologies that 
lead to oxidative damage.   
An example that could support the latter view is the finding that damaged 
mitochondria produce more ROS than healthy ones (Droge and Schipper, 2007). One 
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may imagine a scenario in which ageing causes a deterioration of mitochondrial 
health, possibly through the failure of cellular repair processes that ensure 
mitochondrial maintenance. This could therefore cause an increase in ROS formation 
and consequently an increase in cellular damage with age, without any causal link 
between this damage and the ageing process. In this scenario, any intervention that 
delays ageing would also be expected to reduce ROS at any age, simply because it is 
ageing that is causing increased mitochondrial damage. Slower ageing would 
therefore delay the occurrence of this damage and reduce the increase in ROS and 
oxidative damage. This criticism applies to all interventions shown to reduce 
oxidative damage, including mutations in IIS and caloric restriction: If they delay 
ageing and it is ageing-related pathologies that are causing increased oxidative stress, 
then the fact that these interventions extend lifespan as well as reduce oxidative 
stress is uninformative.  
A similar scenario may be applied to the long-lived animal model mutants, 
which are resistant to oxidative stress, presumably through the up-regulation of a 
number of cytoprotective genes such as superoxide dismutases and catalases. This 
link might also be coincidental. C. elegans, for example, is capable of forming an 
alternate developmental stage, termed the ‘dauer’ larva, under conditions of high 
stress, starvation, or high population density. Dauers are very long-lived (Klass and 
Hirsh, 1976) and very resistant to a number of different stresses (Cassada and 
Russell, 1975). The same IIS pathway that regulates ageing also regulates entry to 
the dauer stage and most of the genes involved in the ageing- phenotype are also 
involved in dauer formation. In fact, many of the genes known to be involved in the 
IIS pathway were first discovered due to their role in dauer formation (the daf- prefix 
of many of these genes refers to genes that when mutated cause worms to have 
abnormal dauer formation). This is also true for daf-16, the transcription factor 
required for lifespan extension by reduced IIS. daf-16 mutant animals are also 
incapable of forming dauers, implying that it is involved in the regulation of genes 
involved in dauer formation. In fact, microarray analyses reveal large overlaps 
between transcriptional changes of IIS mutant worms and dauers (McElwee et al., 
2004).  
It seems possible that the longevity of IIS mutants reflects the misexpression 
of a dauer longevity program regulated by daf-16. If DAF-16 is regulating genes 
important in dauer animals, stress–response genes could be up-regulated by DAF-16 
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simply because of the role of dauer larvae in ensuring survival until conditions 
become more favourable for reproduction. A long lifespan is useful for dauers for 
similar reasons: the animals must survive for however long it takes for the adverse 
conditions to pass. If regulatory programs producing both these dauer traits are being 
regulated by DAF-16, then the fact that IIS mutants are both long-lived and protected 
against ROS would be no surprise, since both traits might be independent 
requirements of dauer larva. While this is also a hypothetical scenario, it too serves 
to illustrate the problems with drawing conclusion from what may merely be the co-
occurrence of two traits.  
A better approach to testing the oxidative stress theory of ageing would be to 
test whether specific interventions that decrease the levels of ROS in organisms lead 
to lifespan extensions. A number of different approaches have been used in several 
different organisms and these will be summarised in the next section.   
6.1.4. Testing the oxidative stress theory of ageing via interventions into 
ROS levels  
The most direct approach to testing the oxidative stress theory of ageing is to 
directly influence the levels of ROS and to test the effects of these alterations on 
lifespan. Based on the theory, one should be able to make straightforward 
predictions: increases in the levels of ROS should exacerbate the damage caused by 
physiological ROS levels and therefore accelerate ageing. Decreasing levels of ROS 
would be expected to extend lifespan, since the same levels of damage that cause 
normal ageing would now be occurring at a later time-point.  
 
6.1.4.1. Non-genetic interventions in C. elegans  
One of the ways in which the levels of ROS formation can be altered is by 
increasing the concentration of ambient oxygen from 21% to 60%, which shortens C. 
elegans lifespan, or decreasing it to 1%-2%, which lengthens it slightly (Adachi et 
al., 1998; Honda et al., 1993). Similarly, a number of pro-oxidant compounds have 
been found to shorten lifespan, including H2O2 (Larsen, 1993), arsenite (Olahova et 
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al., 2008), tert-butylhydroperoxide (An and Blackwell, 2003), paraquat and juglone  
(Van Raamsdonk and Hekimi, 2009; Vanfleteren, 1993). These findings are 
consistent with the theory, but inconclusive, since many bioactive compounds could 
be found to be toxic at some concentration. 
The addition of antioxidant compounds represents the opposite approach. The 
oxidative stress theory of ageing implies that the addition of compounds that mop up 
oxidants to reduce the damage caused by ROS should thereby extend lifespan. 
Studies using antioxidants have yielded contradictory results. Some antioxidants, like 
N-acetylcysteine and vitamin C, had no effect on lifespan (Harrington and Harley, 
1988; Schulz et al., 2007), while others, like α-lipoic acid (Benedetti et al., 2008) and 
a mixture of tocotrienols (Adachi and Ishii, 2000), did. Other antioxidant compounds 
increased lifespan in some studies but not others (Gems and Doonan, 2009).  
The effects of the SOD mimetics EUK-8 and EUK-134, which catalyze the 
removal of O2-, on C. elegans lifespan have have also been tested (Gems and 
Doonan, 2009). It has been found, for example, that 2mM paraquat shortens lifespan 
and generates O2- and that certain concentrations of EUK-8 can rescue this shortened 
lifespan. These same concentrations of EUK-8 however, are not capable of extending 
lifespan in the absence of paraquat. This strongly suggests that O2- levels do not 
usually limit worm lifespan (Keaney et al., 2004). Treatment with higher doses of 
SOD mimetics actually shortens C. elegans lifespan and EUK-8 has also been shown 
to cause increases in oxidative damage in E. coli (Gems and Doonan, 2009). It is 
possible that strongly increased SOD activity actually increases overall ROS by 
increasing levels of H2O2 (Buettner et al., 2006). This further complicates the 
interpretation of this type of study.  
The central problem with this approach is the uncertainty concerning the in 
vivo efficacy of interventions, such as the addition of antioxidant compounds or the 
over-expression of antioxidant enzymes, in actually reducing the levels of ROS. 
Improved methods that allow for a better characterisaton of the efficacy of 
compounds in reducing ROS levels or damage from ROS, would help advance this 
direction of research. Recent work using a fluorescent H2O2-sensitive reporter to 
measure in vivo ROS levels is a promising step in this direction (Back and 
Vanfleteren, 2010 -unpublished).    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6.1.4.2. Loss of antioxidant genes 
 
Two genes code for Mn-SOD in C. elegans: sod-2 and sod-3, which are 
thought to be expressed in the mitochondrial matrix (Doonan et al., 2008). 
Simultaneous deletion of both increases levels of protein oxidation and severely 
sensitises worms to oxidative stress (Doonan et al., 2008; Honda et al., 2008; Van 
Raamsdonk and Hekimi, 2009; Yen et al., 2009) confirming that the deletions lead to 
weakened antioxidant defences. This complete loss of Mn-SOD does not reduce 
lifespan, strongly implying that whatever damage is caused in the mitochondrial 
matrix by the O2- radical does not contribute to ageing. 
The loss of sod-1, the main Cu/Zn SOD, present in the cytosol and 
intermembrane space, leads to only a small reduction in lifespan in some studies and 
none at all in others (Doonan et al., 2008; Van Raamsdonk and Hekimi, 2009; Yang 
et al., 2007). Simultaneous deletion of both intracellular Cu/Zn SOD genes has no 
additional effect on lifespan and deletion of the extracellular Cu/Zn SOD gene sod-4 
also did not reduce lifespan (Doonan et al., 2008; Honda et al., 2008; Van 
Raamsdonk and Hekimi, 2009; Yen et al., 2009). 
It has been suggested that the longevity phenotype of IIS mutant worms is 
attributable to increased expression of SOD enzymes (Larsen, 1993; Vanfleteren, 
1993; Vanfleteren and De Vreese, 1995). Loss of the main Cu/Zn SOD sod-1 leads 
to a small reduction in daf-2 longevity as in wild-type (Doonan et al., 2008; Yang et 
al., 2007) and loss of the other Cu/Zn SOD sod-5 also had little effect (Doonan et al., 
2008). Loss of the main Mn-SOD sod-2 has been found to have either no effect in 
some studies (Doonan et al., 2008; Van Raamsdonk and Hekimi, 2009) or a very 
small effect in another (Honda et al., 2008). Deletion of sod-3 led to no reduction in 
daf-2 mutant lifespan in two studies (Doonan et al., 2008; Honda et al., 2008). There 
is therefore evidence for at most a small role of reductions in cytosolic O2- in the 
longevity of IIS mutants, but this can by no means explain the large lifespan 
extension seen in these mutants. Similar findings with dietary restricted worms 
suggest that this lifespan extension is also not due to reduced levels of O2- levels 
(Yen et al., 2009). 
The H2O2 produced by SOD from O2- is removed by both catalases and 
peroxiredoxins. Deletion of the peroxisomal catalase ctl-2 or of the peroxiredoxin 
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prdx-2 shortens lifespan (Olahova et al., 2008). However, in ctl-2 mutants, it is 
unclear whether or not the shortened lifespan is due to increased levels of damage, as 
protein carbonyl levels were found to be lower in old ctl-2 mutant animals than in 
controls (Petriv and Rachubinski, 2004).  
6.1.5. Over-expression of Cu/Zn SOD in C. elegans 
 
The discovery that over-expression of sod-1, the main C. elegans Cu/Zn 
SOD, modestly extends lifespan (Doonan et al., 2008) provided an opportunity to test 
the role oxidative stress in ageing. The fact that deletion of sod-1 slightly reduces 
lifespan and over-expression extends it would argue for at least a small role of 
cytosolic O2- toxicity in limiting the lifespan of C. elegans. This would support a 
model under which oxidative stress from respiration is one of many sources of 
damage that ultimately cause ageing.  
However, an additional unpublished observation by my colleague (Ryan 
Doonan) led to an alternative hypothesis. In two preliminary trials, Ryan found that 
the lifespan extension by sod-1 over-expression was dependent on the transcription 
factor daf-16. This is not consistent with the oxidative stress theory of ageing, as one 
would not expect the lifespan extension via reduced O2- toxicity to be dependent on 
genetic background. Of course, daf-16 is responsible for the lifespan extension by 
reductions in IIS, which implies that the lifespan extension seen in sod-1 over-
expressing animals may similarly be due to the induction of a daf-16–dependent 
longevity program.  
The role of DAF-16 in protection against H2O2, the ability of exposure to 
H2O2 to induce the nuclear localisation of DAF-16 (Weinkove et al., 2006) and the 
role of SOD enzymes in the dismutation of O2- into H2O2 suggested the hypothesis 
that over-expression of sod-1 leads to an overproduction of H2O2, which activates 
DAF-16 and extends lifespan via mechanisms similar to those found in IIS mutants. 
While a lifespan extension by exposure to a stressor may sound paradoxical, there is 
a precedent for this type of effect, hormesis.  This occurs when exposure to sub-
lethal levels of stress induces a stress response, thereby protecting against a later 
exposure to an otherwise lethal stress. Interestingly, hormetic doses of stress can 
increase lifespan in C. elegans. 
 217 
6.1.6. Hormesis and ageing in C. elegans  
While several definitions of hormesis exist, the one that will be used here is 
that of “stress-response hormesis” (Gems and Partridge, 2008) which describes a 
beneficial response to an exposure to sub-lethal levels of a stressor. Examples are 
plentiful across a number of different biological systems (Calabrese and Baldwin, 
1999; Le Bourg and Minois, 1997; Yanase et al., 1999). The ageing field’s interest in 
this phenomenon lies in the fact that alongside the commonly observed resistance 
against the original stressor, hormetic responses can also extend lifespan in model 
organisms. In worms, exposure to short periods of thermal stress (Lithgow et al., 
1995) and 100% oxygen (Cypser and Johnson, 2002) lead to extensions in lifespan. 
This response to hormetic stress is commonly interpreted as being due to an up-
regulation of cytoprotective genes. It is thought that the consequently higher levels of 
cytoprotective proteins lead to an extended lifespan once animals are returned to the 
standard maintenance conditions.  
A possible example could be the finding that after a brief hormetic heat-
shock, stochastic variability in expression of the heat-stress responsive chaperone 
gene hsp-16.2 is a predictor of lifespan (Rea et al., 2005). This suggests that genes 
co-regulated with hsp-16.2 are likely to be responsible for the lifespan extension 
found in heat-shocked animals. Although no further attempt was made to identify the 
effectors of the lifespan extension, hsp-16.2 is known to be regulated by hsf-1, which 
is itself known to be required for lifespan extension by reduced IIS (Hsu et al., 2003) 
and is also known to regulate other chaperones (see Chapter I). The correlation of 
hsp-16.2 expression with lifespan after hormetic heat stress and the known 
involvement of hsf-1 in the regulation of hsp-16.2 suggests that the cytoprotective 
genes regulated by hsf-1 have a role in the extended lifespan after heat stress.  
Not much research has been carried out to further understand the mechanisms 
by which hormesis extends lifespan. One such experiment did find that lifespan  
extension by hormesis requires several genes which are also required for dauer 
formation, including daf-16 (Cypser and Johnson, 2003). This suggests that the 
mechanisms of lifespan extension are the same in worms subjected to a hormetic 
stress as in worms with reduced IIS and supports our hypothesis concerning the 
longevity of sod-1. 
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6.1.7. Can elevated levels of SOD lead to in vivo increases in H2O2? 
 
Since DAF-16 is known to be both required for protection against H2O2 
(Weinkove et al., 2006), a simple explanation for our observations could be that 
increases in SOD-1 levels are increasing intracellular H2O2, thereby activating DAF-
16. The idea that higher levels of SOD would increase H2O2 levels may seem 
intuitive since the enzyme catalyses a reaction that produces H2O2. However, this 
assertion is highly controversial (Buettner et al., 2006; Liochev and Fridovich, 2007) 
since the traditional view is that higher levels of SOD should have either no effect on 
H2O2 levels or even decrease them. This is based on the fact that O2 − can lead to the 
creation of H2O2 by several different routes (Buettner et al., 2006):  
 
Case 1: This is the dismutation reaction of O2 −, which can occur spontaneously or 
can be catalysed by SOD at a faster rate. This reaction leads to the creation of one 
H2O2 for every two O2 −.  
 
Case 2: This is the reaction of O2 − with electron donors 
 
O2 – + donor-H + H+  H2O2 + donor  
In this case, 1 H2O2 is produced for every O2 −.  
 
Case 3: Participation of O2 − in chain reactions that produce more than one H2O2. 
There are several examples of this scenario, one of which is the oxidation of 6-
hydroxydopamine (6-OHDA) to its semiquinone (SQ −) and quinone (Q) described in 
Buettner et al. (2006): 
 
6-OHDA+Fe3+→SQ –+Fe2+ (Initiation) 
SQ – + O2→ Q + O2 – (Superoxide formation) 
6-OHDA + O2 – → SQ – + H2O2 (Chain propagation) 
SQ – + O2 – + 2H+ → Q + H2O2 (Chain termination) 
2SQ – + 2H+ → 6-OHDA + Q (Chain termination) 
O2 – + O2 – + 2H+ → O2 + H2O2 (Termination) 
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The prediction that increased levels of SOD should decrease levels of H2O2 is based 
on the fact that the dismutation reaction (Case 1) leads to the least amount of H2O2 
being formed. Increasing levels of SOD would increase the rate of the dismutation 
reaction, thereby allowing Case 1 to outcompete Cases 2 and 3. It would therefore 
follow that increased levels of SOD would decrease the amount of H2O2 generated.  
Assertions to the opposite rest on the possibility that alterations in [SOD] 
affects the  reaction that creates O2 − by oxidation of the semiquinone of CoQ (CoQ − 
+ O2  CoQ + O2−) in the electron transport chain. This reaction creates O2 −, but is 
constantly occurring as both a forward and back reaction. Increased removal O2 − by 
dismutation to H2O2 would therefore lead to a replacement of a reaction removing O2
− without creating H2O2 (the back reaction) for a reaction that does create H2O2 (the 
dismutation reaction), thus increasing H2O2 levels. Whether or not this would indeed 
lead to increased formation of H2O2 is a controversial issue in the field (Buettner et 
al., 2006; Liochev and Fridovich, 2007). In practice, while it has been shown that 
increased levels of SOD leads to increased levels of H2O2 in some systems (Buettner 
et al., 2006; Scott et al., 1987), the opposite result has also been found (Teixeira et 
al., 1998). 
 
6.1.8. Aims of this study 
 
At the point at which I joined this project, it was already known that over-
expression of sod-1 extended lifespan and there were strong indications that the same 
was true for sod-2. Several preliminary trials had also demonstrated that the sod-1 
lifespan effect was dependent on daf-16. My role in this project was to confirm that 
the sod-1 lifespan effects are daf-16 dependent and to test whether they require hsf-1 
and aak-2, two other mediators of lifespan and hormesis. Since it is possible that the 
lifespan phenotype of these lines is due to increased H2O2 levels activating DAF-16, I 
also contributed to efforts to test this hypothesis. All data presented here in the form 
of figures and tables was obtained only from my own work. In most cases, my 
colleagues replicated my findings, but their data is only referred to and not presented 
here in any figure or results table.  
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6.2. Results 
6.2.1. Testing dependence on genetic background 
6.2.1.1. Verifying daf-16–dependence of effects of sod-1 over-
expression on lifespan 
 
I first verified whether the effects of sod-1 on lifespan were indeed daf-16 dependent. 
I crossed a line of sod-1 over-expressing animals that carry their sod-1(+) transgene 
in an extra-chromosomal array (wuEx123(sod-1(+)) into a daf-16(mgDf50) mutant 
background in order to independently verify the previous result. Two trials were 
performed, one using the extra-chromosomal wuEx123 daf-16 line I created (see 
Figure 66) and another one using the integrated line (wuIs152 daf-16) tested in 
previous trials (see Figure 67).  
 
 Figure 66 
Testing the effects of sod-1 over-expression on lifespan at 20oC via multi-copy extra-
chromosomal array. Lifespan effects are daf-16 dependent. Several additional trials 
using the same strains were carried out by Ryan Doonan and support the conclusions 
presented here. 
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Figure 67 
Testing the effects of sod-1 over-expression on lifespan at 20oC via an integrated 
multi-copy array. Lifespan effects are daf-16 dependent.  
 
Genotype   n 
 
 
censored 
Mean 
lifespan 
Median 
lifespan 
% Change 
in mean  
[median] 
Log­
Rank  
p­valuea 
Wilcoxon 
p­valuea 
               
rol­6(dm)   117  6  18.3  18       
wuIs152(sod­1(+))   123  2  25.3  23  +38 [+28]  <0.0001  <0.0001 
wuEx123(sod­1(+))   121  0  23.2  22  +27 [+22]  <0.0001  <0.0001 
               
daf­16(mgDf50)   116  1  15.2  16       
wuEx123(sod­1(+)) 
daf­16(mgDf50)   119   15  15.9  16  +5 [+0]   0.0157  0.48 
wuIs152(sod­1(+)) 
daf­16(mgDf50)   92  3  13.9  14  ‐9 [‐13]   <0.0001  <0.0001 
               a calculated by comparing to non‐over‐expressing control strain       
 
Table 13 
This table contains data corresponding to Figure 66 and Figure 67.  
 
The finding that sod-1 over-expression causes a lifespan extension was found 
to be robust, with a slightly greater effect seen in the integrated line. The lifespan 
extension by wuIs152 completely required daf-16, as wuIs152 did not extend lifespan 
in a daf-16(mgDf50) mutant background. In fact a small reduction in lifespan was 
seen. The extra-chromosomal wuEx123 transgene showed a small 5% increase in 
mean lifespan in daf-16 mutants and this change was statistically significant using 
the Log-Rank, but not the Wilcoxon test. The increase in mean lifespan is solely due 
to a significantly longer ‘tail’ in the lifespan curve, so while the mean lifespan was 
slightly higher, the median was unchanged. The magnitude of this increase in mean 
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lifespan is only 5%, much less than the 27% increase seen when daf-16 is present, 
demonstrating that the lifespan extension is at least mostly, and most likely 
completely, dependent on daf-16. The effects of the wuIs152 transgene are 
completely daf-16–dependent.  
This requirement for the transcription factor DAF-16, which mediates stress 
response and longevity programs, suggests that the lifespan extension caused by sod-
1 overexpression does not occur as a consequence of a reduction in oxidative damage 
via the antioxidant activity of SOD-1. An alternative possibility is that sod-1 over-
expression is stressful and extends lifespan via hormesis. As discussed earlier, daf-16 
is required for hormetic effects on lifespan in various contexts. Other pathways have 
also been implicated in hormetic effects on lifespan and I therefore tested their 
involvement in longevity induced by sod-1 over-expression.  
 
6.2.1.2. The hsf-1 transcription factor 
 
I also tested whether the effect of sod-1 over-expression on lifespan was 
dependent on other stress response pathways found to have effects on worm lifespan. 
I tested the hsf-1 transcription factor, which strongly affects lifespan in C. elegans 
(Hsu et al., 2003) and is thought to act together with daf-16 to control a subset of 
genes critical for ageing (see Chapter 3). The fact that expression of an hsp::gfp 
reporter was found to be predictive of future lifespan (Rea et al., 2005) was another 
reason for the inclusion of hsf-1, since heat-shock proteins are known to be regulated 
by this transcription factor.   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Figure 68 
sod-1 over-expression via multi-copy integrated array. Lifespan effects are partially 
dependent on hsf-1. A second trial using the same strains was carried out by Ryan 
Doonan and supports the conclusions presented here. 
 
Genotype   n 
 
 
censored 
Mean 
Lifespan 
Median 
Lifespan 
% Change in 
mean  
[median] 
Log­
Rank p­
valuea 
Wilcoxon 
p­valuea 
               
rol­6(dm)   117  6  18.3  18       
wuIs152(sod­1(+))  123  2  25.3  23  +38 [+28]  <0.0001  <0.0001 
               
               
hsf­1(sy441)  121  0  14.9  16       
wuIs152(sod­1(+)) 
hsf­1(sy441)  122   1  16.8  17  +13 [+6]   <0.0001  <0.0001 
               
               a calculated by comparing to non‐over‐expressing control strain       
 
Table 14 
This table contains data corresponding to Figure 68 
 
In hsf-1 mutant animals wuIs152 transgene extended mean lifespan by 13% and 
median lifespan by 6%, compared to a 38% increase in mean and a 28% increase in 
median lifespan found in hsf-1(+) animals. This indicates that sod-1 over-expression 
partially requires hsf-1, since the increase in mean and median lifespan was greatly 
reduced in its absence.   
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6.2.1.3. AMP-activated protein kinase  
Like hsf-1, AMPK (AMP-activated protein kinase) is required for the lifespan 
extension caused by reduced IIS. Loss of the AMPK α-subunit aak-2 suppresses daf-
2 Age and over-expression of aak-2 also extends lifespan (Apfeld et al., 2004). aak-2 
was also of interest here because of the results of a study of lifespan extension caused 
by glucose restriction in worms. This effect was found when worms are treated with 
2-deoxy-D-glucose (DOG), which blocks glycolysis. The cause of the lifespan 
extension is thought to be increased levels of ROS from the mitochondria, which 
triggers a hormetic response. In this system, the lifespan extension from this 
‘mitohormesis’ was found to require aak-2 (Schulz et al., 2007), which presumably 
acts as a stress sensor and initiates downstream signalling. Given that our hypothesis 
for the mechanisms for lifespan extension in sod-1 over-expressing animals rests on 
a similar premise, I tested for dependence on aak-2 as well.  
 
 
Figure 69 
sod-1 over-expression via multi-copy integrated array. Lifespan effects are not 
dependent, or only very partially dependent, on aak-2. A second trial using the same 
strains was carried out by Ryan Doonan and supports the conclusions presented here.  
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Genotype   n 
 
 
censored 
Mean 
Lifespan 
Median 
Lifespan 
% Change in 
mean  
[median] 
Log­
Rank p­
valuea 
Wilcoxon 
p­valuea 
               
rol­6(dm)  117  6  18.3  18       
wuIs152(sod­1(+))   123  2  25.3  23  +38 [+28]  <0.0001  <0.0001 
               
aak­2(ok524)  119  9  15.9  15       
wuIs152(sod­1(+)) 
aak­2(ok524)   67  41  18.8  20  +18 [+33]  <0.0001  <0.0001 
               a calculated by comparing to non‐over‐expressing control strain       
 
Table 15 
This table contains data corresponding to Figure 69.  
 
The result of this experiment seems to suggest that the effects of sod-1 over-
expression are independent of aak-2, since the increase in median lifespan through 
sod-1 over-expression was not reduced when aak-2 was absent (28% vs 33% 
increase). However, it is clear from the lifespan curves (see Figure 69) that the 
maximum lifespan is much greater in aak-2(+) wuIs152 than in aak-2(-) wuIs152, 
which suggests a possible partial dependence. This would be reflected in the 
extension in mean lifespan, which in fact is much greater in aak-2(+) than in aak-
2(ok524) animals (38% vs 18%). Since the mean lifespan is not considered a reliable 
statistic and the maximum lifespan is highly variable, the 75th percentile, the day at 
which 75% of animals used in this trial had died, can be used instead. Here we also 
see that sod-1 over-expression causes a greater lifespan extension in an aak-2(+) 
than in an aak-2(-) genetic background (45% vs 25%). While these results are 
difficult to interpret with certainty, they suggest that the effects of sod-1 over-
expression are partially dependent on aak-2.  
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6.2.2. Testing the role of H2O2  
This dependence on daf-16 and partial dependence on hsf-1 suggest a 
hormetic cause for the lifespan extension through sod-1 over-expression. We 
wondered whether SOD over-expression was causing an increase in the levels of 
H2O2, which can activate DAF-16 (Weinkove et al., 2006) and could thereby extend 
lifespan. This was tested in sod-1 over-expressing animals through the co-over-
expression of catalase (using a transgene containing copies of ctl-1, ctl-2 and ctl-3), 
which converts H2O2 to water. However, the extent of lifespan extension by sod-1 
over-expression remained similar whether catalase was over-expressed or not 
(Cabreiro et al., 2011 -unpublished; Doonan et al., 2008). This suggests that H2O2  
does not cause the lifespan extension.  
 
6.2.2.1. Can the lifespan extension be suppressed by addition of N-
acetyl cysteine? 
 
In a previous study describing the phenomenon of mito-hormesis, in which 
mitochondrial stress through glucose restriction led to a lifespan extension via and 
aak-2 –dependent mechanism, the anti-oxidant N-acetyl cysteine (NAC) was shown 
to rescue the lifespan effects (Schulz et al., 2007). I therefore tested whether NAC 
could abrogate the lifepan extension seen in our sod-1 over-expressing animals.  
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Figure 70 
The effects of 5mM NAC on the lifespan of wild-type and sod-1 over-expressing 
worms was tested. This concentration of NAC shortened lifespan in both strains, 
suggesting that it is mildly toxic.   
 
Genotype  n 
 
 
censored 
Mean 
Lifespan 
Median 
Lifespan 
% Change in 
mean  
[median] 
Log­Rank 
p­valuea 
Wilcoxon 
p­valuea 
               
rol­6(dm)   117  7  23.5  22       
rol­6(dm) +NAC   93  4  18.9  19  ‐20 [‐14]  <0.0001  <0.0001 
wuIs152(sod­1(+))    88  9  32.3  32       
wuIs152 +NAC   116  1  23.2  23  ‐28 [‐28]  <0.0001  <0.0001 
               a calculated by comparing to non‐over‐expressing control strain       
 
Table 16 
This table contains data corresponding to Figure 70. 
Despite the atypically long lifespan in control worms in this trial (for reasons 
that are unclear), the lifespan extension by sod-1 over-expression was robust 
(p=0.0001 for both statistical tests; lifespan extension +37% [+45%] increase in 
mean [median]). While the NAC did reduce the lifespan of sod-1 over-expressers, it 
also markedly shortened the lifespan of the control animals, suggesting that the NAC 
concentration used was mildly toxic. After consultation with the authors of the 
original publication, I repeated the experiment using 1mM NAC.  
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Figure 71 
The effects of 1mM NAC on the lifespan of wild-type and sod-1 over-expressing 
worms was tested. 1mM NAC does not abrogate the lifespan extension by over-
expression of sod-1   
 
Table 17 
This table contains data corresponding to Figure 71.  
 
1mM NAC treatment also did not abrogate the lifespan extension by sod-1 
over-expression, which is consistent with the result of the catalase over-expression 
studies. Instead, a small increase in lifespan was seen in sod-1 over-expressers, but 
not wild-type animals, treated with NAC. While an elimination of the lifespan 
extension by NAC treatment would have indicated that a mechanism similar to the 
one termed ‘mitohormesis’ might be at play, NAC treatment does not represent a 
direct approach to reducing H2O2 specifically. Instead, NAC is thought to generally 
mimic the ROS-scavanging effect of reduced glutathione (Schulz et al., 2007) and 
may therefore not have been specific enough for this test.   
 
Genotype  n 
 
 
censored 
Mean 
Lifespan 
Median 
Lifespan 
% Change in 
mean  [median] 
Log­Rank 
p­valuea 
Wilcoxon 
p­valuea 
               
rol­6(dm)   79  1  17.9  18       
rol­6(dm) +NAC   83  5  18.9  18    0.1164  0.1582 
wuIs152(sod­
1(+))    105  6  22.4  22       
wuIs152 +NAC   111  2  24.6  24  +10 [+9]  0.0183  0.0077 
               a calculated by comparing to non‐over‐expressing control strain 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6.2.2.2. The effects of catalase co-over-expression on MnSOD over-
expressing lines  
 
Clearly the more direct approach to testing the role of H2O2 in triggering the 
hormetic response is the co-over-expression of catalase, which should reduce the 
possibly elevated H2O2 levels. Using sod-1 over-expressing animals, this intervention 
was not found to eliminate the lifespan extension either (Cabreiro et al., 2011 -
unpublished; Doonan et al., 2008), suggesting that H2O2 is not involved in this 
phenotype of sod-1 over-expression. An alternative explanation is that the levels of 
H2O2 production in this strain are too great to be eliminated by the catalase over-
expressing construct used in these experiments. While one would expect catalase 
over-expression to cause at least a partial elimination of the longevity if H2O2 did 
play a role and this was not observed, it is also possible that H2O2 levels above a 
certain threshold have no additional effect on lifespan. Reductions in H2O2 by 
catalase expression could therefore not cause a change in lifespan if the magnitude of 
the reduction is insufficient.   
Over-expression of the Mn-SOD gene sod-2 also extends lifespan, albeit to a 
lesser extent (Cabreiro et al., 2011 -unpublished). The increase in SOD protein levels 
is less pronounced in the sod-2 over-expressing strains than in the sod-1 strains, so 
the increase in H2O2 production may also be reduced. If catalase over-expression was 
capable of abrogating the lifespan extension in the case of sod-2, then this would 
provide at least some evidence for the role of H2O2 in causing a lifespan extension 
via DAF-16. A small preliminary study by a colleague (Ryan Doonan) had suggested 
that this could be the case. I therefore carried out a lifespan assay to test whether 
catalase co-over-expression is capable of abrogating the lifespan extension by sod-2 
over-expression.  
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Figure 72 
The effect of catalase over-expression on the lifespan of sod-1 over-expressing 
animals was tested. An additional trial by Filipe Cabreiro using the same strains 
supported the overall findings of this trial.  
 
 
Genotype  n 
 
 
censored 
Mean 
Lifespan 
Median 
Lifespan 
% Change in 
mean  
[median] 
Log­
Rank p­
valuea 
Wilcoxon 
p­valuea 
               
rol­6(dm)  125  15  20.0  21       
wuIs151(ctl­1,2,3 (+))  235  180  20.6  21    0.1786a  0.3670a 
               
wuIs156(sod­2(+))  128  17  23.7  25       
wuIs151(ctl­1,2,3 (+)) 
wuIs156(sod­2(+))  106  24  23.8  25    0.5426a  0.6076a 
               
               Additional statistical tests               
rol­6 vs wuIs156        +19 [+19]  <0.0001 b  <0.0001 b   
wuIs151 vs  
wuIs151 wuIs156        +15 [+19]  0.0003 b  <0.0001 b   
               a calculated by comparing to corresponding ctl­1,2,3 (+) non‐over‐expressing control strain     b calculated by comparing to corresponding sod‐2 (+) non‐over‐expressing control strain     
 
Table 18 
This table contains data corresponding to Figure 72.   
As with sod-1, co-over-expression of ctl-1,2,3 in sod-2 does not eliminate the 
lifespan extension of sod-2 lines. Thus the data from catalase and sod over-
expression studies and the results of NAC treatment provide no evidence for a role of 
H2O2 in lifespan extension by sod over-expression.  
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6.2.3. Investigating possible DNA damage in SOD-1 over-expressing 
animals 
 
While creating the strains used to investigating the roles of daf-16, hsf-1 and 
aak-2 in the longevity of sod-1 over-expressing worms, I discovered that a large 
number of sod-1 over-expressing worms were sterile. This was only apparent during 
the process of crossing the strain into other genetic backgrounds because the sterility 
was not complete and strains are usually maintained by transferring a large number 
of adult worms onto fresh plates. The sterility of a fraction of them presumably went 
unnoticed because their non-sterile siblings produced enough progeny to maintain 
the strain. During a C. elegans cross, individual worms are frequently picked onto 
fresh plates to self-fertilise and produce progeny. During the cross to create the 
wuIs152 aak-2 line, for example, individual hermaphrodites of the F2 generation 
were isolated, allowed to lay eggs, and then genotyped for aak-2 in order to identify 
homozygotes of the aak-2 deletion. During this process, I noticed that some F2 
animals were sterile and decided to investigate this phenotype further.  
I was initially concerned that the sod-1 OE line had acquired a recessive 
mutation that caused sterility. Such a mutation could easily remain unnoticed in the 
genetic background since homozygous animals would not pass the mutation on and 
heterozygous ones would appear wild-type. However, after observing the strain for 
many generations and attempting several crosses, the pattern of inheritance of the 
sterility phenotype was not consistent with a recessive mutation causing sterility. For 
example, the severity of the trait was found to increase with passing generations, and 
there was marked variability in the number of sterile animals from different fertile 
parents.  
I investigated the possibility that the phenotype was not due to a separate 
mutation but was instead due to the SOD-1 over-expression itself. This alternative 
hypothesis was made with the knowledge that the sod-1 OE line shows an increase in 
oxidative damage of proteins (Cabreiro et al., 2011 -unpublished). If sod-1 over-
expression was causing damage to DNA as well, it is possible that this would cause 
an cumulative loss in fertility with passing generations. This phenotype has already 
been described in C. elegans and is called the MoRTal germline (Mrt) phenotype.  
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6.2.3.1. Introduction to the Mrt phenotype 
 
A number of genes have been found to be required for the maintenance of an 
immortal germline in C. elegans since their mutation causes a decrease in fertility 
with passing generations (the Mrt phenotype). These genes all have some role in the 
maintenance of DNA, with the best characterised of the Mrt genes having roles 
specifically in telomere maintenance. These include the C. elegans telomerase trt-1 
as well as hus-1, mrt-2 and hpr-17, all three of which are part of the 9-1-1 complex. 
This complex is recruited to sites of DNA damage has also been involved in the 
extension of telomeres (Ahmed and Hodgkin, 2000; Boerckel et al., 2007; Harris et 
al., 2006; Hofmann et al., 2002).  
rfs-1  is thought to play a role in the repair and reinitiation of stalled 
replication forks and is also involved in homologous recombination. The Mrt 
phenotype of rfs-1 mutants could also be related to telomeres, since recombination is 
thought to be one of the mechanisms by which they are extended (Yanowitz, 2008).  
The Mrt phenotypes of other genes have no obvious link to telomere 
maintenance. Besides being Mrt, him-6, dog-1 and msh-2 mutants also have an 
increased mutation rate, which suggests that the slow accumulation of mutations 
leads to eventual sterility (Cheung et al., 2002; Degtyareva et al., 2002; Grabowski et 
al., 2005; Youds et al., 2006). 
In Mrt mutants with impaired telomere maintenance (eg. trt-1 and mrt-2), the 
cause of sterility in is thought to be the dramatic changes in karyotype observed in 
these mutants. DAPI staining of the germline of mutants with impaired telomere 
maintenance reveals the occurrence of chromosome fusions, which leads to a gradual 
reduction in chromosome number with passing generations (Ahmed and Hodgkin, 
2000). These changes in chromosome number are likely to cause failures in mitosis 
and meiosis.  
 
6.2.3.2. Testing the Mrt hypothesis 
 
I decided to test whether sod-1 over-expression causes a Mrt phenotype by 
observing worms for many generation and looking for loss of fecundity. This was 
done by transferring single animals to new plates each generation, which prevented 
the sterility of single animals from being masked by the presence of their fertile 
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siblings. At each generation the size of the brood size was roughly evaluated by eye 
using four categories: wild-type, medium, small and sterile. In order to adequately 
assess whether sod-1 over-expression causes Mrt and to fully exclude the possibility 
of second-site mutations caused by the X-ray integration of the SOD-1 over-
expressing transgene, three separate extra-chromosomal arrays carrying multiple 
copies of the genomic sod-1(+) gene were used. 
A separate strain of worms carrying only the rol-6(su1006) co-injection 
marker in an extra-chromosomal array was used to control for this genetic 
background in the sod-1 over-expressors. Additionally, I considered the possibility 
that a sterility-inducing mutation (which could theoretically even be a Mrt mutation) 
had been present in the wild-type strain we used to generate all our sod-1 over-
expressing lines. Since the rol-6 control line was generated at a different time and 
may therefore not carry this hypothetical mutation, this would lead to incorrectly 
finding that sod-1 over-expression leads to a sterility phenotype. Because the sod-1 
over-expression array in these lines is extra-chromosomal, it is not inherited at a 
100% frequency. It was therefore possible to control for the genetic background by 
creating a line derived by picking non-transgenic (non-Rol) siblings of one of the 
sod-1 over-expressing lines. Over several months, these lines were therefore 
transferred every generation and brood sizes were evaluated. The workload on this 
project initially shared between Daniel Jones, an undergraduate summer project 
student, and me. In the later stages, the project was taken over by the post-doctoral 
researcher Caroline Araiz (Gems Lab, UCL).  
The results were initially encouraging, with all three extra-chromosomal sod-
1 over-expressing lines showing a large degree of sterility by generation 15 and all 
controls remaining fertile. However, by approximately generation 20, the rol-6 
control line began showing some sterility and eventually showed nearly as much as 
the sod-1 over-expressing lines. It is unknown what could be the cause of this 
sterility in the transgenic control worms, which only over-express a cuticle protein 
used as a co-injection marker, could be is unknown. Possibly, the presence of an 
extra-chromosomal repetitive array might itself cause genomic instability, although 
this has never been observed in this laboratory despite extensive use of multi-copy 
arrays. Whatever the cause, it became clear that we would be unable to distinguish 
the sterility caused by sod-1 over-expression from the sterility presumable being 
caused by the presence of any extra-chromosomal array.  
 234 
 
 
 
Figure 73 
Three lines over-expressing sod-1 were used and non-transgenic control animals 
from one of these lines were also tested (see GA228 non-Rol control) to control for 
the genetic background. The y-axis represents the fraction of lines being tested that 
are still viable at each generation.  
 
While the data does show an earlier onset of sterility in the strains over-
expressing sod-1, this result cannot be interpreted to indicate that sod-1 causes Mrt. 
The reason for this is that the assumed mechanism by which the Mrt phenotype 
occurs is through the accumulation of DNA damage, by telomere erosion or possibly 
through the accumulation of inherited mutations. If the rol-6 control line and the 
three sod-1 over-expressing lines had all been outcrossed several times to the same 
genetic background before this experiment was started, then one could have assumed 
that the earlier occurrence of sterility could be caused by a faster rate of 
accumulation of DNA damage. However, this was not done and therefore it is 
possible that the sod-1 over-expressing lines had already accumulated some DNA 
damage and were therefore further along the track to sterility, before the experiment 
had even begun. The experimental design therefore only allows us to ask whether the 
strains show a Mrt phenotype or not. The fact that the control, sod-1 non-over-
expressing, line does exhibit a Mrt phenotype makes the assay uninformative.  
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This outcome cannot be used to demonstrate that sod-1 over-expression does 
not cause DNA damage; we were simply unable to distinguish sterility caused sod-1 
over-expression from that caused by carrying a multi-copy array. There are few 
alternatives to multi-copy arrays for over-expression studies in C. elegans, so this 
problem is a very fundamental one and over-expression by other mean does not seem 
like a viable option. The experiments were therefore aborted after approximately 40 
generations.  Daniel Jones and I also looked for chromosomal fusion in late-
generation sod-1 over-expressing lines by DAPI–staining and microscopy but did not 
see any (data not shown).  
 
6.3. Chapter Discussion 
6.3.1. Overview of results  
The initial finding that led to the initiation of this project was that over-
expression of Cu/Zn SOD leads to an extension in lifespan. Given the large amounts 
of contradictory findings in the supplementation of C. elegans with anti-oxidants, the 
lack of an effect on lifespan when SOD enzymes were removed, and the inherent 
weakness of the large amount of correlative data, the fact that the up-regulation of an 
anti-oxidant enzyme leads to a lifespan extension seemed like a rare opportunity to 
test the oxidative stress theory directly.  
In light of the theory, the lifespan extension by sod-1 or sod-2 over-
expression could be explained by an increase in O2- detoxification and a subsequent 
reduction in oxidative damage to the cell. However, given the results from this study, 
this now seems unlikely. Moreover, Filipe Cabreiro found that sod-1 over-expression 
leads to increased production of H2O2 and increased levels of protein oxidation along 
with the already reported reduction in resistance to oxidative stress (Doonan et al., 
2008) (Cabreiro et al., 2011 -unpublished). The finding that these long-lived animals 
have  increased protein oxidation itself strongly argues against the theory.  
 
Instead, we were able to establish that the lifespan effect requires the actions 
of the transcription factor daf-16 and may also partially require hsf-1. This leads us to 
the intriguing possibility that the lifespan extension is due to a hormetic response: 
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low levels of stress caused by sod-1 over-expression lead to an activation of DAF-16 
(and possibly HSF-1), thereby causing a lifespan extension. Filipe Cabreiro was able 
to exclude the alternative possibility that sod-1 is no longer being effectively over-
expressed in a daf-16(mgDf50) mutant background by showing that SOD-1 
expression and activity were unaffected by this allele. This strongly suggests that 
SOD-1 activity is in fact affecting signalling in a way that activates DAF-16. This is 
not without precedent, as another interaction of SOD-1 with a signalling pathway 
was described in a recent study on the role of ROS in MAPK signalling in C. elegans 
oocyte maturation pathways (Yang et al., 2010). The authors find that ROS have a 
role in promoting phosphorylation of MPK-1 and that SOD-1 has a role attenuating 
this phosphorylation. The MnSOD genes sod-2 and sod-3 have also been reported to 
modulate the Age and Daf-c phenotype of IIS mutants, although the mechanisms by 
which this occurs remain unclear (Honda et al., 2008). Cu/Zn SOD  and Mn SOD 
over-expression can also extend lifespan in Drosophila (Sun and Tower, 1999). 
Interestingly, lifespan extension by Mn SOD over-expression has been shown to be 
associated with changes in the transcriptional profile that resemble those found in C. 
elegans when IIS is reduced. This suggests that a similar mechanism of lifespan 
extension by alteration in signalling may be occurring in SOD over-expressing flies 
as in worms (Curtis et al., 2007).  
While it is tempting to speculate that the mechanism of lifespan extension 
occurring through daf-16 is the same as the one occurring when IIS is reduced, there 
are however at least some signs that they are different. A separate study that 
investigated transcriptional changes in these same sod-1 over-expressing lines found 
that two well characterised daf-16 target genes (sod-3 and mtl-1 (Honda and Honda, 
1999)) were not significantly up-regulated (Back et al., 2010). Since reduced IIS 
leads to nuclear localisation of DAF-16::GFP transgenes (see Chapter 1), similar 
changes could be expected from sod-1 over-expression, if it was activating DAF-16. 
No obvious changes were observed in a DAF-16::GFP line carrying the wuIs152 
transgene. This is not too surprising, since daf-16–mediated increases in lifespan can 
occur without increases in DAF-16 localisation being detectable (Henderson and 
Johnson, 2001). These observations suggest that DAF-16 promotes longevity in sod-
1 and sod-2 over-expressing lines either by a mechanism distinct from that in IIS 
mutants or at least via an atypical activation that does not fully reiterate the 
transcriptional changes mediated by DAF-16 in IIS mutants.   
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The mechanism by which sod-1 over-expression affects signalling remains 
unidentified. Given the known role of DAF-16 in protection against H2O2  
(Weinkove et al., 2006) and the role of SODs in the formation of H2O2, we were 
intrigued by the possibility that SOD over-expression was leading to increased levels 
of H2O2, thus activating DAF-16 and extending lifespan. Despite a large amount of 
controversy about whether over-expression of SODs would lead to increased 
formation of H2O2 (Buettner et al., 2006; Liochev and Fridovich, 2007), we detected 
increased levels of H2O2 in lysates of worms over-expressing Cu/Zn SOD. While the 
in vitro nature of these assays may make them unsuitable for getting an accurate 
picture of the consequences of SOD over-expression within C.elegans cells, our 
collaborators (Vanfleteren group in Ghent, Belgium) were able to cross our sod-1 
over-expressing construct into a genetic background expressing an H2O2–sensitive 
fluorescent protein (Hyper). This in vivo assay allows them to ascertain that H2O2 
levels, which they found were slightly elevated in the over-expressing line (Cabreiro 
et al., 2011 -unpublished).   
We therefore proceeded to test whether H2O2 was in fact extending lifespan 
via DAF-16 by treating the transgenic animals with the anti-oxidant N-acetyl 
cysteine (NAC) and by co-over-expressing catalase. The aim of this approach was to 
reduce the elevated levels of H2O2 back to normal levels and to examine the effects 
on the extended sod-1 over-expressers. Neither of these approaches suppressed 
longevity, indicating that despite its elevated levels in SOD over-expressing worms, 
H2O2 may not be responsible for the daf-16–dependent lifespan extension. Other 
explanations are possible: the lack of specificity of NAC could make it unsuitable for 
use in this case and the increased levels of catalase may be insufficient to act as an 
sink for the excess H2O2 generated by SOD over-expression.  
In conclusion, this study demonstrates that the effect of sod-1 and sod-2 over-
expression on lifespan is unlikely to be a consequence of lowered levels of O2- and 
therefore of reduced oxidative damage. Instead, the lifespan extension is dependent 
on daf-16, which indicates that the over-expression may be causing alterations in 
signalling which activate a DAF-16-controlled longevity program.  The mechanism 
of this activation is still completely unknown. While we were able to detect that SOD 
over-expression causes elevated levels of H2O2 and DAF-16 is known to be 
responsive to H2O2, we currently have no evidence that DAF-16 activation by H2O2 
is responsible for the extended lifespan.  
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6.3.2. The implications for the oxidative stress theory of ageing  
The co-occurrence of a lifespan extension and of increased levels of protein 
carbonylation seems to itself argue against the oxidative stress theory of ageing. 
However, whilst an alternative explanation for the effect on lifespan was identified, 
what the increase in H2O2 and protein damage demonstrate in particular is that use of 
lines over-expressing SOD is not an informative test of the theory. In order to test 
whether ROS play a role in determining lifespan, we would need to artificially 
decrease the levels of oxidative stress and then examine effects on lifespan, which 
was the initial purpose of over-expressing Cu/Zn SOD. Finding that this over-
expression is not reducing, but increasing, the levels of damage, does not help us 
address the question.  It merely means that the lines do not fulfil the role that they 
initially were designed for.  
A lesson that could be drawn from this project, in which the over-expression 
of an anti-oxidant enzyme was found to increase, rather than decrease, oxidative 
damage to proteins, is that the effects of interfering with the cellular redox balance 
are hard to predict. Clearly, interventions used to reduce ROS need to be tested to 
confirm their efficacy, either using existing methods (eg. the oxy-blot) or through the 
development of  new techniques (eg. HyPer). This will allow for a more meaningful 
study of the effects of ROS levels on lifespan.    
6.3.3. What causes ageing?  
There is a great deal of new data on how interventions in ROS levels affect 
lifespan in C. elegans from various research groups. An in depth discussion of how 
this data affects the oxidative stress theory of ageing has been presented elsewhere 
(Gems and Doonan, 2009). Gems and Doonan list three possibilities concerning the 
validity of the oxidative stress theory of ageing in light of recent studies in C. 
elegans. Briefly, these possibilities are that: 1. The theory is broadly correct but the 
details need to be adjusted. In this “neo-oxidative damage theory”, oxidative stress 
and anti-oxidant defences remain the primary determinants of ageing, but O2- and 
SOD are not the critical forms of pro-oxidant and anti-oxidant activity. 2. The theory 
is a ‘half-truth’ and oxidative damage is one of many types of molecular damage that 
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lead to ageing. In this “molecular damage theory of ageing”, changes in lifespan 
could be achieved in a number of different ways, for example by alterations in the 
levels of phase I, II, and III detoxification systems, which would presumably reduce 
diverse sources of damage, thus extending lifespan (McElwee et al., 2004). Both 1. 
and 2. imply a weaker mechanistic link between ageing and the ‘rate of living’, since 
respiration would now only cause a fraction of the damage that leads to ageing. The 
last possibility is 3. The oxidative damage theory is wholly wrong: molecular 
damage is correlated with ageing, but not a cause of it.  
Concerning this last possibility, could it be that ageing is not caused by the 
accumulation of damage? Intuitively, it is easy to understand that the maintenance of 
any complex system requires high levels of investment in repair mechanisms and that 
these mechanisms can be more or less well suited for the job. Given the lack of 
selective pressure on providing systems that maintain organisms long past the age of 
reproduction, we may be right in thinking that the deterioration of our bodies, once 
they are past this age, is due to the changes that occur due to insufficient 
maintenance. A city, for example, is constantly being maintained: roads are re-paved, 
water pipes are replaced and old buildings are either expensively restored or replaced 
by new ones. Ageing organisms may therefore be like insufficiently maintained 
cities: as time passes, pipes begin leaking, buildings crumble and bridges collapse. It 
is an appealing idea that ageing is caused by the accumulation of some sort of 
damage, whether it takes place at a molecular level, or at the level of cells, tissues or 
organ systems.  
But what if ageing has nothing to do with damage? It is jarring to imagine 
how our familiarity with our physical world may be biasing our thinking of 
biological systems. We are used to objects decaying over time and man-made 
machines accumulating faults that eventually lead them to fail. In trying to explain 
ageing, we may simply be applying the intuition we have gained from our personal 
experiences to a sub-cellular world that we, as biologist, may sometimes believe to 
understand quite well, but whose physical realities are well beyond the limits of our 
‘common sense’. Intuitive explanations that, in retrospect, reveal more about the 
false preconceptions of the historical period in question and the lack of information 
available at the time can be found throughout the history of science. An example 
could be found in Aristotelian physics, which was taught for thousands of years but 
which described all matter as being made up of the five elements earth, air, fire, 
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water and aether. This now seems silly. In science, it may be prudent to be wary of 
our ‘common sense’. Clearly, damage does accumulate with age, but since we 
currently have no clear evidence that it is causing ageing, it might be advisable to 
adopt a conservative, or agnostic, attitude toward the question: What causes ageing? 
Answer: We don’t know.  
Without clear evidence, what can really be said about the possible causes of 
ageing? Theories of the evolution of ageing predict that selection acts more weakly 
on traits that occur after reproduction, and therefore that the deterioration in health 
late in life is unlikely to have been actively selected for during evolution. Instead, it 
is thought to be either the consequence of the lack of selection against changes that 
have deleterious effects late in life (mutation accumulation theory), or the selection 
for changes that have beneficial effects early in life, but deleterious ones late in life 
(antagonistic pleiotropy). Despite our ignorance of the mechanisms that may be 
causing ageing, we could thus conservatively state that ageing is caused by 
destructive forces. One of these may be oxidative stress (model 1., see above), or 
molecular damage in general (model 2.), or they could possibly even be completely 
unrelated to damage (model 3.). It has, for example, been proposed that the cause of 
ageing may be cellular hyper-function (Blagosklonny, 2008); this is a good example 
of a theory that does not rely on the steady accumulation of damage to explain 
ageing. Cancer could be seen as another example. Although cancers are initially 
caused by mutations (usually), which are a form of damage, the lethality of cancer is 
due to uncontrolled proliferation of tumour cells, another destructive force different 
from the slow accumulation of damage.  
The example of cancer helps illustrate the complexity of the task ahead: The 
frequency of cancer increases with age in humans, making it an important destructive 
force in human ageing. C. elegans, however, do not get cancer, so while the forces 
that cause ageing in C. elegans may also be relevant to humans, it is naive to think 
that we will be able to find a single destructive force that explains ageing in all 
organisms. In the search of a universal cause of ageing in organisms like C. elegans, 
we may identify forces that can lead to a deterioration of health with time, but the 
degree to which each force contributes to ageing can vary greatly from organism to 
organism. Thus, our focus should not solely lie in identifying a single cause of 
ageing, but in identifying which processes contribute to ageing and to test the extent 
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to which they contribute to the ageing-related pathologies that we are trying to cure 
in humans.  
 
These questions will undoubtedly be discussed for a long time. C. elegans is 
clearly an excellent model for testing theories of ageing, although the vast 
differences between worms and higher organisms need to be kept in mind. We may 
establish that O2- plays no role in C. elegans ageing only to later discover that it does 
play an important role elsewhere, so testing whether any mechanisms of ageing are 
public or private is clearly a priority. That said, if theories of ageing are to be tested 
directly, this will always need to be carried out in well defined biological systems. 
Demonstrating the veracity of a theory should require making specific predictions 
and testing them experimentally in such a way as to unambiguously verify or falsify 
the theory. Hopefully, experimental work on C. elegans and other organisms will 
help identify the causes of ageing and facilitate the development of treatments for 
human age-related disease.  
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Appendix 1 
 
 
The screen described in Chapter 3 was designed to identify RNAi treatments that 
lead to a reduction in the expression of a Pftn-1::gfp transgene from the induced 
levels seen in a daf-2 mutant.  However, a large number of treatments were also 
found to lead to increased expression.  
 
Gene mean % of control n st. dev. description 
     
aha-1 317.1 2 214.4 ortholog of human ARNT 
hif-1 309.5 2 94.9 hypoxia –inducible factor α homolog 
unc-62 258.2 3 87.9 enocodes Meis-class homeodomain protein 
irx-1 195.3 2 10.9 encodes homeodomain protein 
fkh-10 182.3 2 63.6 forkhead transcriptional regulator 
let-607 177.9 2 31.4 CREB/ATF family transcription factor 
ceh-60 177.8 2 17.1 PBX family of homeodomain transcription factors 
ceh-18 166.1 2 19.8 POU-class homeodomain transcription factor 
nhr-165 149.3 2 38.6 nuclear hormone receptor 
gei-17 148.6 2 9.0 encodes zinc finger protein 
pqn-21 148.5 2 14.3 contains Q/N-rich domain 
repo-1 146.2 2 26.1 putative splicing factor 
fkh-9 142.8 2 16.1 forkhead transcriptional regulator 
mep-1 142.0 2 14.1 encodes zinc finger protein 
ztf-23 139.7 2 14.9 encodes zinc finger protein 
Y60A9.3 137.1 2 7.6 encodes zinc finger protein 
pqn-75 136.9 2 18.7 contains Q/N-rich domain 
ztf-22 133.0 2 16.5 none available 
cey-4 131.9 2 6.9 encodes Y-box containing protein 
ceh-52 131.5 2 11.8 encodes homeobox protein 
tbx-36 131.3 2 10.8 T-box factor 
F47G4.6 130.7 2 4.6 none available 
ehn-3 130.3 2 20.5 encodes zinc finger protein 
nhr-7 128.3 2 9.9 nuclear hormone receptor 
nhr-265 127.2 2 14.1 nuclear hormone receptor 
nhr-141 127.2 2 13.4 nuclear hormone receptor 
klf-3 126.1 2 13.3 Krueppel -like factor 
isw-1 121.3 2 15.5 homolog of chromatin remodelling ATPase ISW1 
 
Table 19 
28 genes for which knockdown led to increased fluorescence of the Pftn-1::gfp rrf-
3(pk1426); daf-2(m577) strain, ranked in order of severity of effect of RNAi.   
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Appendix 2 
 
In order to quantify endogenous ftn-1 levels using qRT-PCR, the protocol 
under which worms were treated with RNAi needed to be altered. I therefore tested 
whether the suppression of Pftn-1::GFP by the various RNAi treatments still 
occurred under the new protocol. As clear from Figure A1 and Table A1 below, 
despite an increased baseline of GFP expression using protocol 2, the effects of the 
RNAi treatments remained very similar.  
 
 protocol 1  protocol 2 
      
RNAi target 
gene 
mean %  
of control n  
mean % 
of  control n 
      
L4440 100.0 17  100.0 5 
daf-16 30.2 17  15.9 5 
pqm-1 82.8 6  85.7 2 
T07C12.1 81.8 3  77.8 2 
hsf-1 64.9 5  47.2 4 
blmp-1 73.3 4  80.5 1 
mdl-1 62.1 5  67.2 1 
egr-1 86.0 4  52.9 1 
pbrm-1 74.6 4  61.3 3 
ada-2 65.8 5  59.7 3 
elt-2 73.0 4  47.9 1 
 
Table 20 
Data from Figure 74 displayed as percentage of control.  
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Figure 74 
Pftn-1::GFP daf-2(m577) treated with various RNAi using two different protocols. 
Error bars represent ±s.e.m.  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Appendix 3 
 
From my previous experience in working with this particular strain (GA303: 
rrf-3; daf-2 (see Figure 22 and Table 5)), I would not expect to see such any deaths 
at all (or very few) so early in the lifespan. In discussions with my colleague, he 
agreed that we use different criteria when establishing whether or not a worm is 
dead. I therefore reanalysed this lifespan experiment under the assumption that all 
worms that my colleague scored as dead on day 11 would have been scored as alive 
if I had scored them myself. This involves right-censoring of the data.  
 
 
Figure 75 
The effect of ada-2 and mdl-1 RNAi on rrf-3(pk1426); daf-2(m577) animals at 25oC.  
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This table contains data corresponding to Figure 75.  
 
After this modification, the lifespan curves now show a more typical 
rectangular shape. This reanalysis had no major effect on the interpretation of the 
treatment effects, with animals treated with RNAi of daf-16 and of mdl-1 still 
showing statistically significant lifespan reduction, while RNAi of ada-2 has no  
effect.  
lifespan assay was carried out on rrf-3(pk1426); daf-2(m577) animals at 25oC 
RNAi 
treatment  n 
 
 
censored 
Mean 
Lifespan 
Median 
Lifespan 
% Change in 
mean  
[median] 
Log-
Rank p-
valuea 
Wilcoxon 
p-valuea 
        
control  94 28 29.4 31    
daf-16  105 26 17.4 17 -41 [-45] <0.0001 <0.0001 
ada-2  87 41 28.4 31 none 0.2402 0.4307 
mdl-1 77 26 24.6 25 -16 [-19] <0.0001 <0.0001 
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Appendix 4 
 
 Loss of rrf-3 does not greatly affect the effect of most RNAi treatments on 
Pftn-1::gfp; daf-2 fluorescence.  
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